symbol,gene_id,diseaseid,score,evidencecount,name,parents,therapeuticareas
SLC1A1,ENSG00000106688,HP_0000407,0.3695798546847018,1,Sensorineural hearing impairment,[HP_0000364],[EFO_0000651]
SLC1A1,ENSG00000106688,MONDO_0009110,0.6193693187006689,127,dicarboxylic aminoaciduria,[MONDO_0019216],"[OTAR_0000018, OTAR_0000020]"
SLC1A1,ENSG00000106688,EFO_0004584,0.3833091376349009,3,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
SLC1A1,ENSG00000106688,MONDO_0005090,0.4581665820350356,41,schizophrenia,[EFO_0005407],"[MONDO_0002025, EFO_0000618]"
SLC1A1,ENSG00000106688,EFO_0005772,0.273097600529431,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC1A1,ENSG00000106688,GO_0097336,0.33158968476423145,1,response to risperidone,[GO_0050896],[GO_0008150]
SLC1A1,ENSG00000106688,GO_0097332,0.2638355133850253,1,response to antipsychotic drug,[GO_0050896],[GO_0008150]
SLC1A1,ENSG00000106688,Orphanet_183763,0.26609749537298527,1,Rare genetic intellectual disability with developmental anomaly,[Orphanet_183757],[OTAR_0000018]
SLC1A2,ENSG00000110436,MONDO_0016022,0.5089886542340023,37,early myoclonic encephalopathy,"[MONDO_0100022, MONDO_0015653, MONDO_0016801, MONDO_0000412]","[OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC1A2,ENSG00000110436,EFO_0004713,0.43711676763539786,3,FEV/FEC ratio,"[EFO_0006841, EFO_0003892]",[EFO_0001444]
SLC1A2,ENSG00000110436,EFO_0004705,0.43956650697304667,7,hypothyroidism,[EFO_1000627],[EFO_0001379]
SLC1A2,ENSG00000110436,EFO_0003779,0.31570407407987794,2,Hashimoto's thyroiditis,[EFO_0006812],"[EFO_0001379, EFO_0000540]"
SLC1A2,ENSG00000110436,EFO_0001379,0.28930216073853343,1,endocrine system disease,[],[EFO_0001379]
SLC1A2,ENSG00000110436,HP_0200134,0.42877167295671853,9,Epileptic encephalopathy,[HP_0001298],[EFO_0000651]
SLC1A2,ENSG00000110436,EFO_0007010,0.29017799886581325,1,drug use measurement,[EFO_0001444],[EFO_0001444]
SLC1A2,ENSG00000110436,EFO_0006812,0.29068093556653324,1,autoimmune thyroid disease,"[MONDO_0000569, EFO_0005140, MONDO_0004126]","[EFO_0001379, EFO_0000540]"
SLC1A2,ENSG00000110436,MONDO_0014916,0.7471603358638957,46,"developmental and epileptic encephalopathy, 41","[MONDO_0018614, MONDO_0016022, MONDO_0100455]","[OTAR_0000020, EFO_0000618, OTAR_0000018]"
SLC1A2,ENSG00000110436,EFO_0009933,0.37102215470698574,2,Thyroid preparation use measurement,[EFO_0007010],[EFO_0001444]
SLC1A2,ENSG00000110436,MONDO_0030922,0.3695798546847018,1,"intellectual disability, autosomal dominant 56",[MONDO_0015802],"[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC1A2,ENSG00000110436,EFO_1000627,0.28804494014445126,1,thyroid disease,[EFO_0001379],[EFO_0001379]
SLC1A2,ENSG00000110436,EFO_1001055,0.2876601212041999,1,myxedema,[EFO_0004705],[EFO_0001379]
SLC1A2,ENSG00000110436,MONDO_0005147,0.29798511934945116,2,type 1 diabetes mellitus,"[MONDO_0000569, MONDO_0000588, EFO_0000400]","[OTAR_0000020, EFO_0001379, EFO_0000540, EFO_0009605, EFO_0010282]"
SLC1A2,ENSG00000110436,EFO_0005772,0.45058506448180097,17,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC1A2,ENSG00000110436,MONDO_0044326,0.3695798546847018,1,developmental delay and seizures with or without movement abnormalities,[EFO_0010642],[EFO_0000618]
SLC1A2,ENSG00000110436,MONDO_0005148,0.4721780590012749,7,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC1A2,ENSG00000110436,EFO_0000400,0.29135024909991114,4,diabetes mellitus,"[EFO_0009406, MONDO_0001933]","[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC1A2,ENSG00000110436,MONDO_0018614,0.3695798546847018,1,undetermined early-onset epileptic encephalopathy,"[MONDO_0020071, MONDO_0020070, MONDO_0019216, MONDO_0015653]","[OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC1A2,ENSG00000110436,EFO_0004208,0.3680886840448125,2,Vitiligo,"[EFO_0005809, MONDO_0002406, EFO_0005140]","[EFO_0000540, EFO_0010285]"
SLC1A2,ENSG00000110436,MONDO_0100062,0.5089886542340023,37,developmental and epileptic encephalopathy,"[MONDO_0100022, MONDO_0100038, MONDO_0100500, EFO_0005917]","[OTAR_0000018, EFO_0000618]"
SLC1A3,ENSG00000079215,EFO_0020092,0.3695798546847018,1,neuroinflammatory disorder,"[EFO_0009386, MONDO_0002977]","[EFO_0000540, EFO_0000618]"
SLC1A3,ENSG00000079215,EFO_0010972,0.4175905774169733,2,blood phosphate measurement,[EFO_0001444],[EFO_0001444]
SLC1A3,ENSG00000079215,MONDO_0016227,0.41186272585298644,9,hereditary episodic ataxia,[EFO_0009671],"[OTAR_0000018, EFO_0000618]"
SLC1A3,ENSG00000079215,MONDO_0012982,0.746403713417869,124,episodic ataxia type 6,"[MONDO_0016227, MONDO_0019216]","[OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC1A3,ENSG00000079215,EFO_0004713,0.41719612643816084,2,FEV/FEC ratio,"[EFO_0006841, EFO_0003892]",[EFO_0001444]
SLC1A3,ENSG00000079215,EFO_0007986,0.37399117414498073,2,reticulocyte count,[EFO_0010700],[EFO_0001444]
SLC1A3,ENSG00000079215,EFO_0010700,0.30131467309503834,2,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
SLC1A3,ENSG00000079215,EFO_0004533,0.49976796720693517,6,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC1A3,ENSG00000079215,EFO_0009566,0.216773251817487,1,renal tubule disease,[EFO_0003086],[EFO_0009690]
SLC1A3,ENSG00000079215,EFO_1000638,0.46197481835587717,2,Isaacs syndrome,[EFO_0000618],[EFO_0000618]
SLC1A3,ENSG00000079215,EFO_0005772,0.4904755820981901,7,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC1A3,ENSG00000079215,GO_0007568,0.26883418577057583,1,aging,[GO_0032502],[GO_0008150]
SLC1A3,ENSG00000079215,MONDO_0001085,0.216773251817487,1,interstitial nephritis,[EFO_1002050],[EFO_0009690]
SLC1A3,ENSG00000079215,EFO_0004514,0.42170181674622936,2,bone quantitative ultrasound measurement,[EFO_0004516],[EFO_0001444]
SLC1A3,ENSG00000079215,EFO_0004695,0.27319463867978205,1,intraocular pressure measurement,[EFO_0004731],[EFO_0001444]
SLC1A3,ENSG00000079215,EFO_0007825,0.32463902069762146,1,balding measurement,[EFO_0007821],[EFO_0001444]
SLC1A3,ENSG00000079215,EFO_0007822,0.32776579299129643,1,hair colour measurement,[EFO_0007821],[EFO_0001444]
SLC1A3,ENSG00000079215,EFO_0009270,0.5091205095459538,7,heel bone mineral density,[EFO_0003923],[EFO_0001444]
SLC1A3,ENSG00000079215,EFO_0007620,0.2390137995774407,1,volumetric bone mineral density,[EFO_0004516],[EFO_0001444]
SLC1A4,ENSG00000115902,EFO_0000275,0.20412233917977327,2,atrial fibrillation,"[EFO_0004269, MONDO_0007263]",[EFO_0000319]
SLC1A4,ENSG00000115902,EFO_0000508,0.40813393302250595,14,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC1A4,ENSG00000115902,EFO_0004725,0.33154986242527446,2,metabolite measurement,[EFO_0001444],[EFO_0001444]
SLC1A4,ENSG00000115902,EFO_0004723,0.31419434428049686,1,coronary artery calcification,[HP_0001626],[EFO_0000651]
SLC1A4,ENSG00000115902,MONDO_0014725,0.791542578976847,41,spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome,[MONDO_0018162],"[OTAR_0000018, OTAR_0000020]"
SLC1A4,ENSG00000115902,EFO_0005664,0.39402042834091955,2,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC1A4,ENSG00000115902,EFO_0005653,0.39418540660231266,2,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC1A4,ENSG00000115902,EFO_0005571,0.24406468860104816,1,osteochondrodysplasia,[EFO_0005541],[OTAR_0000006]
SLC1A4,ENSG00000115902,EFO_0004747,0.3207188901140155,2,protein measurement,[EFO_0001444],[EFO_0001444]
SLC1A4,ENSG00000115902,EFO_0004327,0.2856912247653593,4,electrocardiography,[EFO_0004311],[EFO_0001444]
SLC1A4,ENSG00000115902,EFO_1002009,0.39497024977639295,2,macular telangiectasia type 2,[EFO_0003839],"[EFO_0000618, MONDO_0024458]"
SLC1A4,ENSG00000115902,EFO_0005134,0.3150838181581926,1,amino acid measurement,[EFO_0001444],[EFO_0001444]
SLC1A4,ENSG00000115902,EFO_0005090,0.25104243692474437,2,basophil count,"[EFO_0004872, EFO_0803539, EFO_0007987]",[EFO_0001444]
SLC1A4,ENSG00000115902,EFO_0004309,0.20479711981932117,1,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SLC1A4,ENSG00000115902,EFO_0006797,0.2447505073695434,1,neurofibrillary tangles measurement,[EFO_0004464],[EFO_0001444]
SLC1A4,ENSG00000115902,HP_0001249,0.3726180064123515,7,Intellectual disability,"[HP_0012759, HP_0100543]",[EFO_0000651]
SLC1A5,ENSG00000105281,EFO_0020092,0.21318654333935072,1,neuroinflammatory disorder,"[EFO_0009386, MONDO_0002977]","[EFO_0000540, EFO_0000618]"
SLC1A5,ENSG00000105281,MONDO_0002491,0.22812639083098013,1,substance abuse,[MONDO_0002494],[MONDO_0002025]
SLC1A5,ENSG00000105281,EFO_0007052,0.22812639083098013,1,antisocial behaviour measurement,[EFO_0006848],[EFO_0001444]
SLC1A5,ENSG00000105281,EFO_0004980,0.25240025146757333,1,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
SLC1A5,ENSG00000105281,EFO_0003888,0.22812639083098013,1,attention deficit hyperactivity disorder,[MONDO_0000592],"[MONDO_0002025, EFO_0000618]"
SLC1A5,ENSG00000105281,EFO_0004339,0.26689097885463525,1,body height,[EFO_0004324],[EFO_0001444]
SLC1A5,ENSG00000105281,EFO_0005772,0.4624426733837361,3,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC1A5,ENSG00000105281,EFO_0004611,0.23268460851686246,1,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
SLC1A6,ENSG00000105143,MONDO_0024622,0.2309874091779386,2,thyroid gland adenocarcinoma,"[EFO_0000228, EFO_0002892]","[MONDO_0045024, EFO_0001379]"
SLC1A6,ENSG00000105143,EFO_0005772,0.3481436512061995,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC1A7,ENSG00000162383,EFO_0011011,0.29161658154902986,1,sitting height measurement,[EFO_0004302],[EFO_0001444]
SLC1A7,ENSG00000162383,EFO_0008307,0.3017062851282371,2,tuberculin skin test reactivity measurement,[EFO_0001444],[EFO_0001444]
SLC1A7,ENSG00000162383,EFO_0004339,0.39570030280236307,5,body height,[EFO_0004324],[EFO_0001444]
SLC1A7,ENSG00000162383,EFO_0004518,0.28683206327506566,1,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC1A7,ENSG00000162383,EFO_0007814,0.4447629557005263,8,refractive error measurement,[EFO_0004731],[EFO_0001444]
SLC10A1,ENSG00000100652,EFO_0008496,0.27755447086821106,3,chronic hepatitis,[HP_0012115],[EFO_0000651]
SLC10A1,ENSG00000100652,EFO_0000763,0.3762984714609806,28,viral disease,[EFO_0005741],[EFO_0005741]
SLC10A1,ENSG00000100652,MONDO_0100327,0.3695798546847018,1,"hypercholanemia, familial",[MONDO_0019218],"[OTAR_0000018, OTAR_0000020]"
SLC10A2,ENSG00000125255,HP_0012450,0.5086598088084829,12,Chronic constipation,[HP_0002019],[EFO_0000651]
SLC10A2,ENSG00000125255,EFO_0010750,0.2817710066407129,2,PHF-tau measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
SLC10A2,ENSG00000125255,EFO_0003832,0.31789232014167523,1,gallbladder disease,[EFO_0009534],[EFO_0010282]
SLC10A2,ENSG00000125255,MONDO_0015762,0.39329593831644183,16,progressive familial intrahepatic cholestasis,"[MONDO_0017755, MONDO_0017290]","[OTAR_0000018, OTAR_0000020, EFO_0001379, EFO_0010282]"
SLC10A2,ENSG00000125255,MONDO_0011156,0.2673891769651083,2,progressive familial intrahepatic cholestasis type 2,"[MONDO_0011559, MONDO_0015762]","[OTAR_0000018, OTAR_0000020, EFO_0001379, EFO_0010282]"
SLC10A2,ENSG00000125255,MONDO_0017290,0.3718217158171121,5,familial intrahepatic cholestasis,"[MONDO_0019072, MONDO_0019052, MONDO_0015509]","[OTAR_0000018, OTAR_0000020, EFO_0001379, EFO_0010282]"
SLC10A2,ENSG00000125255,EFO_0005653,0.3250059082956457,1,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC10A2,ENSG00000125255,MONDO_0019852,0.4619748183558772,2,inherited primary ovarian failure,"[EFO_0004266, MONDO_0015514, MONDO_0016072]","[OTAR_0000017, OTAR_0000018, EFO_0001379]"
SLC10A2,ENSG00000125255,EFO_0004799,0.4683398344465596,7,cholelithiasis,"[MONDO_0700225, EFO_1000018]","[OTAR_0000018, EFO_0001379, EFO_0009690, EFO_0010282]"
SLC10A2,ENSG00000125255,EFO_0004340,0.23152192673922403,4,body mass index,[EFO_0004324],[EFO_0001444]
SLC10A2,ENSG00000125255,EFO_0009605,0.31789232014167523,1,pancreas disease,"[EFO_0001379, EFO_0010282]",[EFO_0009605]
SLC10A2,ENSG00000125255,EFO_0009534,0.31789232014167523,1,biliary tract disease,[EFO_0010284],[EFO_0010282]
SLC10A2,ENSG00000125255,EFO_1001870,0.2133849550828787,1,late-onset Alzheimers disease,[MONDO_0004975],"[MONDO_0002025, EFO_0000618]"
SLC10A2,ENSG00000125255,HP_0002019,0.36046098507571045,9,Constipation,[HP_0011458],[EFO_0000651]
SLC10A2,ENSG00000125255,MONDO_0007318,0.5274614575274774,28,Alagille syndrome,"[MONDO_0015161, EFO_0003966, MONDO_0015509, MONDO_0015214, EFO_0003777]","[OTAR_0000018, MONDO_0024458, EFO_0001379, EFO_0000319, EFO_0010282]"
SLC10A2,ENSG00000125255,MONDO_0001751,0.2920255742694064,24,cholestasis,[MONDO_0002887],[EFO_0010282]
SLC10A2,ENSG00000125255,EFO_0004614,0.33585375354009167,1,apolipoprotein A 1 measurement,"[EFO_0004872, EFO_0005278, EFO_0004732]",[EFO_0001444]
SLC10A2,ENSG00000125255,MONDO_0008892,0.25870589827929125,1,progressive familial intrahepatic cholestasis type 1,[MONDO_0015762],"[OTAR_0000018, OTAR_0000020, EFO_0001379, EFO_0010282]"
SLC10A2,ENSG00000125255,MONDO_0008867,0.34232817687881567,8,biliary atresia,"[EFO_1000400, MONDO_0001751, MONDO_0015213]","[OTAR_0000018, EFO_0001379, EFO_0010282]"
SLC10A2,ENSG00000125255,EFO_0004266,0.6052210408676193,15,primary ovarian insufficiency,"[EFO_0005771, EFO_0009003]","[OTAR_0000017, EFO_0001379]"
SLC10A2,ENSG00000125255,EFO_0004210,0.39367413204774393,2,gallstones,[EFO_0003832],[EFO_0010282]
SLC10A2,ENSG00000125255,EFO_0007937,0.3447758877291831,2,blood protein measurement,[EFO_0004747],[EFO_0001444]
SLC10A2,ENSG00000125255,HP_0000989,0.527743203677393,19,Pruritus,[HP_0000951],[EFO_0000651]
SLC10A2,ENSG00000125255,EFO_0004531,0.32208719684636206,1,urate measurement,[EFO_0001444],[EFO_0001444]
SLC10A3,ENSG00000126903,NA,NA,NA,NA,NA,NA
SLC10A4,ENSG00000145248,NA,NA,NA,NA,NA,NA
SLC10A5,ENSG00000253598,NA,NA,NA,NA,NA,NA
SLC10A6,ENSG00000145283,EFO_0006336,0.32508373560779336,1,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC10A6,ENSG00000145283,EFO_0004527,0.33232599910938176,2,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC10A7,ENSG00000120519,MONDO_0005351,0.2967009761887643,1,anorexia nervosa,[EFO_0005203],"[MONDO_0002025, OTAR_0000020, EFO_0000618]"
SLC10A7,ENSG00000120519,HP_0002652,0.3754862949810308,10,Skeletal dysplasia,[HP_0011842],[EFO_0000651]
SLC10A7,ENSG00000120519,EFO_0008328,0.3174715944596179,1,chronotype measurement,[EFO_0004870],[EFO_0001444]
SLC10A7,ENSG00000120519,HP_0004322,0.3695798546847018,1,Short stature,[HP_0001510],[EFO_0000651]
SLC10A7,ENSG00000120519,EFO_0004339,0.30721021865511183,1,body height,[EFO_0004324],[EFO_0001444]
SLC10A7,ENSG00000120519,EFO_0004340,0.4487069261765246,4,body mass index,[EFO_0004324],[EFO_0001444]
SLC10A7,ENSG00000120519,MONDO_0004985,0.2967009761887643,1,bipolar disorder,[EFO_0004247],"[MONDO_0002025, EFO_0000618]"
SLC10A7,ENSG00000120519,MONDO_0018230,0.3754862949810308,10,skeletal dysplasia,"[EFO_0000508, EFO_0004260]","[OTAR_0000006, OTAR_0000018]"
SLC10A7,ENSG00000120519,EFO_0004273,0.3695798546847018,1,scoliosis,[MONDO_0000836],[OTAR_0000006]
SLC11A1,ENSG00000018280,MONDO_0009061,0.37193592625831673,3,cystic fibrosis,"[EFO_1000017, EFO_0000684]","[OTAR_0000018, OTAR_0000010]"
SLC11A2,ENSG00000110911,MONDO_0008787,0.7668064344632407,114,microcytic anemia with liver iron overload,"[MONDO_0000104, MONDO_0016624, MONDO_0017763]","[OTAR_0000018, OTAR_0000020, EFO_0005803]"
SLC11A2,ENSG00000110911,HP_0004840,0.3695798546847018,1,Hypochromic microcytic anemia,[HP_0010972],[EFO_0000651]
SLC11A2,ENSG00000110911,EFO_0004528,0.22788144296870275,2,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC12A1,ENSG00000074803,HP_0001919,0.471342641061427,4,Acute kidney injury,[HP_0000083],[EFO_0000651]
SLC12A1,ENSG00000074803,HP_0011950,0.28129133384335636,3,Bronchiolitis,[HP_0002205],[EFO_0000651]
SLC12A1,ENSG00000074803,EFO_0003827,0.4342563292545246,2,pulmonary embolism,[MONDO_0000473],[EFO_0000319]
SLC12A1,ENSG00000074803,EFO_0003818,0.25870589827929125,1,lung disease,[EFO_0009433],[OTAR_0000010]
SLC12A1,ENSG00000074803,EFO_0000373,0.6078754625830471,117,congestive heart failure,[EFO_0003144],[EFO_0000319]
SLC12A1,ENSG00000074803,HP_0003124,0.25870589827929125,1,Hypercholesterolemia,[HP_0003119],[EFO_0000651]
SLC12A1,ENSG00000074803,EFO_0001645,0.25870589827929125,1,coronary artery disease,"[MONDO_0000473, EFO_0003777]",[EFO_0000319]
SLC12A1,ENSG00000074803,EFO_0001422,0.5973144912992426,34,cirrhosis of liver,"[EFO_0001421, EFO_0006890]","[EFO_0001379, MONDO_0045024, EFO_0010282]"
SLC12A1,ENSG00000074803,EFO_0000612,0.3695798546847018,1,myocardial infarction,[MONDO_0024643],[EFO_0000319]
SLC12A1,ENSG00000074803,EFO_0004255,0.6215935145752738,96,nephrotic syndrome,[MONDO_0002331],[EFO_0009690]
SLC12A1,ENSG00000074803,EFO_0004253,0.42205773018423154,6,nephrolithiasis,"[MONDO_0024647, EFO_0003086]",[EFO_0009690]
SLC12A1,ENSG00000074803,MONDO_0024664,0.38805884741893687,2,"hypertension, pregnancy-induced","[EFO_0009682, EFO_0000537]","[OTAR_0000014, EFO_0000319]"
SLC12A1,ENSG00000074803,EFO_0000712,0.3695798546847018,1,stroke,[EFO_0003763],"[EFO_0000618, EFO_0000319]"
SLC12A1,ENSG00000074803,EFO_0000537,0.6080616971479675,151,hypertension,[MONDO_0000473],[EFO_0000319]
SLC12A1,ENSG00000074803,MONDO_0100343,0.37022661943040003,3,antenatal Bartter syndrome,[MONDO_0015231],"[OTAR_0000018, EFO_0009690]"
SLC12A1,ENSG00000074803,EFO_0008583,0.25870589827929125,1,acute myocardial infarction,[EFO_0000612],[EFO_0000319]
SLC12A1,ENSG00000074803,EFO_0007990,0.20068768959507788,2,neutrophil percentage of leukocytes,[EFO_0004833],[EFO_0001444]
SLC12A1,ENSG00000074803,EFO_0000668,0.4544606952742481,5,preeclampsia,"[EFO_0000508, MONDO_0045048]","[OTAR_0000018, OTAR_0000014, EFO_0000319]"
SLC12A1,ENSG00000074803,EFO_0007009,0.379242287090866,9,skin pigmentation measurement,[EFO_0001444],[EFO_0001444]
SLC12A1,ENSG00000074803,EFO_0003758,0.27718489101352634,2,autism,[EFO_0003756],"[MONDO_0002025, EFO_0000618]"
SLC12A1,ENSG00000074803,EFO_0003144,0.5963441594344611,52,heart failure,[EFO_0003777],[EFO_0000319]
SLC12A1,ENSG00000074803,MONDO_0015231,0.6602210238063801,240,Bartter syndrome,"[EFO_1000647, MONDO_0015962]","[OTAR_0000018, EFO_0009690]"
SLC12A1,ENSG00000074803,EFO_0009840,0.25870589827929125,1,tachypnea,[EFO_0009838],[EFO_0000651]
SLC12A1,ENSG00000074803,EFO_0000319,0.5261379875719714,4,cardiovascular disease,[],[EFO_0000319]
SLC12A1,ENSG00000074803,EFO_0003086,0.6040236765924032,39,kidney disease,[EFO_0009690],[EFO_0009690]
SLC12A1,ENSG00000074803,EFO_0005772,0.2340084377847434,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC12A1,ENSG00000074803,EFO_1002048,0.4383627720843546,3,kidney failure,[EFO_0003086],[EFO_0009690]
SLC12A1,ENSG00000074803,MONDO_0005148,0.27436171156801814,4,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC12A1,ENSG00000074803,MONDO_0001567,0.35508349552897733,8,nephrocalcinosis,"[MONDO_0002123, EFO_0003086]","[OTAR_0000020, EFO_0009690]"
SLC12A1,ENSG00000074803,MONDO_0001134,0.25907547813397597,2,essential hypertension,"[EFO_0000537, MONDO_0005044]",[EFO_0000319]
SLC12A1,ENSG00000074803,EFO_0003914,0.25870589827929125,1,atherosclerosis,"[EFO_0009086, MONDO_0002277]",[EFO_0000319]
SLC12A1,ENSG00000074803,MONDO_0019091,0.38805884741893687,2,bronchopulmonary dysplasia,"[MONDO_0015930, MONDO_0015221]","[OTAR_0000018, OTAR_0000010]"
SLC12A1,ENSG00000074803,EFO_0007822,0.22300624683209122,7,hair colour measurement,[EFO_0007821],[EFO_0001444]
SLC12A1,ENSG00000074803,EFO_0000341,0.25870589827929125,1,chronic obstructive pulmonary disease,"[MONDO_0002567, EFO_0009910]",[OTAR_0000010]
SLC12A1,ENSG00000074803,EFO_0004587,0.37208471826502154,5,lymphocyte count,"[EFO_0006843, EFO_0004308, EFO_0803546]",[EFO_0001444]
SLC12A1,ENSG00000074803,EFO_0000401,0.37157343001751353,6,diabetic nephropathy,"[EFO_0000589, EFO_0003884]","[OTAR_0000020, EFO_0009690]"
SLC12A1,ENSG00000074803,EFO_0000400,0.38225607239787496,11,diabetes mellitus,"[EFO_0009406, MONDO_0001933]","[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC12A1,ENSG00000074803,EFO_0003884,0.5292511845423362,9,chronic kidney disease,[EFO_0003086],[EFO_0009690]
SLC12A1,ENSG00000074803,EFO_1001134,0.4619748183558772,2,pulmonary edema,[MONDO_0001208],[OTAR_0000010]
SLC12A1,ENSG00000074803,EFO_1000899,0.3695798546847018,1,diastolic heart failure,[EFO_0000373],[EFO_0000319]
SLC12A1,ENSG00000074803,EFO_0009795,0.2893285362699727,4,serum urea measurement,[EFO_0004742],[EFO_0001444]
SLC12A1,ENSG00000074803,EFO_0009690,0.4619748183558772,2,urinary system disease,[],[EFO_0009690]
SLC12A1,ENSG00000074803,EFO_0009662,0.25870589827929125,1,common wart,"[MONDO_0024666, MONDO_0024294, EFO_0000763]","[EFO_0005741, MONDO_0045024, EFO_0010285]"
SLC12A1,ENSG00000074803,EFO_0004531,0.341557637655689,3,urate measurement,[EFO_0001444],[EFO_0001444]
SLC12A2,ENSG00000064651,HP_0012736,0.25870589827929125,1,Profound global developmental delay,[HP_0001263],[EFO_0000651]
SLC12A2,ENSG00000064651,EFO_1001489,0.2710093940250835,1,skin and soft tissue Staphylococcus aureus infection,[EFO_0005681],[EFO_0005741]
SLC12A2,ENSG00000064651,MONDO_0002561,0.2641053504308255,1,lysosomal storage disease,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
SLC12A2,ENSG00000064651,MONDO_0004634,0.38863489558180886,3,vein disorder,[EFO_0004264],[EFO_0000319]
SLC12A2,ENSG00000064651,EFO_0005409,0.30700694904774056,2,fat body mass,[EFO_0004302],[EFO_0001444]
SLC12A2,ENSG00000064651,HP_0000407,0.3400134663099256,1,Sensorineural hearing impairment,[HP_0000364],[EFO_0000651]
SLC12A2,ENSG00000064651,EFO_0000508,0.4135987472393291,42,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC12A2,ENSG00000064651,HP_0002619,0.4205922158780789,5,Varicose veins,[HP_0002624],[EFO_0000651]
SLC12A2,ENSG00000064651,HP_0002566,0.3695798546847018,1,Intestinal malrotation,[HP_0002242],[EFO_0000651]
SLC12A2,ENSG00000064651,EFO_0004713,0.3807040521166292,3,FEV/FEC ratio,"[EFO_0006841, EFO_0003892]",[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0001379,0.26721876555284,1,endocrine system disease,[],[EFO_0001379]
SLC12A2,ENSG00000064651,EFO_0004995,0.42668185293155747,7,lean body mass,[EFO_0004302],[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0004980,0.3999918145569998,5,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0006335,0.35360578509846796,2,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0008446,0.27406199576681933,1,platelet-to-lymphocyte ratio,[EFO_0004503],[EFO_0001444]
SLC12A2,ENSG00000064651,MONDO_0033664,0.5485525553724485,42,Kilquist syndrome,[EFO_0000508],[OTAR_0000018]
SLC12A2,ENSG00000064651,EFO_0007352,0.3579637869021832,2,lymphatic system disease,"[EFO_0005803, MONDO_0044986]","[EFO_0000540, EFO_0005803]"
SLC12A2,ENSG00000064651,EFO_0003035,0.42373605803977415,4,cellulitis,"[EFO_1000774, MONDO_0024295]","[EFO_0005741, EFO_0010285]"
SLC12A2,ENSG00000064651,EFO_0004238,0.48859929607441405,20,hearing loss,[MONDO_0021945],"[MONDO_0002025, EFO_0000618]"
SLC12A2,ENSG00000064651,EFO_0009373,0.292990783324794,10,edema,[EFO_0000701],[EFO_0010285]
SLC12A2,ENSG00000064651,EFO_0004736,0.2740218374905541,1,aspartate aminotransferase measurement,"[EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0004735,0.41367729959190164,5,serum alanine aminotransferase measurement,"[EFO_0004582, EFO_0004747]",[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0001063,0.395685890927988,75,deafness,[EFO_0004238],"[MONDO_0002025, EFO_0000618]"
SLC12A2,ENSG00000064651,EFO_0007993,0.3667236606177774,2,lymphocyte percentage of leukocytes,[EFO_0004587],[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0007990,0.3705299680001316,2,neutrophil percentage of leukocytes,[EFO_0004833],[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0007988,0.2802748093323293,1,myeloid white cell count,[EFO_0004308],[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0007986,0.27705395256365206,1,reticulocyte count,[EFO_0010700],[EFO_0001444]
SLC12A2,ENSG00000064651,MONDO_0015159,0.3695798546847018,1,multiple congenital anomalies/dysmorphic syndrome-intellectual disability,[MONDO_0019042],[OTAR_0000018]
SLC12A2,ENSG00000064651,EFO_0004339,0.34652813007813493,8,body height,[EFO_0004324],[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0004338,0.20320780523248894,2,body weight,[EFO_0004324],[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0009946,0.2740218374905541,1,low density lipoprotein triglyceride measurement,"[EFO_0004530, EFO_0005278, EFO_0004732]",[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0010700,0.270871780886395,1,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0004343,0.2734352799359103,1,waist-hip ratio,[EFO_0007861],[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0004341,0.4242456269017256,4,body fat distribution,[EFO_0005106],[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0004536,0.34307537032094354,2,total blood protein measurement,[EFO_0004503],[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0004535,0.3968064543439441,3,serum albumin measurement,[EFO_0004747],[EFO_0001444]
SLC12A2,ENSG00000064651,HP_0002019,0.3695798546847018,1,Constipation,[HP_0011458],[EFO_0000651]
SLC12A2,ENSG00000064651,EFO_0004842,0.3877622690870956,5,eosinophil count,"[EFO_0803540, EFO_0007987]",[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0004838,0.354953617897505,2,calcium measurement,[EFO_0001444],[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0005772,0.2648445101401949,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC12A2,ENSG00000064651,EFO_0005763,0.32469953897763776,2,pulse pressure measurement,[EFO_0005278],[EFO_0001444]
SLC12A2,ENSG00000064651,MONDO_0019287,0.3695798546847018,1,ectodermal dysplasia syndrome,[MONDO_0021026],"[OTAR_0000018, EFO_0010285]"
SLC12A2,ENSG00000064651,MONDO_0033667,0.5012021966029392,42,Delpire-McNeill syndrome,[EFO_0000508],[OTAR_0000018]
SLC12A2,ENSG00000064651,MONDO_0033665,0.5172844485339017,38,"hearing loss, autosomal dominant 78",[MONDO_0019587],"[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC12A2,ENSG00000064651,MONDO_0005180,0.2641053504308255,1,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
SLC12A2,ENSG00000064651,EFO_0004696,0.473777636756874,10,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0004614,0.3467142432445357,2,apolipoprotein A 1 measurement,"[EFO_0004872, EFO_0005278, EFO_0004732]",[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0005091,0.27491239077337154,1,monocyte count,"[EFO_0004308, EFO_0803547]",[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0007800,0.39647596043772704,5,body fat percentage,[EFO_0005106],[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0007789,0.28430302778312755,3,BMI-adjusted waist circumference,[EFO_0004342],[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0007788,0.4006288971195275,3,BMI-adjusted waist-hip ratio,[EFO_0004343],[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0009270,0.34380727123616406,5,heel bone mineral density,[EFO_0003923],[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0009253,0.27871430756524956,2,Immature Reticulocyte Fraction Measurement,[EFO_0009233],[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0009188,0.5085204210305672,22,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0004612,0.40618404517631984,5,high density lipoprotein cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0004587,0.4462958567958535,7,lymphocyte count,"[EFO_0006843, EFO_0004308, EFO_0803546]",[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0004314,0.21806468294532674,1,forced expiratory volume,"[EFO_0003892, EFO_0006841]",[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0004312,0.37442849690460067,4,vital capacity,[EFO_0003892],[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0004308,0.2971741521482696,1,leukocyte count,[EFO_0004586],[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0000400,0.2675883454075247,2,diabetes mellitus,"[EFO_0009406, MONDO_0001933]","[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC12A2,ENSG00000064651,EFO_1001176,0.3403830461646103,2,sensorineural hearing loss,[EFO_0004238],"[MONDO_0002025, EFO_0000618]"
SLC12A2,ENSG00000064651,MONDO_0004975,0.2677514610194316,7,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
SLC12A2,ENSG00000064651,EFO_0007937,0.2682447511354265,1,blood protein measurement,[EFO_0004747],[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0007777,0.29132205815151657,1,base metabolic rate measurement,[EFO_0005115],[EFO_0001444]
SLC12A2,ENSG00000064651,EFO_0009805,0.26427862020185255,1,whole body water mass,[EFO_0004302],[EFO_0001444]
SLC12A2,ENSG00000064651,HP_0001249,0.4919518510136364,4,Intellectual disability,"[HP_0012759, HP_0100543]",[EFO_0000651]
SLC12A2,ENSG00000064651,MONDO_0005301,0.2650293000675372,2,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
SLC12A3,ENSG00000070915,HP_0012664,0.4619748183558772,2,Reduced left ventricular ejection fraction,[HP_0011025],[EFO_0000651]
SLC12A3,ENSG00000070915,EFO_1001496,0.25981463784334535,2,Autosomal dominant polycystic kidney disease,"[Orphanet_98056, MONDO_0000426, EFO_0008620]","[OTAR_0000018, EFO_0009690]"
SLC12A3,ENSG00000070915,EFO_0020092,0.23075528408889046,1,neuroinflammatory disorder,"[EFO_0009386, MONDO_0002977]","[EFO_0000540, EFO_0000618]"
SLC12A3,ENSG00000070915,EFO_0000373,0.6058365043672552,133,congestive heart failure,[EFO_0003144],[EFO_0000319]
SLC12A3,ENSG00000070915,EFO_0000195,0.3860749979896257,8,metabolic syndrome,[EFO_0000589],[OTAR_0000020]
SLC12A3,ENSG00000070915,EFO_0000508,0.5343915306346895,60,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC12A3,ENSG00000070915,HP_0003326,0.3695798546847018,2,Myalgia,[HP_0025142],[EFO_0000651]
SLC12A3,ENSG00000070915,HP_0003124,0.3682965913003799,4,Hypercholesterolemia,[HP_0003119],[EFO_0000651]
SLC12A3,ENSG00000070915,HP_0002900,0.37610442494294205,80,Hypokalemia,[HP_0003111],[EFO_0000651]
SLC12A3,ENSG00000070915,EFO_0003777,0.3733064515527725,6,heart disease,[EFO_0000319],[EFO_0000319]
SLC12A3,ENSG00000070915,EFO_0001645,0.36757846925848364,6,coronary artery disease,"[MONDO_0000473, EFO_0003777]",[EFO_0000319]
SLC12A3,ENSG00000070915,EFO_0001422,0.4644284179467007,5,cirrhosis of liver,"[EFO_0001421, EFO_0006890]","[EFO_0001379, MONDO_0045024, EFO_0010282]"
SLC12A3,ENSG00000070915,EFO_0000612,0.5963050076068013,30,myocardial infarction,[MONDO_0024643],[EFO_0000319]
SLC12A3,ENSG00000070915,EFO_0004255,0.6205375554336953,115,nephrotic syndrome,[MONDO_0002331],[EFO_0009690]
SLC12A3,ENSG00000070915,EFO_0004253,0.26787147867547184,2,nephrolithiasis,"[MONDO_0024647, EFO_0003086]",[EFO_0009690]
SLC12A3,ENSG00000070915,EFO_1001375,0.25870589827929125,1,Myocardial Ischemia,"[MONDO_0005053, EFO_0001645, MONDO_0024643]",[EFO_0000319]
SLC12A3,ENSG00000070915,EFO_0000537,0.6186949215623693,930,hypertension,[MONDO_0000473],[EFO_0000319]
SLC12A3,ENSG00000070915,EFO_0009373,0.569067134332723,9,edema,[EFO_0000701],[EFO_0010285]
SLC12A3,ENSG00000070915,EFO_0000668,0.5749009981546056,11,preeclampsia,"[EFO_0000508, MONDO_0045048]","[OTAR_0000018, OTAR_0000014, EFO_0000319]"
SLC12A3,ENSG00000070915,EFO_0003763,0.25870589827929125,1,cerebrovascular disorder,"[EFO_0005774, MONDO_0043218]","[EFO_0000618, EFO_0000319]"
SLC12A3,ENSG00000070915,EFO_0003144,0.5852541774732233,19,heart failure,[EFO_0003777],[EFO_0000319]
SLC12A3,ENSG00000070915,MONDO_0015231,0.5211964475360316,39,Bartter syndrome,"[EFO_1000647, MONDO_0015962]","[OTAR_0000018, EFO_0009690]"
SLC12A3,ENSG00000070915,HP_0001324,0.3695798546847018,2,Muscle weakness,[HP_0011804],[EFO_0000651]
SLC12A3,ENSG00000070915,EFO_0000319,0.5905185152815663,20,cardiovascular disease,[],[EFO_0000319]
SLC12A3,ENSG00000070915,MONDO_0002462,0.5511872888339344,6,glomerulonephritis,"[EFO_1002050, EFO_1002049]",[EFO_0009690]
SLC12A3,ENSG00000070915,MONDO_0009904,0.8482270830229837,837,Gitelman syndrome,"[EFO_1000647, MONDO_0015962]","[OTAR_0000018, EFO_0009690]"
SLC12A3,ENSG00000070915,MONDO_0005148,0.5372679763094738,28,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC12A3,ENSG00000070915,MONDO_0001909,0.4619748183558772,2,renal tubular acidosis,"[EFO_1000647, EFO_0009566, EFO_1000014]","[OTAR_0000020, EFO_0009690, EFO_0005803]"
SLC12A3,ENSG00000070915,MONDO_0001134,0.5889991172325839,36,essential hypertension,"[EFO_0000537, MONDO_0005044]",[EFO_0000319]
SLC12A3,ENSG00000070915,EFO_0003918,0.3695798546847018,1,obstructive sleep apnea,[EFO_0003877],"[MONDO_0002025, EFO_0000618, OTAR_0000010]"
SLC12A3,ENSG00000070915,EFO_0003914,0.3531438172583071,5,atherosclerosis,"[EFO_0009086, MONDO_0002277]",[EFO_0000319]
SLC12A3,ENSG00000070915,EFO_0003913,0.5783838386125503,12,angina pectoris,[HP_0001626],[EFO_0000651]
SLC12A3,ENSG00000070915,EFO_0000401,0.39165108466389326,18,diabetic nephropathy,"[EFO_0000589, EFO_0003884]","[OTAR_0000020, EFO_0009690]"
SLC12A3,ENSG00000070915,EFO_0000400,0.4451630716047333,12,diabetes mellitus,"[EFO_0009406, MONDO_0001933]","[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC12A3,ENSG00000070915,EFO_0004278,0.3233823728491141,2,sudden cardiac arrest,[EFO_0009492],[EFO_0000319]
SLC12A3,ENSG00000070915,EFO_0003884,0.6115690309219273,131,chronic kidney disease,[EFO_0003086],[EFO_0009690]
SLC12A4,ENSG00000124067,HP_0001626,0.3912712868882814,15,Abnormality of the cardiovascular system,[HP_0000118],[EFO_0000651]
SLC12A4,ENSG00000124067,EFO_0020092,0.20848987331076244,1,neuroinflammatory disorder,"[EFO_0009386, MONDO_0002977]","[EFO_0000540, EFO_0000618]"
SLC12A4,ENSG00000124067,MONDO_0002561,0.28806293466293487,2,lysosomal storage disease,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
SLC12A4,ENSG00000124067,Orphanet_79293,0.3326218692162316,1,Familial LCAT deficiency,"[MONDO_0019052, Orphanet_182043, MONDO_0018999]","[OTAR_0000018, OTAR_0000020, EFO_0005803]"
SLC12A4,ENSG00000124067,Orphanet_79292,0.4601269190824538,4,Fish-eye disease,[MONDO_0018999],[OTAR_0000020]
SLC12A4,ENSG00000124067,MONDO_0009515,0.41967845720862806,3,Norum disease,"[MONDO_0018999, MONDO_0001822]","[OTAR_0000018, OTAR_0000020]"
SLC12A4,ENSG00000124067,EFO_0005772,0.30991838429069546,3,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC12A4,ENSG00000124067,MONDO_0005180,0.28806293466293487,2,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
SLC12A4,ENSG00000124067,MONDO_0018999,0.3326218692162316,1,LCAT deficiency,[MONDO_0017773],[OTAR_0000020]
SLC12A4,ENSG00000124067,EFO_0004612,0.27723958360613965,32,high density lipoprotein cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
SLC12A4,ENSG00000124067,MONDO_0004975,0.28898688429964664,3,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
SLC12A4,ENSG00000124067,MONDO_0005301,0.28806293466293487,2,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
SLC12A5,ENSG00000124140,EFO_0005917,0.5851745966453131,31,generalised epilepsy,[MONDO_0015653],"[OTAR_0000018, EFO_0000618]"
SLC12A5,ENSG00000124140,MONDO_0017385,0.6551630088625363,719,malignant migrating partial seizures of infancy,[MONDO_0020070],[EFO_0000618]
SLC12A5,ENSG00000124140,EFO_0008328,0.23338086887776022,1,chronotype measurement,[EFO_0004870],[EFO_0001444]
SLC12A5,ENSG00000124140,EFO_0008579,0.2098302537301092,1,risk-taking behaviour,[GO_0007610],[GO_0008150]
SLC12A5,ENSG00000124140,EFO_0004533,0.23718528630680139,3,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC12A5,ENSG00000124140,EFO_0005772,0.3501793568989099,7,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC12A5,ENSG00000124140,EFO_0007869,0.26326048508865935,2,wellbeing measurement,[EFO_0006848],[EFO_0001444]
SLC12A5,ENSG00000124140,MONDO_0100062,0.5636919948280726,719,developmental and epileptic encephalopathy,"[MONDO_0100022, MONDO_0100038, MONDO_0100500, EFO_0005917]","[OTAR_0000018, EFO_0000618]"
SLC12A6,ENSG00000140199,HP_0000369,0.26609749537298527,1,Low-set ears,[HP_0000377],[EFO_0000651]
SLC12A6,ENSG00000140199,HP_0000316,0.26609749537298527,1,Hypertelorism,[HP_0000478],[EFO_0000651]
SLC12A6,ENSG00000140199,EFO_0000508,0.4696072630268168,73,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC12A6,ENSG00000140199,HP_0004209,0.26609749537298527,1,Clinodactyly of the 5th finger,[HP_0040019],[EFO_0000651]
SLC12A6,ENSG00000140199,HP_0001274,0.26646707522767,2,Agenesis of corpus callosum,[HP_0007370],[EFO_0000651]
SLC12A6,ENSG00000140199,EFO_0004584,0.2749422112520721,4,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
SLC12A6,ENSG00000140199,EFO_0003100,0.33586743515691103,22,peripheral neuropathy,"[EFO_0009387, EFO_1001902]",[EFO_0000618]
SLC12A6,ENSG00000140199,HP_0001999,0.26609749537298527,1,Abnormal facial shape,[HP_0000271],[EFO_0000651]
SLC12A6,ENSG00000140199,MONDO_0000902,0.7692528798093163,350,agenesis of the corpus callosum with peripheral neuropathy,[EFO_0005772],[EFO_0000618]
SLC12A6,ENSG00000140199,Orphanet_1496,0.663291723170903,351,Corpus callosum agenesis - neuronopathy,"[Orphanet_269573, Orphanet_207012]","[OTAR_0000006, OTAR_0000018]"
SLC12A7,ENSG00000113504,EFO_0009390,0.2378425569056094,1,sum of neutrophil and eosinophil counts,[EFO_0007987],[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0009388,0.23753756988701763,1,sum of basophil and neutrophil counts,[EFO_0007987],[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0004833,0.3683556929101265,5,neutrophil count,"[EFO_0803548, EFO_0007987]",[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0007990,0.2030542330064674,1,neutrophil percentage of leukocytes,[EFO_0004833],[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0007988,0.29599244034819083,2,myeloid white cell count,[EFO_0004308],[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0007987,0.23773529928238635,1,granulocyte count,[EFO_0007988],[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0010701,0.3156392877438954,2,mean reticulocyte volume,[EFO_0010700],[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0010700,0.35223102652643007,3,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0004584,0.47645988563542024,12,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0004570,0.273006315529046,1,bilirubin measurement,[EFO_0001444],[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0004541,0.2525114301951163,1,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0004526,0.4749558242349513,17,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0004509,0.38241105211687476,9,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0009253,0.2895891062715183,1,Immature Reticulocyte Fraction Measurement,[EFO_0009233],[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0009188,0.6964496193763694,78,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0004309,0.42932055113830875,5,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0004308,0.35364207305874956,4,leukocyte count,[EFO_0004586],[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0004305,0.40301324551819373,8,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0007985,0.307975682101521,2,platelet crit,[EFO_0005036],[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0007984,0.3586668867600463,5,platelet component distribution width,[EFO_0005036],[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0007978,0.29219564384668,2,red blood cell density measurement,[EFO_0005047],[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0007629,0.25641403042723715,1,hemoglobin A1 measurement,[EFO_0004509],[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0004528,0.5433303847711939,24,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC12A7,ENSG00000113504,EFO_0004527,0.3828653017300903,4,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC12A8,ENSG00000221955,EFO_0007352,0.30111814426250916,1,lymphatic system disease,"[EFO_0005803, MONDO_0044986]","[EFO_0000540, EFO_0005803]"
SLC12A8,ENSG00000221955,EFO_0004735,0.4408870364098441,4,serum alanine aminotransferase measurement,"[EFO_0004582, EFO_0004747]",[EFO_0001444]
SLC12A8,ENSG00000221955,EFO_0007986,0.4478957937663924,4,reticulocyte count,[EFO_0010700],[EFO_0001444]
SLC12A8,ENSG00000221955,EFO_0009924,0.3139267839823521,1,Drugs used in diabetes use measurement,[EFO_0007010],[EFO_0001444]
SLC12A8,ENSG00000221955,EFO_0010736,0.4220211468804983,3,cortical surface area measurement,[EFO_0004464],[EFO_0001444]
SLC12A8,ENSG00000221955,EFO_0010701,0.2281150901202154,2,mean reticulocyte volume,[EFO_0010700],[EFO_0001444]
SLC12A8,ENSG00000221955,EFO_0010700,0.3882067853980454,2,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
SLC12A8,ENSG00000221955,EFO_0004346,0.3790015579406766,2,neuroimaging measurement,[EFO_0001444],[EFO_0001444]
SLC12A8,ENSG00000221955,EFO_0004541,0.39388663717750916,2,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
SLC12A8,ENSG00000221955,EFO_0004840,0.3882975104999644,2,cortical thickness,[EFO_0004464],[EFO_0001444]
SLC12A8,ENSG00000221955,MONDO_0005148,0.46833631358859584,6,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC12A8,ENSG00000221955,EFO_0004526,0.4113926571057866,5,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC12A8,ENSG00000221955,EFO_0004464,0.3888901204333267,2,brain measurement,[EFO_0001444],[EFO_0001444]
SLC12A8,ENSG00000221955,MONDO_0004867,0.302291039085037,1,upper respiratory tract disorder,[EFO_0000684],[OTAR_0000010]
SLC12A8,ENSG00000221955,EFO_0007924,0.38276259088677506,2,tonsillectomy risk measurement,[EFO_0001444],[EFO_0001444]
SLC12A8,ENSG00000221955,EFO_0007629,0.3139267839823521,1,hemoglobin A1 measurement,[EFO_0004509],[EFO_0001444]
SLC12A8,ENSG00000221955,EFO_0007429,0.30455646812021037,1,peritonsillar abscess,"[MONDO_0044986, MONDO_0020592, EFO_0000771, EFO_0003030]","[EFO_0000540, EFO_0005741, OTAR_0000010]"
SLC12A9,ENSG00000146828,EFO_0007822,0.5903639908188743,13,hair colour measurement,[EFO_0007821],[EFO_0001444]
SLC13A1,ENSG00000081800,EFO_0011011,0.45458916829943485,10,sitting height measurement,[EFO_0004302],[EFO_0001444]
SLC13A1,ENSG00000081800,EFO_0005772,0.3373353059126001,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC13A2,ENSG00000007216,NA,NA,NA,NA,NA,NA
SLC13A3,ENSG00000158296,EFO_0020092,0.3574585685951717,1,neuroinflammatory disorder,"[EFO_0009386, MONDO_0002977]","[EFO_0000540, EFO_0000618]"
SLC13A3,ENSG00000158296,MONDO_0002561,0.21005092542662018,1,lysosomal storage disease,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
SLC13A3,ENSG00000158296,EFO_0005208,0.2756258775588658,1,glomerular filtration rate,[EFO_0004742],[EFO_0001444]
SLC13A3,ENSG00000158296,EFO_0005653,0.39196973483895187,2,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC13A3,ENSG00000158296,EFO_0010262,0.5926802642488813,10,"leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate",[EFO_1000017],[OTAR_0000018]
SLC13A3,ENSG00000158296,EFO_0005772,0.42209258604135685,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC13A3,ENSG00000158296,MONDO_0005180,0.21097487506333193,2,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
SLC13A3,ENSG00000158296,EFO_0004464,0.2953232146798584,1,brain measurement,[EFO_0001444],[EFO_0001444]
SLC13A3,ENSG00000158296,EFO_0003884,0.28633829508550745,3,chronic kidney disease,[EFO_0003086],[EFO_0009690]
SLC13A3,ENSG00000158296,MONDO_0004975,0.21005092542662018,1,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
SLC13A3,ENSG00000158296,MONDO_0005301,0.21005092542662018,1,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
SLC13A4,ENSG00000164707,EFO_0011011,0.29136767953941856,1,sitting height measurement,[EFO_0004302],[EFO_0001444]
SLC13A4,ENSG00000164707,EFO_0004526,0.2423950305897043,10,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC13A4,ENSG00000164707,EFO_0007978,0.27132150043638537,2,red blood cell density measurement,[EFO_0005047],[EFO_0001444]
SLC13A4,ENSG00000164707,EFO_0004527,0.21460560505587678,5,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC13A5,ENSG00000141485,MONDO_0009185,0.36994943453938645,2,amelocerebrohypohidrotic syndrome,[MONDO_0019287],"[OTAR_0000018, EFO_0010285]"
SLC13A5,ENSG00000141485,EFO_0000508,0.46614996705682404,67,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC13A5,ENSG00000141485,EFO_0005664,0.33629605080307756,2,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC13A5,ENSG00000141485,HP_0200134,0.3273174405703324,22,Epileptic encephalopathy,[HP_0001298],[EFO_0000651]
SLC13A5,ENSG00000141485,EFO_0004747,0.2664789765282559,1,protein measurement,[EFO_0001444],[EFO_0001444]
SLC13A5,ENSG00000141485,Orphanet_100031,0.3695798546847018,1,Hypoplastic amelogenesis imperfecta,[Orphanet_164001],[OTAR_0000018]
SLC13A5,ENSG00000141485,MONDO_0030922,0.3695798546847018,1,"intellectual disability, autosomal dominant 56",[MONDO_0015802],"[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC13A5,ENSG00000141485,EFO_0004838,0.38317363450681957,4,calcium measurement,[EFO_0001444],[EFO_0001444]
SLC13A5,ENSG00000141485,MONDO_0044326,0.3695798546847018,1,developmental delay and seizures with or without movement abnormalities,[EFO_0010642],[EFO_0000618]
SLC13A5,ENSG00000141485,EFO_0005134,0.2664789765282559,1,amino acid measurement,[EFO_0001444],[EFO_0001444]
SLC13A5,ENSG00000141485,MONDO_0018614,0.6600094966192821,536,undetermined early-onset epileptic encephalopathy,"[MONDO_0020071, MONDO_0020070, MONDO_0019216, MONDO_0015653]","[OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC13A5,ENSG00000141485,EFO_0003884,0.25981463784334535,2,chronic kidney disease,[EFO_0003086],[EFO_0009690]
SLC13A5,ENSG00000141485,MONDO_0100062,0.569052098160347,541,developmental and epileptic encephalopathy,"[MONDO_0100022, MONDO_0100038, MONDO_0100500, EFO_0005917]","[OTAR_0000018, EFO_0000618]"
SLC13A5,ENSG00000141485,EFO_0009700,0.2710408289456708,1,visual perception measurement,[EFO_0004464],[EFO_0001444]
SLC13A5,ENSG00000141485,HP_0001263,0.2661545662943509,13,Global developmental delay,[HP_0012758],[EFO_0000651]
SLC13A5,ENSG00000141485,HP_0001250,0.25870589827929125,1,Seizure,[HP_0012638],[EFO_0000651]
SLC14A1,ENSG00000141469,EFO_0010750,0.2908429785068554,1,PHF-tau measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
SLC14A1,ENSG00000141469,EFO_0007986,0.4094352758176924,3,reticulocyte count,[EFO_0010700],[EFO_0001444]
SLC14A1,ENSG00000141469,EFO_0010701,0.3433429581549334,2,mean reticulocyte volume,[EFO_0010700],[EFO_0001444]
SLC14A1,ENSG00000141469,EFO_0010700,0.3998993538768929,3,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
SLC14A1,ENSG00000141469,EFO_0004348,0.42702148648875476,6,hematocrit,[EFO_0004503],[EFO_0001444]
SLC14A1,ENSG00000141469,MONDO_0004986,0.3952708516783759,13,urinary bladder carcinoma,"[EFO_0000313, MONDO_0001187]","[EFO_0009690, MONDO_0045024]"
SLC14A1,ENSG00000141469,EFO_0004526,0.32891643885111016,1,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC14A1,ENSG00000141469,EFO_0009253,0.4076337321479405,3,Immature Reticulocyte Fraction Measurement,[EFO_0009233],[EFO_0001444]
SLC14A1,ENSG00000141469,EFO_0006797,0.2468368652978816,1,neurofibrillary tangles measurement,[EFO_0004464],[EFO_0001444]
SLC14A1,ENSG00000141469,EFO_0009795,0.297115635695115,5,serum urea measurement,[EFO_0004742],[EFO_0001444]
SLC14A1,ENSG00000141469,EFO_0004528,0.4902666482346361,6,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC14A2,ENSG00000132874,MONDO_0002491,0.2008902460240651,1,substance abuse,[MONDO_0002494],[MONDO_0002025]
SLC14A2,ENSG00000132874,EFO_0007052,0.2008902460240651,1,antisocial behaviour measurement,[EFO_0006848],[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0004191,0.42175570867813705,3,androgenetic alopecia,"[MONDO_0021208, MONDO_0021034, Orphanet_68346]","[OTAR_0000018, EFO_0010285]"
SLC14A2,ENSG00000132874,HP_0000545,0.31846008723572966,1,Myopia,[HP_0000539],[EFO_0000651]
SLC14A2,ENSG00000132874,HP_0000539,0.3146789971801745,1,Abnormality of refraction,[HP_0000478],[EFO_0000651]
SLC14A2,ENSG00000132874,EFO_0004713,0.4543471494387845,3,FEV/FEC ratio,"[EFO_0006841, EFO_0003892]",[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0006336,0.26278929170999,2,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0006335,0.3702001834356375,6,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0003888,0.2008902460240651,1,attention deficit hyperactivity disorder,[MONDO_0000592],"[MONDO_0002025, EFO_0000618]"
SLC14A2,ENSG00000132874,EFO_0008354,0.26957061308378333,1,cognitive function measurement,[EFO_0001444],[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0000305,0.4939403212650214,6,breast carcinoma,"[EFO_0000313, MONDO_0007254]","[OTAR_0000017, MONDO_0045024, EFO_0010285]"
SLC14A2,ENSG00000132874,EFO_0004784,0.43084313809679226,4,self reported educational attainment,[EFO_0011015],[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0004761,0.33250350338839535,3,uric acid measurement,"[EFO_0004742, EFO_0004298]",[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0004741,0.31920820654792437,5,blood urea nitrogen measurement,[EFO_0009795],[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0004339,0.3156680587244613,3,body height,[EFO_0004324],[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0004348,0.4384976183417952,6,hematocrit,[EFO_0004503],[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0004340,0.4641658515004573,10,body mass index,[EFO_0004324],[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0004847,0.31846008723572966,1,age at onset,[EFO_0000246],[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0005772,0.26132288937807474,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC14A2,ENSG00000132874,EFO_0005763,0.36051218736257956,6,pulse pressure measurement,[EFO_0005278],[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0004518,0.3390615913612797,2,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0004509,0.4834223394461997,8,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0004617,0.3507854619767512,2,cystatin C measurement,"[EFO_0004747, EFO_0004742]",[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0007825,0.4512817428575814,6,balding measurement,[EFO_0007821],[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0007824,0.4437337318860905,6,hair shape measurement,[EFO_0007821],[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0007814,0.4214488945032564,3,refractive error measurement,[EFO_0004731],[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0009270,0.4649181609427737,6,heel bone mineral density,[EFO_0003923],[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0009263,0.33044329043887694,1,nicotine withdrawal symptom count,[EFO_0001444],[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0004318,0.20101135968446363,1,smoking behavior,[GO_0007610],[GO_0008150]
SLC14A2,ENSG00000132874,EFO_0004314,0.3800525240417957,2,forced expiratory volume,"[EFO_0003892, EFO_0006841]",[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0004312,0.2608885391444919,1,vital capacity,[EFO_0003892],[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0004305,0.4917198799093756,8,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
SLC14A2,ENSG00000132874,MONDO_0004907,0.4136135643174777,2,alopecia,[MONDO_0019278],[EFO_0010285]
SLC14A2,ENSG00000132874,MONDO_0004892,0.45842273000181594,4,refractive error,[EFO_0003966],[MONDO_0024458]
SLC14A2,ENSG00000132874,EFO_0007978,0.42255673619805967,3,red blood cell density measurement,[EFO_0005047],[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0007937,0.3162783671691839,1,blood protein measurement,[EFO_0004747],[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0009795,0.3661208625839417,5,serum urea measurement,[EFO_0004742],[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0004531,0.3957572466451687,6,urate measurement,[EFO_0001444],[EFO_0001444]
SLC14A2,ENSG00000132874,EFO_0004528,0.3645471338115879,2,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC15A1,ENSG00000088386,EFO_0010750,0.3243201115558264,1,PHF-tau measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
SLC15A1,ENSG00000088386,HP_0000175,0.31657520357767244,1,Cleft palate,[HP_0000202],[EFO_0000651]
SLC15A1,ENSG00000088386,EFO_0004747,0.3257096804350439,1,protein measurement,[EFO_0001444],[EFO_0001444]
SLC15A1,ENSG00000088386,EFO_0004741,0.2043865002512888,4,blood urea nitrogen measurement,[EFO_0009795],[EFO_0001444]
SLC15A1,ENSG00000088386,EFO_0004873,0.33046534114350756,1,cytokine measurement,[EFO_0004747],[EFO_0001444]
SLC15A1,ENSG00000088386,EFO_0004645,0.33046534114350756,1,response to vaccine,[GO_0009410],[GO_0008150]
SLC15A2,ENSG00000163406,EFO_0005208,0.4173280577416899,7,glomerular filtration rate,[EFO_0004742],[EFO_0001444]
SLC15A2,ENSG00000163406,EFO_0003956,0.27076593309843305,1,seasonal allergic rhinitis,[EFO_0005854],"[EFO_0000540, OTAR_0000010]"
SLC15A2,ENSG00000163406,EFO_0005854,0.34250579136829185,2,allergic rhinitis,"[MONDO_0000771, EFO_0008521]","[EFO_0000540, OTAR_0000010]"
SLC15A2,ENSG00000163406,EFO_0006335,0.2989646649585372,1,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC15A2,ENSG00000163406,EFO_0005782,0.2619010448601403,4,age-related hearing impairment,[EFO_1001176],"[MONDO_0002025, EFO_0000618]"
SLC15A2,ENSG00000163406,EFO_0004761,0.2741607503211239,1,uric acid measurement,"[EFO_0004742, EFO_0004298]",[EFO_0001444]
SLC15A2,ENSG00000163406,EFO_0004741,0.3713842480084515,3,blood urea nitrogen measurement,[EFO_0009795],[EFO_0001444]
SLC15A2,ENSG00000163406,EFO_0010638,0.2661075289943091,1,atopic asthma,[MONDO_0004979],[OTAR_0000010]
SLC15A2,ENSG00000163406,EFO_0004348,0.3935775205470605,4,hematocrit,[EFO_0004503],[EFO_0001444]
SLC15A2,ENSG00000163406,MONDO_0004979,0.2933365433941761,2,asthma,[EFO_1002018],[OTAR_0000010]
SLC15A2,ENSG00000163406,EFO_0004617,0.3008199641047874,1,cystatin C measurement,"[EFO_0004747, EFO_0004742]",[EFO_0001444]
SLC15A2,ENSG00000163406,EFO_0004518,0.39709341395080533,3,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC15A2,ENSG00000163406,EFO_0004509,0.43254810210953565,6,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
SLC15A2,ENSG00000163406,EFO_0005140,0.26141242511604473,1,autoimmune disease,[EFO_0000540],[EFO_0000540]
SLC15A2,ENSG00000163406,EFO_0004612,0.21667489377934962,1,high density lipoprotein cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
SLC15A2,ENSG00000163406,EFO_0004309,0.3521871200862488,4,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SLC15A2,ENSG00000163406,EFO_0007985,0.27274186127421074,1,platelet crit,[EFO_0005036],[EFO_0001444]
SLC15A2,ENSG00000163406,EFO_0009795,0.3001064552906172,1,serum urea measurement,[EFO_0004742],[EFO_0001444]
SLC15A2,ENSG00000163406,HP_0000964,0.37286187957933603,3,Eczema,[HP_0011123],[EFO_0000651]
SLC15A2,ENSG00000163406,MONDO_0005301,0.2285514818623225,3,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
SLC15A2,ENSG00000163406,EFO_0004531,0.36672226730402324,2,urate measurement,[EFO_0001444],[EFO_0001444]
SLC15A2,ENSG00000163406,EFO_0004528,0.26602584666386936,1,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC15A3,ENSG00000110446,EFO_0010619,0.24923655911299838,1,cathepsin L1 measurement,[EFO_0007937],[EFO_0001444]
SLC15A4,ENSG00000139370,EFO_0007992,0.235490246772471,1,basophil percentage of leukocytes,[EFO_0005090],[EFO_0001444]
SLC15A4,ENSG00000139370,MONDO_0007915,0.3837035439964978,39,systemic lupus erythematosus,"[MONDO_0004670, EFO_0003086, EFO_0005140]","[OTAR_0000006, EFO_0000540, EFO_0009690]"
SLC15A4,ENSG00000139370,EFO_0005090,0.2942058376279051,2,basophil count,"[EFO_0004872, EFO_0803539, EFO_0007987]",[EFO_0001444]
SLC15A5,ENSG00000188991,EFO_0008328,0.25877334567932914,1,chronotype measurement,[EFO_0004870],[EFO_0001444]
SLC15A5,ENSG00000188991,EFO_0008475,0.2950833664560645,1,mood instability measurement,[EFO_0006848],[EFO_0001444]
SLC15A5,ENSG00000188991,EFO_0004784,0.31845616613140976,1,self reported educational attainment,[EFO_0011015],[EFO_0001444]
SLC15A5,ENSG00000188991,EFO_0006939,0.2419106145228254,1,cup-to-disc ratio measurement,[EFO_0006936],[EFO_0001444]
SLC15A5,ENSG00000188991,EFO_0004339,0.2960523418252804,1,body height,[EFO_0004324],[EFO_0001444]
SLC15A5,ENSG00000188991,EFO_0004338,0.3273533060340461,2,body weight,[EFO_0004324],[EFO_0001444]
SLC15A5,ENSG00000188991,EFO_0009945,0.2739234133663888,1,psychological resilience measurement,"[EFO_0009095, EFO_0006848]",[EFO_0001444]
SLC15A5,ENSG00000188991,EFO_0009940,0.33715106632441133,2,Antidepressant use measurement,[EFO_0007010],[EFO_0001444]
SLC15A5,ENSG00000188991,EFO_0004340,0.41881144396474607,3,body mass index,[EFO_0004324],[EFO_0001444]
SLC15A5,ENSG00000188991,EFO_0007877,0.27237433484458384,1,risky sexual behaviour measurement,[EFO_0006946],[EFO_0001444]
SLC15A5,ENSG00000188991,EFO_0009188,0.26973915448351216,1,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC16A1,ENSG00000155380,HP_0000545,0.25206283823797637,1,Myopia,[HP_0000539],[EFO_0000651]
SLC16A1,ENSG00000155380,HP_0000539,0.27257543462737355,1,Abnormality of refraction,[HP_0000478],[EFO_0000651]
SLC16A1,ENSG00000155380,EFO_0006336,0.43010217206781376,3,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC16A1,ENSG00000155380,EFO_0006335,0.3892456192058824,2,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC16A1,ENSG00000155380,EFO_0008375,0.27417020062310843,1,macula measurement,[EFO_0004731],[EFO_0001444]
SLC16A1,ENSG00000155380,MONDO_0009501,0.7142455715335094,14,metabolic myopathy due to lactate transporter defect,[MONDO_0020123],[OTAR_0000006]
SLC16A1,ENSG00000155380,EFO_0004847,0.25206283823797637,1,age at onset,[EFO_0000246],[EFO_0001444]
SLC16A1,ENSG00000155380,EFO_0005772,0.5058390533333883,5,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC16A1,ENSG00000155380,MONDO_0019052,0.3695798546847018,1,inborn errors of metabolism,"[EFO_0000589, EFO_0000508]","[OTAR_0000018, OTAR_0000020]"
SLC16A1,ENSG00000155380,EFO_0007814,0.3132711389927456,2,refractive error measurement,[EFO_0004731],[EFO_0001444]
SLC16A1,ENSG00000155380,MONDO_0004892,0.32868284126411834,2,refractive error,[EFO_0003966],[MONDO_0024458]
SLC16A1,ENSG00000155380,MONDO_0012396,0.7385376325524521,94,exercise-induced hyperinsulinism,"[MONDO_0015624, MONDO_0017706]","[OTAR_0000018, OTAR_0000020, EFO_0001379, EFO_0009605, EFO_0010282]"
SLC16A10,ENSG00000112394,EFO_0010750,0.2618960426679525,1,PHF-tau measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
SLC16A10,ENSG00000112394,EFO_0005664,0.4441407429826078,4,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC16A10,ENSG00000112394,EFO_0005653,0.32115622101965624,3,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC16A10,ENSG00000112394,EFO_0004761,0.33032037042705015,1,uric acid measurement,"[EFO_0004742, EFO_0004298]",[EFO_0001444]
SLC16A10,ENSG00000112394,EFO_0004747,0.24747679833436337,1,protein measurement,[EFO_0001444],[EFO_0001444]
SLC16A10,ENSG00000112394,EFO_0010701,0.3883067239936825,2,mean reticulocyte volume,[EFO_0010700],[EFO_0001444]
SLC16A10,ENSG00000112394,EFO_0005772,0.37436455698747334,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC16A10,ENSG00000112394,EFO_0004526,0.47951622799266913,11,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC16A10,ENSG00000112394,EFO_0005134,0.3432612372743107,2,amino acid measurement,[EFO_0001444],[EFO_0001444]
SLC16A10,ENSG00000112394,EFO_0005058,0.2615911878214165,1,tyrosine measurement,[EFO_0001444],[EFO_0001444]
SLC16A10,ENSG00000112394,EFO_0009188,0.3780277385574044,4,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC16A10,ENSG00000112394,EFO_0004305,0.4318749262651503,6,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
SLC16A10,ENSG00000112394,EFO_0007978,0.39446919285602106,3,red blood cell density measurement,[EFO_0005047],[EFO_0001444]
SLC16A10,ENSG00000112394,EFO_0004531,0.4308764855347877,3,urate measurement,[EFO_0001444],[EFO_0001444]
SLC16A10,ENSG00000112394,EFO_0004528,0.44300550962360496,4,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC16A10,ENSG00000112394,EFO_0004527,0.46434965276122653,5,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC16A11,ENSG00000174326,EFO_0009924,0.25972707720478444,2,Drugs used in diabetes use measurement,[EFO_0007010],[EFO_0001444]
SLC16A11,ENSG00000174326,MONDO_0005148,0.45411252635234484,38,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC16A12,ENSG00000152779,MONDO_0012786,0.6246021506571068,13,juvenile cataract-microcornea-renal glucosuria syndrome,"[MONDO_0000426, MONDO_0017706]","[OTAR_0000018, OTAR_0000020]"
SLC16A12,ENSG00000152779,EFO_0004339,0.3231709636459775,1,body height,[EFO_0004324],[EFO_0001444]
SLC16A12,ENSG00000152779,EFO_0004327,0.48740893663670154,6,electrocardiography,[EFO_0004311],[EFO_0001444]
SLC16A12,ENSG00000152779,EFO_0004875,0.4044922710107575,3,mathematical ability,[EFO_0003925],[GO_0008150]
SLC16A12,ENSG00000152779,EFO_0004518,0.3177837848552469,1,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC16A12,ENSG00000152779,Orphanet_247794,0.5551580959618514,11,Juvenile cataract - microcornea - renal glucosuria,"[Orphanet_98640, Orphanet_79161, Orphanet_98056]","[OTAR_0000018, OTAR_0000020, EFO_0009690, MONDO_0024458]"
SLC16A13,ENSG00000174327,MONDO_0005148,0.3951568149604516,18,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC16A14,ENSG00000163053,NA,NA,NA,NA,NA,NA
SLC16A2,ENSG00000147100,EFO_0000389,0.21508178632773003,2,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLC16A2,ENSG00000147100,EFO_0000508,0.529991013678572,56,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC16A2,ENSG00000147100,HP_0002928,0.26609749537298527,1,Decreased activity of the pyruvate dehydrogenase complex,[HP_0003287],[EFO_0000651]
SLC16A2,ENSG00000147100,MONDO_0010354,0.8443157290730268,220,Allan-Herndon-Dudley syndrome,[MONDO_0020119],"[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC16A2,ENSG00000147100,EFO_0005772,0.414773709592461,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC16A2,ENSG00000147100,GO_0007568,0.3525556029810822,1,aging,[GO_0032502],[GO_0008150]
SLC16A2,ENSG00000147100,MONDO_0019064,0.3219331349139646,11,hereditary spastic paraplegia,"[EFO_0009679, MONDO_0024237]","[OTAR_0000018, EFO_0000618]"
SLC16A2,ENSG00000147100,HP_0001258,0.5462891935280751,131,Spastic paraplegia,[HP_0002061],[EFO_0000651]
SLC16A2,ENSG00000147100,HP_0001249,0.3450834545208208,15,Intellectual disability,"[HP_0012759, HP_0100543]",[EFO_0000651]
SLC16A3,ENSG00000141526,EFO_0004340,0.2738249644599631,2,body mass index,[EFO_0004324],[EFO_0001444]
SLC16A3,ENSG00000141526,EFO_0000519,0.21061701816941483,10,glioblastoma multiforme,"[EFO_0000272, MONDO_0016680]","[MONDO_0045024, EFO_0000618]"
SLC16A4,ENSG00000168679,NA,NA,NA,NA,NA,NA
SLC16A5,ENSG00000170190,NA,NA,NA,NA,NA,NA
SLC16A6,ENSG00000108932,EFO_0009284,0.2243455430908605,1,chloride measurement,[EFO_0001444],[EFO_0001444]
SLC16A6,ENSG00000108932,EFO_0009282,0.2243455430908605,1,sodium measurement,[EFO_0001444],[EFO_0001444]
SLC16A6,ENSG00000108932,EFO_0004339,0.31747280052962645,3,body height,[EFO_0004324],[EFO_0001444]
SLC16A7,ENSG00000118596,MONDO_0002561,0.27620914450227685,1,lysosomal storage disease,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
SLC16A7,ENSG00000118596,EFO_0008111,0.2910600848763107,3,diet measurement,[EFO_0001444],[EFO_0001444]
SLC16A7,ENSG00000118596,EFO_0008039,0.29559555520068537,1,BMI-adjusted hip circumference,[EFO_0005093],[EFO_0001444]
SLC16A7,ENSG00000118596,EFO_0008579,0.20625504368002595,1,risk-taking behaviour,[GO_0007610],[GO_0008150]
SLC16A7,ENSG00000118596,EFO_0004784,0.34058777352206054,3,self reported educational attainment,[EFO_0011015],[EFO_0001444]
SLC16A7,ENSG00000118596,EFO_0004339,0.42899572458014984,5,body height,[EFO_0004324],[EFO_0001444]
SLC16A7,ENSG00000118596,EFO_0004875,0.2830340379099858,4,mathematical ability,[EFO_0003925],[GO_0008150]
SLC16A7,ENSG00000118596,EFO_0005772,0.2765787243569615,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC16A7,ENSG00000118596,MONDO_0005180,0.27620914450227685,1,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
SLC16A7,ENSG00000118596,EFO_0004526,0.3283675668538558,2,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC16A7,ENSG00000118596,EFO_0007788,0.3614737755499339,2,BMI-adjusted waist-hip ratio,[EFO_0004343],[EFO_0001444]
SLC16A7,ENSG00000118596,MONDO_0004975,0.2792530452498883,4,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
SLC16A7,ENSG00000118596,MONDO_0005301,0.2765787243569615,2,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
SLC16A8,ENSG00000100156,EFO_1001492,0.2096316008926445,2,atrophic macular degeneration,[EFO_0001365],"[MONDO_0002025, OTAR_0000018, MONDO_0024458, EFO_0000618]"
SLC16A8,ENSG00000100156,EFO_0000326,0.22634380834405618,1,central nervous system cancer,"[EFO_0007392, EFO_1000158]","[EFO_0000618, MONDO_0045024]"
SLC16A8,ENSG00000100156,EFO_0005674,0.24962188823257248,11,white matter microstructure measurement,[EFO_0004464],[EFO_0001444]
SLC16A8,ENSG00000100156,EFO_0004683,0.20824567643757685,3,wet macular degeneration,[EFO_0001365],"[MONDO_0002025, OTAR_0000018, MONDO_0024458, EFO_0000618]"
SLC16A8,ENSG00000100156,EFO_0000519,0.2300396068909032,2,glioblastoma multiforme,"[EFO_0000272, MONDO_0016680]","[MONDO_0045024, EFO_0000618]"
SLC16A8,ENSG00000100156,EFO_0001365,0.2854090347483384,22,age-related macular degeneration,"[MONDO_0019118, MONDO_0002175]","[MONDO_0002025, OTAR_0000018, MONDO_0024458, EFO_0000618]"
SLC16A9,ENSG00000165449,MONDO_0023757,0.331980693762426,1,meralgia paresthetica,[EFO_0009487],[EFO_0000618]
SLC16A9,ENSG00000165449,EFO_0011011,0.28143717444775085,1,sitting height measurement,[EFO_0004302],[EFO_0001444]
SLC16A9,ENSG00000165449,EFO_0005409,0.2420717983447854,1,fat body mass,[EFO_0004302],[EFO_0001444]
SLC16A9,ENSG00000165449,EFO_0004725,0.31570392538631525,1,metabolite measurement,[EFO_0001444],[EFO_0001444]
SLC16A9,ENSG00000165449,EFO_0004995,0.24148894160770204,1,lean body mass,[EFO_0004302],[EFO_0001444]
SLC16A9,ENSG00000165449,EFO_0004980,0.28143717444775085,1,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
SLC16A9,ENSG00000165449,EFO_0004908,0.46873208001491296,7,testosterone measurement,"[EFO_0004529, EFO_0011008]",[EFO_0001444]
SLC16A9,ENSG00000165449,EFO_0006335,0.3413895124706937,4,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC16A9,ENSG00000165449,EFO_0005664,0.5086130733090305,13,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC16A9,ENSG00000165449,EFO_0005653,0.4715926229724296,7,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC16A9,ENSG00000165449,EFO_0004761,0.44183671618869297,3,uric acid measurement,"[EFO_0004742, EFO_0004298]",[EFO_0001444]
SLC16A9,ENSG00000165449,EFO_0007010,0.27831963216930083,1,drug use measurement,[EFO_0001444],[EFO_0001444]
SLC16A9,ENSG00000165449,EFO_0004339,0.46770786883660975,8,body height,[EFO_0004324],[EFO_0001444]
SLC16A9,ENSG00000165449,EFO_0004329,0.337053644505002,2,alcohol drinking,[EFO_0004315],[GO_0008150]
SLC16A9,ENSG00000165449,EFO_0010469,0.3800959921266231,2,carnitine measurement,[EFO_0005134],[EFO_0001444]
SLC16A9,ENSG00000165449,EFO_0004509,0.35153691518525326,2,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
SLC16A9,ENSG00000165449,EFO_0004627,0.30130120255969206,1,IGF-1 measurement,"[EFO_0005127, EFO_0004730, EFO_0004747]",[EFO_0001444]
SLC16A9,ENSG00000165449,EFO_0005059,0.46150187966356915,4,acylcarnitine measurement,[EFO_0004725],[EFO_0001444]
SLC16A9,ENSG00000165449,EFO_0004612,0.3810747592423009,2,high density lipoprotein cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
SLC16A9,ENSG00000165449,EFO_0004312,0.27644446315733956,1,vital capacity,[EFO_0003892],[EFO_0001444]
SLC16A9,ENSG00000165449,EFO_0004314,0.28106336984547686,1,forced expiratory volume,"[EFO_0003892, EFO_0006841]",[EFO_0001444]
SLC16A9,ENSG00000165449,EFO_0004274,0.442990959926111,19,gout,"[EFO_0005856, EFO_0000589]","[OTAR_0000006, OTAR_0000020]"
SLC16A9,ENSG00000165449,EFO_0007984,0.40025308974346463,2,platelet component distribution width,[EFO_0005036],[EFO_0001444]
SLC16A9,ENSG00000165449,EFO_0004531,0.4920800366365991,12,urate measurement,[EFO_0001444],[EFO_0001444]
SLC16A9,ENSG00000165449,EFO_0004530,0.4059618963817478,3,triglyceride measurement,[EFO_0004529],[EFO_0001444]
SLC17A1,ENSG00000124568,EFO_0000685,0.2588518944306143,2,rheumatoid arthritis,"[MONDO_0000589, EFO_0005140, EFO_0005755, EFO_0005856]","[OTAR_0000006, EFO_0000540]"
SLC17A1,ENSG00000124568,EFO_0005664,0.33174961784692336,3,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC17A1,ENSG00000124568,EFO_0005653,0.3911898572663477,9,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC17A1,ENSG00000124568,EFO_0004761,0.398524377058419,9,uric acid measurement,"[EFO_0004742, EFO_0004298]",[EFO_0001444]
SLC17A1,ENSG00000124568,EFO_0007010,0.24630372728242783,1,drug use measurement,[EFO_0001444],[EFO_0001444]
SLC17A1,ENSG00000124568,EFO_1000999,0.23593855235682354,1,joint disease,[EFO_0002461],[OTAR_0000006]
SLC17A1,ENSG00000124568,EFO_0005116,0.4234308822829043,28,urinary metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC17A1,ENSG00000124568,EFO_0004274,0.4310408050558204,36,gout,"[EFO_0005856, EFO_0000589]","[OTAR_0000006, OTAR_0000020]"
SLC17A1,ENSG00000124568,EFO_0004531,0.4403524306683563,18,urate measurement,[EFO_0001444],[EFO_0001444]
SLC17A2,ENSG00000112337,EFO_0004339,0.29035720642805773,3,body height,[EFO_0004324],[EFO_0001444]
SLC17A2,ENSG00000112337,MONDO_0007915,0.23228141689598045,3,systemic lupus erythematosus,"[MONDO_0004670, EFO_0003086, EFO_0005140]","[OTAR_0000006, EFO_0000540, EFO_0009690]"
SLC17A2,ENSG00000112337,EFO_0009459,0.3079370713397416,2,ACPA-positive rheumatoid arthritis,[EFO_0000685],"[OTAR_0000006, EFO_0000540]"
SLC17A2,ENSG00000112337,EFO_0004526,0.21690791111780125,13,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC17A2,ENSG00000112337,EFO_0009188,0.3581549804307,6,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC17A3,ENSG00000124564,EFO_0004908,0.27188730028553976,4,testosterone measurement,"[EFO_0004529, EFO_0011008]",[EFO_0001444]
SLC17A3,ENSG00000124564,EFO_0000537,0.22334763296766344,3,hypertension,[MONDO_0000473],[EFO_0000319]
SLC17A3,ENSG00000124564,EFO_0004526,0.20561245298479594,8,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC17A3,ENSG00000124564,EFO_0004518,0.26336471652252313,1,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC17A3,ENSG00000124564,EFO_0005116,0.33404160189547655,24,urinary metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC17A3,ENSG00000124564,EFO_0004308,0.26695611145386794,2,leukocyte count,[EFO_0004586],[EFO_0001444]
SLC17A3,ENSG00000124564,EFO_0007901,0.2098278817427083,5,hepcidin:ferritin ratio,[EFO_0004461],[EFO_0001444]
SLC17A3,ENSG00000124564,EFO_0004531,0.345069131199967,21,urate measurement,[EFO_0001444],[EFO_0001444]
SLC17A3,ENSG00000124564,EFO_0004527,0.33664916420443536,12,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC17A4,ENSG00000146039,MONDO_0005090,0.21333387058333994,1,schizophrenia,[EFO_0005407],"[MONDO_0002025, EFO_0000618]"
SLC17A4,ENSG00000146039,EFO_0005116,0.32025263447610547,22,urinary metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC17A5,ENSG00000119899,MONDO_0002561,0.3725313604686421,4,lysosomal storage disease,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
SLC17A5,ENSG00000119899,EFO_0000508,0.4101771622041823,29,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC17A5,ENSG00000119899,MONDO_0011449,0.8108571010399506,474,Salla disease,"[MONDO_0017706, MONDO_0019366]","[OTAR_0000018, OTAR_0000020]"
SLC17A5,ENSG00000119899,MONDO_0017737,0.45273532198875965,2,intermediate severe Salla disease,"[MONDO_0019366, MONDO_0017706]","[OTAR_0000018, OTAR_0000020]"
SLC17A5,ENSG00000119899,EFO_0004736,0.2974372296108576,2,aspartate aminotransferase measurement,"[EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC17A5,ENSG00000119899,MONDO_0015193,0.3713353589944541,3,hydrops fetalis,[MONDO_0019755],[OTAR_0000018]
SLC17A5,ENSG00000119899,EFO_0005772,0.5030392466541774,3,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC17A5,ENSG00000119899,MONDO_0010027,0.8092047784212123,138,"free sialic acid storage disease, infantile form","[MONDO_0019366, MONDO_0800088, MONDO_0017706]","[OTAR_0000006, OTAR_0000018, OTAR_0000020]"
SLC17A5,ENSG00000119899,GO_0007568,0.5030392466541774,3,aging,[GO_0032502],[GO_0008150]
SLC17A5,ENSG00000119899,MONDO_0019052,0.3695798546847018,1,inborn errors of metabolism,"[EFO_0000589, EFO_0000508]","[OTAR_0000018, OTAR_0000020]"
SLC17A6,ENSG00000091664,EFO_0010750,0.24926160571755876,1,PHF-tau measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
SLC17A6,ENSG00000091664,EFO_0006335,0.3607820062853464,2,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC17A6,ENSG00000091664,EFO_0004747,0.20550060558593203,1,protein measurement,[EFO_0001444],[EFO_0001444]
SLC17A6,ENSG00000091664,EFO_0000537,0.3141691175694819,2,hypertension,[MONDO_0000473],[EFO_0000319]
SLC17A7,ENSG00000104888,NA,NA,NA,NA,NA,NA
SLC17A8,ENSG00000179520,MONDO_0019588,0.36994943453938645,2,"hearing loss, autosomal recessive","[EFO_1000017, MONDO_0016298, MONDO_0016297]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC17A8,ENSG00000179520,MONDO_0019587,0.635490151885945,102,autosomal dominant nonsyndromic hearing loss,"[MONDO_0016297, MONDO_0016298, MONDO_0000426]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC17A8,ENSG00000179520,MONDO_0019497,0.3695798546847018,1,nonsyndromic genetic hearing loss,"[MONDO_0037940, EFO_0004238]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC17A8,ENSG00000179520,EFO_0004238,0.37269109246075344,12,hearing loss,[MONDO_0021945],"[MONDO_0002025, EFO_0000618]"
SLC17A8,ENSG00000179520,EFO_0004458,0.20157714419768216,1,C-reactive protein measurement,"[EFO_0004747, EFO_0004872]",[EFO_0001444]
SLC17A8,ENSG00000179520,EFO_0004533,0.2803453892100879,1,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC17A8,ENSG00000179520,EFO_0003060,0.30706775920771323,1,non-small cell lung carcinoma,[EFO_0001071],"[OTAR_0000010, MONDO_0045024]"
SLC17A8,ENSG00000179520,EFO_0003923,0.21376364179046115,2,bone density,[EFO_0004516],[EFO_0001444]
SLC17A8,ENSG00000179520,EFO_0004696,0.3680838692493473,3,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
SLC17A8,ENSG00000179520,EFO_0004611,0.35476559764106336,2,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
SLC17A8,ENSG00000179520,EFO_0004532,0.3600042921415219,2,serum gamma-glutamyl transferase measurement,[EFO_0004582],[EFO_0001444]
SLC17A8,ENSG00000179520,EFO_0004531,0.21376364179046115,2,urate measurement,[EFO_0001444],[EFO_0001444]
SLC17A9,ENSG00000101194,MONDO_0019212,0.5493291234534363,7,disseminated superficial actinic porokeratosis,[EFO_1000757],"[OTAR_0000018, EFO_0010285]"
SLC18A1,ENSG00000036565,EFO_0000195,0.2669647747320689,5,metabolic syndrome,[EFO_0000589],[OTAR_0000020]
SLC18A1,ENSG00000036565,EFO_0001645,0.3364024330732632,4,coronary artery disease,"[MONDO_0000473, EFO_0003777]",[EFO_0000319]
SLC18A1,ENSG00000036565,EFO_0007986,0.32878243926430006,6,reticulocyte count,[EFO_0010700],[EFO_0001444]
SLC18A1,ENSG00000036565,EFO_0010700,0.27049908460188,2,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
SLC18A1,ENSG00000036565,EFO_0004533,0.2554886236486827,2,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC18A1,ENSG00000036565,EFO_0004526,0.2843013067928186,4,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC18A1,ENSG00000036565,EFO_0004639,0.2485645743530026,1,phospholipid measurement,"[EFO_0004529, EFO_0010968]",[EFO_0001444]
SLC18A1,ENSG00000036565,EFO_0004614,0.41798278877873696,8,apolipoprotein A 1 measurement,"[EFO_0004872, EFO_0005278, EFO_0004732]",[EFO_0001444]
SLC18A1,ENSG00000036565,EFO_0009188,0.35837490832859775,7,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC18A1,ENSG00000036565,EFO_0004612,0.41506766199643025,28,high density lipoprotein cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
SLC18A1,ENSG00000036565,EFO_0007984,0.3333426221604895,3,platelet component distribution width,[EFO_0005036],[EFO_0001444]
SLC18A1,ENSG00000036565,EFO_0007929,0.25300214098068147,1,triglyceride:HDL cholesterol ratio,"[EFO_0004732, EFO_0004529]",[EFO_0001444]
SLC18A1,ENSG00000036565,EFO_0004530,0.41918374694756866,26,triglyceride measurement,[EFO_0004529],[EFO_0001444]
SLC18A2,ENSG00000165646,HP_0012443,0.26609749537298527,1,Abnormal brain morphology,[HP_0002011],[EFO_0000651]
SLC18A2,ENSG00000165646,MONDO_0002561,0.4119464064250153,2,lysosomal storage disease,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
SLC18A2,ENSG00000165646,MONDO_0016158,0.5409211817593593,5,narcolepsy-cataplexy syndrome,"[EFO_0005774, MONDO_0021107]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC18A2,ENSG00000165646,EFO_0005203,0.4002103348888715,12,eating disorder,"[EFO_0000677, MONDO_0002025, EFO_0001069]","[MONDO_0002025, OTAR_0000020, EFO_0000618]"
SLC18A2,ENSG00000165646,EFO_0004152,0.5715789748110867,30,chorea,[EFO_0004280],[EFO_0000618]
SLC18A2,ENSG00000165646,EFO_0003843,0.3695798546847018,1,pain,[EFO_0003765],[EFO_0000651]
SLC18A2,ENSG00000165646,MONDO_0007739,0.5881600810607683,60,Huntington disease,"[MONDO_0000167, EFO_0004280]","[OTAR_0000018, EFO_0000618]"
SLC18A2,ENSG00000165646,EFO_0000389,0.20099542039277465,4,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLC18A2,ENSG00000165646,EFO_0000508,0.447412690996771,18,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC18A2,ENSG00000165646,HP_0003124,0.25870589827929125,1,Hypercholesterolemia,[HP_0003119],[EFO_0000651]
SLC18A2,ENSG00000165646,EFO_0001073,0.5145014002481042,14,obesity,[MONDO_0003916],[OTAR_0000020]
SLC18A2,ENSG00000165646,EFO_0005924,0.4619748183558772,2,binge eating,[EFO_0005203],"[MONDO_0002025, OTAR_0000020, EFO_0000618]"
SLC18A2,ENSG00000165646,EFO_0003777,0.27718489101352634,2,heart disease,[EFO_0000319],[EFO_0000319]
SLC18A2,ENSG00000165646,EFO_0001645,0.25870589827929125,1,coronary artery disease,"[MONDO_0000473, EFO_0003777]",[EFO_0000319]
SLC18A2,ENSG00000165646,EFO_0003890,0.5043828234175624,7,drug dependence,"[EFO_0000677, MONDO_0004938]","[MONDO_0002025, EFO_0000618]"
SLC18A2,ENSG00000165646,EFO_0003888,0.6096774427961651,124,attention deficit hyperactivity disorder,[MONDO_0000592],"[MONDO_0002025, EFO_0000618]"
SLC18A2,ENSG00000165646,EFO_0005653,0.22161744577461223,1,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC18A2,ENSG00000165646,HP_0100543,0.37194446964977046,9,Cognitive impairment,[HP_0011446],[EFO_0000651]
SLC18A2,ENSG00000165646,EFO_0000537,0.546890294486057,9,hypertension,[MONDO_0000473],[EFO_0000319]
SLC18A2,ENSG00000165646,EFO_0003763,0.25870589827929125,1,cerebrovascular disorder,"[EFO_0005774, MONDO_0043218]","[EFO_0000618, EFO_0000319]"
SLC18A2,ENSG00000165646,EFO_1000632,0.4762601063501485,5,cerebral palsy,"[EFO_1000631, MONDO_0044996]",[EFO_0000618]
SLC18A2,ENSG00000165646,EFO_0004895,0.3599840915961768,26,Tourette syndrome,"[MONDO_0002420, EFO_0004280, EFO_0000508]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC18A2,ENSG00000165646,MONDO_0005090,0.4092031061679722,36,schizophrenia,[EFO_0005407],"[MONDO_0002025, EFO_0000618]"
SLC18A2,ENSG00000165646,EFO_0005772,0.4130038154536965,5,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC18A2,ENSG00000165646,MONDO_0004985,0.439350268923858,9,bipolar disorder,[EFO_0004247],"[MONDO_0002025, EFO_0000618]"
SLC18A2,ENSG00000165646,MONDO_0002277,0.5030392466541774,3,arteriosclerosis disorder,[MONDO_0000473],[EFO_0000319]
SLC18A2,ENSG00000165646,Orphanet_238455,0.46883764808151385,8,Infantile dystonia-parkinsonism,"[Orphanet_391799, Orphanet_307055]","[OTAR_0000018, EFO_0000618]"
SLC18A2,ENSG00000165646,MONDO_0005180,0.42128351071547077,94,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
SLC18A2,ENSG00000165646,MONDO_0005148,0.26290088628263947,5,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC18A2,ENSG00000165646,MONDO_0002050,0.5192083652966331,4,depressive disorder,[EFO_0004247],"[MONDO_0002025, EFO_0000618]"
SLC18A2,ENSG00000165646,MONDO_0002009,0.5337785287530633,17,major depressive disorder,[MONDO_0002050],"[MONDO_0002025, EFO_0000618]"
SLC18A2,ENSG00000165646,EFO_0005543,0.25870589827929125,1,glioma,"[EFO_0009386, MONDO_0021193]","[EFO_0000618, MONDO_0045024]"
SLC18A2,ENSG00000165646,MONDO_0018130,0.4342563292545246,2,brain dopamine-serotonin vesicular transport disease,[MONDO_0019219],"[OTAR_0000018, OTAR_0000020]"
SLC18A2,ENSG00000165646,EFO_0003925,0.3695798546847018,1,cognition,[EFO_0004323],[GO_0008150]
SLC18A2,ENSG00000165646,EFO_0003922,0.3695798546847018,1,menopause,[EFO_0003765],[EFO_0000651]
SLC18A2,ENSG00000165646,EFO_0003914,0.25870589827929125,1,atherosclerosis,"[EFO_0009086, MONDO_0002277]",[EFO_0000319]
SLC18A2,ENSG00000165646,EFO_0004280,0.5791016315396132,62,movement disorder,[EFO_0000618],[EFO_0000618]
SLC18A2,ENSG00000165646,MONDO_0004975,0.42287800874018683,12,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
SLC18A2,ENSG00000165646,MONDO_0005041,0.4625291881379043,3,glaucoma,[EFO_0003966],[MONDO_0024458]
SLC18A2,ENSG00000165646,MONDO_0005301,0.43504514734280914,4,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
SLC18A3,ENSG00000187714,Orphanet_98914,0.5001120246365077,10,Presynaptic congenital myasthenic syndromes,[Orphanet_590],"[OTAR_0000006, OTAR_0000018, MONDO_0024458]"
SLC18A3,ENSG00000187714,EFO_0005772,0.3704524737860406,4,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC18A3,ENSG00000187714,Orphanet_590,0.6226988807728948,29,Congenital myasthenic syndromes,"[Orphanet_98495, Orphanet_98690, Orphanet_98577]","[OTAR_0000006, OTAR_0000018, MONDO_0024458]"
SLC18A3,ENSG00000187714,MONDO_0008824,0.37013422446672883,2,fetal akinesia deformation sequence,"[MONDO_0015168, MONDO_0015222, MONDO_0015161, MONDO_0015929]","[OTAR_0000018, OTAR_0000010]"
SLC18A3,ENSG00000187714,EFO_0000519,0.2309874091779386,2,glioblastoma multiforme,"[EFO_0000272, MONDO_0016680]","[MONDO_0045024, EFO_0000618]"
SLC18B1,ENSG00000146409,EFO_0004327,0.22122006731632554,5,electrocardiography,[EFO_0004311],[EFO_0001444]
SLC18B1,ENSG00000146409,EFO_0010736,0.26661332391573417,2,cortical surface area measurement,[EFO_0004464],[EFO_0001444]
SLC18B1,ENSG00000146409,MONDO_0005180,0.24032701706579954,1,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
SLC18B1,ENSG00000146409,EFO_0009270,0.3313746617812809,5,heel bone mineral density,[EFO_0003923],[EFO_0001444]
SLC19A1,ENSG00000173638,HP_0000639,0.25870589827929125,1,Nystagmus,[HP_0000478],[EFO_0000651]
SLC19A1,ENSG00000173638,HP_0000545,0.25870589827929125,1,Myopia,[HP_0000539],[EFO_0000651]
SLC19A1,ENSG00000173638,EFO_0000508,0.4136946516926934,47,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC19A1,ENSG00000173638,Orphanet_71862,0.4599523952621859,5,Retinal dystrophy,[Orphanet_98657],"[OTAR_0000018, MONDO_0024458]"
SLC19A1,ENSG00000173638,EFO_0004713,0.39402081506656406,3,FEV/FEC ratio,"[EFO_0006841, EFO_0003892]",[EFO_0001444]
SLC19A1,ENSG00000173638,EFO_0004980,0.2865834916955937,1,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
SLC19A1,ENSG00000173638,EFO_0006336,0.26985346128304066,1,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC19A1,ENSG00000173638,MONDO_0030038,0.47815405148078716,20,"glaucoma, primary closed-angle",[EFO_0000508],[OTAR_0000018]
SLC19A1,ENSG00000173638,EFO_0005671,0.2755634042338585,1,smoking behaviour measurement,[EFO_0001444],[EFO_0001444]
SLC19A1,ENSG00000173638,EFO_0004747,0.24040795592842581,2,protein measurement,[EFO_0001444],[EFO_0001444]
SLC19A1,ENSG00000173638,HP_0007754,0.25870589827929125,1,Macular dystrophy,[HP_0001103],[EFO_0000651]
SLC19A1,ENSG00000173638,MONDO_0800167,0.495544665605344,17,Knobloch syndrome 1,[MONDO_0800166],"[OTAR_0000018, MONDO_0024458, EFO_0000618]"
SLC19A1,ENSG00000173638,MONDO_0800166,0.5526376043933826,124,Knobloch syndrome,[MONDO_0020248],"[OTAR_0000018, MONDO_0024458, EFO_0000618]"
SLC19A1,ENSG00000173638,EFO_0004584,0.23147791443901664,4,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
SLC19A1,ENSG00000173638,EFO_0004840,0.34324575662228357,2,cortical thickness,[EFO_0004464],[EFO_0001444]
SLC19A1,ENSG00000173638,MONDO_0005129,0.25870589827929125,1,cataract,"[EFO_0009674, EFO_0000508]","[OTAR_0000018, MONDO_0024458]"
SLC19A1,ENSG00000173638,EFO_0005772,0.25870589827929125,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC19A1,ENSG00000173638,MONDO_0019200,0.25870589827929125,1,retinitis pigmentosa,"[MONDO_0019216, MONDO_0019118]","[MONDO_0002025, OTAR_0000018, OTAR_0000020, MONDO_0024458, EFO_0000618]"
SLC19A1,ENSG00000173638,EFO_0004617,0.3626979255942392,2,cystatin C measurement,"[EFO_0004747, EFO_0004742]",[EFO_0001444]
SLC19A1,ENSG00000173638,EFO_0004518,0.38874669508967824,4,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC19A1,ENSG00000173638,Orphanet_2828,0.2785266576659224,1,Young adult-onset Parkinsonism,"[MONDO_0005180, Orphanet_307055]","[OTAR_0000018, EFO_0000618]"
SLC19A1,ENSG00000173638,EFO_0004207,0.25870589827929125,1,pathological myopia,[HP_0000545],[EFO_0000651]
SLC19A1,ENSG00000173638,EFO_0007979,0.2755634042338585,1,childhood trauma measurement,[EFO_0006848],[EFO_0001444]
SLC19A2,ENSG00000117479,HP_0000598,0.3400134663099256,1,Abnormality of the ear,[HP_0000118],[EFO_0000651]
SLC19A2,ENSG00000117479,MONDO_0009575,0.8145693064440681,188,thiamine-responsive megaloblastic anemia syndrome,"[MONDO_0020112, MONDO_0000152, EFO_1000017]","[OTAR_0000018, OTAR_0000020, EFO_0005803]"
SLC19A2,ENSG00000117479,EFO_0000537,0.24044002417344673,2,hypertension,[MONDO_0000473],[EFO_0000319]
SLC19A2,ENSG00000117479,EFO_0009314,0.25718950024295295,11,blood coagulation disease,[EFO_0005803],[EFO_0005803]
SLC19A2,ENSG00000117479,MONDO_0007500,0.3400134663099256,1,ear malformation,[EFO_0000508],[OTAR_0000018]
SLC19A3,ENSG00000135917,EFO_0000508,0.4892260411309127,18,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC19A3,ENSG00000135917,EFO_0004725,0.2530036609593223,1,metabolite measurement,[EFO_0001444],[EFO_0001444]
SLC19A3,ENSG00000135917,HP_0001332,0.37174087022389984,4,Dystonia,"[HP_0100022, HP_0000708]",[EFO_0000651]
SLC19A3,ENSG00000135917,MONDO_0011841,0.8105139943081281,501,biotin-responsive basal ganglia disease,"[EFO_0009533, MONDO_0000152, EFO_0005595]","[OTAR_0000018, OTAR_0000020, EFO_0000618, OTAR_0000009]"
SLC19A3,ENSG00000135917,EFO_0005772,0.34945652137305105,4,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC19A3,ENSG00000135917,Orphanet_199348,0.7848587184531108,465,Thiamine-responsive encephalopathy,"[Orphanet_309827, Orphanet_166472, EFO_0005596]","[OTAR_0000018, OTAR_0000020]"
SLC19A3,ENSG00000135917,EFO_0004614,0.24622118583362587,1,apolipoprotein A 1 measurement,"[EFO_0004872, EFO_0005278, EFO_0004732]",[EFO_0001444]
SLC19A3,ENSG00000135917,EFO_0004612,0.31343677811441745,2,high density lipoprotein cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
SLC19A3,ENSG00000135917,Orphanet_263410,0.3695798546847018,1,Infantile spams - psychomotor retardation - progressive brain atrophy - basal ganglia disease,"[Orphanet_309827, Orphanet_183763, EFO_0005596]","[OTAR_0000018, OTAR_0000020]"
SLC19A3,ENSG00000135917,MONDO_0009723,0.3743074976000028,23,Leigh syndrome,"[MONDO_0016387, MONDO_0020127]","[OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC19A3,ENSG00000135917,EFO_0007660,0.24502047430053628,2,neuroticism measurement,"[EFO_0007911, EFO_0006848]",[EFO_0001444]
SLC2A1,ENSG00000117394,Orphanet_98811,0.8137636254588384,82,Paroxysmal exertion-induced dyskinesia,"[Orphanet_391799, Orphanet_306768]","[OTAR_0000018, EFO_0000618]"
SLC2A1,ENSG00000117394,EFO_0010750,0.24790415464788307,1,PHF-tau measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
SLC2A1,ENSG00000117394,MONDO_0018959,0.3695798546847018,1,potassium-aggravated myotonia,"[EFO_1001899, MONDO_0016120]","[OTAR_0000006, EFO_0000618]"
SLC2A1,ENSG00000117394,MONDO_0016058,0.26646707522767,2,paroxysmal dystonia,[MONDO_0020065],"[OTAR_0000018, EFO_0000618]"
SLC2A1,ENSG00000117394,MONDO_0016025,0.37345832009861574,15,myoclonic-astatic epilepsy,"[MONDO_0015653, MONDO_0020072, MONDO_0019216]","[OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC2A1,ENSG00000117394,MONDO_0012143,0.7555108328564245,37,hereditary cryohydrocytosis with reduced stomatin,"[MONDO_0000508, MONDO_0017706, MONDO_0020102, MONDO_0003689]","[MONDO_0002025, OTAR_0000018, OTAR_0000020, EFO_0000618, EFO_0005803]"
SLC2A1,ENSG00000117394,HP_0000486,0.3326218692162316,1,Strabismus,[HP_0000549],[EFO_0000651]
SLC2A1,ENSG00000117394,HP_0000252,0.42824872616463283,54,Microcephaly,"[HP_0000929, HP_0012443]",[EFO_0000651]
SLC2A1,ENSG00000117394,EFO_0000508,0.5443169513146213,91,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC2A1,ENSG00000117394,MONDO_0012805,0.8089309094748696,85,childhood onset GLUT1 deficiency syndrome 2,"[MONDO_0000188, MONDO_0015427]","[OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC2A1,ENSG00000117394,HP_0002619,0.25947337294381506,1,Varicose veins,[HP_0002624],[EFO_0000651]
SLC2A1,ENSG00000117394,EFO_0005917,0.7912940249048684,63,generalised epilepsy,[MONDO_0015653],"[OTAR_0000018, EFO_0000618]"
SLC2A1,ENSG00000117394,HP_0200134,0.46399807146641997,16,Epileptic encephalopathy,[HP_0001298],[EFO_0000651]
SLC2A1,ENSG00000117394,EFO_0008111,0.27294818185320174,1,diet measurement,[EFO_0001444],[EFO_0001444]
SLC2A1,ENSG00000117394,MONDO_0019487,0.37013422446672883,2,epilepsy with myoclonic absences,"[MONDO_0020072, EFO_0004280]",[EFO_0000618]
SLC2A1,ENSG00000117394,MONDO_0010826,0.3703138813405339,4,childhood absence epilepsy,"[MONDO_0850093, MONDO_0000414, MONDO_0020072, MONDO_0015653]","[OTAR_0000018, EFO_0000618]"
SLC2A1,ENSG00000117394,EFO_0004833,0.42210565258350163,6,neutrophil count,"[EFO_0803548, EFO_0007987]",[EFO_0001444]
SLC2A1,ENSG00000117394,EFO_0004792,0.2517859157525508,1,plasminogen activator inhibitor 1 measurement,[EFO_0004747],[EFO_0001444]
SLC2A1,ENSG00000117394,EFO_0007993,0.32877696979647253,2,lymphocyte percentage of leukocytes,[EFO_0004587],[EFO_0001444]
SLC2A1,ENSG00000117394,EFO_0007990,0.3287773277624567,2,neutrophil percentage of leukocytes,[EFO_0004833],[EFO_0001444]
SLC2A1,ENSG00000117394,EFO_0007988,0.3506072818074769,3,myeloid white cell count,[EFO_0004308],[EFO_0001444]
SLC2A1,ENSG00000117394,EFO_0007986,0.34476911666491156,2,reticulocyte count,[EFO_0010700],[EFO_0001444]
SLC2A1,ENSG00000117394,EFO_0010125,0.251477095744343,1,viral load,[EFO_0006843],[EFO_0001444]
SLC2A1,ENSG00000117394,Orphanet_3175,0.3400134663099256,1,Spasticity - intellectual disability - X-linked epilepsy,"[MONDO_0020119, MONDO_0015921]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC2A1,ENSG00000117394,EFO_0010701,0.38187875091944323,4,mean reticulocyte volume,[EFO_0010700],[EFO_0001444]
SLC2A1,ENSG00000117394,EFO_0010700,0.24385486546258037,1,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
SLC2A1,ENSG00000117394,MONDO_0015427,0.4664860964842241,14,paroxysmal dyskinesia,[MONDO_0016058],"[OTAR_0000018, EFO_0000618]"
SLC2A1,ENSG00000117394,HP_0001332,0.5518148507097017,48,Dystonia,"[HP_0100022, HP_0000708]",[EFO_0000651]
SLC2A1,ENSG00000117394,MONDO_0010632,0.3400134663099256,1,"developmental and epileptic encephalopathy, 1","[MONDO_0018097, MONDO_0100062]","[OTAR_0000018, EFO_0000618]"
SLC2A1,ENSG00000117394,EFO_0004344,0.2868060363944253,2,birth weight,[EFO_0004338],[EFO_0001444]
SLC2A1,ENSG00000117394,MONDO_0011724,0.8519959372087553,222,encephalopathy due to GLUT1 deficiency,[MONDO_0000188],"[OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC2A1,ENSG00000117394,HP_0001939,0.25870589827929125,1,Abnormality of metabolism/homeostasis,[HP_0000118],[EFO_0000651]
SLC2A1,ENSG00000117394,MONDO_0007295,0.3326218692162316,1,childhood epilepsy with centrotemporal spikes,"[MONDO_0000414, MONDO_0017704]","[OTAR_0000018, EFO_0000618]"
SLC2A1,ENSG00000117394,EFO_0004838,0.3997233964622133,4,calcium measurement,[EFO_0001444],[EFO_0001444]
SLC2A1,ENSG00000117394,MONDO_0005129,0.4635917302201228,4,cataract,"[EFO_0009674, EFO_0000508]","[OTAR_0000018, MONDO_0024458]"
SLC2A1,ENSG00000117394,EFO_0005772,0.5270621572876205,5,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC2A1,ENSG00000117394,MONDO_0019226,0.550699860461203,59,glucose transport disorder,"[MONDO_0017706, MONDO_0045015]","[OTAR_0000018, OTAR_0000020]"
SLC2A1,ENSG00000117394,Orphanet_53583,0.6416316921609407,6,Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity,"[Orphanet_391799, Orphanet_306768]","[OTAR_0000018, EFO_0000618]"
SLC2A1,ENSG00000117394,Orphanet_1945,0.3326218692162316,1,Rolandic epilepsy,"[Orphanet_182083, Orphanet_166475]",[OTAR_0000018]
SLC2A1,ENSG00000117394,EFO_0004526,0.37884905220546544,6,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC2A1,ENSG00000117394,MONDO_0018226,0.3400134663099256,1,infantile epileptic-dyskinetic encephalopathy,[MONDO_0018329],"[OTAR_0000018, EFO_0000618]"
SLC2A1,ENSG00000117394,MONDO_0018097,0.3403830461646103,2,West syndrome,"[MONDO_0100022, MONDO_0000413]",[EFO_0000618]
SLC2A1,ENSG00000117394,EFO_1000116,0.25195411086149366,3,Benign Ovarian Neoplasm,"[EFO_0003893, MONDO_0000624]","[OTAR_0000017, MONDO_0045024, EFO_0001379]"
SLC2A1,ENSG00000117394,EFO_0005091,0.42771329937183766,7,monocyte count,"[EFO_0004308, EFO_0803547]",[EFO_0001444]
SLC2A1,ENSG00000117394,MONDO_0000437,0.3326218692162316,1,cerebellar ataxia,"[MONDO_0002427, MONDO_0100308, EFO_0004280]",[EFO_0000618]
SLC2A1,ENSG00000117394,MONDO_0000188,0.5974898285749217,37,GLUT1 deficiency syndrome,"[MONDO_0015653, MONDO_0100033, MONDO_0019226]","[OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC2A1,ENSG00000117394,EFO_0009253,0.28402651313416094,1,Immature Reticulocyte Fraction Measurement,[EFO_0009233],[EFO_0001444]
SLC2A1,ENSG00000117394,EFO_0009188,0.42469586413858845,8,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC2A1,ENSG00000117394,EFO_0009139,0.5569809830360032,591,"glut1 deficiency syndrome 1, autosomal recessive","[Orphanet_79161, Orphanet_71859]","[OTAR_0000018, OTAR_0000020]"
SLC2A1,ENSG00000117394,EFO_0004308,0.40366261064842446,4,leukocyte count,[EFO_0004586],[EFO_0001444]
SLC2A1,ENSG00000117394,EFO_0004305,0.32412411141152014,2,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
SLC2A1,ENSG00000117394,EFO_0000474,0.25998543135371993,11,epilepsy,[EFO_0005774],[EFO_0000618]
SLC2A1,ENSG00000117394,MONDO_0100062,0.34429125046683035,6,developmental and epileptic encephalopathy,"[MONDO_0100022, MONDO_0100038, MONDO_0100500, EFO_0005917]","[OTAR_0000018, EFO_0000618]"
SLC2A1,ENSG00000117394,EFO_0007978,0.26161894395311935,1,red blood cell density measurement,[EFO_0005047],[EFO_0001444]
SLC2A1,ENSG00000117394,MONDO_0010983,0.791304692494124,140,dystonia 9,"[MONDO_0017706, MONDO_0016058]","[OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC2A1,ENSG00000117394,EFO_0009671,0.4619748183558772,2,hereditary ataxia,"[MONDO_0100308, MONDO_0024237]","[OTAR_0000018, EFO_0000618]"
SLC2A1,ENSG00000117394,HP_0001263,0.5670942197746361,69,Global developmental delay,[HP_0012758],[EFO_0000651]
SLC2A1,ENSG00000117394,HP_0001258,0.4623443982105619,3,Spastic paraplegia,[HP_0002061],[EFO_0000651]
SLC2A1,ENSG00000117394,HP_0001250,0.5773541813256071,11,Seizure,[HP_0012638],[EFO_0000651]
SLC2A1,ENSG00000117394,HP_0001249,0.6184941173817798,36,Intellectual disability,"[HP_0012759, HP_0100543]",[EFO_0000651]
SLC2A1,ENSG00000117394,EFO_0004528,0.39704720848579755,7,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC2A10,ENSG00000197496,HP_0001626,0.45371567236066485,7,Abnormality of the cardiovascular system,[HP_0000118],[EFO_0000651]
SLC2A10,ENSG00000197496,MONDO_0019625,0.5402017696854701,199,familial thoracic aortic aneurysm and aortic dissection,"[EFO_0000508, EFO_0004264]","[OTAR_0000018, EFO_0000319]"
SLC2A10,ENSG00000197496,MONDO_0008818,0.8289269126198723,434,arterial tortuosity syndrome,"[MONDO_0100237, EFO_0004264, MONDO_0023603]","[OTAR_0000006, OTAR_0000018, MONDO_0024458, EFO_0010285, EFO_0000319]"
SLC2A10,ENSG00000197496,Orphanet_285014,0.5258228560330965,190,Rare disease with thoracic aortic aneurysm and aortic dissection,[Orphanet_233655],[OTAR_0000018]
SLC2A11,ENSG00000133460,EFO_0005271,0.28702014411036625,1,sleep duration,[EFO_0004870],[EFO_0001444]
SLC2A11,ENSG00000133460,EFO_0004747,0.2921748495753378,9,protein measurement,[EFO_0001444],[EFO_0001444]
SLC2A12,ENSG00000146411,EFO_0001645,0.29655630331603716,7,coronary artery disease,"[MONDO_0000473, EFO_0003777]",[EFO_0000319]
SLC2A12,ENSG00000146411,EFO_0004627,0.33584941389092865,1,IGF-1 measurement,"[EFO_0005127, EFO_0004730, EFO_0004747]",[EFO_0001444]
SLC2A12,ENSG00000146411,EFO_0004314,0.32387724705443466,1,forced expiratory volume,"[EFO_0003892, EFO_0006841]",[EFO_0001444]
SLC2A13,ENSG00000151229,EFO_0000638,0.2841003532559609,1,overall survival,"[EFO_0004557, EFO_0000714]",[EFO_0001444]
SLC2A13,ENSG00000151229,EFO_0000384,0.21848690897373232,6,Crohn's disease,[EFO_0003767],"[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLC2A13,ENSG00000151229,EFO_0003767,0.2512911334576738,4,inflammatory bowel disease,"[EFO_0000508, EFO_0005140, EFO_0009431]","[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLC2A13,ENSG00000151229,EFO_0007988,0.23438810805710936,1,myeloid white cell count,[EFO_0004308],[EFO_0001444]
SLC2A13,ENSG00000151229,EFO_0004584,0.2071716738669355,3,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
SLC2A13,ENSG00000151229,MONDO_0005180,0.4130027225217957,5,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
SLC2A13,ENSG00000151229,MONDO_0019037,0.2841003532559609,1,progressive supranuclear palsy,"[MONDO_0004884, MONDO_0020257, EFO_0004280]","[MONDO_0024458, EFO_0000618]"
SLC2A13,ENSG00000151229,EFO_0004611,0.36353992645143735,3,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
SLC2A13,ENSG00000151229,EFO_0004532,0.22556247185982944,2,serum gamma-glutamyl transferase measurement,[EFO_0004582],[EFO_0001444]
SLC2A14,ENSG00000173262,EFO_0004517,0.2531160072066909,1,arterial stiffness measurement,[EFO_0005278],[EFO_0001444]
SLC2A14,ENSG00000173262,EFO_0003870,0.2408489865425443,1,brain aneurysm,[EFO_1000859],"[EFO_0000618, EFO_0000319]"
SLC2A2,ENSG00000163581,MONDO_0009216,0.8266839945879685,307,glycogen storage disease due to GLUT2 deficiency,[MONDO_0002412],"[OTAR_0000018, OTAR_0000020]"
SLC2A2,ENSG00000163581,EFO_0005409,0.39613541064286606,5,fat body mass,[EFO_0004302],[EFO_0001444]
SLC2A2,ENSG00000163581,MONDO_0020525,0.3866702024454945,4,transient neonatal diabetes mellitus,[MONDO_0016391],"[OTAR_0000018, OTAR_0000020, EFO_0000540, EFO_0001379, EFO_0009605, EFO_0010282]"
SLC2A2,ENSG00000163581,EFO_0004995,0.41818176111070626,11,lean body mass,[EFO_0004302],[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0008036,0.28499194188654825,1,BMI-adjusted fasting blood glucose measurement,[EFO_0004465],[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_1000647,0.3695798546847018,1,renal tubular transport disease,[EFO_0003086],[EFO_0009690]
SLC2A2,ENSG00000163581,EFO_0004784,0.284334760396794,1,self reported educational attainment,[EFO_0011015],[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0004761,0.3029954390417,2,uric acid measurement,"[EFO_0004742, EFO_0004298]",[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0004736,0.4179356541781718,3,aspartate aminotransferase measurement,"[EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0004735,0.4135550848036592,5,serum alanine aminotransferase measurement,"[EFO_0004582, EFO_0004747]",[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0004339,0.2824103352653982,1,body height,[EFO_0004324],[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0004338,0.3769704968842458,3,body weight,[EFO_0004324],[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0009946,0.2827953084063812,1,low density lipoprotein triglyceride measurement,"[EFO_0004530, EFO_0005278, EFO_0004732]",[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0004458,0.4328183300864577,5,C-reactive protein measurement,"[EFO_0004747, EFO_0004872]",[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0004342,0.2434606182490205,1,waist circumference,[EFO_0004324],[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0004340,0.4706624915007695,10,body mass index,[EFO_0004324],[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0004574,0.23795820745437116,1,total cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0004570,0.27683300494382723,1,bilirubin measurement,[EFO_0001444],[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0004541,0.4545848412901001,7,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0005772,0.2589866290798124,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC2A2,ENSG00000163581,GO_1901558,0.26966328772352444,1,response to metformin,[GO_0050896],[GO_0008150]
SLC2A2,ENSG00000163581,MONDO_0005148,0.6940092165167243,148,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC2A2,ENSG00000163581,EFO_0004696,0.37621538569172,3,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0004628,0.2545393460461469,1,insulin like growth factor measurement,[EFO_0001444],[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0004627,0.31680394934878525,1,IGF-1 measurement,"[EFO_0005127, EFO_0004730, EFO_0004747]",[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0004468,0.4698687059694668,8,glucose measurement,[EFO_0006842],[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0004465,0.42717252085689317,8,fasting blood glucose measurement,[EFO_0004468],[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0007800,0.41796020861940275,7,body fat percentage,[EFO_0005106],[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0004612,0.2827953084063812,1,high density lipoprotein cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0004611,0.33217027254769144,2,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
SLC2A2,ENSG00000163581,MONDO_0016391,0.37188382262222747,8,neonatal diabetes mellitus,[EFO_1001511],"[OTAR_0000018, OTAR_0000020, EFO_0000540, EFO_0001379, EFO_0009605, EFO_0010282]"
SLC2A2,ENSG00000163581,EFO_0000400,0.21588446328644467,190,diabetes mellitus,"[EFO_0009406, MONDO_0001933]","[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC2A2,ENSG00000163581,MONDO_0100164,0.36994943453938645,2,permanent neonatal diabetes mellitus,"[MONDO_0017688, MONDO_0016391]","[OTAR_0000018, OTAR_0000020, EFO_0000540, EFO_0001379, EFO_0009605, EFO_0010282]"
SLC2A2,ENSG00000163581,EFO_0007777,0.273989829824392,1,base metabolic rate measurement,[EFO_0005115],[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0007629,0.3130526200344448,1,hemoglobin A1 measurement,[EFO_0004509],[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0009805,0.27435325892029133,1,whole body water mass,[EFO_0004302],[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0004532,0.4399328559828063,5,serum gamma-glutamyl transferase measurement,[EFO_0004582],[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0004531,0.3235352500245161,3,urate measurement,[EFO_0001444],[EFO_0001444]
SLC2A2,ENSG00000163581,EFO_0004530,0.44326209327422517,6,triglyceride measurement,[EFO_0004529],[EFO_0001444]
SLC2A3,ENSG00000059804,MONDO_0007739,0.3887717295198249,14,Huntington disease,"[MONDO_0000167, EFO_0004280]","[OTAR_0000018, EFO_0000618]"
SLC2A3,ENSG00000059804,EFO_0005772,0.40352955168874965,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC2A3,ENSG00000059804,EFO_0009700,0.21362359172949513,1,visual perception measurement,[EFO_0004464],[EFO_0001444]
SLC2A4,ENSG00000181856,MONDO_0002561,0.22270175903720313,1,lysosomal storage disease,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
SLC2A4,ENSG00000181856,EFO_0006336,0.22820596422165107,3,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC2A4,ENSG00000181856,EFO_0006335,0.24315058014069937,5,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC2A4,ENSG00000181856,EFO_0004736,0.23899264868303208,3,aspartate aminotransferase measurement,"[EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC2A4,ENSG00000181856,EFO_0004735,0.27344198766773853,4,serum alanine aminotransferase measurement,"[EFO_0004582, EFO_0004747]",[EFO_0001444]
SLC2A4,ENSG00000181856,EFO_0000537,0.21708514306613566,22,hypertension,[MONDO_0000473],[EFO_0000319]
SLC2A4,ENSG00000181856,EFO_0005772,0.22270175903720313,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC2A4,ENSG00000181856,MONDO_0005180,0.22270175903720313,1,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
SLC2A4,ENSG00000181856,MONDO_0005148,0.4092585427153581,394,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC2A4,ENSG00000181856,MONDO_0004975,0.23208795353305733,13,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
SLC2A4,ENSG00000181856,MONDO_0005301,0.22270175903720313,1,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
SLC2A5,ENSG00000142583,HP_0001657,0.3326218692162316,1,Prolonged QT interval,[HP_0003115],[EFO_0000651]
SLC2A5,ENSG00000142583,EFO_0005772,0.2249672246908527,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC2A5,ENSG00000142583,EFO_0006797,0.22110607209100164,1,neurofibrillary tangles measurement,[EFO_0004464],[EFO_0001444]
SLC2A6,ENSG00000160326,EFO_0004533,0.41843363983375753,5,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC2A7,ENSG00000197241,NA,NA,NA,NA,NA,NA
SLC2A8,ENSG00000136856,EFO_0005772,0.3446411070772794,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC2A8,ENSG00000136856,GO_0007568,0.21389383352493757,1,aging,[GO_0032502],[GO_0008150]
SLC2A8,ENSG00000136856,EFO_0000519,0.2309874091779386,2,glioblastoma multiforme,"[EFO_0000272, MONDO_0016680]","[MONDO_0045024, EFO_0000618]"
SLC2A8,ENSG00000136856,EFO_0007710,0.2081770456570667,1,cognitive decline measurement,[EFO_0007998],[EFO_0001444]
SLC2A9,ENSG00000109667,MONDO_0012793,0.6717633367299357,112,"hypouricemia, renal, 2",[MONDO_0009071],"[OTAR_0000018, EFO_0009690]"
SLC2A9,ENSG00000109667,EFO_0004725,0.2863109749453591,1,metabolite measurement,[EFO_0001444],[EFO_0001444]
SLC2A9,ENSG00000109667,EFO_0004713,0.26934065573549304,1,FEV/FEC ratio,"[EFO_0006841, EFO_0003892]",[EFO_0001444]
SLC2A9,ENSG00000109667,EFO_0005856,0.30275027089266304,1,arthritis,"[EFO_0005755, MONDO_0002614, EFO_1000999]",[OTAR_0000006]
SLC2A9,ENSG00000109667,EFO_0005664,0.46407170629727557,4,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC2A9,ENSG00000109667,EFO_0005653,0.46306022305205,7,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC2A9,ENSG00000109667,EFO_1000647,0.3695798546847018,1,renal tubular transport disease,[EFO_0003086],[EFO_0009690]
SLC2A9,ENSG00000109667,MONDO_0009071,0.38453150013886184,35,hereditary renal hypouricemia,[MONDO_0015962],"[OTAR_0000018, EFO_0009690]"
SLC2A9,ENSG00000109667,EFO_0004761,0.5399172373336496,35,uric acid measurement,"[EFO_0004742, EFO_0004298]",[EFO_0001444]
SLC2A9,ENSG00000109667,EFO_0004742,0.328093689832881,1,renal system measurement,[EFO_0001444],[EFO_0001444]
SLC2A9,ENSG00000109667,EFO_0007988,0.240245246620656,1,myeloid white cell count,[EFO_0004308],[EFO_0001444]
SLC2A9,ENSG00000109667,EFO_0007010,0.4014235412186845,3,drug use measurement,[EFO_0001444],[EFO_0001444]
SLC2A9,ENSG00000109667,EFO_0004339,0.353642748910766,3,body height,[EFO_0004324],[EFO_0001444]
SLC2A9,ENSG00000109667,EFO_0010637,0.29718060655032424,1,salivary metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC2A9,ENSG00000109667,EFO_1000999,0.29821276016217807,1,joint disease,[EFO_0002461],[OTAR_0000006]
SLC2A9,ENSG00000109667,GO_0006306,0.32704097245202357,2,DNA methylation,"[GO_0044260, GO_0043412, GO_0006139]",[GO_0008150]
SLC2A9,ENSG00000109667,EFO_0000546,0.2767104373908157,1,injury,[OTAR_0000009],[OTAR_0000009]
SLC2A9,ENSG00000109667,EFO_0003923,0.24864678537166526,1,bone density,[EFO_0004516],[EFO_0001444]
SLC2A9,ENSG00000109667,EFO_0004526,0.2875831065054319,3,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC2A9,ENSG00000109667,EFO_0005090,0.3464033029762672,2,basophil count,"[EFO_0004872, EFO_0803539, EFO_0007987]",[EFO_0001444]
SLC2A9,ENSG00000109667,EFO_0009104,0.2827353961889383,138,hyperuricemia,[Orphanet_79191],"[OTAR_0000018, OTAR_0000020]"
SLC2A9,ENSG00000109667,EFO_0004314,0.21760520882226522,1,forced expiratory volume,"[EFO_0003892, EFO_0006841]",[EFO_0001444]
SLC2A9,ENSG00000109667,EFO_0004312,0.3649165712288539,2,vital capacity,[EFO_0003892],[EFO_0001444]
SLC2A9,ENSG00000109667,EFO_0004309,0.2747132515427418,1,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SLC2A9,ENSG00000109667,EFO_0004305,0.35669553544861676,2,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
SLC2A9,ENSG00000109667,EFO_0004274,0.5686148680362343,211,gout,"[EFO_0005856, EFO_0000589]","[OTAR_0000006, OTAR_0000020]"
SLC2A9,ENSG00000109667,EFO_0006527,0.25876314640236214,1,smoking status measurement,[EFO_0005671],[EFO_0001444]
SLC2A9,ENSG00000109667,EFO_0007978,0.20539962613535606,1,red blood cell density measurement,[EFO_0005047],[EFO_0001444]
SLC2A9,ENSG00000109667,EFO_0009676,0.2767104373908157,1,musculoskeletal system disease,[OTAR_0000006],[OTAR_0000006]
SLC2A9,ENSG00000109667,EFO_0004531,0.7295464394413399,100,urate measurement,[EFO_0001444],[EFO_0001444]
SLC20A1,ENSG00000144136,EFO_0010269,0.2087432266864524,1,amenorrhea,[EFO_0010270],"[OTAR_0000017, EFO_0001379]"
SLC20A1,ENSG00000144136,EFO_0005772,0.31783801218326474,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC20A1,ENSG00000144136,GO_0097327,0.2087432266864524,1,response to antineoplastic agent,[GO_0050896],[GO_0008150]
SLC20A2,ENSG00000168575,MONDO_0002491,0.23319181878071765,1,substance abuse,[MONDO_0002494],[MONDO_0002025]
SLC20A2,ENSG00000168575,EFO_0007052,0.23319181878071765,1,antisocial behaviour measurement,[EFO_0006848],[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0000508,0.41024653169039965,20,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC20A2,ENSG00000168575,EFO_0004980,0.2335950977514189,1,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0004908,0.28084711433363035,1,testosterone measurement,"[EFO_0004529, EFO_0011008]",[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0006335,0.3905712695871638,4,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0003888,0.23319181878071765,1,attention deficit hyperactivity disorder,[MONDO_0000592],"[MONDO_0002025, EFO_0000618]"
SLC20A2,ENSG00000168575,MONDO_0008947,0.6463574820748746,205,bilateral striopallidodentate calcinosis,"[MONDO_0015547, EFO_0009533]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC20A2,ENSG00000168575,EFO_0004833,0.26124023246327643,2,neutrophil count,"[EFO_0803548, EFO_0007987]",[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0004784,0.31473449063047904,5,self reported educational attainment,[EFO_0011015],[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0004761,0.27944483490838695,1,uric acid measurement,"[EFO_0004742, EFO_0004298]",[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0006933,0.2127640107650698,1,pallidum volume,[EFO_0006930],[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0006930,0.2972613532739436,4,brain volume measurement,"[EFO_0005052, EFO_0004464]",[EFO_0001444]
SLC20A2,ENSG00000168575,HP_0001332,0.46608511097586025,6,Dystonia,"[HP_0100022, HP_0000708]",[EFO_0000651]
SLC20A2,ENSG00000168575,EFO_0004348,0.30610582995526453,3,hematocrit,[EFO_0004503],[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0004346,0.2902643670321778,4,neuroimaging measurement,[EFO_0001444],[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0004570,0.28786963594120435,2,bilirubin measurement,[EFO_0001444],[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0004541,0.27941257819580506,3,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_1000640,0.3695798546847018,1,basal ganglia cerebrovascular disease,"[EFO_0003763, EFO_0009533]","[EFO_0000618, EFO_0000319]"
SLC20A2,ENSG00000168575,HP_0002135,0.5502800536440319,118,Basal ganglia calcification,"[HP_0002514, HP_0002134]",[EFO_0000651]
SLC20A2,ENSG00000168575,EFO_0005772,0.25336344513957004,5,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC20A2,ENSG00000168575,EFO_0005763,0.38641978906815383,4,pulse pressure measurement,[EFO_0005278],[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0004696,0.4274782299386122,7,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0004617,0.24055560863618064,1,cystatin C measurement,"[EFO_0004747, EFO_0004742]",[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0004526,0.39843337644126303,9,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0004509,0.35610400414200477,7,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0004464,0.23635248769951783,2,brain measurement,[EFO_0001444],[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0009188,0.31247831561260886,5,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0004305,0.3071208915725168,5,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0006525,0.21887095451394184,1,cigarettes per day measurement,[EFO_0005671],[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0007978,0.2906244485342166,2,red blood cell density measurement,[EFO_0005047],[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0007937,0.20638173059544096,1,blood protein measurement,[EFO_0004747],[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0009749,0.20523551249949412,1,age at first sexual intercourse measurement,[EFO_0007862],[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0004531,0.3831883605237184,3,urate measurement,[EFO_0001444],[EFO_0001444]
SLC20A2,ENSG00000168575,EFO_0004528,0.33757361562251265,9,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC22A1,ENSG00000175003,MONDO_0008315,0.21052213038449197,1,prostate cancer,"[MONDO_0021259, EFO_0007355]","[OTAR_0000017, MONDO_0045024]"
SLC22A1,ENSG00000175003,EFO_0005208,0.2938961899445929,5,glomerular filtration rate,[EFO_0004742],[EFO_0001444]
SLC22A1,ENSG00000175003,EFO_0005271,0.3058825944126787,1,sleep duration,[EFO_0004870],[EFO_0001444]
SLC22A1,ENSG00000175003,EFO_0000389,0.21766119753382762,5,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLC22A1,ENSG00000175003,MONDO_0021187,0.3291896853012358,2,hyperlipidemia,[EFO_0000589],[OTAR_0000020]
SLC22A1,ENSG00000175003,HP_0003124,0.42880387763062194,4,Hypercholesterolemia,[HP_0003119],[EFO_0000651]
SLC22A1,ENSG00000175003,EFO_0004725,0.30571511038939564,1,metabolite measurement,[EFO_0001444],[EFO_0001444]
SLC22A1,ENSG00000175003,EFO_0001663,0.32660607768945077,11,prostate carcinoma,"[MONDO_0008315, EFO_0000313]","[OTAR_0000017, MONDO_0045024]"
SLC22A1,ENSG00000175003,EFO_0001645,0.26939202886575847,3,coronary artery disease,"[MONDO_0000473, EFO_0003777]",[EFO_0000319]
SLC22A1,ENSG00000175003,EFO_0004980,0.2988703381680995,1,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
SLC22A1,ENSG00000175003,EFO_0004918,0.22245001958231717,1,age at diagnosis,[EFO_0004949],[EFO_0001444]
SLC22A1,ENSG00000175003,EFO_0005664,0.43539418147125153,4,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC22A1,ENSG00000175003,EFO_0005653,0.4660528560745713,9,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC22A1,ENSG00000175003,EFO_0008075,0.35927202499191485,3,cation-independent mannose-6-phosphate receptor measurement,"[EFO_0010968, EFO_0007937]",[EFO_0001444]
SLC22A1,ENSG00000175003,EFO_0007355,0.26315266298061496,2,male reproductive organ cancer,"[MONDO_0024582, MONDO_0002149]","[OTAR_0000017, MONDO_0045024]"
SLC22A1,ENSG00000175003,EFO_0004736,0.3854528374305643,2,aspartate aminotransferase measurement,"[EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC22A1,ENSG00000175003,EFO_0006925,0.41474144301751137,5,lipoprotein A measurement,[EFO_0004732],[EFO_0001444]
SLC22A1,ENSG00000175003,EFO_0009932,0.3119734572281038,1,HMG CoA reductase inhibitor use measurement,[EFO_0007010],[EFO_0001444]
SLC22A1,ENSG00000175003,EFO_0004574,0.47644823560869054,10,total cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
SLC22A1,ENSG00000175003,EFO_0004570,0.4821888528600386,8,bilirubin measurement,[EFO_0001444],[EFO_0001444]
SLC22A1,ENSG00000175003,EFO_0004533,0.42702733937639575,4,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC22A1,ENSG00000175003,MONDO_0001134,0.22245001958231717,1,essential hypertension,"[EFO_0000537, MONDO_0005044]",[EFO_0000319]
SLC22A1,ENSG00000175003,EFO_0004627,0.44176626705724514,5,IGF-1 measurement,"[EFO_0005127, EFO_0004730, EFO_0004747]",[EFO_0001444]
SLC22A1,ENSG00000175003,EFO_0004615,0.4543579668893513,5,apolipoprotein B measurement,[EFO_0004732],[EFO_0001444]
SLC22A1,ENSG00000175003,EFO_0004518,0.3546364187316809,2,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC22A1,ENSG00000175003,EFO_0005116,0.4331015461034128,4,urinary metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC22A1,ENSG00000175003,EFO_0007796,0.2195252689103298,3,parental longevity,[EFO_0004300],[EFO_0001444]
SLC22A1,ENSG00000175003,EFO_0004611,0.4914811393813176,15,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
SLC22A1,ENSG00000175003,EFO_1000985,0.257036957325882,1,intermediate coronary syndrome,[EFO_0001645],[EFO_0000319]
SLC22A1,ENSG00000175003,EFO_0007937,0.28639483657730036,5,blood protein measurement,[EFO_0004747],[EFO_0001444]
SLC22A1,ENSG00000175003,EFO_0004532,0.38486213848484113,2,serum gamma-glutamyl transferase measurement,[EFO_0004582],[EFO_0001444]
SLC22A1,ENSG00000175003,EFO_0004530,0.45943128279088624,6,triglyceride measurement,[EFO_0004529],[EFO_0001444]
SLC22A10,ENSG00000184999,NA,NA,NA,NA,NA,NA
SLC22A11,ENSG00000168065,EFO_0001073,0.26794539464640876,2,obesity,[MONDO_0003916],[OTAR_0000020]
SLC22A11,ENSG00000168065,EFO_0000544,0.26979329391983226,3,infection,[OBI_1110122],[GO_0008150]
SLC22A11,ENSG00000168065,EFO_0004908,0.4304545019011181,7,testosterone measurement,"[EFO_0004529, EFO_0011008]",[EFO_0001444]
SLC22A11,ENSG00000168065,EFO_0007328,0.3695798546847018,1,influenza,"[MONDO_0024352, MONDO_0100329]","[EFO_0005741, OTAR_0000010]"
SLC22A11,ENSG00000168065,EFO_0004248,0.25870589827929125,1,male infertility,"[EFO_0000545, EFO_0009555]",[OTAR_0000017]
SLC22A11,ENSG00000168065,EFO_0004761,0.2652509187173056,4,uric acid measurement,"[EFO_0004742, EFO_0004298]",[EFO_0001444]
SLC22A11,ENSG00000168065,EFO_0004340,0.20453524291957262,1,body mass index,[EFO_0004324],[EFO_0001444]
SLC22A11,ENSG00000168065,EFO_0003103,0.3521274726579242,3,urinary tract infection,"[EFO_0000771, EFO_0009690]","[EFO_0005741, EFO_0009690]"
SLC22A11,ENSG00000168065,EFO_1000025,0.25870589827929125,1,cystitis,[EFO_1000018],[EFO_0009690]
SLC22A11,ENSG00000168065,EFO_0005772,0.31571524671231094,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC22A11,ENSG00000168065,EFO_0004274,0.5935664017500499,28,gout,"[EFO_0005856, EFO_0000589]","[OTAR_0000006, OTAR_0000020]"
SLC22A11,ENSG00000168065,EFO_0000474,0.3695798546847018,1,epilepsy,[EFO_0005774],[EFO_0000618]
SLC22A11,ENSG00000168065,EFO_0004531,0.6241155846746733,16,urate measurement,[EFO_0001444],[EFO_0001444]
SLC22A12,ENSG00000197891,MONDO_0009071,0.6506746550687105,175,hereditary renal hypouricemia,[MONDO_0015962],"[OTAR_0000018, EFO_0009690]"
SLC22A12,ENSG00000197891,EFO_0004761,0.3127867113062462,7,uric acid measurement,"[EFO_0004742, EFO_0004298]",[EFO_0001444]
SLC22A12,ENSG00000197891,EFO_0007010,0.32589977261736136,4,drug use measurement,[EFO_0001444],[EFO_0001444]
SLC22A12,ENSG00000197891,EFO_0004340,0.2659882472898502,4,body mass index,[EFO_0004324],[EFO_0001444]
SLC22A12,ENSG00000197891,EFO_1000639,0.3695798546847018,1,acquired metabolic disease,[EFO_0000589],[OTAR_0000020]
SLC22A12,ENSG00000197891,MONDO_0005148,0.39281205499446514,5,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC22A12,ENSG00000197891,EFO_0009104,0.42241109017132206,186,hyperuricemia,[Orphanet_79191],"[OTAR_0000018, OTAR_0000020]"
SLC22A12,ENSG00000197891,EFO_0004274,0.7371906447699238,167,gout,"[EFO_0005856, EFO_0000589]","[OTAR_0000006, OTAR_0000020]"
SLC22A12,ENSG00000197891,EFO_0004531,0.6994591098591052,45,urate measurement,[EFO_0001444],[EFO_0001444]
SLC22A13,ENSG00000172940,EFO_0004531,0.2755418381600989,1,urate measurement,[EFO_0001444],[EFO_0001444]
SLC22A14,ENSG00000144671,EFO_0002571,0.4619748183558772,2,medical procedure,[],[EFO_0002571]
SLC22A14,ENSG00000144671,EFO_1001329,0.3695798546847018,1,Follicular Cyst,[EFO_1000763],[EFO_0010285]
SLC22A14,ENSG00000144671,EFO_0005772,0.3967008454308569,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC22A15,ENSG00000163393,EFO_0005772,0.20033587775217013,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC22A16,ENSG00000004809,EFO_0005664,0.5066788579650011,8,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC22A16,ENSG00000004809,EFO_0005653,0.45414452294636953,3,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC22A16,ENSG00000004809,EFO_0007986,0.5159497094254947,11,reticulocyte count,[EFO_0010700],[EFO_0001444]
SLC22A16,ENSG00000004809,EFO_0010701,0.382928659567628,2,mean reticulocyte volume,[EFO_0010700],[EFO_0001444]
SLC22A16,ENSG00000004809,EFO_0010700,0.4456129109829248,3,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
SLC22A16,ENSG00000004809,EFO_0004584,0.3198296030815605,5,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
SLC22A16,ENSG00000004809,EFO_0004570,0.3320514278409163,1,bilirubin measurement,[EFO_0001444],[EFO_0001444]
SLC22A16,ENSG00000004809,EFO_0004541,0.35343641762339084,2,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
SLC22A16,ENSG00000004809,EFO_0004526,0.43413802792481576,6,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC22A16,ENSG00000004809,EFO_0005059,0.3318886799829635,1,acylcarnitine measurement,[EFO_0004725],[EFO_0001444]
SLC22A16,ENSG00000004809,EFO_0009270,0.32383602038738557,2,heel bone mineral density,[EFO_0003923],[EFO_0001444]
SLC22A16,ENSG00000004809,EFO_0009253,0.39505689957326046,2,Immature Reticulocyte Fraction Measurement,[EFO_0009233],[EFO_0001444]
SLC22A16,ENSG00000004809,EFO_0009188,0.48387993714369687,5,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC22A16,ENSG00000004809,EFO_0004305,0.3153227852349484,1,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
SLC22A16,ENSG00000004809,EFO_0007629,0.3318886799829635,1,hemoglobin A1 measurement,[EFO_0004509],[EFO_0001444]
SLC22A16,ENSG00000004809,EFO_0004528,0.3909479512263037,2,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC22A16,ENSG00000004809,EFO_0004527,0.33254857168825636,2,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC22A17,ENSG00000092096,NA,NA,NA,NA,NA,NA
SLC22A18,ENSG00000110628,EFO_0001071,0.45273532198875965,2,lung carcinoma,"[MONDO_0008903, EFO_0000313]","[OTAR_0000010, MONDO_0045024]"
SLC22A18,ENSG00000110628,EFO_0002918,0.4531459662717427,3,rhabdomyosarcoma,"[EFO_0007384, EFO_1001968]","[OTAR_0000006, MONDO_0045024]"
SLC22A18,ENSG00000110628,EFO_0004574,0.2569907847621503,3,total cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
SLC22A18,ENSG00000110628,EFO_0004570,0.3583907443970076,9,bilirubin measurement,[EFO_0001444],[EFO_0001444]
SLC22A18,ENSG00000110628,EFO_0004838,0.2690642161408729,7,calcium measurement,[EFO_0001444],[EFO_0001444]
SLC22A18,ENSG00000110628,EFO_0005772,0.25429703519483354,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC22A18,ENSG00000110628,GO_0007568,0.25429703519483354,1,aging,[GO_0032502],[GO_0008150]
SLC22A18,ENSG00000110628,EFO_0003060,0.20813074306496324,8,non-small cell lung carcinoma,[EFO_0001071],"[OTAR_0000010, MONDO_0045024]"
SLC22A18,ENSG00000110628,EFO_0000571,0.21480583565706227,3,lung adenocarcinoma,"[EFO_0000228, EFO_0003060]","[OTAR_0000010, MONDO_0045024]"
SLC22A18,ENSG00000110628,EFO_0004518,0.25523664482270025,8,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC22A18,ENSG00000110628,EFO_0004614,0.313690259029089,3,apolipoprotein A 1 measurement,"[EFO_0004872, EFO_0005278, EFO_0004732]",[EFO_0001444]
SLC22A18,ENSG00000110628,EFO_0004612,0.3752224080470845,9,high density lipoprotein cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
SLC22A18,ENSG00000110628,EFO_0004531,0.29916927219606504,3,urate measurement,[EFO_0001444],[EFO_0001444]
SLC22A2,ENSG00000112499,EFO_0005208,0.5273460020036194,17,glomerular filtration rate,[EFO_0004742],[EFO_0001444]
SLC22A2,ENSG00000112499,EFO_0000389,0.21766119753382762,5,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLC22A2,ENSG00000112499,EFO_0001663,0.41505376946877964,18,prostate carcinoma,"[MONDO_0008315, EFO_0000313]","[OTAR_0000017, MONDO_0045024]"
SLC22A2,ENSG00000112499,EFO_0004253,0.3596856638653453,2,nephrolithiasis,"[MONDO_0024647, EFO_0003086]",[EFO_0009690]
SLC22A2,ENSG00000112499,MONDO_0024647,0.3192310248081136,1,urolithiasis,[EFO_0009690],[EFO_0009690]
SLC22A2,ENSG00000112499,MONDO_0024622,0.2309874091779386,2,thyroid gland adenocarcinoma,"[EFO_0000228, EFO_0002892]","[MONDO_0045024, EFO_0001379]"
SLC22A2,ENSG00000112499,EFO_0005664,0.41550093721591785,2,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC22A2,ENSG00000112499,EFO_0005653,0.33271162725927633,1,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC22A2,ENSG00000112499,EFO_0009931,0.28852595831259636,1,Agents acting on the renin-angiotensin system use measurement,[EFO_0007010],[EFO_0001444]
SLC22A2,ENSG00000112499,EFO_0009926,0.28852595831259636,1,Vasodilators used in cardiac diseases use measurement,[EFO_0007010],[EFO_0001444]
SLC22A2,ENSG00000112499,EFO_0006925,0.6709984825106371,14,lipoprotein A measurement,[EFO_0004732],[EFO_0001444]
SLC22A2,ENSG00000112499,EFO_0004342,0.21237075484192788,1,waist circumference,[EFO_0004324],[EFO_0001444]
SLC22A2,ENSG00000112499,EFO_0004533,0.3227514935984496,1,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC22A2,ENSG00000112499,MONDO_0005148,0.32546007336197347,11,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC22A2,ENSG00000112499,EFO_0004518,0.7107246861213338,28,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC22A2,ENSG00000112499,EFO_0004611,0.3407797242882122,9,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
SLC22A2,ENSG00000112499,EFO_0003884,0.4391436156849583,13,chronic kidney disease,[EFO_0003086],[EFO_0009690]
SLC22A20P,ENSG00000197847,NA,NA,NA,NA,NA,NA
SLC22A23,ENSG00000137266,EFO_0010750,0.32380677732005586,1,PHF-tau measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
SLC22A23,ENSG00000137266,EFO_0000384,0.3994846406624885,3,Crohn's disease,[EFO_0003767],"[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLC22A23,ENSG00000137266,EFO_0001075,0.2519075746226792,2,ovarian carcinoma,[MONDO_0018364],"[OTAR_0000017, MONDO_0045024, EFO_0001379]"
SLC22A23,ENSG00000137266,EFO_0008354,0.3085940160212292,1,cognitive function measurement,[EFO_0001444],[EFO_0001444]
SLC22A23,ENSG00000137266,EFO_0004784,0.45867715417215366,5,self reported educational attainment,[EFO_0011015],[EFO_0001444]
SLC22A23,ENSG00000137266,EFO_0004337,0.4515327107271321,4,intelligence,[EFO_0003925],[GO_0008150]
SLC22A23,ENSG00000137266,EFO_0004327,0.4296595608947987,34,electrocardiography,[EFO_0004311],[EFO_0001444]
SLC22A23,ENSG00000137266,EFO_0010130,0.3064414839503234,1,health study participation,[EFO_0000651],[EFO_0000651]
SLC22A23,ENSG00000137266,EFO_0004584,0.500885115554954,9,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
SLC22A23,ENSG00000137266,EFO_0004541,0.32504518542487276,1,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
SLC22A23,ENSG00000137266,EFO_0004875,0.3085940160212292,1,mathematical ability,[EFO_0003925],[GO_0008150]
SLC22A23,ENSG00000137266,EFO_0007822,0.31547000287635313,1,hair colour measurement,[EFO_0007821],[EFO_0001444]
SLC22A23,ENSG00000137266,EFO_0009188,0.5224083165624729,15,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC22A23,ENSG00000137266,EFO_0007629,0.32951649998411414,1,hemoglobin A1 measurement,[EFO_0004509],[EFO_0001444]
SLC22A23,ENSG00000137266,EFO_0004528,0.336933725900274,2,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC22A23,ENSG00000137266,EFO_0004527,0.36742861129133925,2,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC22A24,ENSG00000197658,EFO_0004908,0.37813622114022555,6,testosterone measurement,"[EFO_0004529, EFO_0011008]",[EFO_0001444]
SLC22A24,ENSG00000197658,EFO_0005653,0.24070002863573914,1,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC22A24,ENSG00000197658,EFO_0005116,0.3088175489509405,3,urinary metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC22A25,ENSG00000196600,NA,NA,NA,NA,NA,NA
SLC22A3,ENSG00000146477,MONDO_0021661,0.22117010945200172,1,coronary atherosclerosis,"[EFO_0003914, EFO_0001645]",[EFO_0000319]
SLC22A3,ENSG00000146477,EFO_0005409,0.38845184784003306,4,fat body mass,[EFO_0004302],[EFO_0001444]
SLC22A3,ENSG00000146477,MONDO_0005575,0.31011648137035386,7,colorectal cancer,"[EFO_0007330, EFO_0004142]","[MONDO_0045024, EFO_0010282]"
SLC22A3,ENSG00000146477,EFO_0001663,0.48956395938609826,9,prostate carcinoma,"[MONDO_0008315, EFO_0000313]","[OTAR_0000017, MONDO_0045024]"
SLC22A3,ENSG00000146477,EFO_0001645,0.39785340579202305,22,coronary artery disease,"[MONDO_0000473, EFO_0003777]",[EFO_0000319]
SLC22A3,ENSG00000146477,EFO_0004995,0.45294936553292736,10,lean body mass,[EFO_0004302],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0004980,0.401493071674797,3,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0004908,0.3666305894618691,2,testosterone measurement,"[EFO_0004529, EFO_0011008]",[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0006335,0.2875566304845651,1,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0000612,0.4174906660264451,7,myocardial infarction,[MONDO_0024643],[EFO_0000319]
SLC22A3,ENSG00000146477,EFO_0000589,0.23300960321256203,2,metabolic disease,[OTAR_0000020],[OTAR_0000020]
SLC22A3,ENSG00000146477,EFO_1001375,0.22117010945200172,1,Myocardial Ischemia,"[MONDO_0005053, EFO_0001645, MONDO_0024643]",[EFO_0000319]
SLC22A3,ENSG00000146477,EFO_0008039,0.3541048585201424,2,BMI-adjusted hip circumference,[EFO_0005093],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0008024,0.2642226012788999,1,angiostatin measurement,[EFO_0007937],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0004761,0.2978746199862746,1,uric acid measurement,"[EFO_0004742, EFO_0004298]",[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0004735,0.26096244604071583,2,serum alanine aminotransferase measurement,"[EFO_0004582, EFO_0004747]",[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0007989,0.2717639642912331,1,monocyte percentage of leukocytes,[EFO_0005091],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0004339,0.441957439390935,7,body height,[EFO_0004324],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0004338,0.4122178890586902,4,body weight,[EFO_0004324],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0009931,0.2163577379824813,2,Agents acting on the renin-angiotensin system use measurement,[EFO_0007010],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0009926,0.21468798775058917,2,Vasodilators used in cardiac diseases use measurement,[EFO_0007010],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0010701,0.2650065192485901,2,mean reticulocyte volume,[EFO_0010700],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0010648,0.33129148257783375,1,response to vitamin B3,[GO_0033273],[GO_0008150]
SLC22A3,ENSG00000146477,EFO_0006925,0.6105561242958982,19,lipoprotein A measurement,[EFO_0004732],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0004343,0.4141250076055853,4,waist-hip ratio,[EFO_0007861],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0004340,0.4588799791335244,9,body mass index,[EFO_0004324],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0004574,0.40316666342975743,6,total cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0004570,0.38679957154938815,2,bilirubin measurement,[EFO_0001444],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0004535,0.30805993077270943,1,serum albumin measurement,[EFO_0004747],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0005772,0.46570388172644533,3,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC22A3,ENSG00000146477,EFO_0005763,0.28646885446592585,1,pulse pressure measurement,[EFO_0005278],[EFO_0001444]
SLC22A3,ENSG00000146477,MONDO_0004992,0.3292322547751355,25,cancer,[EFO_0000616],[MONDO_0045024]
SLC22A3,ENSG00000146477,GO_0036273,0.33129148257783375,1,response to statin,[GO_0050896],[GO_0008150]
SLC22A3,ENSG00000146477,MONDO_0005148,0.46110512700084755,19,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC22A3,ENSG00000146477,EFO_0004526,0.296815194873589,1,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0004696,0.4644559335472908,7,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0004628,0.29412062520214366,1,insulin like growth factor measurement,[EFO_0001444],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0004627,0.30890534729849595,1,IGF-1 measurement,"[EFO_0005127, EFO_0004730, EFO_0004747]",[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0004615,0.36353907432752114,4,apolipoprotein B measurement,[EFO_0004732],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0004614,0.26869689032130284,3,apolipoprotein A 1 measurement,"[EFO_0004872, EFO_0005278, EFO_0004732]",[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0005093,0.2743445355646133,1,hip circumference,"[EFO_0004512, EFO_0004324]",[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0005091,0.4459896770270783,4,monocyte count,"[EFO_0004308, EFO_0803547]",[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0007800,0.36202924513563667,2,body fat percentage,[EFO_0005106],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0007789,0.28826535907605316,1,BMI-adjusted waist circumference,[EFO_0004342],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0007788,0.45350754516691044,6,BMI-adjusted waist-hip ratio,[EFO_0004343],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0004611,0.5093029544859302,17,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0007937,0.3708932343255325,5,blood protein measurement,[EFO_0004747],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0007777,0.29163720038972335,1,base metabolic rate measurement,[EFO_0005115],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0009805,0.29683656268926495,1,whole body water mass,[EFO_0004302],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0009767,0.28690279735355595,1,glycine measurement,[EFO_0005134],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0004532,0.30826468731570766,1,serum gamma-glutamyl transferase measurement,[EFO_0004582],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0004531,0.4120824630309747,3,urate measurement,[EFO_0001444],[EFO_0001444]
SLC22A3,ENSG00000146477,EFO_0004530,0.402015855347733,7,triglyceride measurement,[EFO_0004529],[EFO_0001444]
SLC22A31,ENSG00000259803,EFO_0005772,0.36644184066249624,3,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC22A31,ENSG00000259803,EFO_0009188,0.28957977988083605,2,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC22A4,ENSG00000197208,EFO_0005208,0.24151755808158243,3,glomerular filtration rate,[EFO_0004742],[EFO_0001444]
SLC22A4,ENSG00000197208,EFO_0000685,0.4207507679651362,39,rheumatoid arthritis,"[MONDO_0000589, EFO_0005140, EFO_0005755, EFO_0005856]","[OTAR_0000006, EFO_0000540]"
SLC22A4,ENSG00000197208,EFO_0000384,0.358226287805468,76,Crohn's disease,[EFO_0003767],"[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLC22A4,ENSG00000197208,EFO_0004725,0.21263831514007275,3,metabolite measurement,[EFO_0001444],[EFO_0001444]
SLC22A4,ENSG00000197208,EFO_0003767,0.3599825367317467,53,inflammatory bowel disease,"[EFO_0000508, EFO_0005140, EFO_0009431]","[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLC22A4,ENSG00000197208,EFO_0001645,0.291572941805745,4,coronary artery disease,"[MONDO_0000473, EFO_0003777]",[EFO_0000319]
SLC22A4,ENSG00000197208,EFO_0004995,0.2414107844375487,6,lean body mass,[EFO_0004302],[EFO_0001444]
SLC22A4,ENSG00000197208,EFO_0004980,0.2176702962168191,3,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
SLC22A4,ENSG00000197208,EFO_0006336,0.31709579935995263,6,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC22A4,ENSG00000197208,EFO_0005664,0.31167799089452974,10,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC22A4,ENSG00000197208,EFO_0005653,0.43294963626605404,10,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC22A4,ENSG00000197208,EFO_0000305,0.25666933176721324,2,breast carcinoma,"[EFO_0000313, MONDO_0007254]","[OTAR_0000017, MONDO_0045024, EFO_0010285]"
SLC22A4,ENSG00000197208,EFO_0007988,0.20808653950335915,4,myeloid white cell count,[EFO_0004308],[EFO_0001444]
SLC22A4,ENSG00000197208,EFO_0004339,0.24234414482629743,8,body height,[EFO_0004324],[EFO_0001444]
SLC22A4,ENSG00000197208,EFO_0004584,0.32591638497829,7,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
SLC22A4,ENSG00000197208,EFO_0004570,0.22881721010891712,1,bilirubin measurement,[EFO_0001444],[EFO_0001444]
SLC22A4,ENSG00000197208,EFO_0005772,0.3250051888311299,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC22A4,ENSG00000197208,MONDO_0004979,0.23955418891834504,11,asthma,[EFO_1002018],[OTAR_0000010]
SLC22A4,ENSG00000197208,EFO_0004518,0.3206482066326403,2,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC22A4,ENSG00000197208,EFO_0005091,0.23274676455519494,7,monocyte count,"[EFO_0004308, EFO_0803547]",[EFO_0001444]
SLC22A4,ENSG00000197208,EFO_0005090,0.21349758612431294,5,basophil count,"[EFO_0004872, EFO_0803539, EFO_0007987]",[EFO_0001444]
SLC22A4,ENSG00000197208,EFO_0005059,0.20680104368865268,2,acylcarnitine measurement,[EFO_0004725],[EFO_0001444]
SLC22A4,ENSG00000197208,EFO_0007789,0.2388902829556401,3,BMI-adjusted waist circumference,[EFO_0004342],[EFO_0001444]
SLC22A4,ENSG00000197208,EFO_0004318,0.2191459770260663,2,smoking behavior,[GO_0007610],[GO_0008150]
SLC22A4,ENSG00000197208,EFO_0004312,0.25158104967808054,3,vital capacity,[EFO_0003892],[EFO_0001444]
SLC22A4,ENSG00000197208,EFO_0004309,0.249849761230885,8,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SLC22A4,ENSG00000197208,EFO_0004308,0.24037674492177297,11,leukocyte count,[EFO_0004586],[EFO_0001444]
SLC22A4,ENSG00000197208,EFO_0004302,0.2113724813336923,1,anthropometric measurement,[EFO_0001444],[EFO_0001444]
SLC22A4,ENSG00000197208,EFO_0003870,0.24256211812135234,2,brain aneurysm,[EFO_1000859],"[EFO_0000618, EFO_0000319]"
SLC22A4,ENSG00000197208,EFO_1000391,0.2169292638723474,4,Nasal Cavity Polyp,"[EFO_0000662, MONDO_0002232]","[OTAR_0000010, MONDO_0045024]"
SLC22A4,ENSG00000197208,EFO_0000729,0.31490700896747376,28,ulcerative colitis,[EFO_0003872],"[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLC22A4,ENSG00000197208,EFO_0004531,0.2975657242544932,2,urate measurement,[EFO_0001444],[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0005208,0.25895667933496147,3,glomerular filtration rate,[EFO_0004742],[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0000384,0.2602386845120517,58,Crohn's disease,[EFO_0003767],"[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLC22A5,ENSG00000197375,EFO_0000508,0.48100985850563727,17,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC22A5,ENSG00000197375,HP_0003234,0.5259320433873831,83,Decreased circulating carnitine concentration,"[HP_0003119, HP_0004354, HP_0003287]",[EFO_0000651]
SLC22A5,ENSG00000197375,MONDO_0011628,0.3779415988969431,2,propionic acidemia,[MONDO_0019215],"[OTAR_0000018, OTAR_0000020]"
SLC22A5,ENSG00000197375,EFO_0004725,0.2059004983361014,3,metabolite measurement,[EFO_0001444],[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0003767,0.2975718312621789,37,inflammatory bowel disease,"[EFO_0000508, EFO_0005140, EFO_0009431]","[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLC22A5,ENSG00000197375,EFO_0004995,0.3121977400445399,6,lean body mass,[EFO_0004302],[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0004980,0.20340255501996943,3,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0006336,0.23519825056202956,6,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0005664,0.41146879168357525,12,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0005653,0.35840020728925603,10,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0000407,0.3754809670227736,6,dilated cardiomyopathy,[MONDO_0000591],"[OTAR_0000006, EFO_0000319]"
SLC22A5,ENSG00000197375,HP_0008936,0.3400134663099256,1,Axial hypotonia,[HP_0001252],[EFO_0000651]
SLC22A5,ENSG00000197375,EFO_0009390,0.2312879904613394,1,sum of neutrophil and eosinophil counts,[EFO_0007987],[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0009388,0.2251530482653291,1,sum of basophil and neutrophil counts,[EFO_0007987],[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0004833,0.25072125142323515,9,neutrophil count,"[EFO_0803548, EFO_0007987]",[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0007988,0.2529864290122591,6,myeloid white cell count,[EFO_0004308],[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0007987,0.23260845538408734,1,granulocyte count,[EFO_0007988],[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0006941,0.22891627581826954,2,grip strength measurement,[EFO_0004302],[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0004339,0.26494470880397625,8,body height,[EFO_0004324],[EFO_0001444]
SLC22A5,ENSG00000197375,Orphanet_300751,0.25870589827929125,1,Familial dilated cardiomyopathy with conduction defect due to LMNA mutation,"[Orphanet_98054, EFO_0002945]","[OTAR_0000006, OTAR_0000018, EFO_0000319]"
SLC22A5,ENSG00000197375,EFO_0010700,0.28887030537390385,3,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0004584,0.3206673060410655,9,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0004574,0.2186531826375341,4,total cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
SLC22A5,ENSG00000197375,MONDO_0007269,0.25870589827929125,1,dilated cardiomyopathy 1A,[MONDO_0015470],"[OTAR_0000006, OTAR_0000018, EFO_0000319]"
SLC22A5,ENSG00000197375,EFO_0005772,0.3210969562747099,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC22A5,ENSG00000197375,MONDO_0002320,0.26609749537298527,1,congenital nervous system disorder,[EFO_0000618],[EFO_0000618]
SLC22A5,ENSG00000197375,EFO_0004518,0.21723075988121954,2,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0004623,0.25753157838194185,6,fibrinogen measurement,"[EFO_0004747, EFO_0004634, EFO_0004503]",[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0004615,0.22669474442710477,2,apolipoprotein B measurement,[EFO_0004732],[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0005110,0.27704525123664997,1,fatty acid measurement,[EFO_0004529],[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0005091,0.4040094690943038,7,monocyte count,"[EFO_0004308, EFO_0803547]",[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0005090,0.2575102330615214,5,basophil count,"[EFO_0004872, EFO_0803539, EFO_0007987]",[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0005059,0.33889967141439825,3,acylcarnitine measurement,[EFO_0004725],[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0007789,0.25410483469629563,3,BMI-adjusted waist circumference,[EFO_0004342],[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0009253,0.25584021095446424,2,Immature Reticulocyte Fraction Measurement,[EFO_0009233],[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0004611,0.3372281132670918,7,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0004587,0.20480323277689857,2,lymphocyte count,"[EFO_0006843, EFO_0004308, EFO_0803546]",[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0004318,0.2327895476219413,2,smoking behavior,[GO_0007610],[GO_0008150]
SLC22A5,ENSG00000197375,EFO_0004312,0.2582018459485157,3,vital capacity,[EFO_0003892],[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0004309,0.3742883718368191,12,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SLC22A5,ENSG00000197375,EFO_0004308,0.3205676187149925,12,leukocyte count,[EFO_0004586],[EFO_0001444]
SLC22A5,ENSG00000197375,MONDO_0008919,0.8372410070620664,1039,systemic primary carnitine deficiency disease,"[MONDO_0017713, MONDO_0017716]","[OTAR_0000018, OTAR_0000020]"
SLC22A5,ENSG00000197375,Orphanet_158,0.8645098639602378,1025,Systemic primary carnitine deficiency,"[Orphanet_79174, Orphanet_217616, Orphanet_206634]","[OTAR_0000006, OTAR_0000018, OTAR_0000020, EFO_0000319]"
SLC22A5,ENSG00000197375,EFO_0000729,0.28764424765302077,20,ulcerative colitis,[EFO_0003872],"[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLC22A6,ENSG00000197901,EFO_0020092,0.22913550701166882,1,neuroinflammatory disorder,"[EFO_0009386, MONDO_0002977]","[EFO_0000540, EFO_0000618]"
SLC22A6,ENSG00000197901,EFO_0001073,0.2688693442831205,3,obesity,[MONDO_0003916],[OTAR_0000020]
SLC22A6,ENSG00000197901,EFO_0000544,0.26794539464640876,2,infection,[OBI_1110122],[GO_0008150]
SLC22A6,ENSG00000197901,EFO_0007328,0.3695798546847018,1,influenza,"[MONDO_0024352, MONDO_0100329]","[EFO_0005741, OTAR_0000010]"
SLC22A6,ENSG00000197901,EFO_0004248,0.25870589827929125,1,male infertility,"[EFO_0000545, EFO_0009555]",[OTAR_0000017]
SLC22A6,ENSG00000197901,EFO_0003103,0.3521274726579242,3,urinary tract infection,"[EFO_0000771, EFO_0009690]","[EFO_0005741, EFO_0009690]"
SLC22A6,ENSG00000197901,EFO_1000025,0.25870589827929125,1,cystitis,[EFO_1000018],[EFO_0009690]
SLC22A6,ENSG00000197901,EFO_0004274,0.5073542454492275,8,gout,"[EFO_0005856, EFO_0000589]","[OTAR_0000006, OTAR_0000020]"
SLC22A6,ENSG00000197901,EFO_0000474,0.3695798546847018,1,epilepsy,[EFO_0005774],[EFO_0000618]
SLC22A6,ENSG00000197901,EFO_0004531,0.33479880759151687,3,urate measurement,[EFO_0001444],[EFO_0001444]
SLC22A7,ENSG00000137204,EFO_0006335,0.32868993155531745,16,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC22A7,ENSG00000137204,EFO_0005763,0.3098254451704615,8,pulse pressure measurement,[EFO_0005278],[EFO_0001444]
SLC22A7,ENSG00000137204,EFO_0004518,0.5574357570454007,9,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC22A7,ENSG00000137204,EFO_0006527,0.22428286030221048,4,smoking status measurement,[EFO_0005671],[EFO_0001444]
SLC22A8,ENSG00000149452,EFO_0001073,0.2684997644284358,3,obesity,[MONDO_0003916],[OTAR_0000020]
SLC22A8,ENSG00000149452,EFO_0000544,0.2723033570995659,5,infection,[OBI_1110122],[GO_0008150]
SLC22A8,ENSG00000149452,EFO_0007328,0.36994943453938645,2,influenza,"[MONDO_0024352, MONDO_0100329]","[EFO_0005741, OTAR_0000010]"
SLC22A8,ENSG00000149452,EFO_0004248,0.25870589827929125,1,male infertility,"[EFO_0000545, EFO_0009555]",[OTAR_0000017]
SLC22A8,ENSG00000149452,EFO_0003103,0.3526818424399512,4,urinary tract infection,"[EFO_0000771, EFO_0009690]","[EFO_0005741, EFO_0009690]"
SLC22A8,ENSG00000149452,EFO_1000025,0.25870589827929125,1,cystitis,[EFO_1000018],[EFO_0009690]
SLC22A8,ENSG00000149452,EFO_0005772,0.23400852076968753,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC22A8,ENSG00000149452,EFO_0004274,0.5069833823311584,9,gout,"[EFO_0005856, EFO_0000589]","[OTAR_0000006, OTAR_0000020]"
SLC22A8,ENSG00000149452,EFO_0000474,0.3695798546847018,1,epilepsy,[EFO_0005774],[EFO_0000618]
SLC22A9,ENSG00000149742,NA,NA,NA,NA,NA,NA
SV2A,ENSG00000159164,EFO_0005230,0.28298719207100537,7,anxiety,[HP_0000708],[EFO_0000651]
SV2A,ENSG00000159164,EFO_0003843,0.3695798546847018,1,pain,[EFO_0003765],[EFO_0000651]
SV2A,ENSG00000159164,EFO_0008526,0.3438600739696982,11,status epilepticus,[EFO_0000474],[EFO_0000618]
SV2A,ENSG00000159164,MONDO_0007079,0.450045601935221,5,alcohol dependence,"[MONDO_0021698, EFO_0003890]","[MONDO_0002025, EFO_0000618]"
SV2A,ENSG00000159164,EFO_0004263,0.5419747797576797,13,partial epilepsy,[EFO_0000474],[EFO_0000618]
SV2A,ENSG00000159164,EFO_0004262,0.25870589827929125,1,panic disorder,[EFO_0006788],"[MONDO_0002025, EFO_0000618]"
SV2A,ENSG00000159164,EFO_0005669,0.25870589827929125,1,intracerebral hemorrhage,[EFO_0000551],"[EFO_0000618, EFO_0000319]"
SV2A,ENSG00000159164,EFO_0007262,0.3521274726579242,3,epilepsy with generalized tonic-clonic seizures,"[MONDO_0000415, MONDO_0100030]",[EFO_0000618]
SV2A,ENSG00000159164,EFO_0000713,0.25870589827929125,1,subarachnoid hemorrhage,"[EFO_0005774, EFO_0003763]","[EFO_0000618, EFO_0000319]"
SV2A,ENSG00000159164,HP_0007359,0.3281355804246423,5,Focal-onset seizure,[HP_0001250],[EFO_0000651]
SV2A,ENSG00000159164,EFO_0004777,0.25870589827929125,1,alcohol withdrawal,"[EFO_0005800, EFO_0003890]","[MONDO_0002025, EFO_0000618]"
SV2A,ENSG00000159164,EFO_0004339,0.20084123919781155,7,body height,[EFO_0004324],[EFO_0001444]
SV2A,ENSG00000159164,Orphanet_308,0.25870589827929125,1,Unverricht-Lundborg disease,"[MONDO_0020074, Orphanet_98261]","[OTAR_0000018, EFO_0000618]"
SV2A,ENSG00000159164,EFO_0009562,0.38805884741893687,2,polyneuropathy,[EFO_0003100],[EFO_0000618]
SV2A,ENSG00000159164,EFO_0003086,0.3695798546847018,1,kidney disease,[EFO_0009690],[EFO_0009690]
SV2A,ENSG00000159164,HP_0002069,0.603438303137454,82,Bilateral tonic-clonic seizure,[HP_0001250],[EFO_0000651]
SV2A,ENSG00000159164,MONDO_0007295,0.3695798546847018,1,childhood epilepsy with centrotemporal spikes,"[MONDO_0000414, MONDO_0017704]","[OTAR_0000018, EFO_0000618]"
SV2A,ENSG00000159164,EFO_0004895,0.36994943453938645,2,Tourette syndrome,"[MONDO_0002420, EFO_0004280, EFO_0000508]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SV2A,ENSG00000159164,MONDO_0005090,0.297661202438943,23,schizophrenia,[EFO_0005407],"[MONDO_0002025, EFO_0000618]"
SV2A,ENSG00000159164,EFO_0005772,0.5408408021342467,11,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SV2A,ENSG00000159164,Orphanet_1945,0.3695798546847018,1,Rolandic epilepsy,"[Orphanet_182083, Orphanet_166475]",[OTAR_0000018]
SV2A,ENSG00000159164,MONDO_0005180,0.4732294656998521,13,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
SV2A,ENSG00000159164,MONDO_0002050,0.25870589827929125,1,depressive disorder,[EFO_0004247],"[MONDO_0002025, EFO_0000618]"
SV2A,ENSG00000159164,EFO_0005543,0.389167586982991,3,glioma,"[EFO_0009386, MONDO_0021193]","[EFO_0000618, MONDO_0045024]"
SV2A,ENSG00000159164,EFO_0005542,0.5783838386125503,12,botulism,"[MONDO_0020010, MONDO_0000314, MONDO_0020125, EFO_1000874]","[EFO_0005741, EFO_0000618]"
SV2A,ENSG00000159164,EFO_0004280,0.27718489101352634,2,movement disorder,[EFO_0000618],[EFO_0000618]
SV2A,ENSG00000159164,EFO_0000474,0.6123731091407553,234,epilepsy,[EFO_0005774],[EFO_0000618]
SV2A,ENSG00000159164,HP_0001250,0.6076509164404551,161,Seizure,[HP_0012638],[EFO_0000651]
SV2A,ENSG00000159164,MONDO_0005301,0.36994943453938645,2,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
SV2B,ENSG00000185518,MONDO_0005148,0.305302777632877,1,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SV2B,ENSG00000185518,EFO_0005542,0.5783838386125503,12,botulism,"[MONDO_0020010, MONDO_0000314, MONDO_0020125, EFO_1000874]","[EFO_0005741, EFO_0000618]"
SV2C,ENSG00000122012,EFO_0010750,0.33252427337028223,1,PHF-tau measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
SV2C,ENSG00000122012,EFO_0005944,0.3321671885330578,1,cumulative dose response to bevacizumab,[EFO_0005943],[GO_0008150]
SV2C,ENSG00000122012,EFO_0007986,0.3162651609779491,2,reticulocyte count,[EFO_0010700],[EFO_0001444]
SV2C,ENSG00000122012,EFO_0010700,0.25784796230624285,2,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
SV2C,ENSG00000122012,EFO_0004541,0.27125774531779595,1,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
SV2C,ENSG00000122012,MONDO_0005180,0.24009854126157634,15,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
SV2C,ENSG00000122012,EFO_0005542,0.569067134332723,9,botulism,"[MONDO_0020010, MONDO_0000314, MONDO_0020125, EFO_1000874]","[EFO_0005741, EFO_0000618]"
SV2C,ENSG00000122012,EFO_0004526,0.4212183096701296,7,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SV2C,ENSG00000122012,EFO_0004615,0.231950348689943,1,apolipoprotein B measurement,[EFO_0004732],[EFO_0001444]
SV2C,ENSG00000122012,EFO_0005091,0.3598467705869394,3,monocyte count,"[EFO_0004308, EFO_0803547]",[EFO_0001444]
SV2C,ENSG00000122012,EFO_0007874,0.3217390556515752,1,gut microbiome measurement,[EFO_0007882],[EFO_0001444]
SV2C,ENSG00000122012,EFO_0009188,0.39546690970573434,6,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SV2C,ENSG00000122012,EFO_0004309,0.34289275841040256,4,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SV2C,ENSG00000122012,EFO_0007985,0.2014389583134188,1,platelet crit,[EFO_0005036],[EFO_0001444]
SV2C,ENSG00000122012,EFO_0007984,0.32012980580140016,3,platelet component distribution width,[EFO_0005036],[EFO_0001444]
SVOP,ENSG00000166111,NA,NA,NA,NA,NA,NA
SVOPL,ENSG00000157703,EFO_0004627,0.20802960772890242,1,IGF-1 measurement,"[EFO_0005127, EFO_0004730, EFO_0004747]",[EFO_0001444]
SLC23A1,ENSG00000170482,EFO_0600003,0.2933766066717763,1,vitamin C measurement,[EFO_0004729],[EFO_0001444]
SLC23A1,ENSG00000170482,EFO_0004518,0.3384647880246864,3,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC23A2,ENSG00000089057,EFO_0005772,0.5193939731225711,5,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC23A2,ENSG00000089057,EFO_0004526,0.4934553838336491,7,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC23A2,ENSG00000089057,EFO_0003923,0.4059766574303603,2,bone density,[EFO_0004516],[EFO_0001444]
SLC23A2,ENSG00000089057,EFO_0009188,0.4865541298309534,5,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC23A2,ENSG00000089057,EFO_0004308,0.32332904142462787,1,leukocyte count,[EFO_0004586],[EFO_0001444]
SLC23A2,ENSG00000089057,EFO_0004531,0.4059766574303603,2,urate measurement,[EFO_0001444],[EFO_0001444]
SLC23A2,ENSG00000089057,EFO_0004528,0.40959465818348545,2,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC23A2,ENSG00000089057,EFO_0004527,0.44744928321317634,3,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC23A3,ENSG00000213901,NA,NA,NA,NA,NA,NA
SLC23A4P,ENSG00000276067,NA,NA,NA,NA,NA,NA
SLC24A1,ENSG00000074621,Orphanet_71862,0.46319073607778993,5,Retinal dystrophy,[Orphanet_98657],"[OTAR_0000018, MONDO_0024458]"
SLC24A1,ENSG00000074621,EFO_0005772,0.2542287814294563,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC24A1,ENSG00000074621,MONDO_0019200,0.4386649152074599,68,retinitis pigmentosa,"[MONDO_0019216, MONDO_0019118]","[MONDO_0002025, OTAR_0000018, OTAR_0000020, MONDO_0024458, EFO_0000618]"
SLC24A1,ENSG00000074621,EFO_0004526,0.4133963273317203,10,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC24A1,ENSG00000074621,MONDO_0016293,0.69876004825929106,125,congenital stationary night blindness,[MONDO_0004587],"[MONDO_0002025, OTAR_0000018, EFO_0000618, MONDO_0024458]"
SLC24A1,ENSG00000074621,EFO_0004305,0.28103854262434735,5,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
SLC24A1,ENSG00000074621,EFO_0007937,0.3015483904629556,2,blood protein measurement,[EFO_0004747],[EFO_0001444]
SLC24A1,ENSG00000074621,EFO_0004528,0.40692210048523275,11,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC24A1,ENSG00000074621,EFO_0004527,0.25960066233437007,7,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC24A2,ENSG00000155886,EFO_0008579,0.4236280427218844,2,risk-taking behaviour,[GO_0007610],[GO_0008150]
SLC24A2,ENSG00000155886,EFO_0004747,0.2658740103051619,3,protein measurement,[EFO_0001444],[EFO_0001444]
SLC24A2,ENSG00000155886,EFO_0004875,0.3172967143083832,2,mathematical ability,[EFO_0003925],[GO_0008150]
SLC24A2,ENSG00000155886,EFO_0005423,0.24377437268064217,1,adolescent idiopathic scoliosis,[MONDO_0000726],[OTAR_0000006]
SLC24A3,ENSG00000185052,HP_0011141,0.297085596870932,1,Age-related cataract,[HP_0000517],[EFO_0000651]
SLC24A3,ENSG00000185052,EFO_0003966,0.2893308200459504,1,eye disease,[MONDO_0024458],[MONDO_0024458]
SLC24A3,ENSG00000185052,EFO_0004713,0.3692541882465576,2,FEV/FEC ratio,"[EFO_0006841, EFO_0003892]",[EFO_0001444]
SLC24A3,ENSG00000185052,EFO_0006336,0.38063946709826857,3,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC24A3,ENSG00000185052,EFO_0006335,0.3067060992898515,2,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC24A3,ENSG00000185052,EFO_0008039,0.4235008821899364,2,BMI-adjusted hip circumference,[EFO_0005093],[EFO_0001444]
SLC24A3,ENSG00000185052,EFO_0004784,0.22488854811741893,3,self reported educational attainment,[EFO_0011015],[EFO_0001444]
SLC24A3,ENSG00000185052,EFO_1001986,0.20590040402583246,1,connective tissue disease,[OTAR_0000006],[OTAR_0000006]
SLC24A3,ENSG00000185052,EFO_0004584,0.4631050439390349,6,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
SLC24A3,ENSG00000185052,EFO_0009546,0.2893308200459504,1,eye adnexa disease,[EFO_0003966],[MONDO_0024458]
SLC24A3,ENSG00000185052,MONDO_0005129,0.45769974772910926,11,cataract,"[EFO_0009674, EFO_0000508]","[OTAR_0000018, MONDO_0024458]"
SLC24A3,ENSG00000185052,EFO_0005763,0.462983861900546,10,pulse pressure measurement,[EFO_0005278],[EFO_0001444]
SLC24A3,ENSG00000185052,EFO_0004309,0.41484679074993985,4,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SLC24A3,ENSG00000185052,EFO_0003870,0.2449377951725096,1,brain aneurysm,[EFO_1000859],"[EFO_0000618, EFO_0000319]"
SLC24A3,ENSG00000185052,EFO_0006798,0.30488187572141207,1,neuritic plaque measurement,[EFO_0006514],[EFO_0001444]
SLC24A3,ENSG00000185052,MONDO_0004847,0.2918214922927597,1,senile cataract,[MONDO_0005129],"[OTAR_0000018, MONDO_0024458]"
SLC24A3,ENSG00000185052,EFO_0009676,0.20590040402583246,1,musculoskeletal system disease,[OTAR_0000006],[OTAR_0000006]
SLC24A3,ENSG00000185052,EFO_0009674,0.29922343669612317,2,lens disease,[EFO_0003966],[MONDO_0024458]
SLC24A3,ENSG00000185052,MONDO_0005277,0.4607476369992727,15,migraine disorder,"[MONDO_0017181, EFO_0005774, MONDO_0043218]","[EFO_0000618, EFO_0000319]"
SLC24A4,ENSG00000140090,EFO_0003949,0.4377724549384192,5,eye color,[EFO_0000651],[EFO_0000651]
SLC24A4,ENSG00000140090,EFO_0000389,0.3241472745642864,1,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLC24A4,ENSG00000140090,EFO_0003784,0.3639152687776745,2,skin pigmentation,[EFO_0000651],[EFO_0000651]
SLC24A4,ENSG00000140090,MONDO_0019507,0.5896529589921741,17,amelogenesis imperfecta,"[EFO_1001304, EFO_0000508]","[OTAR_0000006, OTAR_0000018, EFO_0010282]"
SLC24A4,ENSG00000140090,EFO_0004731,0.2982823707781947,1,eye measurement,[EFO_0001444],[EFO_0001444]
SLC24A4,ENSG00000140090,Orphanet_100033,0.6757290602556005,17,Hypomaturation amelogenesis imperfecta,[Orphanet_164001],[OTAR_0000018]
SLC24A4,ENSG00000140090,Orphanet_100032,0.3917066005846749,3,Hypocalcified amelogenesis imperfecta,[Orphanet_164001],[OTAR_0000018]
SLC24A4,ENSG00000140090,EFO_1001870,0.2503167149720514,2,late-onset Alzheimers disease,[MONDO_0004975],"[MONDO_0002025, EFO_0000618]"
SLC24A4,ENSG00000140090,EFO_0003924,0.5145458852533529,23,hair color,[EFO_0005038],[EFO_0000651]
SLC24A4,ENSG00000140090,EFO_0004628,0.3013890308907231,1,insulin like growth factor measurement,[EFO_0001444],[EFO_0001444]
SLC24A4,ENSG00000140090,EFO_0004627,0.29984684734449196,1,IGF-1 measurement,"[EFO_0005127, EFO_0004730, EFO_0004747]",[EFO_0001444]
SLC24A4,ENSG00000140090,EFO_0007874,0.3323767252987382,1,gut microbiome measurement,[EFO_0007882],[EFO_0001444]
SLC24A4,ENSG00000140090,EFO_0007822,0.4612761444904083,5,hair colour measurement,[EFO_0007821],[EFO_0001444]
SLC24A4,ENSG00000140090,EFO_0007821,0.2952611158423423,1,hair morphology measurement,[EFO_0001444],[EFO_0001444]
SLC24A4,ENSG00000140090,EFO_0009268,0.3586217198145506,3,family history of Alzheimer’s disease,[EFO_0006514],[EFO_0001444]
SLC24A4,ENSG00000140090,EFO_0004279,0.29678415646916895,1,suntan,[EFO_0003784],[EFO_0000651]
SLC24A4,ENSG00000140090,MONDO_0004975,0.3994209312363271,21,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
SLC24A4,ENSG00000140090,EFO_0007984,0.35237519870338413,3,platelet component distribution width,[EFO_0005036],[EFO_0001444]
SLC24A4,ENSG00000140090,EFO_0007906,0.296560807723665,1,synophrys measurement,[EFO_0007821],[EFO_0001444]
SLC24A4,ENSG00000140090,EFO_0009716,0.296969571834679,1,age at first facial hair,[EFO_0000246],[EFO_0001444]
SLC24A5,ENSG00000188467,MONDO_0018910,0.6515115941092633,23,oculocutaneous albinism,"[MONDO_0100118, MONDO_0020275, MONDO_0018134, MONDO_0019290]","[OTAR_0000018, OTAR_0000020, MONDO_0024458, EFO_0010285]"
SLC24A5,ENSG00000188467,EFO_0003949,0.2737992817773845,1,eye color,[EFO_0000651],[EFO_0000651]
SLC24A5,ENSG00000188467,EFO_0000389,0.25870968280582024,1,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLC24A5,ENSG00000188467,EFO_0000508,0.40275890709025974,9,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC24A5,ENSG00000188467,EFO_0003784,0.3982801189174338,2,skin pigmentation,[EFO_0000651],[EFO_0000651]
SLC24A5,ENSG00000188467,MONDO_0014070,0.37876760987216346,2,oculocutaneous albinism type 7,[MONDO_0018910],"[OTAR_0000018, OTAR_0000020, MONDO_0024458, EFO_0010285]"
SLC24A5,ENSG00000188467,EFO_0007009,0.494928129867672,9,skin pigmentation measurement,[EFO_0001444],[EFO_0001444]
SLC24A5,ENSG00000188467,MONDO_0002898,0.28683397976987374,1,skin cancer,"[EFO_0004198, MONDO_0000653]","[MONDO_0045024, EFO_0010285]"
SLC24A5,ENSG00000188467,EFO_0005772,0.34385191303289203,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC24A5,ENSG00000188467,GO_0007568,0.34385191303289203,1,aging,[GO_0032502],[GO_0008150]
SLC24A5,ENSG00000188467,MONDO_0018264,0.6761982575770927,19,oculocutaneous albinism type 6,[MONDO_0018910],"[OTAR_0000018, OTAR_0000020, MONDO_0024458, EFO_0010285]"
SLC24A5,ENSG00000188467,EFO_0003924,0.25870968280582024,1,hair color,[EFO_0005038],[EFO_0000651]
SLC24A5,ENSG00000188467,EFO_0007843,0.3131830077674202,1,nose morphology measurement,[EFO_0007841],[EFO_0001444]
SLC24A5,ENSG00000188467,EFO_0007822,0.4732521394466076,7,hair colour measurement,[EFO_0007821],[EFO_0001444]
SLC24A5,ENSG00000188467,EFO_0009260,0.28683397976987374,1,non-melanoma skin carcinoma,[EFO_0009259],"[MONDO_0045024, EFO_0010285]"
SLC24A5,ENSG00000188467,EFO_0009764,0.456877876023223,5,eye colour measurement,[EFO_0004731],[EFO_0001444]
SLC25A1,ENSG00000100075,Orphanet_98914,0.5261379875719712,5,Presynaptic congenital myasthenic syndromes,[Orphanet_590],"[OTAR_0000006, OTAR_0000018, MONDO_0024458]"
SLC25A1,ENSG00000100075,MONDO_0016001,0.5055637033350543,8,2-hydroxyglutaric aciduria,[MONDO_0019213],"[OTAR_0000018, EFO_0000618, OTAR_0000020]"
SLC25A1,ENSG00000100075,EFO_0000508,0.40683074116683715,12,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC25A1,ENSG00000100075,MONDO_0014072,0.790348509610933,21,"D,L-2-hydroxyglutaric aciduria",[MONDO_0016001],"[OTAR_0000018, EFO_0000618, OTAR_0000020]"
SLC25A1,ENSG00000100075,EFO_0005772,0.3097916424408305,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A1,ENSG00000100075,GO_0007568,0.3097916424408305,1,aging,[GO_0032502],[GO_0008150]
SLC25A10,ENSG00000183048,MONDO_0033545,0.43610422852794806,2,mitochondrial DNA depletion syndrome 19,[MONDO_0018158],"[OTAR_0000018, OTAR_0000020]"
SLC25A10,ENSG00000183048,EFO_0005772,0.5030392466541774,3,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A10,ENSG00000183048,MONDO_0100133,0.26609749537298527,1,mitochondrial complex I deficiency,[MONDO_0000066],"[OTAR_0000018, OTAR_0000020]"
SLC25A11,ENSG00000108528,MONDO_0017366,0.3695798546847018,1,hereditary pheochromocytoma-paraganglioma,[EFO_0005539],[EFO_0001379]
SLC25A11,ENSG00000108528,EFO_1000453,0.6666238882023015,13,Paraganglioma,"[MONDO_0025511, MONDO_0002366]","[OTAR_0000018, MONDO_0045024, EFO_0001379, EFO_0000618]"
SLC25A12,ENSG00000115840,HP_0000545,0.25777793319953696,5,Myopia,[HP_0000539],[EFO_0000651]
SLC25A12,ENSG00000115840,HP_0000539,0.2985969843281786,1,Abnormality of refraction,[HP_0000478],[EFO_0000651]
SLC25A12,ENSG00000115840,EFO_0000508,0.40853636441982916,16,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC25A12,ENSG00000115840,EFO_0004784,0.2457487575671565,5,self reported educational attainment,[EFO_0011015],[EFO_0001444]
SLC25A12,ENSG00000115840,Orphanet_353217,0.7675769481842357,31,Epileptic encephalopathy with global cerebral demyelination,"[Orphanet_79200, Orphanet_183530, Orphanet_183512, EFO_0010238]","[OTAR_0000018, OTAR_0000014, OTAR_0000020]"
SLC25A12,ENSG00000115840,Orphanet_3175,0.26609749537298527,1,Spasticity - intellectual disability - X-linked epilepsy,"[MONDO_0020119, MONDO_0015921]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC25A12,ENSG00000115840,MONDO_0010632,0.26609749537298527,1,"developmental and epileptic encephalopathy, 1","[MONDO_0018097, MONDO_0100062]","[OTAR_0000018, EFO_0000618]"
SLC25A12,ENSG00000115840,EFO_0004875,0.22795183284913123,2,mathematical ability,[EFO_0003925],[GO_0008150]
SLC25A12,ENSG00000115840,EFO_0004847,0.23168762643975468,2,age at onset,[EFO_0000246],[EFO_0001444]
SLC25A12,ENSG00000115840,MONDO_0013056,0.7605062067439761,33,"developmental and epileptic encephalopathy, 39","[MONDO_0100455, MONDO_0016801]","[OTAR_0000020, EFO_0000618, OTAR_0000018]"
SLC25A12,ENSG00000115840,MONDO_0018226,0.26609749537298527,1,infantile epileptic-dyskinetic encephalopathy,[MONDO_0018329],"[OTAR_0000018, EFO_0000618]"
SLC25A12,ENSG00000115840,MONDO_0018097,0.26609749537298527,1,West syndrome,"[MONDO_0100022, MONDO_0000413]",[EFO_0000618]
SLC25A12,ENSG00000115840,MONDO_0004892,0.2073045271288717,3,refractive error,[EFO_0003966],[MONDO_0024458]
SLC25A12,ENSG00000115840,MONDO_0100062,0.2667442601186835,3,developmental and epileptic encephalopathy,"[MONDO_0100022, MONDO_0100038, MONDO_0100500, EFO_0005917]","[OTAR_0000018, EFO_0000618]"
SLC25A12,ENSG00000115840,HP_0001263,0.3702907825996161,5,Global developmental delay,[HP_0012758],[EFO_0000651]
SLC25A13,ENSG00000004864,MONDO_0015991,0.5229762357353076,54,citrullinemia,[MONDO_0004739],"[OTAR_0000018, OTAR_0000020]"
SLC25A13,ENSG00000004864,EFO_0000508,0.3384458376100669,23,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC25A13,ENSG00000004864,MONDO_0011601,0.7669294999924317,128,neonatal intrahepatic cholestasis due to citrin deficiency,[MONDO_0016602],"[OTAR_0000018, OTAR_0000020]"
SLC25A13,ENSG00000004864,EFO_0008111,0.39354673225989867,3,diet measurement,[EFO_0001444],[EFO_0001444]
SLC25A13,ENSG00000004864,EFO_0008006,0.2640223385857965,1,skin aging measurement,[EFO_0001444],[EFO_0001444]
SLC25A13,ENSG00000004864,MONDO_0008988,0.41414078200870663,43,citrullinemia type I,"[MONDO_0015991, MONDO_0800153]","[OTAR_0000018, OTAR_0000020]"
SLC25A13,ENSG00000004864,EFO_0004339,0.23925338345712316,1,body height,[EFO_0004324],[EFO_0001444]
SLC25A13,ENSG00000004864,EFO_0010100,0.312256276514724,2,multisite chronic pain,[HP_0012532],[EFO_0000651]
SLC25A13,ENSG00000004864,MONDO_0016603,0.6535391006583838,181,citrullinemia type II,[MONDO_0016602],"[OTAR_0000018, OTAR_0000020]"
SLC25A13,ENSG00000004864,MONDO_0016602,0.6506230004228748,549,citrin deficiency,"[MONDO_0800153, MONDO_0015991]","[OTAR_0000018, OTAR_0000020]"
SLC25A13,ENSG00000004864,EFO_0005772,0.2921013841032381,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A13,ENSG00000004864,EFO_0004514,0.31785675092168403,10,bone quantitative ultrasound measurement,[EFO_0004516],[EFO_0001444]
SLC25A13,ENSG00000004864,EFO_0009270,0.39810628025087264,16,heel bone mineral density,[EFO_0003923],[EFO_0001444]
SLC25A14,ENSG00000102078,NA,NA,NA,NA,NA,NA
SLC25A15,ENSG00000102743,EFO_0020092,0.3516339128202257,1,neuroinflammatory disorder,"[EFO_0009386, MONDO_0002977]","[EFO_0000540, EFO_0000618]"
SLC25A15,ENSG00000102743,EFO_0000508,0.44242070423472507,12,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC25A15,ENSG00000102743,EFO_0003779,0.28057037358478143,2,Hashimoto's thyroiditis,[EFO_0006812],"[EFO_0001379, EFO_0000540]"
SLC25A15,ENSG00000102743,MONDO_0009393,0.8453510358343955,351,ornithine translocase deficiency,[MONDO_0800153],"[OTAR_0000018, OTAR_0000020]"
SLC25A15,ENSG00000102743,EFO_0005772,0.22752025858999647,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A15,ENSG00000102743,Orphanet_415,0.8161405748026676,335,Hyperornithinemia-hyperammonemia-homocitrullinuria,[Orphanet_79167],"[OTAR_0000018, OTAR_0000020]"
SLC25A15,ENSG00000102743,EFO_0005140,0.2639234738881121,1,autoimmune disease,[EFO_0000540],[EFO_0000540]
SLC25A15,ENSG00000102743,EFO_0005090,0.2721620555087471,2,basophil count,"[EFO_0004872, EFO_0803539, EFO_0007987]",[EFO_0001444]
SLC25A16,ENSG00000122912,Orphanet_79369,0.3326218692162316,1,Isolated nail anomaly,[Orphanet_68346],[OTAR_0000018]
SLC25A16,ENSG00000122912,EFO_0004995,0.2240086708511642,8,lean body mass,[EFO_0004302],[EFO_0001444]
SLC25A16,ENSG00000122912,MONDO_0019284,0.3326218692162316,1,inherited isolated nail anomaly,"[MONDO_0002884, EFO_0000508]","[OTAR_0000018, EFO_0010285]"
SLC25A16,ENSG00000122912,Orphanet_183763,0.26609749537298527,1,Rare genetic intellectual disability with developmental anomaly,[Orphanet_183757],[OTAR_0000018]
SLC25A17,ENSG00000100372,EFO_0005772,0.3258714760695471,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A17,ENSG00000100372,EFO_0004611,0.22807329323935946,6,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
SLC25A18,ENSG00000182902,NA,NA,NA,NA,NA,NA
SLC25A19,ENSG00000125454,MONDO_0011790,0.7890690498859831,58,Amish lethal microcephaly,[MONDO_0000152],"[OTAR_0000018, OTAR_0000020]"
SLC25A19,ENSG00000125454,MONDO_0013382,0.7799698060961171,32,progressive demyelinating neuropathy with bilateral striatal necrosis,"[MONDO_0000152, MONDO_0020127]","[OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC25A2,ENSG00000120329,NA,NA,NA,NA,NA,NA
SLC25A20,ENSG00000178537,MONDO_0008918,0.8181117529610862,183,carnitine-acylcarnitine translocase deficiency,"[MONDO_0017713, MONDO_0017716]","[OTAR_0000018, OTAR_0000020]"
SLC25A21,ENSG00000183032,EFO_0010750,0.3143519374282763,1,PHF-tau measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
SLC25A21,ENSG00000183032,HP_0000175,0.22811260087983257,1,Cleft palate,[HP_0000202],[EFO_0000651]
SLC25A21,ENSG00000183032,MONDO_0032932,0.5171428245532285,6,mitochondrial DNA depletion syndrome 18,[MONDO_0018158],"[OTAR_0000018, OTAR_0000020]"
SLC25A21,ENSG00000183032,EFO_0000305,0.2278185648572137,4,breast carcinoma,"[EFO_0000313, MONDO_0007254]","[OTAR_0000017, MONDO_0045024, EFO_0010285]"
SLC25A21,ENSG00000183032,EFO_0004747,0.35771480779220616,2,protein measurement,[EFO_0001444],[EFO_0001444]
SLC25A21,ENSG00000183032,EFO_0007986,0.38296761039709254,4,reticulocyte count,[EFO_0010700],[EFO_0001444]
SLC25A21,ENSG00000183032,EFO_0004339,0.21714459716285373,3,body height,[EFO_0004324],[EFO_0001444]
SLC25A21,ENSG00000183032,EFO_0010701,0.2551111251128096,2,mean reticulocyte volume,[EFO_0010700],[EFO_0001444]
SLC25A21,ENSG00000183032,EFO_0010700,0.28125172420350386,3,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
SLC25A21,ENSG00000183032,MONDO_0005147,0.3186699984889013,1,type 1 diabetes mellitus,"[MONDO_0000569, MONDO_0000588, EFO_0000400]","[OTAR_0000020, EFO_0001379, EFO_0000540, EFO_0009605, EFO_0010282]"
SLC25A21,ENSG00000183032,MONDO_0045002,0.3456047304298982,2,vertebral disorder,[MONDO_0000812],[OTAR_0000006]
SLC25A21,ENSG00000183032,EFO_0004526,0.4533137723400389,10,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC25A21,ENSG00000183032,MONDO_0000812,0.3016774964023489,1,vertebral column disorder,[EFO_0002461],[OTAR_0000006]
SLC25A21,ENSG00000183032,EFO_0009253,0.27532351195271265,1,Immature Reticulocyte Fraction Measurement,[EFO_0009233],[EFO_0001444]
SLC25A21,ENSG00000183032,EFO_0004314,0.34718858672386654,2,forced expiratory volume,"[EFO_0003892, EFO_0006841]",[EFO_0001444]
SLC25A21,ENSG00000183032,EFO_0004312,0.4739303128318085,5,vital capacity,[EFO_0003892],[EFO_0001444]
SLC25A21,ENSG00000183032,EFO_0004305,0.2298028247757949,5,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
SLC25A21,ENSG00000183032,EFO_0007667,0.23450418265788325,2,lobe attachment,[EFO_0007664],[EFO_0000651]
SLC25A21,ENSG00000183032,EFO_0007627,0.27045299372782167,1,airway imaging measurement,[EFO_0006841],[EFO_0001444]
SLC25A21,ENSG00000183032,EFO_0004528,0.2719895400746853,3,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC25A21,ENSG00000183032,EFO_0004527,0.2989794376561859,7,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC25A22,ENSG00000177542,MONDO_0016022,0.6260875038090633,124,early myoclonic encephalopathy,"[MONDO_0100022, MONDO_0015653, MONDO_0016801, MONDO_0000412]","[OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC25A22,ENSG00000177542,MONDO_0017385,0.37004182950305764,3,malignant migrating partial seizures of infancy,[MONDO_0020070],[EFO_0000618]
SLC25A22,ENSG00000177542,EFO_1001900,0.6921034967989531,24,myoclonic epilepsy,[EFO_0000474],[EFO_0000618]
SLC25A22,ENSG00000177542,MONDO_0100062,0.6759301789098945,378,developmental and epileptic encephalopathy,"[MONDO_0100022, MONDO_0100038, MONDO_0100500, EFO_0005917]","[OTAR_0000018, EFO_0000618]"
SLC25A23,ENSG00000125648,EFO_0005772,0.28391188564147957,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A24,ENSG00000085491,MONDO_0012853,0.6732220460968646,21,Fontaine progeroid syndrome,"[MONDO_0015161, MONDO_0019287]","[OTAR_0000018, EFO_0010285]"
SLC25A24,ENSG00000085491,EFO_0007997,0.29114281081527377,1,granulocyte percentage of myeloid white cells,[EFO_0007987],[EFO_0001444]
SLC25A24,ENSG00000085491,EFO_0009390,0.2840371309559711,1,sum of neutrophil and eosinophil counts,[EFO_0007987],[EFO_0001444]
SLC25A24,ENSG00000085491,EFO_0009388,0.28247313902054483,1,sum of basophil and neutrophil counts,[EFO_0007987],[EFO_0001444]
SLC25A24,ENSG00000085491,EFO_0004833,0.4495498118405502,8,neutrophil count,"[EFO_0803548, EFO_0007987]",[EFO_0001444]
SLC25A24,ENSG00000085491,EFO_0007990,0.36338651446873577,2,neutrophil percentage of leukocytes,[EFO_0004833],[EFO_0001444]
SLC25A24,ENSG00000085491,EFO_0007989,0.39160490631022177,3,monocyte percentage of leukocytes,[EFO_0005091],[EFO_0001444]
SLC25A24,ENSG00000085491,EFO_0007988,0.40381984506533497,3,myeloid white cell count,[EFO_0004308],[EFO_0001444]
SLC25A24,ENSG00000085491,EFO_0007987,0.28438848833744734,1,granulocyte count,[EFO_0007988],[EFO_0001444]
SLC25A24,ENSG00000085491,HP_0002069,0.2956638837477614,2,Bilateral tonic-clonic seizure,[HP_0001250],[EFO_0000651]
SLC25A24,ENSG00000085491,MONDO_0001627,0.2956638837477614,2,dementia,[MONDO_0002039],"[MONDO_0002025, EFO_0000618]"
SLC25A24,ENSG00000085491,EFO_0004308,0.432968296300833,5,leukocyte count,[EFO_0004586],[EFO_0001444]
SLC25A24,ENSG00000085491,Orphanet_2963,0.5543697820270527,3,"Progeroid syndrome, Petty type",[MONDO_0019303],[OTAR_0000018]
SLC25A24,ENSG00000085491,EFO_0007629,0.20368275518880471,1,hemoglobin A1 measurement,[EFO_0004509],[EFO_0001444]
SLC25A25,ENSG00000148339,EFO_0004253,0.3326218692162316,1,nephrolithiasis,"[MONDO_0024647, EFO_0003086]",[EFO_0009690]
SLC25A26,ENSG00000144741,EFO_0000275,0.21605457012713458,4,atrial fibrillation,"[EFO_0004269, MONDO_0007263]",[EFO_0000319]
SLC25A26,ENSG00000144741,EFO_0000508,0.4096092847849519,21,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC25A26,ENSG00000144741,MONDO_0013987,0.6781831610314859,17,combined oxidative phosphorylation defect type 15,[MONDO_0000732],"[OTAR_0000018, OTAR_0000020]"
SLC25A26,ENSG00000144741,EFO_0004526,0.31463595944082956,6,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC25A26,ENSG00000144741,EFO_0004509,0.24114057829043262,3,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
SLC25A26,ENSG00000144741,EFO_0004462,0.20846348453050467,1,PR interval,[EFO_0004327],[EFO_0001444]
SLC25A26,ENSG00000144741,EFO_0009188,0.2875674391328402,6,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC25A26,ENSG00000144741,EFO_0004528,0.29455728313326385,6,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC25A26,ENSG00000144741,EFO_0004527,0.28309627861446973,4,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC25A27,ENSG00000153291,NA,NA,NA,NA,NA,NA
SLC25A28,ENSG00000155287,MONDO_0002516,0.30056759808588224,2,digestive system cancer,"[EFO_0010282, MONDO_0004992, EFO_0008549]","[MONDO_0045024, EFO_0010282]"
SLC25A28,ENSG00000155287,MONDO_0005575,0.35196619846026156,5,colorectal cancer,"[EFO_0007330, EFO_0004142]","[MONDO_0045024, EFO_0010282]"
SLC25A29,ENSG00000197119,EFO_0005208,0.30929730211472,4,glomerular filtration rate,[EFO_0004742],[EFO_0001444]
SLC25A29,ENSG00000197119,EFO_0005772,0.3695798546847018,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A29,ENSG00000197119,EFO_0004518,0.31980499848161825,2,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC25A29,ENSG00000197119,EFO_0004530,0.2859871417825805,3,triglyceride measurement,[EFO_0004529],[EFO_0001444]
SLC25A3,ENSG00000075415,Orphanet_91130,0.7059837198060018,45,Cardiomyopathy - hypotonia - lactic acidosis,"[Orphanet_79200, Orphanet_217595, Orphanet_183530]","[OTAR_0000018, OTAR_0000020, EFO_0000319]"
SLC25A3,ENSG00000075415,EFO_0005772,0.5367708167940541,5,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A3,ENSG00000075415,MONDO_0012557,0.6296828183720227,42,cardiomyopathy-hypotonia-lactic acidosis syndrome,"[EFO_1000017, EFO_1000036, MONDO_0016801, MONDO_0024573]","[OTAR_0000006, OTAR_0000020, EFO_0000319, OTAR_0000018]"
SLC25A3,ENSG00000075415,EFO_0007937,0.2457744663139421,1,blood protein measurement,[EFO_0004747],[EFO_0001444]
SLC25A30,ENSG00000174032,EFO_0005772,0.4550846501819274,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A30,ENSG00000174032,EFO_0004531,0.278403539396012,1,urate measurement,[EFO_0001444],[EFO_0001444]
SLC25A30,ENSG00000174032,EFO_0004530,0.3015022803138058,2,triglyceride measurement,[EFO_0004529],[EFO_0001444]
SLC25A31,ENSG00000151475,NA,NA,NA,NA,NA,NA
SLC25A32,ENSG00000164933,MONDO_0014795,0.4923624952966193,4,"exercise intolerance, riboflavin-responsive",[EFO_0000508],[OTAR_0000018]
SLC25A32,ENSG00000164933,EFO_0003105,0.47023677600735375,3,spina bifida,"[EFO_0000508, MONDO_0017059, EFO_0009488, MONDO_0002320]","[OTAR_0000018, EFO_0000618]"
SLC25A32,ENSG00000164933,EFO_0005772,0.3242324926237437,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A32,ENSG00000164933,MONDO_0019351,0.4731915669455579,3,isolated spina bifida,"[MONDO_0015219, EFO_0003105]","[OTAR_0000018, EFO_0000618]"
SLC25A32,ENSG00000164933,GO_0007568,0.3242324926237437,2,aging,[GO_0032502],[GO_0008150]
SLC25A32,ENSG00000164933,MONDO_0018333,0.3695798546847018,1,"multiple acyl-CoA dehydrogenase deficiency, mild type",[MONDO_0009282],"[OTAR_0000006, OTAR_0000020, EFO_0000319, OTAR_0000018]"
SLC25A32,ENSG00000164933,EFO_0004305,0.23286190279681418,4,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
SLC25A33,ENSG00000171612,EFO_0004713,0.29939020023484464,3,FEV/FEC ratio,"[EFO_0006841, EFO_0003892]",[EFO_0001444]
SLC25A33,ENSG00000171612,EFO_0004980,0.24980794273433227,3,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
SLC25A33,ENSG00000171612,HP_0100790,0.2324664365102079,1,Hernia,[HP_0003549],[EFO_0000651]
SLC25A33,ENSG00000171612,EFO_0004339,0.35690797289527515,5,body height,[EFO_0004324],[EFO_0001444]
SLC25A33,ENSG00000171612,HP_0000023,0.23781457773356254,2,Inguinal hernia,[HP_0004299],[EFO_0000651]
SLC25A34,ENSG00000162461,NA,NA,NA,NA,NA,NA
SLC25A35,ENSG00000125434,EFO_0004269,0.20352069023315483,103,cardiac arrhythmia,[EFO_0003777],[EFO_0000319]
SLC25A36,ENSG00000114120,EFO_0005772,0.5220525843496443,5,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A37,ENSG00000147454,EFO_0011011,0.2897289002491264,1,sitting height measurement,[EFO_0004302],[EFO_0001444]
SLC25A37,ENSG00000147454,MONDO_0002561,0.32846723482085477,1,lysosomal storage disease,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
SLC25A37,ENSG00000147454,EFO_0005409,0.40093465959034635,5,fat body mass,[EFO_0004302],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0004705,0.2805438464329101,2,hypothyroidism,[EFO_1000627],[EFO_0001379]
SLC25A37,ENSG00000147454,EFO_0005939,0.2775451039227363,1,parental genotype effect measurement,[EFO_0007958],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0001663,0.33729269751654045,4,prostate carcinoma,"[MONDO_0008315, EFO_0000313]","[OTAR_0000017, MONDO_0045024]"
SLC25A37,ENSG00000147454,EFO_0004995,0.3946412698713693,11,lean body mass,[EFO_0004302],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0004908,0.38288178988808846,3,testosterone measurement,"[EFO_0004529, EFO_0011008]",[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0006340,0.2842286262360446,1,mean arterial pressure,[EFO_0004325],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0006336,0.40720448136828874,3,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0006335,0.3749689554774095,2,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0008039,0.3664389093856807,3,BMI-adjusted hip circumference,[EFO_0005093],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0007990,0.31958688980740707,2,neutrophil percentage of leukocytes,[EFO_0004833],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0007986,0.37539451411666386,7,reticulocyte count,[EFO_0010700],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0000537,0.3440073044715418,2,hypertension,[MONDO_0000473],[EFO_0000319]
SLC25A37,ENSG00000147454,EFO_0003761,0.2665767177634666,1,unipolar depression,[MONDO_0002050],"[MONDO_0002025, EFO_0000618]"
SLC25A37,ENSG00000147454,EFO_0004339,0.4525080357153341,6,body height,[EFO_0004324],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0004338,0.36023538519043924,3,body weight,[EFO_0004324],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0009933,0.3546083239090853,2,Thyroid preparation use measurement,[EFO_0007010],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0010700,0.32934475891920284,2,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0004348,0.4057643548420324,3,hematocrit,[EFO_0004503],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0004344,0.3121515783482884,2,birth weight,[EFO_0004338],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0004342,0.2445703568575865,1,waist circumference,[EFO_0004324],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0004341,0.2698870990712234,1,body fat distribution,[EFO_0005106],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0004340,0.4167840083021368,6,body mass index,[EFO_0004324],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0004584,0.3906727009131935,5,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0004570,0.40795221234246215,3,bilirubin measurement,[EFO_0001444],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0004541,0.2876708925383456,2,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0004533,0.3060759180728564,1,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0009589,0.26869887229023104,1,worry measurement,[EFO_0007803],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0004838,0.34714545396443974,3,calcium measurement,[EFO_0001444],[EFO_0001444]
SLC25A37,ENSG00000147454,MONDO_0005147,0.26121370618435596,2,type 1 diabetes mellitus,"[MONDO_0000569, MONDO_0000588, EFO_0000400]","[OTAR_0000020, EFO_0001379, EFO_0000540, EFO_0009605, EFO_0010282]"
SLC25A37,ENSG00000147454,EFO_0005772,0.48755352046126743,5,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A37,ENSG00000147454,GO_0007568,0.4630978976849618,3,aging,[GO_0032502],[GO_0008150]
SLC25A37,ENSG00000147454,EFO_0004696,0.4368570724495967,5,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0004624,0.25244093843206156,1,prostate specific antigen measurement,"[EFO_0004747, EFO_0005127]",[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0004526,0.4839465680400223,13,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0004509,0.4100755239621457,6,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0004459,0.2668215885253782,1,ferritin measurement,[EFO_0004461],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0005093,0.26798648693853455,1,hip circumference,"[EFO_0004512, EFO_0004324]",[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0007874,0.2992354634720473,1,gut microbiome measurement,[EFO_0007882],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0007800,0.3651525697885479,4,body fat percentage,[EFO_0005106],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0009188,0.48524576339121633,12,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0004314,0.2824639310339958,1,forced expiratory volume,"[EFO_0003892, EFO_0006841]",[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0004309,0.428929439706771,4,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0004305,0.4538231278256595,6,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0007985,0.34971563932901495,2,platelet crit,[EFO_0005036],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0007978,0.34703087241836944,2,red blood cell density measurement,[EFO_0005047],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0007777,0.2560648759133564,1,base metabolic rate measurement,[EFO_0005115],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0007629,0.2895011677971075,1,hemoglobin A1 measurement,[EFO_0004509],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0009805,0.2611883714529103,1,whole body water mass,[EFO_0004302],[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0004528,0.49600565702818483,22,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC25A37,ENSG00000147454,EFO_0004527,0.5142294899547784,13,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC25A38,ENSG00000144659,MONDO_0016828,0.7038255481259165,115,autosomal recessive sideroblastic anemia,"[EFO_1000017, MONDO_0020099]","[OTAR_0000018, EFO_0005803]"
SLC25A38,ENSG00000144659,Orphanet_255132,0.7901467681227768,115,Adult-onset autosomal recessive sideroblastic anemia,"[Orphanet_183530, Orphanet_79200, Orphanet_98362]","[OTAR_0000018, OTAR_0000020, EFO_0005803]"
SLC25A39,ENSG00000013306,EFO_0007989,0.20939802907920355,2,monocyte percentage of leukocytes,[EFO_0005091],[EFO_0001444]
SLC25A39,ENSG00000013306,EFO_0004842,0.23023653758767254,3,eosinophil count,"[EFO_0803540, EFO_0007987]",[EFO_0001444]
SLC25A39,ENSG00000013306,EFO_0005772,0.33567674168693096,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A39,ENSG00000013306,GO_0007568,0.33567674168693096,1,aging,[GO_0032502],[GO_0008150]
SLC25A4,ENSG00000151729,MONDO_0008003,0.37271518832533507,14,autosomal dominant progressive external ophthalmoplegia,"[MONDO_0000426, MONDO_0016797, MONDO_0000090]","[OTAR_0000006, OTAR_0000020, OTAR_0000018]"
SLC25A4,ENSG00000151729,MONDO_0002561,0.32500518953733,1,lysosomal storage disease,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
SLC25A4,ENSG00000151729,MONDO_0012238,0.6904645689046313,101,"progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2",[MONDO_0008003],"[OTAR_0000006, OTAR_0000020, OTAR_0000018]"
SLC25A4,ENSG00000151729,HP_0000545,0.26609749537298527,1,Myopia,[HP_0000539],[EFO_0000651]
SLC25A4,ENSG00000151729,HP_0000408,0.26609749537298527,1,Progressive sensorineural hearing impairment,"[HP_0000407, HP_0001730]",[EFO_0000651]
SLC25A4,ENSG00000151729,EFO_0000508,0.4016039700443702,9,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC25A4,ENSG00000151729,MONDO_0012853,0.4157773365202895,2,Fontaine progeroid syndrome,"[MONDO_0015161, MONDO_0019287]","[OTAR_0000018, EFO_0010285]"
SLC25A4,ENSG00000151729,HP_0003287,0.3400134663099256,1,Abnormality of mitochondrial metabolism,[HP_0012103],[EFO_0000651]
SLC25A4,ENSG00000151729,Orphanet_1369,0.7057948613770347,8,Congenital cataract - hypertrophic cardiomyopathy - mitochondrial myopathy,"[Orphanet_79200, Orphanet_183530, Orphanet_98647, Orphanet_352312, Orphanet_217587]","[OTAR_0000018, OTAR_0000020, MONDO_0024458, EFO_0000319]"
SLC25A4,ENSG00000151729,EFO_0000538,0.4551945747152946,11,hypertrophic cardiomyopathy,[MONDO_0000591],"[OTAR_0000006, EFO_0000319]"
SLC25A4,ENSG00000151729,MONDO_0000090,0.40012086588644113,9,progressive external ophthalmoplegia with mitochondrial DNA deletions,[EFO_0002509],"[OTAR_0000006, OTAR_0000018, OTAR_0000020]"
SLC25A4,ENSG00000151729,MONDO_0014175,0.7845565920286992,35,"mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive",[MONDO_0018158],"[OTAR_0000018, OTAR_0000020]"
SLC25A4,ENSG00000151729,MONDO_0014959,0.7439063292428963,30,"mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant",[MONDO_0018158],"[OTAR_0000018, OTAR_0000020]"
SLC25A4,ENSG00000151729,HP_0002321,0.26609749537298527,1,Vertigo,[HP_0000598],[EFO_0000651]
SLC25A4,ENSG00000151729,EFO_0000764,0.3695798546847018,1,HIV infection,"[MONDO_0021682, EFO_1001357]","[OTAR_0000017, EFO_0005741]"
SLC25A4,ENSG00000151729,EFO_0005772,0.526683660266359,7,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A4,ENSG00000151729,Orphanet_206966,0.34301358316684305,13,Mitochondrial myopathy,[Orphanet_206634],"[OTAR_0000006, OTAR_0000018]"
SLC25A4,ENSG00000151729,MONDO_0044970,0.5103517933266479,10,mitochondrial disease,[OTAR_0000018],[OTAR_0000018]
SLC25A4,ENSG00000151729,MONDO_0005180,0.32791049783943477,4,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
SLC25A4,ENSG00000151729,MONDO_0001384,0.26609749537298527,1,myopia,[MONDO_0004892],[MONDO_0024458]
SLC25A4,ENSG00000151729,MONDO_0009637,0.3400134663099256,1,inborn mitochondrial myopathy,"[MONDO_0002921, MONDO_0004069]","[OTAR_0000006, OTAR_0000018, OTAR_0000020]"
SLC25A4,ENSG00000151729,MONDO_0004975,0.3279609270098224,6,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
SLC25A4,ENSG00000151729,MONDO_0005301,0.32500518953733,1,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
SLC25A40,ENSG00000075303,EFO_0005772,0.3695798546847018,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A41,ENSG00000181240,NA,NA,NA,NA,NA,NA
SLC25A42,ENSG00000181035,EFO_0000508,0.33291477022989674,12,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC25A42,ENSG00000181035,EFO_0010255,0.7067188110137465,9,"metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression",[EFO_1000017],[OTAR_0000018]
SLC25A42,ENSG00000181035,EFO_0005772,0.4280930147738005,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A42,ENSG00000181035,Orphanet_206966,0.5297137411067596,8,Mitochondrial myopathy,[Orphanet_206634],"[OTAR_0000006, OTAR_0000018]"
SLC25A42,ENSG00000181035,MONDO_0009637,0.26609749537298527,1,inborn mitochondrial myopathy,"[MONDO_0002921, MONDO_0004069]","[OTAR_0000006, OTAR_0000018, OTAR_0000020]"
SLC25A43,ENSG00000077713,EFO_0005772,0.5010540129669966,3,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A44,ENSG00000160785,NA,NA,NA,NA,NA,NA
SLC25A45,ENSG00000162241,EFO_0005653,0.2844063177970481,2,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC25A45,ENSG00000162241,EFO_0005418,0.29691394942789356,1,serum dimethylarginine measurement,[EFO_0001444],[EFO_0001444]
SLC25A45,ENSG00000162241,EFO_0004518,0.529758891459847,7,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC25A46,ENSG00000164209,EFO_0003956,0.2576970082036562,4,seasonal allergic rhinitis,[EFO_0005854],"[EFO_0000540, OTAR_0000010]"
SLC25A46,ENSG00000164209,MONDO_0017845,0.26609749537298527,1,spastic ataxia,[EFO_0009671],"[OTAR_0000018, EFO_0000618]"
SLC25A46,ENSG00000164209,MONDO_0015626,0.25870589827929125,1,Charcot-Marie-Tooth disease,[MONDO_0020127],"[OTAR_0000018, EFO_0000618]"
SLC25A46,ENSG00000164209,EFO_0000508,0.4948303320283943,60,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC25A46,ENSG00000164209,EFO_0005854,0.24649381632219783,8,allergic rhinitis,"[MONDO_0000771, EFO_0008521]","[EFO_0000540, OTAR_0000010]"
SLC25A46,ENSG00000164209,MONDO_0014671,0.7581686080134953,284,"neuropathy, hereditary motor and sensory, type 6B","[MONDO_0002316, MONDO_0019551]","[OTAR_0000018, EFO_0000618]"
SLC25A46,ENSG00000164209,MONDO_0019551,0.3695798546847018,1,hereditary motor and sensory neuropathy type 6,[MONDO_0018775],"[OTAR_0000018, EFO_0000618]"
SLC25A46,ENSG00000164209,EFO_0009075,0.7918281303821885,291,"neuropathy, hereditary motor and sensory, type vib","[Orphanet_71859, MONDO_0024257, MONDO_0015626]","[OTAR_0000018, EFO_0000618]"
SLC25A46,ENSG00000164209,MONDO_0030260,0.5148213958531807,10,"pontocerebellar hypoplasia, type 1E",[MONDO_0020135],"[OTAR_0000018, EFO_0000618]"
SLC25A46,ENSG00000164209,EFO_0005772,0.29527526832150613,4,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A46,ENSG00000164209,MONDO_0004979,0.297005715281976,9,asthma,[EFO_1002018],[OTAR_0000010]
SLC25A46,ENSG00000164209,GO_0007568,0.29477222907485195,1,aging,[GO_0032502],[GO_0008150]
SLC25A46,ENSG00000164209,MONDO_0016396,0.3695798546847018,1,pontocerebellar hypoplasia type 1,"[MONDO_0015327, MONDO_0020135, MONDO_0019502, MONDO_0016113, MONDO_0024257, MONDO_0015219]","[MONDO_0002025, OTAR_0000020, EFO_0000618, OTAR_0000018]"
SLC25A46,ENSG00000164209,HP_0000964,0.23610255363419994,4,Eczema,[HP_0011123],[EFO_0000651]
SLC25A46,ENSG00000164209,MONDO_0005271,0.24604783556781706,7,allergic disease,[EFO_1002003],[EFO_0000540]
SLC25A47,ENSG00000140107,EFO_0005772,0.22295145998848998,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A47,ENSG00000140107,GO_0007568,0.22295145998848998,1,aging,[GO_0032502],[GO_0008150]
SLC25A47,ENSG00000140107,EFO_0004696,0.3988422547629228,6,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
SLC25A47,ENSG00000140107,EFO_0004614,0.22063818301372545,1,apolipoprotein A 1 measurement,"[EFO_0004872, EFO_0005278, EFO_0004732]",[EFO_0001444]
SLC25A48,ENSG00000145832,NA,NA,NA,NA,NA,NA
MTCH1,ENSG00000137409,EFO_0005772,0.4393010969314744,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A5,ENSG00000005022,EFO_0020092,0.2641053504308255,1,neuroinflammatory disorder,"[EFO_0009386, MONDO_0002977]","[EFO_0000540, EFO_0000618]"
SLC25A5,ENSG00000005022,EFO_0000702,0.4868290635834234,5,small cell lung carcinoma,"[EFO_0005220, EFO_0001071, Orphanet_271847, EFO_0008524, MONDO_0025511]","[OTAR_0000018, OTAR_0000010, MONDO_0045024, EFO_0001379]"
SLC25A5,ENSG00000005022,EFO_0006312,0.2589790935127453,1,mitochondrial DNA measurement,[EFO_0001444],[EFO_0001444]
SLC25A5,ENSG00000005022,EFO_0000764,0.3706423967669203,3,HIV infection,"[MONDO_0021682, EFO_1001357]","[OTAR_0000017, EFO_0005741]"
SLC25A5,ENSG00000005022,EFO_0005772,0.48418586638492106,5,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A5,ENSG00000005022,MONDO_0008903,0.49606855995054094,6,lung cancer,"[MONDO_0021117, MONDO_0003274, MONDO_0000376]","[OTAR_0000010, MONDO_0045024]"
MTCH2,ENSG00000109919,EFO_0004736,0.2841520064364778,5,aspartate aminotransferase measurement,"[EFO_0004747, EFO_0004582]",[EFO_0001444]
MTCH2,ENSG00000109919,EFO_0004339,0.29169554827149474,5,body height,[EFO_0004324],[EFO_0001444]
MTCH2,ENSG00000109919,EFO_0004340,0.233862669538691,36,body mass index,[EFO_0004324],[EFO_0001444]
MTCH2,ENSG00000109919,EFO_0004533,0.269551286898033,3,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
MTCH2,ENSG00000109919,EFO_0005763,0.2916907417750272,2,pulse pressure measurement,[EFO_0005278],[EFO_0001444]
MTCH2,ENSG00000109919,EFO_0007800,0.21656921280641464,10,body fat percentage,[EFO_0005106],[EFO_0001444]
MTCH2,ENSG00000109919,EFO_0004532,0.21789343201845549,1,serum gamma-glutamyl transferase measurement,[EFO_0004582],[EFO_0001444]
SLC25A51,ENSG00000122696,EFO_0005772,0.49012168068498624,3,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A51,ENSG00000122696,GO_0007568,0.2533217609619814,1,aging,[GO_0032502],[GO_0008150]
SLC25A52,ENSG00000141437,NA,NA,NA,NA,NA,NA
SLC25A53,ENSG00000269743,NA,NA,NA,NA,NA,NA
SLC25A6,ENSG00000169100,MONDO_0002561,0.31203148956012966,1,lysosomal storage disease,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
SLC25A6,ENSG00000169100,EFO_0007328,0.3695798546847018,1,influenza,"[MONDO_0024352, MONDO_0100329]","[EFO_0005741, OTAR_0000010]"
SLC25A6,ENSG00000169100,EFO_0000764,0.3695798546847018,1,HIV infection,"[MONDO_0021682, EFO_1001357]","[OTAR_0000017, EFO_0005741]"
SLC25A6,ENSG00000169100,EFO_0005772,0.31203148956012966,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC25A6,ENSG00000169100,MONDO_0005180,0.31203148956012966,1,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
SLC25A6,ENSG00000169100,EFO_0000349,0.26212865043576977,4,clear cell renal carcinoma,"[MONDO_0007763, EFO_0000348, EFO_0005708]","[EFO_0009690, MONDO_0045024]"
SLC25A6,ENSG00000169100,MONDO_0004975,0.31295543919684143,2,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
SLC25A6,ENSG00000169100,MONDO_0005301,0.3124010694148143,2,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
UCP1,ENSG00000109424,EFO_0010750,0.20848311208078024,1,PHF-tau measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
UCP2,ENSG00000175567,MONDO_0017183,0.3695798546847018,1,hyperinsulinism due to UCP2 deficiency,[MONDO_0015624],"[OTAR_0000018, OTAR_0000020, EFO_0001379, EFO_0009605, EFO_0010282]"
UCP2,ENSG00000175567,EFO_0004584,0.2670481785457857,3,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
UCP2,ENSG00000175567,MONDO_0019115,0.2284598936161782,6,obesity due to melanocortin 4 receptor deficiency,[MONDO_0020075],"[OTAR_0000018, EFO_0001379, OTAR_0000020]"
UCP3,ENSG00000175564,EFO_0001074,0.3326218692162316,1,morbid obesity,[EFO_0001073],[OTAR_0000020]
UCP3,ENSG00000175564,EFO_0001073,0.23904056059496595,195,obesity,[MONDO_0003916],[OTAR_0000020]
SLC26A1,ENSG00000145217,EFO_0004253,0.5505964173378644,8,nephrolithiasis,"[MONDO_0024647, EFO_0003086]",[EFO_0009690]
SLC26A1,ENSG00000145217,HP_0006515,0.3400134663099256,1,Interstitial pneumonitis,[HP_0006530],[EFO_0000651]
SLC26A1,ENSG00000145217,EFO_0009065,0.4612549075074043,70,calcium oxalate urolithiasis,[MONDO_0024647],[EFO_0009690]
SLC26A1,ENSG00000145217,EFO_0004747,0.26923337608359404,1,protein measurement,[EFO_0001444],[EFO_0001444]
SLC26A1,ENSG00000145217,EFO_0010701,0.22504159693292117,2,mean reticulocyte volume,[EFO_0010700],[EFO_0001444]
SLC26A1,ENSG00000145217,MONDO_0011760,0.5038325567548331,11,Scheie syndrome,"[MONDO_0800088, MONDO_0001586]","[OTAR_0000006, OTAR_0000018, OTAR_0000020, MONDO_0024458]"
SLC26A1,ENSG00000145217,MONDO_0011759,0.5157645201166149,15,Hurler-Scheie syndrome,"[MONDO_0800088, MONDO_0001586]","[OTAR_0000006, OTAR_0000018, OTAR_0000020, MONDO_0024458]"
SLC26A1,ENSG00000145217,MONDO_0011758,0.5546310721788449,65,Hurler syndrome,"[MONDO_0800088, MONDO_0016340, MONDO_0001586]","[OTAR_0000006, OTAR_0000020, MONDO_0024458, EFO_0000319, OTAR_0000018]"
SLC26A1,ENSG00000145217,MONDO_0001586,0.5688730869138213,157,mucopolysaccharidosis type 1,"[MONDO_0019249, EFO_0003966, EFO_0004260]","[OTAR_0000006, OTAR_0000018, OTAR_0000020, MONDO_0024458]"
SLC26A10P,ENSG00000135502,NA,NA,NA,NA,NA,NA
SLC26A11,ENSG00000181045,MONDO_0009655,0.540498715277286,61,mucopolysaccharidosis type 3A,"[MONDO_0018937, MONDO_0800088]","[OTAR_0000006, OTAR_0000018, OTAR_0000020]"
SLC26A2,ENSG00000155850,Orphanet_93298,0.7894711472297632,656,Achondrogenesis type 1B,"[Orphanet_364526, Orphanet_364803]","[OTAR_0000006, OTAR_0000018]"
SLC26A2,ENSG00000155850,MONDO_0009189,0.8026802568729486,691,multiple epiphyseal dysplasia type 4,"[MONDO_0019688, MONDO_0016648]","[OTAR_0000006, OTAR_0000018, OTAR_0000020]"
SLC26A2,ENSG00000155850,EFO_0000508,0.4106503319019997,21,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC26A2,ENSG00000155850,MONDO_0017398,0.4794272003826548,4,3MC syndrome,"[MONDO_0015159, EFO_0000508]",[OTAR_0000018]
SLC26A2,ENSG00000155850,EFO_0005571,0.3653111047020227,8,osteochondrodysplasia,[EFO_0005541],[OTAR_0000006]
SLC26A2,ENSG00000155850,MONDO_0009107,0.7968881764314087,716,diastrophic dysplasia,"[EFO_0005571, MONDO_0019688]","[OTAR_0000006, OTAR_0000018, OTAR_0000020]"
SLC26A2,ENSG00000155850,MONDO_0015369,0.49206272497004183,6,Joubert syndrome and related disorders,[MONDO_0020043],"[OTAR_0000018, EFO_0000618]"
SLC26A2,ENSG00000155850,EFO_1001986,0.49462835191604304,17,connective tissue disease,[OTAR_0000006],[OTAR_0000006]
SLC26A2,ENSG00000155850,MONDO_0016648,0.5601188549694989,22,multiple epiphyseal dysplasia,"[MONDO_0019692, EFO_0005571]","[OTAR_0000006, OTAR_0000018]"
SLC26A2,ENSG00000155850,EFO_0005772,0.2886388005357095,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC26A2,ENSG00000155850,MONDO_0009727,0.8081323490865453,649,atelosteogenesis type II,"[MONDO_0018187, MONDO_0019688, MONDO_0018751, MONDO_0000389, MONDO_0019697]","[OTAR_0000006, OTAR_0000018, OTAR_0000020]"
SLC26A2,ENSG00000155850,Orphanet_628,0.7439733007539895,651,Diastrophic dwarfism,"[Orphanet_364536, Orphanet_364803]","[OTAR_0000006, OTAR_0000018]"
SLC26A2,ENSG00000155850,EFO_0004526,0.21828766561706978,3,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC26A2,ENSG00000155850,EFO_0009270,0.3156619827872977,2,heel bone mineral density,[EFO_0003923],[EFO_0001444]
SLC26A2,ENSG00000155850,MONDO_0010966,0.7593353688759605,651,achondrogenesis type IB,"[MONDO_0019688, MONDO_0019648]","[OTAR_0000006, OTAR_0000018, OTAR_0000020]"
SLC26A2,ENSG00000155850,EFO_0004530,0.32522180033433895,2,triglyceride measurement,[EFO_0004529],[EFO_0001444]
SLC26A3,ENSG00000091138,HP_0001561,0.46279610692184325,3,Polyhydramnios,[HP_0001560],[EFO_0000651]
SLC26A3,ENSG00000091138,MONDO_0004565,0.42501683288740705,2,intestinal obstruction,[EFO_0009431],[EFO_0010282]
SLC26A3,ENSG00000091138,EFO_0003832,0.27477452981207856,2,gallbladder disease,[EFO_0009534],[EFO_0010282]
SLC26A3,ENSG00000091138,EFO_0003767,0.308533288399617,30,inflammatory bowel disease,"[EFO_0000508, EFO_0005140, EFO_0009431]","[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLC26A3,ENSG00000091138,EFO_0004252,0.242902103198867,1,nasopharyngeal neoplasm,"[MONDO_0021246, EFO_0005950, MONDO_0004821, EFO_0003853]","[OTAR_0000010, MONDO_0045024]"
SLC26A3,ENSG00000091138,MONDO_0008964,0.8142415936654098,200,congenital secretory chloride diarrhea 1,"[MONDO_0045032, MONDO_0015178]","[OTAR_0000018, EFO_0010282]"
SLC26A3,ENSG00000091138,HP_0005208,0.37013422446672883,2,Secretory diarrhea,[HP_0002014],[EFO_0000651]
SLC26A3,ENSG00000091138,HP_0004796,0.3400134663099256,1,Gastrointestinal obstruction,[HP_0012719],[EFO_0000651]
SLC26A3,ENSG00000091138,EFO_0004799,0.33394040782854817,7,cholelithiasis,"[MONDO_0700225, EFO_1000018]","[OTAR_0000018, EFO_0001379, EFO_0009690, EFO_0010282]"
SLC26A3,ENSG00000091138,MONDO_0015193,0.46279610692184325,3,hydrops fetalis,[MONDO_0019755],[OTAR_0000018]
SLC26A3,ENSG00000091138,EFO_0009605,0.21864427943836878,1,pancreas disease,"[EFO_0001379, EFO_0010282]",[EFO_0009605]
SLC26A3,ENSG00000091138,EFO_0009534,0.21864427943836878,1,biliary tract disease,[EFO_0010284],[EFO_0010282]
SLC26A3,ENSG00000091138,Orphanet_53689,0.7840793296201367,39,Congenital chloride diarrhea,[Orphanet_165655],"[OTAR_0000018, EFO_0010282]"
SLC26A3,ENSG00000091138,EFO_0004210,0.2751023770891422,2,gallstones,[EFO_0003832],[EFO_0010282]
SLC26A3,ENSG00000091138,EFO_0000729,0.4135225259492697,44,ulcerative colitis,[EFO_0003872],"[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLC26A4,ENSG00000091137,HP_0011387,0.4619748183558772,2,Enlarged vestibular aqueduct,[HP_0000359],[EFO_0000651]
SLC26A4,ENSG00000091137,MONDO_0023069,0.69039761609918,62,enlarged vestibular aqueduct syndrome,"[MONDO_0024654, EFO_0009672]","[OTAR_0000006, MONDO_0021205, EFO_0000618]"
SLC26A4,ENSG00000091137,Orphanet_96210,0.5612316974805914,64,Rare genetic deafness,[MONDO_0037940],"[OTAR_0000018, EFO_0000618]"
SLC26A4,ENSG00000091137,HP_0000598,0.43610422852794817,3,Abnormality of the ear,[HP_0000118],[EFO_0000651]
SLC26A4,ENSG00000091137,HP_0000407,0.3704986712678762,4,Sensorineural hearing impairment,[HP_0000364],[EFO_0000651]
SLC26A4,ENSG00000091137,MONDO_0010134,0.8500799168481806,854,Pendred syndrome,"[EFO_1000017, MONDO_0015778]","[OTAR_0000018, EFO_0001379]"
SLC26A4,ENSG00000091137,EFO_1000642,0.3695798546847018,1,hemochromatosis,[EFO_0000589],[OTAR_0000020]
SLC26A4,ENSG00000091137,MONDO_0019861,0.37010599267227373,5,thyroid hypoplasia,"[MONDO_0009043, MONDO_0016409]","[OTAR_0000018, OTAR_0000020, EFO_0001379]"
SLC26A4,ENSG00000091137,MONDO_0019855,0.3695798546847018,1,athyreosis,"[MONDO_0016409, MONDO_0009043]","[OTAR_0000018, OTAR_0000020, EFO_0001379]"
SLC26A4,ENSG00000091137,MONDO_0019588,0.6737462960741406,424,"hearing loss, autosomal recessive","[EFO_1000017, MONDO_0016298, MONDO_0016297]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC26A4,ENSG00000091137,EFO_0004238,0.6076561748396787,291,hearing loss,[MONDO_0021945],"[MONDO_0002025, EFO_0000618]"
SLC26A4,ENSG00000091137,EFO_0004747,0.2965951063721263,1,protein measurement,[EFO_0001444],[EFO_0001444]
SLC26A4,ENSG00000091137,EFO_0001063,0.5408239075680356,80,deafness,[EFO_0004238],"[MONDO_0002025, EFO_0000618]"
SLC26A4,ENSG00000091137,MONDO_0007500,0.4374422327855594,11,ear malformation,[EFO_0000508],[OTAR_0000018]
SLC26A4,ENSG00000091137,EFO_1001450,0.25870589827929125,1,Wolff-Parkinson-White Syndrome,"[EFO_0000508, MONDO_0000992]","[OTAR_0000018, EFO_0000319]"
SLC26A4,ENSG00000091137,EFO_0004283,0.3733211560185666,69,goiter,[EFO_1000627],[EFO_0001379]
SLC26A4,ENSG00000091137,EFO_1001176,0.3773361456472394,36,sensorineural hearing loss,[EFO_0004238],"[MONDO_0002025, EFO_0000618]"
SLC26A4,ENSG00000091137,MONDO_0010933,0.8229503229903261,470,autosomal recessive nonsyndromic hearing loss 4,[MONDO_0019588],"[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC26A5,ENSG00000170615,EFO_0008328,0.31011805713391627,5,chronotype measurement,[EFO_0004870],[EFO_0001444]
SLC26A5,ENSG00000170615,MONDO_0019588,0.591462482867695,21,"hearing loss, autosomal recessive","[EFO_1000017, MONDO_0016298, MONDO_0016297]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC26A5,ENSG00000170615,EFO_0004238,0.47934505063279037,45,hearing loss,[MONDO_0021945],"[MONDO_0002025, EFO_0000618]"
SLC26A5,ENSG00000170615,EFO_0001063,0.5946233258331921,78,deafness,[EFO_0004238],"[MONDO_0002025, EFO_0000618]"
SLC26A5,ENSG00000170615,EFO_0007616,0.4289453777170692,2,hearing measurement,[EFO_0001444],[EFO_0001444]
SLC26A6,ENSG00000225697,NA,NA,NA,NA,NA,NA
SLC26A7,ENSG00000147606,EFO_0004339,0.31813153282287027,4,body height,[EFO_0004324],[EFO_0001444]
SLC26A7,ENSG00000147606,MONDO_0005147,0.25448685171134705,1,type 1 diabetes mellitus,"[MONDO_0000569, MONDO_0000588, EFO_0000400]","[OTAR_0000020, EFO_0001379, EFO_0000540, EFO_0009605, EFO_0010282]"
SLC26A7,ENSG00000147606,EFO_0005763,0.35613010278230584,3,pulse pressure measurement,[EFO_0005278],[EFO_0001444]
SLC26A7,ENSG00000147606,EFO_0004695,0.3178922320269714,1,intraocular pressure measurement,[EFO_0004731],[EFO_0001444]
SLC26A7,ENSG00000147606,MONDO_0018612,0.2748373745291402,7,congenital hypothyroidism,[EFO_0004705],[EFO_0001379]
SLC26A8,ENSG00000112053,MONDO_0017173,0.6021158466689328,17,non-syndromic male infertility due to sperm motility disorder,[EFO_0004248],[OTAR_0000017]
SLC26A9,ENSG00000174502,EFO_0004713,0.36522410133570304,3,FEV/FEC ratio,"[EFO_0006841, EFO_0003892]",[EFO_0001444]
SLC26A9,ENSG00000174502,MONDO_0009061,0.4400818649844251,44,cystic fibrosis,"[EFO_1000017, EFO_0000684]","[OTAR_0000018, OTAR_0000010]"
SLC26A9,ENSG00000174502,MONDO_0005148,0.24181112368205576,3,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC26A9,ENSG00000174502,EFO_0004608,0.2577569205421069,1,cystic fibrosis associated meconium ileus,"[EFO_0010238, MONDO_0004567]","[OTAR_0000014, EFO_0010282]"
SLC26A9,ENSG00000174502,EFO_0009718,0.2994914366866401,3,peak expiratory flow,[EFO_0003892],[EFO_0001444]
SLC27A1,ENSG00000130304,NA,NA,NA,NA,NA,NA
SLC27A2,ENSG00000140284,EFO_0005664,0.27902871321960415,1,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC27A2,ENSG00000140284,EFO_0005091,0.20837400404877698,1,monocyte count,"[EFO_0004308, EFO_0803547]",[EFO_0001444]
SLC27A3,ENSG00000143554,EFO_0004339,0.20169160357500188,1,body height,[EFO_0004324],[EFO_0001444]
SLC27A4,ENSG00000167114,MONDO_0012089,0.8017897356406861,54,ichthyosis prematurity syndrome,"[MONDO_0017270, EFO_1001991]","[OTAR_0000018, OTAR_0000010, EFO_0010285]"
SLC27A4,ENSG00000167114,EFO_0000508,0.46690925977543346,25,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC27A4,ENSG00000167114,MONDO_0017778,0.3724704311231545,5,lamellar ichthyosis,"[MONDO_0020162, MONDO_0017262]","[OTAR_0000018, MONDO_0024458, EFO_0010285]"
SLC27A4,ENSG00000167114,EFO_1000017,0.3695798546847018,1,autosomal recessive disease,[MONDO_0000429],[OTAR_0000018]
SLC27A4,ENSG00000167114,EFO_0005772,0.4847986775693931,3,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC27A4,ENSG00000167114,GO_0007568,0.36311032484817746,1,aging,[GO_0032502],[GO_0008150]
SLC27A5,ENSG00000083807,EFO_0004696,0.3354901571639343,5,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
SLC27A6,ENSG00000113396,EFO_0010948,0.22480796905649994,1,lower face morphology measurement,[EFO_0007841],[EFO_0001444]
SLC27A6,ENSG00000113396,EFO_0000275,0.248564399004742,2,atrial fibrillation,"[EFO_0004269, MONDO_0007263]",[EFO_0000319]
SLC27A6,ENSG00000113396,EFO_0004698,0.21472381395004872,1,insomnia,[EFO_0008568],"[MONDO_0002025, EFO_0000618]"
SLC27A6,ENSG00000113396,EFO_0004908,0.2354122931013904,3,testosterone measurement,"[EFO_0004529, EFO_0011008]",[EFO_0001444]
SLC27A6,ENSG00000113396,EFO_0000182,0.4157773365202895,2,hepatocellular carcinoma,[MONDO_0018532],"[MONDO_0045024, EFO_0001379, EFO_0010282]"
SLC27A6,ENSG00000113396,EFO_0006336,0.25610946990828826,3,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC27A6,ENSG00000113396,EFO_0006335,0.299771212090622,8,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC27A6,ENSG00000113396,EFO_0008111,0.22590222150586983,1,diet measurement,[EFO_0001444],[EFO_0001444]
SLC27A6,ENSG00000113396,EFO_0000537,0.29308425935865995,6,hypertension,[MONDO_0000473],[EFO_0000319]
SLC27A6,ENSG00000113396,EFO_0004325,0.24170016081350842,2,blood pressure,[EFO_0004303],[EFO_0001444]
SLC27A6,ENSG00000113396,EFO_0009931,0.27323787821709644,2,Agents acting on the renin-angiotensin system use measurement,[EFO_0007010],[EFO_0001444]
SLC27A6,ENSG00000113396,EFO_0009930,0.21228654747450687,2,Calcium channel blocker use measurement,[EFO_0007010],[EFO_0001444]
SLC27A6,ENSG00000113396,EFO_0010736,0.23360106752260262,1,cortical surface area measurement,[EFO_0004464],[EFO_0001444]
SLC27A6,ENSG00000113396,EFO_0010699,0.24414031304560035,1,diffuse plaque measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
SLC27A6,ENSG00000113396,EFO_0004536,0.21472381395004872,1,total blood protein measurement,[EFO_0004503],[EFO_0001444]
SLC27A6,ENSG00000113396,EFO_0004840,0.3782576165106751,2,cortical thickness,[EFO_0004464],[EFO_0001444]
SLC27A6,ENSG00000113396,EFO_0003923,0.2565601906921961,1,bone density,[EFO_0004516],[EFO_0001444]
SLC27A6,ENSG00000113396,EFO_0004682,0.23910114327760076,1,QT interval,"[EFO_0004327, EFO_0000719]",[EFO_0001444]
SLC27A6,ENSG00000113396,EFO_0007814,0.4386596970914154,10,refractive error measurement,[EFO_0004731],[EFO_0001444]
SLC27A6,ENSG00000113396,EFO_0009270,0.40918318854735,9,heel bone mineral density,[EFO_0003923],[EFO_0001444]
SLC28A1,ENSG00000156222,EFO_0006335,0.34428805410477753,4,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC28A1,ENSG00000156222,EFO_0005653,0.45725739871687254,8,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC28A1,ENSG00000156222,EFO_0004747,0.22169593394703851,2,protein measurement,[EFO_0001444],[EFO_0001444]
SLC28A1,ENSG00000156222,EFO_0007789,0.3635842218354285,2,BMI-adjusted waist circumference,[EFO_0004342],[EFO_0001444]
SLC28A1,ENSG00000156222,EFO_0007788,0.3688228777857041,2,BMI-adjusted waist-hip ratio,[EFO_0004343],[EFO_0001444]
SLC28A2,ENSG00000137860,NA,NA,NA,NA,NA,NA
SLC28A3,ENSG00000197506,EFO_0004747,0.24876156808238056,3,protein measurement,[EFO_0001444],[EFO_0001444]
SLC29A1,ENSG00000112759,EFO_0002687,0.3695798546847018,1,ischemia reperfusion injury,[EFO_0000546],[OTAR_0000009]
SLC29A1,ENSG00000112759,EFO_0001645,0.5409211817593593,5,coronary artery disease,"[MONDO_0000473, EFO_0003777]",[EFO_0000319]
SLC29A1,ENSG00000112759,EFO_0006336,0.26560752210749106,1,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC29A1,ENSG00000112759,EFO_1001375,0.46886850925645435,6,Myocardial Ischemia,"[MONDO_0005053, EFO_0001645, MONDO_0024643]",[EFO_0000319]
SLC29A1,ENSG00000112759,EFO_0000712,0.5481074567115619,6,stroke,[EFO_0003763],"[EFO_0000618, EFO_0000319]"
SLC29A1,ENSG00000112759,HP_0004419,0.3695798546847018,1,Recurrent thrombophlebitis,[HP_0004418],[EFO_0000651]
SLC29A1,ENSG00000112759,EFO_0600064,0.3695798546847018,1,serum lipopolysaccharide activity,[MONDO_0021678],[EFO_0005741]
SLC29A1,ENSG00000112759,MONDO_0004985,0.3695798546847018,1,bipolar disorder,[EFO_0004247],"[MONDO_0002025, EFO_0000618]"
SLC29A1,ENSG00000112759,EFO_0003913,0.25870589827929125,1,angina pectoris,[HP_0001626],[EFO_0000651]
SLC29A1,ENSG00000112759,EFO_0009270,0.2890726035778563,3,heel bone mineral density,[EFO_0003923],[EFO_0001444]
SLC29A1,ENSG00000112759,EFO_0000400,0.3728292797532604,8,diabetes mellitus,"[EFO_0009406, MONDO_0001933]","[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC29A1,ENSG00000112759,EFO_1000937,0.3326218692162316,1,fetal erythroblastosis,[MONDO_0001245],[EFO_0005803]
SLC29A1,ENSG00000112759,MONDO_0100096,0.29355419874393623,7,COVID-19,[MONDO_0020753],[EFO_0005741]
SLC29A1,ENSG00000112759,EFO_1000059,0.25870589827929125,1,cervical artery dissection,[MONDO_0000473],[EFO_0000319]
SLC29A2,ENSG00000174669,EFO_0005772,0.2727280186982802,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC29A3,ENSG00000198246,MONDO_0006412,0.6590955830589338,27,sinus histiocytosis with massive lymphadenopathy,[MONDO_0015531],"[EFO_0000540, EFO_0005803]"
SLC29A3,ENSG00000198246,Orphanet_79062,0.3695798546847018,1,Disorder of amino acid and other organic acid metabolism,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
SLC29A3,ENSG00000198246,MONDO_0011273,0.8236151938068533,489,H syndrome,"[MONDO_0019289, MONDO_0006412, EFO_0009673]","[OTAR_0000010, EFO_0000540, EFO_0010285, EFO_0005803]"
SLC29A3,ENSG00000198246,EFO_1000660,0.3326218692162316,1,acanthosis nigricans,[MONDO_0002406],[EFO_0010285]
SLC29A3,ENSG00000198246,MONDO_0009138,0.38051684044981465,7,dysosteosclerosis,[MONDO_0017198],"[OTAR_0000006, OTAR_0000018]"
SLC29A3,ENSG00000198246,EFO_0007988,0.30905285131268806,1,myeloid white cell count,[EFO_0004308],[EFO_0001444]
SLC29A3,ENSG00000198246,EFO_0005772,0.44205674616503415,4,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC29A3,ENSG00000198246,EFO_0004587,0.41854370682528597,3,lymphocyte count,"[EFO_0006843, EFO_0004308, EFO_0803546]",[EFO_0001444]
SLC29A3,ENSG00000198246,EFO_0004308,0.279492394819773,1,leukocyte count,[EFO_0004586],[EFO_0001444]
SLC29A3,ENSG00000198246,EFO_0006798,0.30753663957540744,1,neuritic plaque measurement,[EFO_0006514],[EFO_0001444]
SLC29A4,ENSG00000164638,EFO_0005772,0.363584004418813,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC29A4,ENSG00000164638,GO_0007568,0.363584004418813,1,aging,[GO_0032502],[GO_0008150]
SLC29A4,ENSG00000164638,EFO_0009700,0.21305822576111977,1,visual perception measurement,[EFO_0004464],[EFO_0001444]
SLC3A1,ENSG00000138079,EFO_0010826,0.5230771619009664,15,cystine urolithiasis,[MONDO_0024647],[EFO_0009690]
SLC3A1,ENSG00000138079,EFO_0004253,0.2725903917499782,8,nephrolithiasis,"[MONDO_0024647, EFO_0003086]",[EFO_0009690]
SLC3A1,ENSG00000138079,EFO_0008039,0.2764740476691466,1,BMI-adjusted hip circumference,[EFO_0005093],[EFO_0001444]
SLC3A1,ENSG00000138079,MONDO_0009067,0.8539934404980262,481,cystinuria,"[MONDO_0015962, MONDO_0019216]","[OTAR_0000018, OTAR_0000020, EFO_0009690]"
SLC3A1,ENSG00000138079,MONDO_0019745,0.37109733930193006,6,cystinuria type A,[MONDO_0009067],"[OTAR_0000018, OTAR_0000020, EFO_0009690]"
SLC3A1,ENSG00000138079,HP_0008209,0.3326218692162316,1,Premature ovarian insufficiency,[HP_0000078],[EFO_0000651]
SLC3A1,ENSG00000138079,EFO_0004747,0.31429468661089943,4,protein measurement,[EFO_0001444],[EFO_0001444]
SLC3A1,ENSG00000138079,EFO_0003756,0.3326218692162316,1,autism spectrum disorder,[MONDO_0000594],"[MONDO_0002025, EFO_0000618]"
SLC3A1,ENSG00000138079,MONDO_0011669,0.3809074240760977,17,hypotonia-cystinuria syndrome,"[MONDO_0018246, MONDO_0004069, MONDO_0019216]","[OTAR_0000018, OTAR_0000020]"
SLC3A1,ENSG00000138079,Orphanet_238523,0.36994943453938645,2,Atypical hypotonia - cystinuria syndrome,[Orphanet_238517],"[OTAR_0000018, OTAR_0000020, EFO_0009690]"
SLC3A1,ENSG00000138079,MONDO_0001567,0.25870589827929125,1,nephrocalcinosis,"[MONDO_0002123, EFO_0003086]","[OTAR_0000020, EFO_0009690]"
SLC3A1,ENSG00000138079,MONDO_0018246,0.3695798546847018,1,homozygous 2p21 microdeletion syndrome,[MONDO_0015583],[OTAR_0000018]
SLC3A1,ENSG00000138079,EFO_0004302,0.276005894247759,1,anthropometric measurement,[EFO_0001444],[EFO_0001444]
SLC3A1,ENSG00000138079,Orphanet_163690,0.3719226403779407,15,Hypotonia - cystinuria syndrome,[Orphanet_238517],"[OTAR_0000018, OTAR_0000020, EFO_0009690]"
SLC35B4,ENSG00000205060,EFO_0004584,0.45648661884139846,6,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
SLC35B4,ENSG00000205060,EFO_0007876,0.27877566981891344,1,insomnia measurement,[EFO_0004870],[EFO_0001444]
SLC35B4,ENSG00000205060,EFO_0006527,0.24413066448553222,1,smoking status measurement,[EFO_0005671],[EFO_0001444]
SLC35B4,ENSG00000205060,EFO_0007984,0.34556524953541856,2,platelet component distribution width,[EFO_0005036],[EFO_0001444]
SLC35B4,ENSG00000205060,EFO_0007937,0.41239801708304036,3,blood protein measurement,[EFO_0004747],[EFO_0001444]
SLC3A2,ENSG00000168003,HP_0000407,0.3695798546847018,1,Sensorineural hearing impairment,[HP_0000364],[EFO_0000651]
SLC3A2,ENSG00000168003,EFO_0005772,0.3231379221431186,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC30A1,ENSG00000170385,EFO_0004980,0.3376989250025717,2,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
SLC30A1,ENSG00000170385,EFO_0004784,0.253895580020049,1,self reported educational attainment,[EFO_0011015],[EFO_0001444]
SLC30A1,ENSG00000170385,EFO_0004735,0.2599754284974969,1,serum alanine aminotransferase measurement,"[EFO_0004582, EFO_0004747]",[EFO_0001444]
SLC30A1,ENSG00000170385,EFO_0004533,0.2028043317325164,4,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC30A1,ENSG00000170385,EFO_0005772,0.4614135907043948,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC30A1,ENSG00000170385,GO_0007568,0.36733494407877204,1,aging,[GO_0032502],[GO_0008150]
SLC30A1,ENSG00000170385,EFO_0004632,0.2515982534620934,1,nevus count,[EFO_0001444],[EFO_0001444]
SLC30A1,ENSG00000170385,EFO_0004528,0.3126122929030334,6,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC30A1,ENSG00000170385,EFO_0004527,0.2632779287404771,3,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC30A10,ENSG00000196660,EFO_0005271,0.37615890600229535,2,sleep duration,[EFO_0004870],[EFO_0001444]
SLC30A10,ENSG00000196660,EFO_0004713,0.3286736240989544,3,FEV/FEC ratio,"[EFO_0006841, EFO_0003892]",[EFO_0001444]
SLC30A10,ENSG00000196660,MONDO_0024647,0.30792504918983926,1,urolithiasis,[EFO_0009690],[EFO_0009690]
SLC30A10,ENSG00000196660,EFO_0004736,0.46455441496978805,4,aspartate aminotransferase measurement,"[EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC30A10,ENSG00000196660,EFO_0004735,0.4167564553981127,4,serum alanine aminotransferase measurement,"[EFO_0004582, EFO_0004747]",[EFO_0001444]
SLC30A10,ENSG00000196660,EFO_0007986,0.4837019752537151,11,reticulocyte count,[EFO_0010700],[EFO_0001444]
SLC30A10,ENSG00000196660,Orphanet_309854,0.7856661698615074,66,Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome,"[Orphanet_101940, Orphanet_307055, MONDO_0019052]","[OTAR_0000018, OTAR_0000020, EFO_0000618, EFO_0010282]"
SLC30A10,ENSG00000196660,EFO_0010700,0.42876044090606236,3,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
SLC30A10,ENSG00000196660,EFO_0004533,0.2940545171456038,1,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC30A10,ENSG00000196660,EFO_0004838,0.4344267227151843,4,calcium measurement,[EFO_0001444],[EFO_0001444]
SLC30A10,ENSG00000196660,MONDO_0013208,0.6690380757715583,58,cirrhosis - dystonia - polycythemia - hypermanganesemia syndrome,"[MONDO_0017766, MONDO_0021095, MONDO_0000214]","[OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC30A10,ENSG00000196660,EFO_0004526,0.3232669702759337,3,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC30A10,ENSG00000196660,EFO_0004514,0.4380605922227733,6,bone quantitative ultrasound measurement,[EFO_0004516],[EFO_0001444]
SLC30A10,ENSG00000196660,EFO_0003923,0.322085022432473,3,bone density,[EFO_0004516],[EFO_0001444]
SLC30A10,ENSG00000196660,EFO_0004695,0.2464038476146416,1,intraocular pressure measurement,[EFO_0004731],[EFO_0001444]
SLC30A10,ENSG00000196660,EFO_0007825,0.3579671462752664,2,balding measurement,[EFO_0007821],[EFO_0001444]
SLC30A10,ENSG00000196660,EFO_0007824,0.25380938181103857,1,hair shape measurement,[EFO_0007821],[EFO_0001444]
SLC30A10,ENSG00000196660,EFO_0000341,0.32695365183608016,5,chronic obstructive pulmonary disease,"[MONDO_0002567, EFO_0009910]",[OTAR_0000010]
SLC30A10,ENSG00000196660,EFO_0009270,0.4794111829308657,16,heel bone mineral density,[EFO_0003923],[EFO_0001444]
SLC30A10,ENSG00000196660,EFO_0009253,0.3945060229664943,3,Immature Reticulocyte Fraction Measurement,[EFO_0009233],[EFO_0001444]
SLC30A10,ENSG00000196660,EFO_0009188,0.4579768164195992,5,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC30A10,ENSG00000196660,EFO_0006527,0.21920065495337018,2,smoking status measurement,[EFO_0005671],[EFO_0001444]
SLC30A10,ENSG00000196660,EFO_0007903,0.30792504918983926,1,magnesium:calcium ratio,[EFO_0004838],[EFO_0001444]
SLC30A10,ENSG00000196660,EFO_0007581,0.3031552460714128,1,blood manganese measurement,[EFO_0007574],[EFO_0001444]
SLC30A10,ENSG00000196660,EFO_0004531,0.26062377648819335,1,urate measurement,[EFO_0001444],[EFO_0001444]
SLC30A10,ENSG00000196660,EFO_0004530,0.38373023893754,7,triglyceride measurement,[EFO_0004529],[EFO_0001444]
SLC30A10,ENSG00000196660,EFO_0004528,0.38608593056316215,2,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC30A10,ENSG00000196660,EFO_0004527,0.22357740316032282,1,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
TMEM163,ENSG00000152128,EFO_1001486,0.41809381615531693,5,primary biliary cirrhosis,"[MONDO_0007329, EFO_0004267, MONDO_0015509]","[OTAR_0000018, MONDO_0045024, EFO_0001379, EFO_0010282]"
TMEM163,ENSG00000152128,MONDO_0002491,0.30408364461952037,1,substance abuse,[MONDO_0002494],[MONDO_0002025]
TMEM163,ENSG00000152128,EFO_0007052,0.30408364461952037,1,antisocial behaviour measurement,[EFO_0006848],[EFO_0001444]
TMEM163,ENSG00000152128,EFO_0000389,0.31187353515397365,1,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
TMEM163,ENSG00000152128,EFO_0004908,0.2934877853993193,1,testosterone measurement,"[EFO_0004529, EFO_0011008]",[EFO_0001444]
TMEM163,ENSG00000152128,EFO_0003888,0.30408364461952037,1,attention deficit hyperactivity disorder,[MONDO_0000592],"[MONDO_0002025, EFO_0000618]"
TMEM163,ENSG00000152128,EFO_0008354,0.2871380415840754,1,cognitive function measurement,[EFO_0001444],[EFO_0001444]
TMEM163,ENSG00000152128,EFO_0004348,0.3836733530321503,3,hematocrit,[EFO_0004503],[EFO_0001444]
TMEM163,ENSG00000152128,EFO_0004343,0.28642076586631693,1,waist-hip ratio,[EFO_0007861],[EFO_0001444]
TMEM163,ENSG00000152128,EFO_0004566,0.3003789720408518,1,body weight gain,[HP_0004323],[EFO_0000651]
TMEM163,ENSG00000152128,EFO_0600017,0.3003789720408518,1,response to dolutegravir,[GO_0061479],[GO_0008150]
TMEM163,ENSG00000152128,EFO_0004875,0.4184392148594955,5,mathematical ability,[EFO_0003925],[GO_0008150]
TMEM163,ENSG00000152128,GO_0061479,0.3003789720408518,1,response to reverse transcriptase inhibitor,[GO_0046677],[GO_0008150]
TMEM163,ENSG00000152128,MONDO_0005180,0.4259952014967247,11,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
TMEM163,ENSG00000152128,EFO_0003924,0.44110833312299197,4,hair color,[EFO_0005038],[EFO_0000651]
TMEM163,ENSG00000152128,EFO_0004696,0.21890052388103418,2,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
TMEM163,ENSG00000152128,EFO_0004509,0.22003625495043438,2,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
TMEM163,ENSG00000152128,EFO_0007874,0.25843701185485396,1,gut microbiome measurement,[EFO_0007882],[EFO_0001444]
TMEM163,ENSG00000152128,EFO_0007822,0.31164084624986493,1,hair colour measurement,[EFO_0007821],[EFO_0001444]
TMEM163,ENSG00000152128,EFO_0004612,0.27216341027231833,1,high density lipoprotein cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
TMEM163,ENSG00000152128,EFO_0004611,0.307634954244589,2,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
TMEM163,ENSG00000152128,EFO_0004305,0.3136311543322682,2,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
TMEM163,ENSG00000152128,EFO_0007984,0.3079710891225845,2,platelet component distribution width,[EFO_0005036],[EFO_0001444]
TMEM163,ENSG00000152128,EFO_0007660,0.4541483743850018,6,neuroticism measurement,"[EFO_0007911, EFO_0006848]",[EFO_0001444]
SLC30A2,ENSG00000158014,MONDO_0011973,0.6189042493185536,25,"zinc deficiency, transient neonatal",[EFO_0000508],[OTAR_0000018]
SLC30A3,ENSG00000115194,EFO_0004530,0.23642021592113038,2,triglyceride measurement,[EFO_0004529],[EFO_0001444]
SLC30A4,ENSG00000104154,NA,NA,NA,NA,NA,NA
SLC30A5,ENSG00000145740,EFO_0000538,0.3326218692162316,2,hypertrophic cardiomyopathy,[MONDO_0000591],"[OTAR_0000006, EFO_0000319]"
SLC30A5,ENSG00000145740,MONDO_0015193,0.3326218692162316,2,hydrops fetalis,[MONDO_0019755],[OTAR_0000018]
SLC30A5,ENSG00000145740,EFO_0004533,0.2883897715306759,2,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC30A5,ENSG00000145740,EFO_0000318,0.23283530845136213,3,cardiomyopathy,"[EFO_0003777, MONDO_0003939]","[OTAR_0000006, EFO_0000319]"
SLC30A6,ENSG00000152683,MONDO_0008438,0.5269418982492046,10,hereditary spastic paraplegia 4,"[MONDO_0100523, MONDO_0017914]","[OTAR_0000018, EFO_0000618]"
SLC30A6,ENSG00000152683,Orphanet_100985,0.5269418982492046,10,Autosomal dominant spastic paraplegia type 4,[Orphanet_183500],"[OTAR_0000018, EFO_0000618]"
SLC30A7,ENSG00000162695,EFO_0007993,0.23172109625928328,2,lymphocyte percentage of leukocytes,[EFO_0004587],[EFO_0001444]
SLC30A7,ENSG00000162695,HP_0008734,0.27034766370185936,2,Decreased testicular size,[HP_0000078],[EFO_0000651]
SLC30A7,ENSG00000162695,HP_0000029,0.26609749537298527,1,Testicular atrophy,[HP_0000078],[EFO_0000651]
SLC30A7,ENSG00000162695,MONDO_0018772,0.3344697684896551,2,Joubert syndrome,[EFO_0003900],[OTAR_0000018]
SLC30A7,ENSG00000162695,MONDO_0005301,0.22400085026500755,3,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
SLC30A8,ENSG00000164756,EFO_0001379,0.2884003067449512,1,endocrine system disease,[],[EFO_0001379]
SLC30A8,ENSG00000164756,EFO_0008036,0.396396163523305,3,BMI-adjusted fasting blood glucose measurement,[EFO_0004465],[EFO_0001444]
SLC30A8,ENSG00000164756,EFO_0009924,0.3927580591557405,3,Drugs used in diabetes use measurement,[EFO_0007010],[EFO_0001444]
SLC30A8,ENSG00000164756,EFO_0000676,0.28824896974114295,1,psoriasis,"[MONDO_0002406, EFO_1000636, EFO_0000540, MONDO_0100118]","[OTAR_0000018, EFO_0000540, EFO_0010285]"
SLC30A8,ENSG00000164756,EFO_0004340,0.360550355482592,2,body mass index,[EFO_0004324],[EFO_0001444]
SLC30A8,ENSG00000164756,EFO_0004541,0.6535291701929551,15,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
SLC30A8,ENSG00000164756,EFO_0009518,0.2884844783157738,1,complication,[OTAR_0000009],[OTAR_0000009]
SLC30A8,ENSG00000164756,MONDO_0004979,0.28271405852332676,4,asthma,[EFO_1002018],[OTAR_0000010]
SLC30A8,ENSG00000164756,MONDO_0005148,0.6078703021320987,234,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC30A8,ENSG00000164756,EFO_0004469,0.28824896974114295,1,HOMA-B,"[EFO_0004468, EFO_0004467]",[EFO_0001444]
SLC30A8,ENSG00000164756,EFO_0004468,0.48376627304963227,10,glucose measurement,[EFO_0006842],[EFO_0001444]
SLC30A8,ENSG00000164756,EFO_0004467,0.3961393776953326,3,insulin measurement,"[EFO_0004747, EFO_0004730, EFO_0006842]",[EFO_0001444]
SLC30A8,ENSG00000164756,EFO_0004466,0.28824896974114295,1,fasting blood insulin measurement,[EFO_0004467],[EFO_0001444]
SLC30A8,ENSG00000164756,EFO_0004465,0.4560152608582912,12,fasting blood glucose measurement,[EFO_0004468],[EFO_0001444]
SLC30A8,ENSG00000164756,EFO_0004696,0.39631097006668115,3,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
SLC30A8,ENSG00000164756,EFO_0000400,0.46518957887631146,105,diabetes mellitus,"[EFO_0009406, MONDO_0001933]","[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC30A8,ENSG00000164756,EFO_0007629,0.3641042858317031,2,hemoglobin A1 measurement,[EFO_0004509],[EFO_0001444]
SLC30A8,ENSG00000164756,EFO_0004530,0.4144117241321264,4,triglyceride measurement,[EFO_0004529],[EFO_0001444]
SLC30A9,ENSG00000014824,MONDO_0005351,0.22609503850650062,1,anorexia nervosa,[EFO_0005203],"[MONDO_0002025, OTAR_0000020, EFO_0000618]"
SLC30A9,ENSG00000014824,EFO_0003888,0.22609503850650062,1,attention deficit hyperactivity disorder,[MONDO_0000592],"[MONDO_0002025, EFO_0000618]"
SLC30A9,ENSG00000014824,EFO_0004242,0.22609503850650062,1,obsessive-compulsive disorder,"[EFO_0000508, EFO_0006788]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC30A9,ENSG00000014824,EFO_0003761,0.31719451138820415,5,unipolar depression,[MONDO_0002050],"[MONDO_0002025, EFO_0000618]"
SLC30A9,ENSG00000014824,EFO_0003756,0.23871389567582546,2,autism spectrum disorder,[MONDO_0000594],"[MONDO_0002025, EFO_0000618]"
SLC30A9,ENSG00000014824,EFO_0004895,0.22609503850650062,1,Tourette syndrome,"[MONDO_0002420, EFO_0004280, EFO_0000508]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC30A9,ENSG00000014824,MONDO_0005090,0.22609503850650062,1,schizophrenia,[EFO_0005407],"[MONDO_0002025, EFO_0000618]"
SLC30A9,ENSG00000014824,EFO_0005772,0.4128276559866955,3,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC30A9,ENSG00000014824,MONDO_0004985,0.2826187981331258,2,bipolar disorder,[EFO_0004247],"[MONDO_0002025, EFO_0000618]"
SLC30A9,ENSG00000014824,MONDO_0044726,0.5907095751702532,15,psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome,"[MONDO_0015962, MONDO_0017764, MONDO_0024237]","[OTAR_0000018, OTAR_0000020, EFO_0009690, EFO_0000618]"
SLC30A9,ENSG00000014824,GO_0007568,0.4128276559866955,3,aging,[GO_0032502],[GO_0008150]
SLC31A1,ENSG00000136868,NA,NA,NA,NA,NA,NA
SLC31A2,ENSG00000136867,EFO_0007988,0.27096670245108345,1,myeloid white cell count,[EFO_0004308],[EFO_0001444]
SLC31A2,ENSG00000136867,EFO_0004526,0.37016194803178776,6,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC31A2,ENSG00000136867,EFO_0004528,0.2718024969200526,2,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC31A2,ENSG00000136867,EFO_0004527,0.20853669958862434,2,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC32A1,ENSG00000101438,EFO_0020092,0.25390900371987785,1,neuroinflammatory disorder,"[EFO_0009386, MONDO_0002977]","[EFO_0000540, EFO_0000618]"
SLC32A1,ENSG00000101438,MONDO_0005090,0.28824413200794746,24,schizophrenia,[EFO_0005407],"[MONDO_0002025, EFO_0000618]"
SLC32A1,ENSG00000101438,EFO_0005772,0.26185792195993823,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC32A1,ENSG00000101438,GO_0007568,0.26185792195993823,1,aging,[GO_0032502],[GO_0008150]
SLC32A1,ENSG00000101438,MONDO_0018214,0.37980652105199536,8,generalized epilepsy with febrile seizures plus,[MONDO_0015653],"[OTAR_0000018, EFO_0000618]"
SLC32A1,ENSG00000101438,EFO_0007793,0.23348541697384084,1,BMI-adjusted leptin measurement,[EFO_0005000],[EFO_0001444]
SLC32A1,ENSG00000101438,MONDO_0100062,0.3714277539581253,2,developmental and epileptic encephalopathy,"[MONDO_0100022, MONDO_0100038, MONDO_0100500, EFO_0005917]","[OTAR_0000018, EFO_0000618]"
SLC32A1,ENSG00000101438,HP_0001250,0.37124296403078294,5,Seizure,[HP_0012638],[EFO_0000651]
SLC32A1,ENSG00000101438,HP_0001249,0.36994943453938645,5,Intellectual disability,"[HP_0012759, HP_0100543]",[EFO_0000651]
SLC33A1,ENSG00000169359,MONDO_0012928,0.47597259249834356,10,hereditary spastic paraplegia 42,[MONDO_0015088],"[OTAR_0000018, EFO_0000618]"
SLC33A1,ENSG00000169359,EFO_0004705,0.25870589827929125,1,hypothyroidism,[EFO_1000627],[EFO_0001379]
SLC33A1,ENSG00000169359,EFO_1000642,0.3695798546847018,1,hemochromatosis,[EFO_0000589],[OTAR_0000020]
SLC33A1,ENSG00000169359,EFO_0004784,0.2100830768440404,1,self reported educational attainment,[EFO_0011015],[EFO_0001444]
SLC33A1,ENSG00000169359,EFO_0004735,0.26233675447817734,4,serum alanine aminotransferase measurement,"[EFO_0004582, EFO_0004747]",[EFO_0001444]
SLC33A1,ENSG00000169359,HP_0001508,0.25870589827929125,1,Failure to thrive,[HP_0004325],[EFO_0000651]
SLC33A1,ENSG00000169359,EFO_0004533,0.2692619088582963,3,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC33A1,ENSG00000169359,EFO_0004875,0.2317750068543747,3,mathematical ability,[EFO_0003925],[GO_0008150]
SLC33A1,ENSG00000169359,MONDO_0005129,0.3695798546847018,1,cataract,"[EFO_0009674, EFO_0000508]","[OTAR_0000018, MONDO_0024458]"
SLC33A1,ENSG00000169359,EFO_0005772,0.462494967780989,5,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC33A1,ENSG00000169359,MONDO_0019064,0.4144558856749477,17,hereditary spastic paraplegia,"[EFO_0009679, MONDO_0024237]","[OTAR_0000018, EFO_0000618]"
SLC33A1,ENSG00000169359,Orphanet_171863,0.6222767281271383,12,Autosomal dominant spastic paraplegia type 42,[Orphanet_183500],"[OTAR_0000018, EFO_0000618]"
SLC33A1,ENSG00000169359,HP_0001263,0.2606788555560721,10,Global developmental delay,[HP_0012758],[EFO_0000651]
SLC33A1,ENSG00000169359,HP_0001258,0.41598894930860486,121,Spastic paraplegia,[HP_0002061],[EFO_0000651]
SLC33A1,ENSG00000169359,MONDO_0013772,0.7045807501756985,14,congenital cataract-hearing loss-severe developmental delay syndrome,[EFO_0000508],[OTAR_0000018]
SLC33A1,ENSG00000169359,EFO_0004530,0.20165671177523023,1,triglyceride measurement,[EFO_0004529],[EFO_0001444]
MFSD3,ENSG00000167700,NA,NA,NA,NA,NA,NA
SLC34A1,ENSG00000131183,EFO_0010972,0.34613945095330745,4,blood phosphate measurement,[EFO_0001444],[EFO_0001444]
SLC34A1,ENSG00000131183,EFO_0010968,0.27407291212868773,1,phosphate measurement,[EFO_0001444],[EFO_0001444]
SLC34A1,ENSG00000131183,EFO_0005208,0.3298078392885459,15,glomerular filtration rate,[EFO_0004742],[EFO_0001444]
SLC34A1,ENSG00000131183,MONDO_0007600,0.49074610926237217,48,primary Fanconi syndrome,[MONDO_0100238],"[OTAR_0000018, EFO_0009690]"
SLC34A1,ENSG00000131183,EFO_0004253,0.4693183482990007,22,nephrolithiasis,"[MONDO_0024647, EFO_0003086]",[EFO_0009690]
SLC34A1,ENSG00000131183,MONDO_0024525,0.3826368799633031,7,Fanconi renotubular syndrome 1,[MONDO_0007600],"[OTAR_0000018, EFO_0009690]"
SLC34A1,ENSG00000131183,EFO_1000647,0.3695798546847018,1,renal tubular transport disease,[EFO_0003086],[EFO_0009690]
SLC34A1,ENSG00000131183,MONDO_0009431,0.38171785951293435,11,hereditary hypophosphatemic rickets with hypercalciuria,"[MONDO_0000044, MONDO_0800096]","[OTAR_0000006, OTAR_0000018]"
SLC34A1,ENSG00000131183,Orphanet_300547,0.7203224722906026,71,Autosomal recessive infantile hypercalcemia,"[Orphanet_98056, Orphanet_183634]","[OTAR_0000018, EFO_0001379, EFO_0009690]"
SLC34A1,ENSG00000131183,EFO_0004348,0.21102173511794342,5,hematocrit,[EFO_0004503],[EFO_0001444]
SLC34A1,ENSG00000131183,HP_0002148,0.37477048709662814,39,Hypophosphatemia,[HP_0100529],[EFO_0000651]
SLC34A1,ENSG00000131183,EFO_0004838,0.31033676072808875,4,calcium measurement,[EFO_0001444],[EFO_0001444]
SLC34A1,ENSG00000131183,MONDO_0009804,0.26609749537298527,1,osteogenesis imperfecta type 3,[MONDO_0800064],"[OTAR_0000006, OTAR_0000018]"
SLC34A1,ENSG00000131183,MONDO_0001567,0.38434320750909745,22,nephrocalcinosis,"[MONDO_0002123, EFO_0003086]","[OTAR_0000020, EFO_0009690]"
SLC34A1,ENSG00000131183,EFO_0004518,0.540799754481689,22,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC34A1,ENSG00000131183,EFO_0004617,0.49942868603327484,10,cystatin C measurement,"[EFO_0004747, EFO_0004742]",[EFO_0001444]
SLC34A1,ENSG00000131183,MONDO_0000212,0.27015889251533975,9,"hypercalcemia, infantile","[MONDO_0019052, EFO_1000017, MONDO_0001566]","[OTAR_0000018, OTAR_0000020]"
SLC34A1,ENSG00000131183,MONDO_0016579,0.6060634875531948,113,dominant hypophosphatemia with nephrolithiasis or osteoporosis,[MONDO_0015962],"[OTAR_0000018, EFO_0009690]"
SLC34A1,ENSG00000131183,EFO_0003884,0.2640526081181757,22,chronic kidney disease,[EFO_0003086],[EFO_0009690]
SLC34A1,ENSG00000131183,EFO_0004531,0.26786671702736925,1,urate measurement,[EFO_0001444],[EFO_0001444]
SLC34A2,ENSG00000157765,EFO_0002517,0.27718489101352634,1,pancreatic ductal adenocarcinoma,[EFO_1000044],"[MONDO_0045024, EFO_0001379, EFO_0009605, EFO_0010282]"
SLC34A2,ENSG00000157765,EFO_0000640,0.2797388190598996,2,papillary renal cell carcinoma,"[MONDO_0002512, EFO_0005708]","[EFO_0009690, MONDO_0045024]"
SLC34A2,ENSG00000157765,EFO_0000181,0.27718489101352634,1,head and neck squamous cell carcinoma,"[MONDO_0002038, EFO_0000707]",[MONDO_0045024]
SLC34A2,ENSG00000157765,EFO_0000178,0.27718489101352634,1,gastric carcinoma,"[MONDO_0001056, EFO_1000218]","[MONDO_0045024, EFO_0010282]"
SLC34A2,ENSG00000157765,MONDO_0002529,0.27718489101352634,1,skin squamous cell carcinoma,"[EFO_0000707, EFO_0009259]","[MONDO_0045024, EFO_0010285]"
SLC34A2,ENSG00000157765,MONDO_0004379,0.27718489101352634,1,female breast carcinoma,[EFO_0000305],"[OTAR_0000017, MONDO_0045024, EFO_0010285]"
SLC34A2,ENSG00000157765,MONDO_0003892,0.27718489101352634,1,acinar lung adenocarcinoma,[EFO_0000571],"[OTAR_0000010, MONDO_0045024]"
SLC34A2,ENSG00000157765,EFO_0000702,0.2816403321727637,3,small cell lung carcinoma,"[EFO_0005220, EFO_0001071, Orphanet_271847, EFO_0008524, MONDO_0025511]","[OTAR_0000018, OTAR_0000010, MONDO_0045024, EFO_0001379]"
SLC34A2,ENSG00000157765,EFO_0008550,0.27718489101352634,1,Hepatobiliary Neoplasm,"[EFO_0008549, EFO_0010284]","[MONDO_0045024, EFO_0010282]"
SLC34A2,ENSG00000157765,EFO_0000389,0.3267566260539687,3,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLC34A2,ENSG00000157765,EFO_0001071,0.2905120202569456,5,lung carcinoma,"[MONDO_0008903, EFO_0000313]","[OTAR_0000010, MONDO_0045024]"
SLC34A2,ENSG00000157765,MONDO_0020638,0.27718489101352634,1,superficial spreading melanoma,[EFO_0000389],"[MONDO_0045024, EFO_0010285]"
SLC34A2,ENSG00000157765,EFO_0002892,0.2776468658318822,3,thyroid carcinoma,"[EFO_0000313, MONDO_0002108]","[EFO_0001379, MONDO_0045024]"
SLC34A2,ENSG00000157765,EFO_0001663,0.27957478411589975,2,prostate carcinoma,"[MONDO_0008315, EFO_0000313]","[OTAR_0000017, MONDO_0045024]"
SLC34A2,ENSG00000157765,EFO_0001642,0.27718489101352634,1,lymphoid neoplasm,[MONDO_0044881],"[MONDO_0045024, EFO_0005803]"
SLC34A2,ENSG00000157765,EFO_0000308,0.27718489101352634,1,bronchoalveolar adenocarcinoma,[EFO_0000571],"[OTAR_0000010, MONDO_0045024]"
SLC34A2,ENSG00000157765,EFO_0000095,0.27718489101352634,1,chronic lymphocytic leukemia,"[MONDO_0001014, EFO_0000220, EFO_0000096, MONDO_0017594]","[EFO_0005803, OTAR_0000018, MONDO_0045024, EFO_0000540]"
SLC34A2,ENSG00000157765,EFO_0000094,0.27718489101352634,1,B-cell acute lymphoblastic leukemia,"[EFO_0000220, EFO_1001938]","[EFO_0005803, OTAR_0000018, MONDO_0045024, EFO_0000540]"
SLC34A2,ENSG00000157765,EFO_0000182,0.2987402590336423,9,hepatocellular carcinoma,[MONDO_0018532],"[MONDO_0045024, EFO_0001379, EFO_0010282]"
SLC34A2,ENSG00000157765,EFO_0006318,0.27718489101352634,1,breast ductal adenocarcinoma,[EFO_0000304],"[OTAR_0000017, MONDO_0045024, EFO_0010285]"
SLC34A2,ENSG00000157765,EFO_0005631,0.27718489101352634,1,rectal adenocarcinoma,"[MONDO_0044937, EFO_0000365]","[MONDO_0045024, EFO_0010282]"
SLC34A2,ENSG00000157765,EFO_1001949,0.27755447086821106,2,colon adenocarcinoma,"[EFO_1001950, EFO_0000365]","[MONDO_0045024, EFO_0010282]"
SLC34A2,ENSG00000157765,EFO_0000305,0.27718489101352634,1,breast carcinoma,"[EFO_0000313, MONDO_0007254]","[OTAR_0000017, MONDO_0045024, EFO_0010285]"
SLC34A2,ENSG00000157765,EFO_0002917,0.27718489101352634,1,ovarian serous adenocarcinoma,"[EFO_0006460, EFO_0003825, MONDO_0024885]","[OTAR_0000017, MONDO_0045024, EFO_0001379]"
SLC34A2,ENSG00000157765,EFO_0008515,0.27718489101352634,1,nodular melanoma,[EFO_0000389],"[MONDO_0045024, EFO_0010285]"
SLC34A2,ENSG00000157765,EFO_0008509,0.27718489101352634,1,lobular breast carcinoma,[EFO_0000304],"[OTAR_0000017, MONDO_0045024, EFO_0010285]"
SLC34A2,ENSG00000157765,EFO_0000756,0.3110538806765972,3,melanoma,[MONDO_0021143],[MONDO_0045024]
SLC34A2,ENSG00000157765,MONDO_0019472,0.27718489101352634,1,extranodal nasal NK/T cell lymphoma,"[MONDO_0015817, MONDO_0017343]","[EFO_0005803, OTAR_0000018, EFO_0005741, MONDO_0045024, EFO_0010285]"
SLC34A2,ENSG00000157765,MONDO_0019471,0.27718489101352634,1,adult T-cell leukemia/lymphoma,"[EFO_1001303, EFO_0007316, MONDO_0024294, MONDO_0017341, MONDO_0003660, MONDO_0000621, MONDO_0015817, EFO_0005592]","[EFO_0005803, OTAR_0000018, EFO_0005741, MONDO_0045024, EFO_0000540, EFO_0010285]"
SLC34A2,ENSG00000157765,EFO_0000708,0.3695798546847018,1,squamous cell lung carcinoma,"[EFO_0001071, EFO_0000707]","[OTAR_0000010, MONDO_0045024]"
SLC34A2,ENSG00000157765,EFO_0000402,0.27718489101352634,1,diffuse gastric adenocarcinoma,"[MONDO_0021652, EFO_0000503]","[MONDO_0045024, EFO_0010282]"
SLC34A2,ENSG00000157765,EFO_0004784,0.2785712216773786,1,self reported educational attainment,[EFO_0011015],[EFO_0001444]
SLC34A2,ENSG00000157765,EFO_0000673,0.27718489101352634,1,prostate adenocarcinoma,"[EFO_0000228, EFO_0001663]","[OTAR_0000017, MONDO_0045024]"
SLC34A2,ENSG00000157765,MONDO_0003582,0.26609749537298527,1,hereditary breast ovarian cancer syndrome,"[MONDO_0000426, MONDO_0015356]","[OTAR_0000018, MONDO_0045024]"
SLC34A2,ENSG00000157765,MONDO_0003219,0.27718489101352634,1,gastroesophageal junction adenocarcinoma,"[EFO_1000218, EFO_0000228]","[MONDO_0045024, EFO_0010282]"
SLC34A2,ENSG00000157765,MONDO_0003193,0.27718489101352634,1,bile duct adenocarcinoma,"[MONDO_0018532, EFO_0005540]","[MONDO_0045024, EFO_0001379, EFO_0010282]"
SLC34A2,ENSG00000157765,EFO_1000020,0.27718489101352634,1,cecum adenocarcinoma,"[EFO_1000021, EFO_1001949]","[MONDO_0045024, EFO_0010282]"
SLC34A2,ENSG00000157765,MONDO_0004986,0.27972061946094634,4,urinary bladder carcinoma,"[EFO_0000313, MONDO_0001187]","[EFO_0009690, MONDO_0045024]"
SLC34A2,ENSG00000157765,MONDO_0044785,0.27718489101352634,1,desmoplastic melanoma,"[EFO_0000389, MONDO_0020663, EFO_1000546]","[MONDO_0045024, EFO_0010285]"
SLC34A2,ENSG00000157765,MONDO_0009928,0.6953044601735878,51,pulmonary alveolar microlithiasis,[EFO_0003818],[OTAR_0000010]
SLC34A2,ENSG00000157765,EFO_0003060,0.3988669404251654,56,non-small cell lung carcinoma,[EFO_0001071],"[OTAR_0000010, MONDO_0045024]"
SLC34A2,ENSG00000157765,EFO_0005540,0.27718489101352634,1,bile duct carcinoma,"[MONDO_0003059, MONDO_0018531]","[MONDO_0045024, EFO_0001379, EFO_0010282]"
SLC34A2,ENSG00000157765,EFO_0005423,0.2504861577852003,1,adolescent idiopathic scoliosis,[MONDO_0000726],[OTAR_0000006]
SLC34A2,ENSG00000157765,EFO_0000571,0.4022048267993738,5,lung adenocarcinoma,"[EFO_0000228, EFO_0003060]","[OTAR_0000010, MONDO_0045024]"
SLC34A2,ENSG00000157765,EFO_1001469,0.27718489101352634,1,Mantle cell lymphoma,[MONDO_0017595],"[OTAR_0000018, MONDO_0045024, EFO_0000540, EFO_0005803]"
SLC34A2,ENSG00000157765,EFO_1000233,0.27718489101352634,1,Endometrial Endometrioid Adenocarcinoma,[EFO_0000466],"[OTAR_0000017, MONDO_0045024]"
SLC34A2,ENSG00000157765,EFO_1000218,0.27718489101352634,1,Digestive System Carcinoma,"[MONDO_0002516, EFO_0000313]","[MONDO_0045024, EFO_0010282]"
SLC34A2,ENSG00000157765,EFO_1000172,0.27718489101352634,1,cervical squamous cell carcinoma,"[EFO_0001061, EFO_0000707]","[OTAR_0000017, MONDO_0045024]"
SLC34A2,ENSG00000157765,EFO_1000098,0.27718489101352634,1,Atypical Endometrial Hyperplasia,"[EFO_0000536, MONDO_0000931]","[OTAR_0000017, MONDO_0045024]"
SLC34A2,ENSG00000157765,EFO_0000365,0.31191236268718153,2,colorectal adenocarcinoma,"[EFO_0000228, EFO_1001951]","[MONDO_0045024, EFO_0010282]"
SLC34A2,ENSG00000157765,EFO_0000349,0.27718489101352634,1,clear cell renal carcinoma,"[MONDO_0007763, EFO_0000348, EFO_0005708]","[EFO_0009690, MONDO_0045024]"
SLC34A2,ENSG00000157765,MONDO_0000640,0.27718489101352634,1,central nervous system primitive neuroectodermal neoplasm,"[EFO_0000326, EFO_0005235]","[MONDO_0045024, EFO_0000618]"
SLC34A2,ENSG00000157765,MONDO_0018531,0.27718489101352634,1,carcinoma of liver and intrahepatic biliary tract,"[EFO_1000218, MONDO_0002691]","[MONDO_0045024, EFO_0001379, EFO_0010282]"
SLC34A2,ENSG00000157765,Orphanet_145,0.26609749537298527,1,Hereditary breast and ovarian cancer syndrome,"[EFO_0005771, EFO_1001331, Orphanet_227535]","[OTAR_0000017, OTAR_0000018, MONDO_0045024, EFO_0001379, EFO_0010285]"
SLC34A2,ENSG00000157765,EFO_0003865,0.27718489101352634,1,kidney neoplasm,"[EFO_0003086, MONDO_0021066]","[EFO_0009690, MONDO_0045024]"
SLC34A2,ENSG00000157765,EFO_0000222,0.33377587683735577,3,acute myeloid leukemia,"[EFO_1000068, MONDO_0004643]","[OTAR_0000006, EFO_0005803, MONDO_0045024, EFO_0000540]"
SLC34A2,ENSG00000157765,EFO_1000524,0.27718489101352634,1,Signet Ring Cell Gastric Adenocarcinoma,"[EFO_0000698, EFO_0000503]","[MONDO_0045024, EFO_0010282]"
SLC34A2,ENSG00000157765,EFO_1000417,0.27718489101352634,1,Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation,[EFO_1000416],"[OTAR_0000017, MONDO_0045024, EFO_0001379]"
SLC34A2,ENSG00000157765,EFO_0000503,0.27718489101352634,1,gastric adenocarcinoma,"[EFO_0000228, EFO_0000178]","[MONDO_0045024, EFO_0010282]"
SLC34A2,ENSG00000157765,EFO_0000478,0.28688081850117947,2,esophageal adenocarcinoma,"[EFO_0000228, EFO_0002916]","[MONDO_0045024, EFO_0010282]"
SLC34A2,ENSG00000157765,EFO_0006545,0.27718489101352634,1,brain glioblastoma,"[EFO_0000519, MONDO_0005499]","[MONDO_0045024, EFO_0000618]"
SLC34A2,ENSG00000157765,EFO_0006544,0.27718489101352634,1,bladder transitional cell carcinoma,"[MONDO_0004986, EFO_0008528]","[EFO_0009690, MONDO_0045024]"
SLC34A2,ENSG00000157765,EFO_1000082,0.27718489101352634,1,Anaplastic (Malignant) Meningioma,[EFO_0003851],"[EFO_0000618, MONDO_0045024]"
SLC34A2,ENSG00000157765,EFO_1000058,0.27718489101352634,1,nasopharyngeal squamous cell carcinoma,"[EFO_0000181, EFO_0000684]","[OTAR_0000010, MONDO_0045024]"
SLC34A2,ENSG00000157765,EFO_1000045,0.27718489101352634,1,pancreatic neuroendocrine tumor,"[MONDO_0000386, EFO_0007331]","[MONDO_0045024, EFO_0001379, EFO_0009605, EFO_0010282]"
SLC34A2,ENSG00000157765,MONDO_0005341,0.27718489101352634,1,skin basal cell carcinoma,"[EFO_0004193, MONDO_0002529]","[MONDO_0045024, EFO_0010285]"
SLC34A2,ENSG00000157765,EFO_1000294,0.27718489101352634,1,HER2 Positive Breast Carcinoma,[EFO_1000143],"[OTAR_0000017, MONDO_0045024, EFO_0010285]"
SLC34A2,ENSG00000157765,EFO_1000266,0.27718489101352634,1,Gallbladder Small Cell Neuroendocrine Carcinoma,"[Orphanet_271847, MONDO_0025511, EFO_1001956, MONDO_0700225, EFO_0008524, MONDO_0024502]","[OTAR_0000018, MONDO_0045024, EFO_0001379, EFO_0010282]"
SLC34A3,ENSG00000198569,EFO_0010972,0.2384485492596141,2,blood phosphate measurement,[EFO_0001444],[EFO_0001444]
SLC34A3,ENSG00000198569,EFO_0010968,0.5798211735302006,13,phosphate measurement,[EFO_0001444],[EFO_0001444]
SLC34A3,ENSG00000198569,EFO_0004253,0.23011001692344402,20,nephrolithiasis,"[MONDO_0024647, EFO_0003086]",[EFO_0009690]
SLC34A3,ENSG00000198569,Orphanet_89936,0.36994943453938645,2,X-linked hypophosphatemia,"[Orphanet_183634, Orphanet_183592, EFO_0005596, Orphanet_93447]","[OTAR_0000006, OTAR_0000018, OTAR_0000020, EFO_0009690, EFO_0001379]"
SLC34A3,ENSG00000198569,MONDO_0009431,0.7895117099917204,187,hereditary hypophosphatemic rickets with hypercalciuria,"[MONDO_0000044, MONDO_0800096]","[OTAR_0000006, OTAR_0000018]"
SLC34A3,ENSG00000198569,EFO_0004348,0.2748158932428563,3,hematocrit,[EFO_0004503],[EFO_0001444]
SLC34A3,ENSG00000198569,EFO_0004518,0.6276470687431995,18,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC34A3,ENSG00000198569,EFO_0004617,0.6346325467623889,18,cystatin C measurement,"[EFO_0004747, EFO_0004742]",[EFO_0001444]
SLC34A3,ENSG00000198569,MONDO_0016579,0.3400134663099256,1,dominant hypophosphatemia with nephrolithiasis or osteoporosis,[MONDO_0015962],"[OTAR_0000018, EFO_0009690]"
SLC34A3,ENSG00000198569,EFO_0004305,0.22656679365007387,4,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
SLC34A3,ENSG00000198569,EFO_0009795,0.40431729409601486,7,serum urea measurement,[EFO_0004742],[EFO_0001444]
SLC35A1,ENSG00000164414,MONDO_0012885,0.4157773365202895,2,SRD5A3-congenital disorder of glycosylation,"[EFO_0005545, MONDO_0017749]","[OTAR_0000018, OTAR_0000020]"
SLC35A1,ENSG00000164414,MONDO_0011342,0.7454720300579356,55,SLC35A1-congenital disorder of glycosylation,"[MONDO_0017749, EFO_0005546]","[OTAR_0000018, OTAR_0000020]"
SLC35A1,ENSG00000164414,EFO_0005546,0.3695798546847018,1,congenital disorder of glycosylation type II,[MONDO_0015286],"[OTAR_0000018, OTAR_0000020]"
SLC35A2,ENSG00000102100,EFO_0000508,0.4081875602331719,31,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC35A2,ENSG00000102100,HP_0200134,0.26273818530469645,10,Epileptic encephalopathy,[HP_0001298],[EFO_0000651]
SLC35A2,ENSG00000102100,MONDO_0015286,0.5297185622454942,12,congenital disorder of glycosylation,"[MONDO_0024322, MONDO_0019052]","[OTAR_0000018, OTAR_0000020]"
SLC35A2,ENSG00000102100,MONDO_0010478,0.7995110616047952,215,SLC35A2-congenital disorder of glycosylation,"[MONDO_0015327, MONDO_0017749, EFO_0005546]","[OTAR_0000018, OTAR_0000020]"
SLC35A2,ENSG00000102100,EFO_0005546,0.3695798546847018,1,congenital disorder of glycosylation type II,[MONDO_0015286],"[OTAR_0000018, OTAR_0000020]"
SLC35A2,ENSG00000102100,EFO_0000474,0.37188972877648113,3,epilepsy,[EFO_0005774],[EFO_0000618]
SLC35A2,ENSG00000102100,MONDO_0100148,0.3695798546847018,1,X-linked complex neurodevelopmental disorder,"[MONDO_0000425, MONDO_0100038, MONDO_0100500]","[OTAR_0000018, EFO_0000618]"
SLC35A2,ENSG00000102100,HP_0001249,0.46273194375262716,6,Intellectual disability,"[HP_0012759, HP_0100543]",[EFO_0000651]
SLC35A3,ENSG00000117620,MONDO_0015650,0.3695798546847018,1,epilepsy syndrome,[EFO_0000474],[EFO_0000618]
SLC35A3,ENSG00000117620,EFO_0000508,0.3290277260806618,9,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC35A3,ENSG00000117620,MONDO_0019942,0.3695798546847018,1,distal arthrogryposis,"[MONDO_0003939, MONDO_0015225, EFO_0000508]","[OTAR_0000006, OTAR_0000018]"
SLC35A3,ENSG00000117620,EFO_0005548,0.3695798546847018,1,developmental disorder of mental health,[EFO_0000677],"[MONDO_0002025, EFO_0000618]"
SLC35A3,ENSG00000117620,MONDO_0014248,0.657619284396658,178,autism spectrum disorder - epilepsy - arthrogryposis syndrome,"[MONDO_0019942, MONDO_0017740, MONDO_0015327]","[OTAR_0000006, OTAR_0000018, OTAR_0000020]"
SLC35A3,ENSG00000117620,EFO_0005772,0.27611155643316676,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC35A3,ENSG00000117620,Orphanet_370943,0.6981909395553786,178,Autism spectrum disorder-epilepsy-arthrogryposis syndrome,"[Orphanet_180772, MONDO_0019052, Orphanet_404577, Orphanet_371071, Orphanet_371064, Orphanet_371235]","[OTAR_0000018, OTAR_0000020]"
SLC35A3,ENSG00000117620,GO_0007568,0.27611155643316676,1,aging,[GO_0032502],[GO_0008150]
SLC35A3,ENSG00000117620,EFO_0007874,0.23005099219178357,1,gut microbiome measurement,[EFO_0007882],[EFO_0001444]
SLC35A4,ENSG00000176087,NA,NA,NA,NA,NA,NA
SLC35A5,ENSG00000138459,EFO_0005772,0.5496501987923134,6,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC35A5,ENSG00000138459,GO_0007568,0.4505399844187822,2,aging,[GO_0032502],[GO_0008150]
SLC35B1,ENSG00000121073,EFO_0010701,0.3025427628303589,2,mean reticulocyte volume,[EFO_0010700],[EFO_0001444]
SLC35B1,ENSG00000121073,EFO_0000319,0.2777851139196193,2,cardiovascular disease,[],[EFO_0000319]
SLC35B1,ENSG00000121073,EFO_0005772,0.42096557331125367,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC35B1,ENSG00000121073,EFO_0005763,0.21268276900814917,1,pulse pressure measurement,[EFO_0005278],[EFO_0001444]
SLC35B2,ENSG00000157593,MONDO_0800086,0.3326218692162316,1,primary bone dysplasia with multiple joint dislocations,[MONDO_0018230],"[OTAR_0000006, OTAR_0000018]"
SLC35B3,ENSG00000124786,EFO_0006928,0.20395450093538092,1,motion sickness,[EFO_0003765],[EFO_0000651]
SLC35C1,ENSG00000181830,MONDO_0002561,0.36923379550118957,1,lysosomal storage disease,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
SLC35C1,ENSG00000181830,MONDO_0015286,0.5256981013957669,258,congenital disorder of glycosylation,"[MONDO_0024322, MONDO_0019052]","[OTAR_0000018, OTAR_0000020]"
SLC35C1,ENSG00000181830,EFO_0005772,0.4561092916443913,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC35C1,ENSG00000181830,MONDO_0009953,0.7895722898706459,275,leukocyte adhesion deficiency type II,"[MONDO_0017570, MONDO_0017749, EFO_0005546]","[OTAR_0000018, OTAR_0000020, EFO_0000540]"
SLC35C1,ENSG00000181830,GO_0007568,0.34750198457280673,1,aging,[GO_0032502],[GO_0008150]
SLC35C1,ENSG00000181830,MONDO_0005180,0.36923379550118957,1,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
SLC35C1,ENSG00000181830,MONDO_0005148,0.24443858147100284,4,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC35C1,ENSG00000181830,EFO_0005546,0.3695798546847018,1,congenital disorder of glycosylation type II,[MONDO_0015286],"[OTAR_0000018, OTAR_0000020]"
SLC35C1,ENSG00000181830,MONDO_0004975,0.3851737591898766,2,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
SLC35C1,ENSG00000181830,MONDO_0005301,0.36923379550118957,1,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
SLC35C2,ENSG00000080189,NA,NA,NA,NA,NA,NA
SLC35D1,ENSG00000116704,EFO_0000389,0.21508178632773003,2,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLC35D1,ENSG00000116704,EFO_0007993,0.23616214280585526,3,lymphocyte percentage of leukocytes,[EFO_0004587],[EFO_0001444]
SLC35D1,ENSG00000116704,EFO_0007988,0.2603859824384322,2,myeloid white cell count,[EFO_0004308],[EFO_0001444]
SLC35D1,ENSG00000116704,EFO_0006935,0.2678629060664291,1,thalamus volume,[EFO_0006930],[EFO_0001444]
SLC35D1,ENSG00000116704,EFO_0004339,0.23262820439803447,3,body height,[EFO_0004324],[EFO_0001444]
SLC35D1,ENSG00000116704,EFO_0005772,0.3871410536344614,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC35D1,ENSG00000116704,MONDO_0010013,0.785084911377321,120,schneckenbecken dysplasia,"[EFO_0005571, MONDO_0018292, MONDO_0800080, MONDO_0017744]","[OTAR_0000006, OTAR_0000018, OTAR_0000020]"
SLC35D1,ENSG00000116704,EFO_0004696,0.25598582876327775,2,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
SLC35D1,ENSG00000116704,EFO_0004518,0.21906153927540925,3,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC35D1,ENSG00000116704,EFO_0005091,0.2868606229945101,4,monocyte count,"[EFO_0004308, EFO_0803547]",[EFO_0001444]
SLC35D1,ENSG00000116704,EFO_0004587,0.44155391111888875,8,lymphocyte count,"[EFO_0006843, EFO_0004308, EFO_0803546]",[EFO_0001444]
SLC35D1,ENSG00000116704,EFO_0004308,0.3699363606572748,4,leukocyte count,[EFO_0004586],[EFO_0001444]
SLC35D2,ENSG00000130958,EFO_0011011,0.21525507402087737,2,sitting height measurement,[EFO_0004302],[EFO_0001444]
SLC35D2,ENSG00000130958,EFO_0010924,0.20017072338135927,1,proheparin-binding EGF-like growth factor measurement,[EFO_0007937],[EFO_0001444]
SLC35D2,ENSG00000130958,EFO_0005409,0.21237839328531516,2,fat body mass,[EFO_0004302],[EFO_0001444]
SLC35D2,ENSG00000130958,EFO_0004995,0.31368030011404224,8,lean body mass,[EFO_0004302],[EFO_0001444]
SLC35D2,ENSG00000130958,EFO_0004980,0.25166401479645234,4,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
SLC35D2,ENSG00000130958,EFO_0008446,0.22331083415259592,1,platelet-to-lymphocyte ratio,[EFO_0004503],[EFO_0001444]
SLC35D2,ENSG00000130958,EFO_0008354,0.25744285220185287,2,cognitive function measurement,[EFO_0001444],[EFO_0001444]
SLC35D2,ENSG00000130958,EFO_0008264,0.23260556962753728,1,platelet-derived growth factor BB measurement,[EFO_0007937],[EFO_0001444]
SLC35D2,ENSG00000130958,EFO_0008039,0.3825090184919076,4,BMI-adjusted hip circumference,[EFO_0005093],[EFO_0001444]
SLC35D2,ENSG00000130958,EFO_0004784,0.3202688522144729,5,self reported educational attainment,[EFO_0011015],[EFO_0001444]
SLC35D2,ENSG00000130958,EFO_0004339,0.3364752704252573,6,body height,[EFO_0004324],[EFO_0001444]
SLC35D2,ENSG00000130958,EFO_0004584,0.3298518134036046,6,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
SLC35D2,ENSG00000130958,EFO_0004526,0.25991559877270015,5,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC35D2,ENSG00000130958,EFO_0007789,0.2854175634418365,2,BMI-adjusted waist circumference,[EFO_0004342],[EFO_0001444]
SLC35D2,ENSG00000130958,EFO_0004587,0.27902537870527,4,lymphocyte count,"[EFO_0006843, EFO_0004308, EFO_0803546]",[EFO_0001444]
SLC35D2,ENSG00000130958,EFO_0004312,0.2534610430465643,2,vital capacity,[EFO_0003892],[EFO_0001444]
SLC35D2,ENSG00000130958,EFO_0004309,0.39869793475663823,11,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SLC35D2,ENSG00000130958,EFO_0004302,0.22818950298759016,1,anthropometric measurement,[EFO_0001444],[EFO_0001444]
SLC35D2,ENSG00000130958,EFO_0009805,0.21108551377203144,1,whole body water mass,[EFO_0004302],[EFO_0001444]
SLC35D2,ENSG00000130958,EFO_0004528,0.29697166348805626,6,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC35D2,ENSG00000130958,EFO_0004527,0.24308040452585905,3,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC35D3,ENSG00000182747,EFO_0010972,0.39430516549914,2,blood phosphate measurement,[EFO_0001444],[EFO_0001444]
SLC35D3,ENSG00000182747,EFO_0004838,0.4286034353426187,4,calcium measurement,[EFO_0001444],[EFO_0001444]
SLC35D3,ENSG00000182747,EFO_0005772,0.3194172759807238,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC35D3,ENSG00000182747,MONDO_0005148,0.2370692640111558,10,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC35D3,ENSG00000182747,EFO_0004468,0.32833640729171804,2,glucose measurement,[EFO_0006842],[EFO_0001444]
TMEM241,ENSG00000134490,EFO_0004342,0.23043669400006336,2,waist circumference,[EFO_0004324],[EFO_0001444]
TMEM241,ENSG00000134490,EFO_0009589,0.37417439765723326,2,worry measurement,[EFO_0007803],[EFO_0001444]
TMEM241,ENSG00000134490,MONDO_0005178,0.30000393383272433,1,osteoarthritis,[EFO_0005856],[OTAR_0000006]
TMEM241,ENSG00000134490,EFO_0004309,0.34317916121953246,4,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
TMEM241,ENSG00000134490,EFO_0004530,0.32748298823748334,3,triglyceride measurement,[EFO_0004529],[EFO_0001444]
SLC35E1,ENSG00000127526,NA,NA,NA,NA,NA,NA
SLC35E2A,ENSG00000215790,NA,NA,NA,NA,NA,NA
SLC35E2B,ENSG00000189339,EFO_0004995,0.20537177852345723,3,lean body mass,[EFO_0004302],[EFO_0001444]
SLC35E2B,ENSG00000189339,EFO_0004340,0.268167222782504,9,body mass index,[EFO_0004324],[EFO_0001444]
SLC35E2B,ENSG00000189339,EFO_0005772,0.4295567865776079,4,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC35E2B,ENSG00000189339,EFO_0007800,0.24190885502540516,8,body fat percentage,[EFO_0005106],[EFO_0001444]
SLC35E3,ENSG00000175782,EFO_0004339,0.3758474254195583,3,body height,[EFO_0004324],[EFO_0001444]
SLC35E3,ENSG00000175782,EFO_0005772,0.34447105216596935,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC35E3,ENSG00000175782,GO_0007568,0.34447105216596935,1,aging,[GO_0032502],[GO_0008150]
SLC35E4,ENSG00000100036,EFO_0004339,0.28032279054214293,2,body height,[EFO_0004324],[EFO_0001444]
SLC35F1,ENSG00000196376,EFO_0000275,0.3749732998162329,6,atrial fibrillation,"[EFO_0004269, MONDO_0007263]",[EFO_0000319]
SLC35F1,ENSG00000196376,EFO_0004995,0.2299542807971738,2,lean body mass,[EFO_0004302],[EFO_0001444]
SLC35F1,ENSG00000196376,EFO_0006336,0.29834156399357836,5,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC35F1,ENSG00000196376,EFO_0006335,0.22169721436382842,2,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC35F1,ENSG00000196376,EFO_0008111,0.21466843722419096,3,diet measurement,[EFO_0001444],[EFO_0001444]
SLC35F1,ENSG00000196376,EFO_0000537,0.32678579226976523,2,hypertension,[MONDO_0000473],[EFO_0000319]
SLC35F1,ENSG00000196376,EFO_0004325,0.27415927439983495,1,blood pressure,[EFO_0004303],[EFO_0001444]
SLC35F1,ENSG00000196376,EFO_0004351,0.39519767322460186,4,resting heart rate,[EFO_0004326],[EFO_0001444]
SLC35F1,ENSG00000196376,EFO_0005055,0.333899014169462,6,QRS duration,"[EFO_0004327, EFO_0000719]",[EFO_0001444]
SLC35F1,ENSG00000196376,EFO_0009270,0.2566849500984651,2,heel bone mineral density,[EFO_0003923],[EFO_0001444]
SLC35F1,ENSG00000196376,EFO_0004298,0.2620299770177566,1,cardiovascular measurement,[EFO_0001444],[EFO_0001444]
SLC35F2,ENSG00000110660,EFO_0005674,0.3165105934710975,1,white matter microstructure measurement,[EFO_0004464],[EFO_0001444]
SLC35F2,ENSG00000110660,EFO_0004308,0.28234235477140224,1,leukocyte count,[EFO_0004586],[EFO_0001444]
SLC35F2,ENSG00000110660,EFO_0007937,0.33629427994229394,4,blood protein measurement,[EFO_0004747],[EFO_0001444]
SLC35F3,ENSG00000183780,EFO_0005271,0.26843463832215536,1,sleep duration,[EFO_0004870],[EFO_0001444]
SLC35F3,ENSG00000183780,EFO_0000537,0.31625977911394365,7,hypertension,[MONDO_0000473],[EFO_0000319]
SLC35F3,ENSG00000183780,EFO_0009959,0.2646797403623103,2,diverticular disease,[EFO_0009431],[EFO_0010282]
SLC35F3,ENSG00000183780,EFO_0005772,0.36923366623235165,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC35F3,ENSG00000183780,EFO_0000341,0.3025560660854471,1,chronic obstructive pulmonary disease,"[MONDO_0002567, EFO_0009910]",[OTAR_0000010]
SLC35F3,ENSG00000183780,EFO_0004530,0.26843463832215536,1,triglyceride measurement,[EFO_0004529],[EFO_0001444]
SLC35F4,ENSG00000151812,EFO_0004784,0.3069399157868106,2,self reported educational attainment,[EFO_0011015],[EFO_0001444]
SLC35F4,ENSG00000151812,EFO_0004747,0.29992676738085533,1,protein measurement,[EFO_0001444],[EFO_0001444]
SLC35F4,ENSG00000151812,EFO_0004875,0.2442684979109803,1,mathematical ability,[EFO_0003925],[GO_0008150]
SLC35F5,ENSG00000115084,EFO_0007989,0.2973417242862564,1,monocyte percentage of leukocytes,[EFO_0005091],[EFO_0001444]
SLC35F5,ENSG00000115084,EFO_0004343,0.30145475130375693,3,waist-hip ratio,[EFO_0007861],[EFO_0001444]
SLC35F5,ENSG00000115084,EFO_0004838,0.28409229076056147,1,calcium measurement,[EFO_0001444],[EFO_0001444]
SLC35F5,ENSG00000115084,EFO_0007789,0.2449289714257302,3,BMI-adjusted waist circumference,[EFO_0004342],[EFO_0001444]
SLC35F5,ENSG00000115084,EFO_0007788,0.3767438007208048,6,BMI-adjusted waist-hip ratio,[EFO_0004343],[EFO_0001444]
SLC35F6,ENSG00000213699,NA,NA,NA,NA,NA,NA
SLC35G1,ENSG00000176273,EFO_0008457,0.32383506213998153,1,cannabis dependence measurement,[EFO_0006848],[EFO_0001444]
SLC35G1,ENSG00000176273,EFO_0009700,0.3297695874421568,1,visual perception measurement,[EFO_0004464],[EFO_0001444]
SLC35G2,ENSG00000168917,EFO_0005213,0.21939946191813764,3,central corneal thickness,[EFO_0004731],[EFO_0001444]
SLC35G2,ENSG00000168917,EFO_0004339,0.20997283586499463,3,body height,[EFO_0004324],[EFO_0001444]
SLC35G2,ENSG00000168917,EFO_0004343,0.2382918317517039,1,waist-hip ratio,[EFO_0007861],[EFO_0001444]
SLC35G2,ENSG00000168917,EFO_0004535,0.22259450566790354,1,serum albumin measurement,[EFO_0004747],[EFO_0001444]
SLC35G2,ENSG00000168917,EFO_0005091,0.295805083488385,5,monocyte count,"[EFO_0004308, EFO_0803547]",[EFO_0001444]
SLC35G2,ENSG00000168917,EFO_0009188,0.20390705116737465,2,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC35G2,ENSG00000168917,EFO_0004587,0.3079362603785125,6,lymphocyte count,"[EFO_0006843, EFO_0004308, EFO_0803546]",[EFO_0001444]
SLC35G2,ENSG00000168917,EFO_0004309,0.32557484066076503,6,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SLC35G2,ENSG00000168917,EFO_0004308,0.2868289170370713,4,leukocyte count,[EFO_0004586],[EFO_0001444]
SLC35G2,ENSG00000168917,EFO_0007985,0.29127880790581795,3,platelet crit,[EFO_0005036],[EFO_0001444]
SLC35G3,ENSG00000164729,EFO_0005772,0.2300268018592692,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC35G4,ENSG00000236396,EFO_0007010,0.24934476396928748,1,drug use measurement,[EFO_0001444],[EFO_0001444]
SLC35G4,ENSG00000236396,EFO_0004279,0.21802556001683132,1,suntan,[EFO_0003784],[EFO_0000651]
SLC35G4,ENSG00000236396,EFO_0009749,0.2310135792449727,1,age at first sexual intercourse measurement,[EFO_0007862],[EFO_0001444]
SLC35G5,ENSG00000177710,EFO_0001073,0.264051196151297,1,obesity,[MONDO_0003916],[OTAR_0000020]
SLC35G5,ENSG00000177710,EFO_0001663,0.29348439298322226,1,prostate carcinoma,"[MONDO_0008315, EFO_0000313]","[OTAR_0000017, MONDO_0045024]"
SLC35G5,ENSG00000177710,EFO_0004259,0.21030550864590772,2,osteonecrosis,[EFO_0004260],[OTAR_0000006]
SLC35G5,ENSG00000177710,EFO_0009958,0.21030550864590772,2,response to bisphosphonate,[GO_0009410],[GO_0008150]
SLC35G6,ENSG00000259224,NA,NA,NA,NA,NA,NA
SLC36A1,ENSG00000123643,MONDO_0002561,0.3695798546847018,1,lysosomal storage disease,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
SLC36A1,ENSG00000123643,EFO_0007995,0.2798505590621192,1,basophil percentage of granulocytes,[EFO_0005090],[EFO_0001444]
SLC36A1,ENSG00000123643,EFO_0007992,0.39723861719217557,3,basophil percentage of leukocytes,[EFO_0005090],[EFO_0001444]
SLC36A1,ENSG00000123643,EFO_0005772,0.4244578502948692,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC36A1,ENSG00000123643,MONDO_0005180,0.3695798546847018,1,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
SLC36A1,ENSG00000123643,EFO_0005423,0.22892810246367268,1,adolescent idiopathic scoliosis,[MONDO_0000726],[OTAR_0000006]
SLC36A1,ENSG00000123643,EFO_0005090,0.43308077700879194,5,basophil count,"[EFO_0004872, EFO_0803539, EFO_0007987]",[EFO_0001444]
SLC36A1,ENSG00000123643,EFO_0009188,0.38713674246354957,2,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC36A1,ENSG00000123643,MONDO_0004975,0.3695798546847018,1,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
SLC36A1,ENSG00000123643,EFO_0007937,0.3026204779339384,1,blood protein measurement,[EFO_0004747],[EFO_0001444]
SLC36A1,ENSG00000123643,MONDO_0005301,0.3695798546847018,1,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
SLC36A2,ENSG00000186335,EFO_0005408,0.24384856526125734,1,pyroglutamine measurement,[EFO_0004725],[EFO_0001444]
SLC36A2,ENSG00000186335,HP_0000407,0.3695798546847018,1,Sensorineural hearing impairment,[HP_0000364],[EFO_0000651]
SLC36A2,ENSG00000186335,HP_0003108,0.22959742451941267,20,Hyperglycinuria,[HP_0003110],[EFO_0000651]
SLC36A2,ENSG00000186335,MONDO_0009448,0.4884554909080167,20,iminoglycinuria,[MONDO_0019216],"[OTAR_0000018, OTAR_0000020]"
SLC36A3,ENSG00000186334,NA,NA,NA,NA,NA,NA
SLC36A4,ENSG00000180773,EFO_0008328,0.3230183930363158,1,chronotype measurement,[EFO_0004870],[EFO_0001444]
SLC37A1,ENSG00000160190,EFO_0005409,0.3275406791981317,2,fat body mass,[EFO_0004302],[EFO_0001444]
SLC37A1,ENSG00000160190,EFO_0004995,0.2891866864191793,1,lean body mass,[EFO_0004302],[EFO_0001444]
SLC37A1,ENSG00000160190,EFO_0004784,0.20960800641840302,1,self reported educational attainment,[EFO_0011015],[EFO_0001444]
SLC37A1,ENSG00000160190,EFO_0004340,0.20764692557021872,1,body mass index,[EFO_0004324],[EFO_0001444]
SLC37A1,ENSG00000160190,MONDO_0016575,0.383683432583753,6,primary ciliary dyskinesia,"[EFO_0000684, EFO_0003900]","[OTAR_0000018, OTAR_0000010]"
SLC37A2,ENSG00000134955,EFO_0009270,0.21384384544602741,2,heel bone mineral density,[EFO_0003923],[EFO_0001444]
SLC37A2,ENSG00000134955,EFO_0004531,0.2169343695534191,1,urate measurement,[EFO_0001444],[EFO_0001444]
SLC37A3,ENSG00000157800,EFO_0007814,0.42848965646642845,3,refractive error measurement,[EFO_0004731],[EFO_0001444]
SLC37A4,ENSG00000137700,HP_0001744,0.25870589827929125,1,Splenomegaly,"[HP_0002012, HP_0001438, HP_0100763]",[EFO_0000651]
SLC37A4,ENSG00000137700,MONDO_0023258,0.3400134663099256,1,glycogen storage disease type 1 due to SLC37A4 mutation,[MONDO_0002413],"[OTAR_0000018, OTAR_0000020]"
SLC37A4,ENSG00000137700,MONDO_0009288,0.8554006402119009,177,glycogen storage disease Ib,"[MONDO_0023258, MONDO_0015134]","[OTAR_0000018, OTAR_0000020, EFO_0000540, EFO_0005803]"
SLC37A4,ENSG00000137700,EFO_0000508,0.413264915465334,42,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC37A4,ENSG00000137700,MONDO_0021094,0.25870589827929125,1,immunodeficiency disease,"[EFO_0000508, EFO_0000540]","[OTAR_0000018, EFO_0000540]"
SLC37A4,ENSG00000137700,Orphanet_79259,0.821158688207743,919,Glycogen storage disease due to glucose-6-phosphatase deficiency type b,"[Orphanet_364, Orphanet_331184]","[OTAR_0000018, OTAR_0000020, EFO_0009690, EFO_0000540, EFO_0010282]"
SLC37A4,ENSG00000137700,EFO_0004233,0.25976844036150976,3,leukopenia,[HP_0001881],[EFO_0000651]
SLC37A4,ENSG00000137700,MONDO_0015286,0.25870589827929125,1,congenital disorder of glycosylation,"[MONDO_0024322, MONDO_0019052]","[OTAR_0000018, OTAR_0000020]"
SLC37A4,ENSG00000137700,HP_0002240,0.2592602680613183,2,Hepatomegaly,"[HP_0001392, HP_0001438]",[EFO_0000651]
SLC37A4,ENSG00000137700,HP_0002205,0.25870589827929125,1,Recurrent respiratory infections,"[HP_0002719, HP_0002088]",[EFO_0000651]
SLC37A4,ENSG00000137700,MONDO_0002412,0.34155270644018304,12,disorder of glycogen metabolism,"[MONDO_0019214, MONDO_0019243]","[OTAR_0000018, OTAR_0000020]"
SLC37A4,ENSG00000137700,Orphanet_364,0.8207168895578519,887,Glycogen storage disease due to glucose-6-phosphatase deficiency,"[Orphanet_101940, Orphanet_98056, Orphanet_79161]","[OTAR_0000018, OTAR_0000020, EFO_0009690, EFO_0010282]"
SLC37A4,ENSG00000137700,MONDO_0001475,0.2647107712012567,32,neutropenia,[MONDO_0004805],"[EFO_0000540, EFO_0005803]"
SLC38A1,ENSG00000111371,EFO_0010750,0.24652311086625994,1,PHF-tau measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
SLC38A1,ENSG00000111371,EFO_0004995,0.2710790117541356,10,lean body mass,[EFO_0004302],[EFO_0001444]
SLC38A1,ENSG00000111371,EFO_0004747,0.2540540543148666,1,protein measurement,[EFO_0001444],[EFO_0001444]
SLC38A1,ENSG00000111371,EFO_0004339,0.33106319665533146,3,body height,[EFO_0004324],[EFO_0001444]
SLC38A1,ENSG00000111371,EFO_0004338,0.35796497889831547,3,body weight,[EFO_0004324],[EFO_0001444]
SLC38A1,ENSG00000111371,EFO_0010736,0.2327032007193682,1,cortical surface area measurement,[EFO_0004464],[EFO_0001444]
SLC38A1,ENSG00000111371,EFO_0004344,0.3065549846379912,2,birth weight,[EFO_0004338],[EFO_0001444]
SLC38A1,ENSG00000111371,EFO_0004842,0.4001919270940812,6,eosinophil count,"[EFO_0803540, EFO_0007987]",[EFO_0001444]
SLC38A1,ENSG00000111371,MONDO_0005147,0.2407602109784472,1,type 1 diabetes mellitus,"[MONDO_0000569, MONDO_0000588, EFO_0000400]","[OTAR_0000020, EFO_0001379, EFO_0000540, EFO_0009605, EFO_0010282]"
SLC38A1,ENSG00000111371,EFO_0005772,0.37503087018891046,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC38A1,ENSG00000111371,EFO_0003924,0.20094842788763803,2,hair color,[EFO_0005038],[EFO_0000651]
SLC38A1,ENSG00000111371,EFO_1001119,0.3083268302105756,1,posterior uveitis,"[EFO_1001231, EFO_1001082]",[MONDO_0024458]
SLC38A10,ENSG00000157637,EFO_0000537,0.21553678223615408,1,hypertension,[MONDO_0000473],[EFO_0000319]
SLC38A10,ENSG00000157637,EFO_0005772,0.37179733381281,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC38A10,ENSG00000157637,EFO_0004631,0.23292816910797398,4,vitamin D measurement,"[EFO_0004529, EFO_0004729]",[EFO_0001444]
SLC38A11,ENSG00000169507,NA,NA,NA,NA,NA,NA
TMEM104,ENSG00000109066,EFO_0007989,0.22278167154826742,3,monocyte percentage of leukocytes,[EFO_0005091],[EFO_0001444]
TMEM104,ENSG00000109066,EFO_0005772,0.3695798546847018,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
TMEM104,ENSG00000109066,GO_0007568,0.3695798546847018,1,aging,[GO_0032502],[GO_0008150]
SLC38A2,ENSG00000134294,EFO_0011011,0.3278977199780042,2,sitting height measurement,[EFO_0004302],[EFO_0001444]
SLC38A2,ENSG00000134294,EFO_0005409,0.4428191845257901,5,fat body mass,[EFO_0004302],[EFO_0001444]
SLC38A2,ENSG00000134294,EFO_0003784,0.2813923020348313,1,skin pigmentation,[EFO_0000651],[EFO_0000651]
SLC38A2,ENSG00000134294,EFO_0004995,0.5123971872954978,16,lean body mass,[EFO_0004302],[EFO_0001444]
SLC38A2,ENSG00000134294,EFO_0004980,0.46095403581461636,8,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
SLC38A2,ENSG00000134294,EFO_0000731,0.33031375631709475,2,uterine fibroid,"[Orphanet_271832, MONDO_0017127, MONDO_0001572, MONDO_0021525, EFO_0002424, MONDO_0023603]","[OTAR_0000006, OTAR_0000017, OTAR_0000018, MONDO_0045024]"
SLC38A2,ENSG00000134294,EFO_0006941,0.3373340254925524,2,grip strength measurement,[EFO_0004302],[EFO_0001444]
SLC38A2,ENSG00000134294,EFO_0004339,0.44818452500504097,6,body height,[EFO_0004324],[EFO_0001444]
SLC38A2,ENSG00000134294,EFO_0004338,0.356714369966558,3,body weight,[EFO_0004324],[EFO_0001444]
SLC38A2,ENSG00000134294,EFO_0004327,0.30584911082522764,2,electrocardiography,[EFO_0004311],[EFO_0001444]
SLC38A2,ENSG00000134294,EFO_0010736,0.30637659573171455,2,cortical surface area measurement,[EFO_0004464],[EFO_0001444]
SLC38A2,ENSG00000134294,EFO_0004842,0.353794670967142,5,eosinophil count,"[EFO_0803540, EFO_0007987]",[EFO_0001444]
SLC38A2,ENSG00000134294,EFO_0004840,0.2633587247226635,1,cortical thickness,[EFO_0004464],[EFO_0001444]
SLC38A2,ENSG00000134294,EFO_0003924,0.3589468441025032,2,hair color,[EFO_0005038],[EFO_0000651]
SLC38A2,ENSG00000134294,EFO_0004514,0.29911644253586456,2,bone quantitative ultrasound measurement,[EFO_0004516],[EFO_0001444]
SLC38A2,ENSG00000134294,EFO_0007822,0.289159150574236,1,hair colour measurement,[EFO_0007821],[EFO_0001444]
SLC38A2,ENSG00000134294,EFO_0007777,0.3399311182728985,2,base metabolic rate measurement,[EFO_0005115],[EFO_0001444]
SLC38A2,ENSG00000134294,EFO_0009805,0.34797828446741036,2,whole body water mass,[EFO_0004302],[EFO_0001444]
SLC38A3,ENSG00000188338,EFO_0020092,0.33820581410873346,1,neuroinflammatory disorder,"[EFO_0009386, MONDO_0002977]","[EFO_0000540, EFO_0000618]"
SLC38A3,ENSG00000188338,MONDO_0030922,0.3695798546847018,1,"intellectual disability, autosomal dominant 56",[MONDO_0015802],"[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC38A3,ENSG00000188338,EFO_0005772,0.5407495869976453,5,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC38A3,ENSG00000188338,MONDO_0044326,0.3695798546847018,1,developmental delay and seizures with or without movement abnormalities,[EFO_0010642],[EFO_0000618]
SLC38A3,ENSG00000188338,MONDO_0018614,0.3695798546847018,1,undetermined early-onset epileptic encephalopathy,"[MONDO_0020071, MONDO_0020070, MONDO_0019216, MONDO_0015653]","[OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC38A4,ENSG00000139209,EFO_0005939,0.3124242520528392,1,parental genotype effect measurement,[EFO_0007958],[EFO_0001444]
SLC38A4,ENSG00000139209,EFO_0004908,0.29851565445655415,1,testosterone measurement,"[EFO_0004529, EFO_0011008]",[EFO_0001444]
SLC38A4,ENSG00000139209,EFO_0005664,0.29476287124960066,1,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC38A4,ENSG00000139209,EFO_0004747,0.29476287124960066,1,protein measurement,[EFO_0001444],[EFO_0001444]
SLC38A4,ENSG00000139209,EFO_0004741,0.3180926489208066,1,blood urea nitrogen measurement,[EFO_0009795],[EFO_0001444]
SLC38A4,ENSG00000139209,EFO_0004735,0.32389084976183663,2,serum alanine aminotransferase measurement,"[EFO_0004582, EFO_0004747]",[EFO_0001444]
SLC38A4,ENSG00000139209,EFO_0004339,0.4736556014255295,7,body height,[EFO_0004324],[EFO_0001444]
SLC38A4,ENSG00000139209,EFO_0004458,0.3892703629161484,2,C-reactive protein measurement,"[EFO_0004747, EFO_0004872]",[EFO_0001444]
SLC38A4,ENSG00000139209,EFO_0004344,0.3867165179338702,2,birth weight,[EFO_0004338],[EFO_0001444]
SLC38A4,ENSG00000139209,EFO_0004535,0.39996254252196106,2,serum albumin measurement,[EFO_0004747],[EFO_0001444]
SLC38A4,ENSG00000139209,EFO_0004838,0.3182588993382361,1,calcium measurement,[EFO_0001444],[EFO_0001444]
SLC38A4,ENSG00000139209,EFO_0004627,0.3209753214562284,1,IGF-1 measurement,"[EFO_0005127, EFO_0004730, EFO_0004747]",[EFO_0001444]
SLC38A4,ENSG00000139209,EFO_0004617,0.3209753214562284,1,cystatin C measurement,"[EFO_0004747, EFO_0004742]",[EFO_0001444]
SLC38A4,ENSG00000139209,EFO_0005134,0.29476287124960066,1,amino acid measurement,[EFO_0001444],[EFO_0001444]
SLC38A4,ENSG00000139209,EFO_0007789,0.29801635248736663,1,BMI-adjusted waist circumference,[EFO_0004342],[EFO_0001444]
SLC38A4,ENSG00000139209,EFO_0004309,0.4276475665093551,6,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SLC38A4,ENSG00000139209,EFO_0009795,0.31896152598648475,1,serum urea measurement,[EFO_0004742],[EFO_0001444]
SLC38A4,ENSG00000139209,EFO_0009767,0.248230883969642,1,glycine measurement,[EFO_0005134],[EFO_0001444]
SLC38A4,ENSG00000139209,EFO_0004531,0.38949986316941265,2,urate measurement,[EFO_0001444],[EFO_0001444]
SLC38A4,ENSG00000139209,EFO_0004530,0.3209753214562284,1,triglyceride measurement,[EFO_0004529],[EFO_0001444]
SLC38A5,ENSG00000017483,EFO_0004536,0.2315361655246442,1,total blood protein measurement,[EFO_0004503],[EFO_0001444]
SLC38A5,ENSG00000017483,EFO_0004526,0.2315361655246442,1,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC38A5,ENSG00000017483,EFO_0004305,0.2315361655246442,1,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
SLC38A5,ENSG00000017483,EFO_0004527,0.2315361655246442,1,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC38A6,ENSG00000139974,NA,NA,NA,NA,NA,NA
SLC38A7,ENSG00000103042,EFO_0004346,0.23109721662040342,2,neuroimaging measurement,[EFO_0001444],[EFO_0001444]
SLC38A7,ENSG00000103042,GO_0061477,0.4006512747358283,4,response to aromatase inhibitor,[EFO_0007613],[GO_0008150]
SLC38A8,ENSG00000166558,MONDO_0012216,0.7912551214793418,36,foveal hypoplasia - optic nerve decussation defect - anterior segment dysgenesis syndrome,"[MONDO_0020249, MONDO_0020238, MONDO_0019216, MONDO_0044203]","[OTAR_0000018, OTAR_0000020, MONDO_0024458, EFO_0000618]"
SLC38A8,ENSG00000166558,EFO_0000508,0.41266751317005385,35,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC38A8,ENSG00000166558,HP_0007750,0.4157773365202895,2,Hypoplasia of the fovea,[HP_0001103],[EFO_0000651]
SLC38A8,ENSG00000166558,MONDO_0044203,0.41665508867516565,4,foveal hypoplasia,[EFO_0000508],[OTAR_0000018]
SLC38A8,ENSG00000166558,Orphanet_397618,0.7291732713927501,29,Foveal hypoplasia-optic nerve decussation defect-anterior segment dysgenesis syndrome,"[Orphanet_98671, Orphanet_98657]","[OTAR_0000018, MONDO_0024458]"
SLC38A8,ENSG00000166558,MONDO_0018998,0.25870589827929125,1,Leber congenital amaurosis,"[MONDO_0002320, MONDO_0019118, MONDO_0020210, MONDO_0020211]","[MONDO_0002025, OTAR_0000018, MONDO_0024458, EFO_0000618]"
SLC38A9,ENSG00000177058,EFO_0005409,0.28479623912936736,2,fat body mass,[EFO_0004302],[EFO_0001444]
SLC38A9,ENSG00000177058,EFO_0004995,0.332988813501382,5,lean body mass,[EFO_0004302],[EFO_0001444]
SLC38A9,ENSG00000177058,EFO_0004980,0.31418773506580283,3,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
SLC38A9,ENSG00000177058,EFO_0008039,0.21177688376686724,1,BMI-adjusted hip circumference,[EFO_0005093],[EFO_0001444]
SLC38A9,ENSG00000177058,EFO_0004833,0.3216920891376477,2,neutrophil count,"[EFO_0803548, EFO_0007987]",[EFO_0001444]
SLC38A9,ENSG00000177058,EFO_0007988,0.2350564140282207,1,myeloid white cell count,[EFO_0004308],[EFO_0001444]
SLC38A9,ENSG00000177058,EFO_0004339,0.38023539939678075,9,body height,[EFO_0004324],[EFO_0001444]
SLC38A9,ENSG00000177058,EFO_0004343,0.3246744813587394,2,waist-hip ratio,[EFO_0007861],[EFO_0001444]
SLC38A9,ENSG00000177058,EFO_0005772,0.3287536173995946,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC38A9,ENSG00000177058,MONDO_0005148,0.2669153663612111,2,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC38A9,ENSG00000177058,EFO_0005091,0.3201404729200216,4,monocyte count,"[EFO_0004308, EFO_0803547]",[EFO_0001444]
SLC38A9,ENSG00000177058,EFO_0007789,0.3483158693371074,3,BMI-adjusted waist circumference,[EFO_0004342],[EFO_0001444]
SLC38A9,ENSG00000177058,EFO_0007788,0.3666661831394754,5,BMI-adjusted waist-hip ratio,[EFO_0004343],[EFO_0001444]
SLC38A9,ENSG00000177058,EFO_0009270,0.25711745561498917,2,heel bone mineral density,[EFO_0003923],[EFO_0001444]
SLC38A9,ENSG00000177058,EFO_0004587,0.27522770920962575,5,lymphocyte count,"[EFO_0006843, EFO_0004308, EFO_0803546]",[EFO_0001444]
SLC38A9,ENSG00000177058,EFO_0004314,0.22977627257395347,1,forced expiratory volume,"[EFO_0003892, EFO_0006841]",[EFO_0001444]
SLC38A9,ENSG00000177058,EFO_0004309,0.2796085553744518,4,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SLC38A9,ENSG00000177058,EFO_0004308,0.29017378771725993,3,leukocyte count,[EFO_0004586],[EFO_0001444]
SLC38A9,ENSG00000177058,EFO_0007985,0.25135085490961606,2,platelet crit,[EFO_0005036],[EFO_0001444]
SLC38A9,ENSG00000177058,EFO_0009805,0.23394092593523053,1,whole body water mass,[EFO_0004302],[EFO_0001444]
SLC38A9,ENSG00000177058,EFO_0004532,0.28551796463966866,1,serum gamma-glutamyl transferase measurement,[EFO_0004582],[EFO_0001444]
SLC39A1,ENSG00000143570,EFO_0005772,0.3004673315317077,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC39A1,ENSG00000143570,GO_0007568,0.3004673315317077,1,aging,[GO_0032502],[GO_0008150]
SLC39A10,ENSG00000196950,MONDO_0002561,0.365290109127023,1,lysosomal storage disease,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
SLC39A10,ENSG00000196950,EFO_0004348,0.23392499094176183,2,hematocrit,[EFO_0004503],[EFO_0001444]
SLC39A10,ENSG00000196950,EFO_0005772,0.4993303119855546,3,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC39A10,ENSG00000196950,MONDO_0005180,0.365290109127023,1,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
SLC39A10,ENSG00000196950,MONDO_0005148,0.2554298552716125,1,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC39A10,ENSG00000196950,EFO_0004509,0.24218866047072465,2,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
SLC39A10,ENSG00000196950,MONDO_0004975,0.36796498784488246,5,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
SLC39A10,ENSG00000196950,MONDO_0005301,0.365290109127023,1,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
SLC39A11,ENSG00000133195,EFO_0005409,0.2820603350194003,5,fat body mass,[EFO_0004302],[EFO_0001444]
SLC39A11,ENSG00000133195,EFO_0000384,0.2602271281489544,1,Crohn's disease,[EFO_0003767],"[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLC39A11,ENSG00000133195,EFO_0003767,0.3287502300017921,3,inflammatory bowel disease,"[EFO_0000508, EFO_0005140, EFO_0009431]","[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLC39A11,ENSG00000133195,EFO_0004995,0.3246841462005317,11,lean body mass,[EFO_0004302],[EFO_0001444]
SLC39A11,ENSG00000133195,EFO_0004736,0.25120079006184415,1,aspartate aminotransferase measurement,"[EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC39A11,ENSG00000133195,EFO_0004735,0.25120079006184415,1,serum alanine aminotransferase measurement,"[EFO_0004582, EFO_0004747]",[EFO_0001444]
SLC39A11,ENSG00000133195,EFO_0000676,0.2602271281489544,1,psoriasis,"[MONDO_0002406, EFO_1000636, EFO_0000540, MONDO_0100118]","[OTAR_0000018, EFO_0000540, EFO_0010285]"
SLC39A11,ENSG00000133195,EFO_0004338,0.2620979134544007,2,body weight,[EFO_0004324],[EFO_0001444]
SLC39A11,ENSG00000133195,EFO_0009946,0.25120079006184415,1,low density lipoprotein triglyceride measurement,"[EFO_0004530, EFO_0005278, EFO_0004732]",[EFO_0001444]
SLC39A11,ENSG00000133195,MONDO_0005148,0.35130514597836565,2,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC39A11,ENSG00000133195,EFO_0003898,0.2602271281489544,1,ankylosing spondylitis,"[MONDO_0003937, EFO_0000685, EFO_0009477, EFO_0000706]","[OTAR_0000006, EFO_0000540]"
SLC39A11,ENSG00000133195,EFO_0004696,0.25120079006184415,1,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
SLC39A11,ENSG00000133195,EFO_0004628,0.21939301210539042,1,insulin like growth factor measurement,[EFO_0001444],[EFO_0001444]
SLC39A11,ENSG00000133195,EFO_0005093,0.21096587603292188,1,hip circumference,"[EFO_0004512, EFO_0004324]",[EFO_0001444]
SLC39A11,ENSG00000133195,EFO_0007874,0.29943588036588253,1,gut microbiome measurement,[EFO_0007882],[EFO_0001444]
SLC39A11,ENSG00000133195,EFO_0007800,0.31051992258108296,2,body fat percentage,[EFO_0005106],[EFO_0001444]
SLC39A11,ENSG00000133195,EFO_0004612,0.25120079006184415,1,high density lipoprotein cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
SLC39A11,ENSG00000133195,EFO_0004268,0.2602271281489544,1,sclerosing cholangitis,"[EFO_0001421, MONDO_0004789]","[EFO_0001379, EFO_0010282]"
SLC39A11,ENSG00000133195,EFO_0007777,0.20919602612069965,1,base metabolic rate measurement,[EFO_0005115],[EFO_0001444]
SLC39A11,ENSG00000133195,EFO_0009805,0.20919602612069965,1,whole body water mass,[EFO_0004302],[EFO_0001444]
SLC39A11,ENSG00000133195,EFO_0000729,0.37705209019802977,5,ulcerative colitis,[EFO_0003872],"[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLC39A12,ENSG00000148482,EFO_0006336,0.259117587798472,1,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC39A12,ENSG00000148482,EFO_0006335,0.3858905251931067,2,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC39A12,ENSG00000148482,EFO_0004833,0.4708721163020254,5,neutrophil count,"[EFO_0803548, EFO_0007987]",[EFO_0001444]
SLC39A12,ENSG00000148482,EFO_0004736,0.47561221709194296,5,aspartate aminotransferase measurement,"[EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC39A12,ENSG00000148482,EFO_0007988,0.4122416899722207,2,myeloid white cell count,[EFO_0004308],[EFO_0001444]
SLC39A12,ENSG00000148482,EFO_0006930,0.2535972676902716,1,brain volume measurement,"[EFO_0005052, EFO_0004464]",[EFO_0001444]
SLC39A12,ENSG00000148482,EFO_0004346,0.2535972676902716,1,neuroimaging measurement,[EFO_0001444],[EFO_0001444]
SLC39A12,ENSG00000148482,EFO_0004535,0.29689919021500394,1,serum albumin measurement,[EFO_0004747],[EFO_0001444]
SLC39A12,ENSG00000148482,EFO_0004875,0.4113997044127142,2,mathematical ability,[EFO_0003925],[GO_0008150]
SLC39A12,ENSG00000148482,EFO_0005091,0.3025111558107408,2,monocyte count,"[EFO_0004308, EFO_0803547]",[EFO_0001444]
SLC39A12,ENSG00000148482,EFO_0004308,0.44957571564379606,4,leukocyte count,[EFO_0004586],[EFO_0001444]
SLC39A12,ENSG00000148482,EFO_0007937,0.44147055553697523,3,blood protein measurement,[EFO_0004747],[EFO_0001444]
SLC39A12,ENSG00000148482,EFO_0007906,0.30317410261802996,1,synophrys measurement,[EFO_0007821],[EFO_0001444]
SLC39A12,ENSG00000148482,EFO_0009716,0.2930952343938079,1,age at first facial hair,[EFO_0000246],[EFO_0001444]
SLC39A13,ENSG00000165915,EFO_0005208,0.2405612240218048,5,glomerular filtration rate,[EFO_0004742],[EFO_0001444]
SLC39A13,ENSG00000165915,MONDO_0012873,0.7168165264337828,234,"Ehlers-Danlos syndrome, spondylocheirodysplastic type","[MONDO_0007526, MONDO_0016761]","[OTAR_0000006, OTAR_0000018, OTAR_0000020]"
SLC39A13,ENSG00000165915,EFO_0004584,0.23363885311618693,5,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
SLC39A13,ENSG00000165915,EFO_0004627,0.22525466654750773,1,IGF-1 measurement,"[EFO_0005127, EFO_0004730, EFO_0004747]",[EFO_0001444]
SLC39A13,ENSG00000165915,EFO_0004617,0.2574876860645895,1,cystatin C measurement,"[EFO_0004747, EFO_0004742]",[EFO_0001444]
SLC39A13,ENSG00000165915,EFO_0004518,0.3019420690613174,2,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC39A13,ENSG00000165915,EFO_0007878,0.20271516166007417,6,alcohol consumption measurement,[EFO_0001444],[EFO_0001444]
SLC39A13,ENSG00000165915,EFO_0004309,0.3502459157307356,5,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SLC39A13,ENSG00000165915,Orphanet_168451,0.46197481835587717,2,Spondyloepimetaphyseal dysplasia - abnormal dentition,[Orphanet_253],"[OTAR_0000006, OTAR_0000018]"
SLC39A13,ENSG00000165915,EFO_0007985,0.2495276129940488,2,platelet crit,[EFO_0005036],[EFO_0001444]
SLC39A13,ENSG00000165915,MONDO_0011124,0.46197481835587717,2,spondyloepimetaphyseal dysplasia-abnormal dentition syndrome,[MONDO_0100510],"[OTAR_0000006, OTAR_0000018]"
SLC39A14,ENSG00000104635,EFO_0000508,0.33209348166393077,11,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC39A14,ENSG00000104635,Orphanet_309854,0.6872864414567809,22,Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome,"[Orphanet_101940, Orphanet_307055, MONDO_0019052]","[OTAR_0000018, OTAR_0000020, EFO_0000618, EFO_0010282]"
SLC39A14,ENSG00000104635,MONDO_0007765,0.46061069366491386,8,hyperostosis cranialis interna,[EFO_0000508],[OTAR_0000018]
SLC39A2,ENSG00000165794,NA,NA,NA,NA,NA,NA
SLC39A3,ENSG00000141873,EFO_0005772,0.2760854692392016,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC39A3,ENSG00000141873,GO_0007568,0.2770094188759133,2,aging,[GO_0032502],[GO_0008150]
SLC39A4,ENSG00000147804,MONDO_0008713,0.822986644294274,210,acrodermatitis enteropathica,"[MONDO_0017764, MONDO_0015180, MONDO_0004689]","[OTAR_0000018, OTAR_0000020, EFO_0010282]"
SLC39A4,ENSG00000147804,EFO_0000508,0.469847505077461,47,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC39A4,ENSG00000147804,EFO_0004533,0.3244008324875376,6,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC39A4,ENSG00000147804,EFO_0004696,0.2795654138433286,5,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
SLC39A5,ENSG00000139540,HP_0000545,0.6107899395310596,18,Myopia,[HP_0000539],[EFO_0000651]
SLC39A5,ENSG00000139540,EFO_0004533,0.5193929911810621,9,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC39A6,ENSG00000141424,EFO_0002916,0.2588298116962889,2,esophageal carcinoma,"[EFO_1000218, MONDO_0007576]","[MONDO_0045024, EFO_0010282]"
SLC39A6,ENSG00000141424,EFO_0000707,0.25661233256818067,1,squamous cell carcinoma,"[MONDO_0002532, EFO_0000313]",[MONDO_0045024]
SLC39A6,ENSG00000141424,EFO_0000714,0.25661233256818067,1,survival time,[EFO_0004949],[EFO_0001444]
SLC39A7,ENSG00000112473,MONDO_0002561,0.24887251561546536,1,lysosomal storage disease,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
SLC39A7,ENSG00000112473,MONDO_0015977,0.5083365579046581,4,agammaglobulinemia,"[MONDO_0002211, MONDO_0015132]","[OTAR_0000018, EFO_0000540, EFO_0005803]"
SLC39A7,ENSG00000112473,EFO_0005772,0.4562742288763073,5,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC39A7,ENSG00000112473,MONDO_0002211,0.4619748183558772,2,B cell deficiency,"[MONDO_0004805, MONDO_0021094, MONDO_0003778]","[OTAR_0000018, EFO_0000540, EFO_0005803]"
SLC39A7,ENSG00000112473,MONDO_0005180,0.24887251561546536,1,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
SLC39A7,ENSG00000112473,MONDO_0004975,0.24924209547015005,2,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
SLC39A7,ENSG00000112473,MONDO_0011096,0.3695798546847018,1,autosomal agammaglobulinemia,[MONDO_0016462],"[OTAR_0000018, EFO_0000540, EFO_0005803]"
SLC39A7,ENSG00000112473,MONDO_0005301,0.24887251561546536,1,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
SLC39A8,ENSG00000138821,HP_0030834,0.3421189733256977,1,Shoulder pain,"[HP_0025142, EFO_0003843]",[EFO_0000651]
SLC39A8,ENSG00000138821,HP_0030833,0.3421189733256977,1,Neck pain,"[EFO_0003843, HP_0025142]",[EFO_0000651]
SLC39A8,ENSG00000138821,EFO_0020864,0.3407281488119507,1,cerebellar volume measurement,[EFO_0006930],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0011011,0.3420990814313107,1,sitting height measurement,[EFO_0004302],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0010821,0.339225044136863,1,liver fat measurement,[EFO_0006845],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0010750,0.2553191611749405,1,PHF-tau measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0007041,0.2936536833579335,1,obese body mass index status,[EFO_0004340],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0005409,0.4688318691500424,5,fat body mass,[EFO_0004302],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0005278,0.29432513942970634,1,cardiovascular disease biomarker measurement,[EFO_0004298],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0005271,0.42937860133082534,4,sleep duration,[EFO_0004870],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0003948,0.34029336883463435,1,gastroesophageal reflux disease,"[EFO_0009544, EFO_0000508, EFO_0009608]","[OTAR_0000018, EFO_0010282]"
SLC39A8,ENSG00000138821,EFO_0003940,0.34124828990859124,1,physical activity,[GO_0008150],[GO_0008150]
SLC39A8,ENSG00000138821,HP_0000539,0.3421283575416544,1,Abnormality of refraction,[HP_0000478],[EFO_0000651]
SLC39A8,ENSG00000138821,MONDO_0007079,0.4281887524678202,4,alcohol dependence,"[MONDO_0021698, EFO_0003890]","[MONDO_0002025, EFO_0000618]"
SLC39A8,ENSG00000138821,MONDO_0005351,0.35679551259443687,2,anorexia nervosa,[EFO_0005203],"[MONDO_0002025, OTAR_0000020, EFO_0000618]"
SLC39A8,ENSG00000138821,EFO_0000384,0.3688387320075674,22,Crohn's disease,[EFO_0003767],"[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLC39A8,ENSG00000138821,EFO_0000195,0.2948795092117334,2,metabolic syndrome,[EFO_0000589],[OTAR_0000020]
SLC39A8,ENSG00000138821,HP_0003040,0.3430239333625896,1,Arthropathy,[HP_0011842],[EFO_0000651]
SLC39A8,ENSG00000138821,EFO_0004995,0.45556848328820315,5,lean body mass,[EFO_0004302],[EFO_0001444]
SLC39A8,ENSG00000138821,MONDO_0014746,0.767590302925848,36,SLC39A8-CDG,"[EFO_0005546, MONDO_0002320, MONDO_0015159, MONDO_0017740, MONDO_0015327, MONDO_0020022]","[OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC39A8,ENSG00000138821,EFO_0006340,0.496496393058842,5,mean arterial pressure,[EFO_0004325],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0006336,0.5402872107054356,16,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0006335,0.5400843101344327,15,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0003893,0.2990913078166003,1,ovarian neoplasm,"[EFO_0005771, MONDO_0021148]","[OTAR_0000017, EFO_0001379, MONDO_0045024]"
SLC39A8,ENSG00000138821,EFO_0003888,0.35710712636744396,3,attention deficit hyperactivity disorder,[MONDO_0000592],"[MONDO_0002025, EFO_0000618]"
SLC39A8,ENSG00000138821,EFO_1001250,0.29458287106132847,2,rotator cuff tear,"[MONDO_0020120, EFO_0002970]",[OTAR_0000006]
SLC39A8,ENSG00000138821,EFO_0008394,0.34066618214649036,1,verbal-numerical reasoning measurement,[EFO_0008354],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0008354,0.48481164379314423,5,cognitive function measurement,[EFO_0001444],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0008111,0.404195236956093,2,diet measurement,[EFO_0001444],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0008006,0.3412650096736408,1,skin aging measurement,[EFO_0001444],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0008002,0.525154131848854,9,physical activity measurement,[EFO_0001444],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004242,0.24420655327419588,1,obsessive-compulsive disorder,"[EFO_0000508, EFO_0006788]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC39A8,ENSG00000138821,EFO_0000537,0.45788444704590653,7,hypertension,[MONDO_0000473],[EFO_0000319]
SLC39A8,ENSG00000138821,EFO_0008579,0.43018301210735216,3,risk-taking behaviour,[GO_0007610],[GO_0008150]
SLC39A8,ENSG00000138821,EFO_0004784,0.49720165145464973,6,self reported educational attainment,[EFO_0011015],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004765,0.3405938840320073,1,visceral adipose tissue measurement,[EFO_0004764],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004761,0.33989359242340983,1,uric acid measurement,"[EFO_0004742, EFO_0004298]",[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004736,0.496604347664783,6,aspartate aminotransferase measurement,"[EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004735,0.4155004966423988,2,serum alanine aminotransferase measurement,"[EFO_0004582, EFO_0004747]",[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0007991,0.3100001993122063,4,eosinophil percentage of leukocytes,[EFO_0004842],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0007989,0.42380836955885953,4,monocyte percentage of leukocytes,[EFO_0005091],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004339,0.5015797861158716,6,body height,[EFO_0004324],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004338,0.2256425226914563,2,body weight,[EFO_0004324],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004337,0.4996406838528805,5,intelligence,[EFO_0003925],[GO_0008150]
SLC39A8,ENSG00000138821,EFO_0004333,0.3404701489591702,1,episodic memory,[EFO_0004323],[GO_0008150]
SLC39A8,ENSG00000138821,EFO_0004330,0.3411702202810081,1,coffee consumption,[EFO_0004315],[GO_0008150]
SLC39A8,ENSG00000138821,EFO_0004329,0.5275612242844958,10,alcohol drinking,[EFO_0004315],[GO_0008150]
SLC39A8,ENSG00000138821,EFO_0004325,0.2550092922492984,3,blood pressure,[EFO_0004303],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0010100,0.4609439302838081,4,multisite chronic pain,[HP_0012532],[EFO_0000651]
SLC39A8,ENSG00000138821,EFO_0010092,0.34066618214649036,1,bitter alcoholic beverage consumption measurement,[EFO_0010089],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0009946,0.3419598381706015,1,low density lipoprotein triglyceride measurement,"[EFO_0004530, EFO_0005278, EFO_0004732]",[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0009931,0.41347487728083643,2,Agents acting on the renin-angiotensin system use measurement,[EFO_0007010],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0009902,0.34154010377896216,1,handedness,[EFO_0003889],[EFO_0000651]
SLC39A8,ENSG00000138821,EFO_0010736,0.4813340896477477,4,cortical surface area measurement,[EFO_0004464],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0010724,0.3411707930265829,1,lifestyle measurement,[EFO_0001444],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0010599,0.28753010795871575,1,ST2 protein measurement,[EFO_0007937],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0007010,0.21395047525198574,1,drug use measurement,[EFO_0001444],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0006941,0.5067598461307762,6,grip strength measurement,[EFO_0004302],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0006935,0.45622381701261827,3,thalamus volume,[EFO_0006930],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0006931,0.2941626338871891,1,nucleus accumbens volume,[EFO_0006930],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0006930,0.5081753311308473,9,brain volume measurement,"[EFO_0005052, EFO_0004464]",[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0006873,0.2926090835441653,1,theta wave measurement,[EFO_0004357],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0006845,0.339225044136863,1,liver disease biomarker,[EFO_0001444],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0003761,0.24420655327419588,1,unipolar depression,[MONDO_0002050],"[MONDO_0002025, EFO_0000618]"
SLC39A8,ENSG00000138821,EFO_0003756,0.3824950030527853,2,autism spectrum disorder,[MONDO_0000594],"[MONDO_0002025, EFO_0000618]"
SLC39A8,ENSG00000138821,EFO_0004458,0.34029336883463435,1,C-reactive protein measurement,"[EFO_0004747, EFO_0004872]",[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004348,0.5082240824921481,6,hematocrit,[EFO_0004503],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004346,0.5374180826570181,13,neuroimaging measurement,[EFO_0001444],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004343,0.3422088723522685,1,waist-hip ratio,[EFO_0007861],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004340,0.5530417886822596,32,body mass index,[EFO_0004324],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004574,0.5127429423840129,7,total cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004535,0.4274558935374147,3,serum albumin measurement,[EFO_0004747],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0009458,0.526568971195756,9,alcohol use disorder measurement,[EFO_0006848],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_1000999,0.3033259462813852,1,joint disease,[EFO_0002461],[OTAR_0000006]
SLC39A8,ENSG00000138821,EFO_0004875,0.29432513942970634,1,mathematical ability,[EFO_0003925],[GO_0008150]
SLC39A8,ENSG00000138821,EFO_0004895,0.24420655327419588,1,Tourette syndrome,"[MONDO_0002420, EFO_0004280, EFO_0000508]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC39A8,ENSG00000138821,EFO_0004842,0.32458767697513824,10,eosinophil count,"[EFO_0803540, EFO_0007987]",[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004840,0.48671325581355374,4,cortical thickness,[EFO_0004464],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004838,0.4648738969389375,4,calcium measurement,[EFO_0001444],[EFO_0001444]
SLC39A8,ENSG00000138821,MONDO_0005090,0.5437001044552306,54,schizophrenia,[EFO_0005407],"[MONDO_0002025, EFO_0000618]"
SLC39A8,ENSG00000138821,EFO_0005772,0.3420191819889024,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC39A8,ENSG00000138821,MONDO_0004985,0.39440735407926286,3,bipolar disorder,[EFO_0004247],"[MONDO_0002025, EFO_0000618]"
SLC39A8,ENSG00000138821,MONDO_0005178,0.48994320225455745,18,osteoarthritis,[EFO_0005856],[OTAR_0000006]
SLC39A8,ENSG00000138821,MONDO_0005148,0.34255644837934507,3,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC39A8,ENSG00000138821,EFO_0005546,0.6714949287146056,26,congenital disorder of glycosylation type II,[MONDO_0015286],"[OTAR_0000018, OTAR_0000020]"
SLC39A8,ENSG00000138821,EFO_0005422,0.3187936674757106,1,skin aging,[GO_0007568],[GO_0008150]
SLC39A8,ENSG00000138821,EFO_0000546,0.3426078604893526,2,injury,[OTAR_0000009],[OTAR_0000009]
SLC39A8,ENSG00000138821,EFO_0004526,0.4706990540605703,10,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004509,0.5176093080380216,7,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004468,0.32782734111191364,1,glucose measurement,[EFO_0006842],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004464,0.4646395789454023,3,brain measurement,[EFO_0001444],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004696,0.3419598381706015,1,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004629,0.2286955016742678,1,von Willebrand factor measurement,"[EFO_0004747, EFO_0004503, EFO_0004634]",[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004627,0.34029336883463435,1,IGF-1 measurement,"[EFO_0005127, EFO_0004730, EFO_0004747]",[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004614,0.42885743928536724,3,apolipoprotein A 1 measurement,"[EFO_0004872, EFO_0005278, EFO_0004732]",[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0005093,0.39352801584013686,2,hip circumference,"[EFO_0004512, EFO_0004324]",[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0007878,0.5354153543250082,12,alcohol consumption measurement,[EFO_0001444],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0007876,0.3954621060531078,2,insomnia measurement,[EFO_0004870],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0007835,0.34066618214649036,1,alcohol dependence measurement,[EFO_0006848],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0007825,0.42746732152497374,2,balding measurement,[EFO_0007821],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0007824,0.2994185437979062,1,hair shape measurement,[EFO_0007821],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0007805,0.34124828990859124,1,HDL cholesterol change measurement,[EFO_0004612],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0007800,0.5291275397953848,11,body fat percentage,[EFO_0005106],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0007789,0.46547275976551133,3,BMI-adjusted waist circumference,[EFO_0004342],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0007788,0.509995170415959,6,BMI-adjusted waist-hip ratio,[EFO_0004343],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0009188,0.39198977542690155,3,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004612,0.5459358152743045,21,high density lipoprotein cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004611,0.4932894531142479,5,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004318,0.4853653976203486,4,smoking behavior,[GO_0007610],[GO_0008150]
SLC39A8,ENSG00000138821,EFO_0004314,0.3423651878368425,1,forced expiratory volume,"[EFO_0003892, EFO_0006841]",[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004312,0.45944445594216665,3,vital capacity,[EFO_0003892],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004308,0.30107796831741,3,leukocyte count,[EFO_0004586],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004305,0.49916791851701114,7,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_1001178,0.2940285012793014,1,shoulder impingement syndrome,[EFO_1000999],[OTAR_0000006]
SLC39A8,ENSG00000138821,MONDO_0004892,0.29432513942970634,1,refractive error,[EFO_0003966],[MONDO_0024458]
SLC39A8,ENSG00000138821,EFO_0007985,0.25785772376327526,1,platelet crit,[EFO_0005036],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0007984,0.46462787192794774,3,platelet component distribution width,[EFO_0005036],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0007978,0.42973651256847395,3,red blood cell density measurement,[EFO_0005047],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0007928,0.32782734111191364,1,ventricular rate measurement,[EFO_0004326],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0007680,0.3420471378134097,1,gait measurement,[EFO_0001444],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0007645,0.4652230469782434,3,longitudinal alcohol consumption measurement,[EFO_0007878],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0007581,0.3409097532165206,1,blood manganese measurement,[EFO_0007574],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0009795,0.3442602267145148,1,serum urea measurement,[EFO_0004742],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0009676,0.34223828063466794,1,musculoskeletal system disease,[OTAR_0000006],[OTAR_0000006]
SLC39A8,ENSG00000138821,EFO_0009666,0.3429700732498805,1,enthesopathy,"[EFO_1001986, EFO_0009676]",[OTAR_0000006]
SLC39A8,ENSG00000138821,HP_0000964,0.35519710475374283,3,Eczema,[HP_0011123],[EFO_0000651]
SLC39A8,ENSG00000138821,EFO_0004532,0.46510503997306213,3,serum gamma-glutamyl transferase measurement,[EFO_0004582],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004531,0.46758926573437215,4,urate measurement,[EFO_0001444],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004530,0.4919169023479002,5,triglyceride measurement,[EFO_0004529],[EFO_0001444]
SLC39A8,ENSG00000138821,EFO_0004528,0.40709258902255313,4,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC39A9,ENSG00000029364,EFO_0007997,0.29317050637954484,1,granulocyte percentage of myeloid white cells,[EFO_0007987],[EFO_0001444]
SLC39A9,ENSG00000029364,EFO_0009390,0.2799028991961874,1,sum of neutrophil and eosinophil counts,[EFO_0007987],[EFO_0001444]
SLC39A9,ENSG00000029364,EFO_0009388,0.28067808830303054,1,sum of basophil and neutrophil counts,[EFO_0007987],[EFO_0001444]
SLC39A9,ENSG00000029364,EFO_0004833,0.4574186488970032,8,neutrophil count,"[EFO_0803548, EFO_0007987]",[EFO_0001444]
SLC39A9,ENSG00000029364,EFO_0007993,0.3454517027252105,2,lymphocyte percentage of leukocytes,[EFO_0004587],[EFO_0001444]
SLC39A9,ENSG00000029364,EFO_0007990,0.3932283640444798,3,neutrophil percentage of leukocytes,[EFO_0004833],[EFO_0001444]
SLC39A9,ENSG00000029364,EFO_0007989,0.2700841455776375,1,monocyte percentage of leukocytes,[EFO_0005091],[EFO_0001444]
SLC39A9,ENSG00000029364,EFO_0007988,0.35169704163076737,2,myeloid white cell count,[EFO_0004308],[EFO_0001444]
SLC39A9,ENSG00000029364,EFO_0004533,0.2594758966040041,2,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC39A9,ENSG00000029364,EFO_0005772,0.4619748183558772,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC39A9,ENSG00000029364,EFO_0004627,0.2797709474272192,1,IGF-1 measurement,"[EFO_0005127, EFO_0004730, EFO_0004747]",[EFO_0001444]
SLC39A9,ENSG00000029364,EFO_0004308,0.4245238092285458,4,leukocyte count,[EFO_0004586],[EFO_0001444]
SLC4A1,ENSG00000004939,EFO_0002571,0.2501548990717632,1,medical procedure,[],[EFO_0002571]
SLC4A1,ENSG00000004939,MONDO_0008494,0.7275159846100966,68,cryohydrocytosis,[MONDO_0020102],[EFO_0005803]
SLC4A1,ENSG00000004939,MONDO_0008368,0.7971008071907238,201,autosomal dominant distal renal tubular acidosis,"[MONDO_0015827, MONDO_0000426]","[OTAR_0000018, EFO_0009690]"
SLC4A1,ENSG00000004939,Orphanet_93610,0.7966642988198622,72,Distal renal tubular acidosis with anemia,"[MONDO_0100191, Orphanet_183592, EFO_0009566, Orphanet_98364]","[OTAR_0000018, EFO_0009690, EFO_0005803]"
SLC4A1,ENSG00000004939,MONDO_0008165,0.7397901369880169,93,southeast Asian ovalocytosis,"[MONDO_0017319, MONDO_0020102]",[EFO_0005803]
SLC4A1,ENSG00000004939,MONDO_0015827,0.5819142256259436,108,distal renal tubular acidosis,[MONDO_0017828],"[OTAR_0000018, EFO_0009690]"
SLC4A1,ENSG00000004939,MONDO_0017910,0.3884305504275653,15,dehydrated hereditary stomatocytosis,[MONDO_0020102],[EFO_0005803]
SLC4A1,ENSG00000004939,EFO_0000508,0.4129023837393958,32,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC4A1,ENSG00000004939,MONDO_0012700,0.7880388924609816,74,"renal tubular acidosis, distal, 4, with hemolytic anemia","[MONDO_0015827, MONDO_0003689]","[OTAR_0000018, EFO_0009690, EFO_0005803]"
SLC4A1,ENSG00000004939,MONDO_0017828,0.3695798546847018,1,primary renal tubular acidosis,[MONDO_0015962],"[OTAR_0000018, EFO_0009690]"
SLC4A1,ENSG00000004939,MONDO_0017319,0.4351581259537191,44,hereditary elliptocytosis,[MONDO_0004139],[EFO_0005803]
SLC4A1,ENSG00000004939,EFO_0005803,0.5704696148551449,14,hematologic disease,[],[EFO_0005803]
SLC4A1,ENSG00000004939,EFO_0005558,0.7008612322880263,175,hemolytic anemia,"[MONDO_0004139, EFO_0004272]","[EFO_0000651, EFO_0005803]"
SLC4A1,ENSG00000004939,EFO_0004784,0.22026509174281242,3,self reported educational attainment,[EFO_0011015],[EFO_0001444]
SLC4A1,ENSG00000004939,EFO_0007993,0.24863754778294492,5,lymphocyte percentage of leukocytes,[EFO_0004587],[EFO_0001444]
SLC4A1,ENSG00000004939,EFO_0007990,0.24456790656797775,5,neutrophil percentage of leukocytes,[EFO_0004833],[EFO_0001444]
SLC4A1,ENSG00000004939,EFO_0007986,0.6943127131738505,45,reticulocyte count,[EFO_0010700],[EFO_0001444]
SLC4A1,ENSG00000004939,HP_0004804,0.5724123892236329,10,Congenital hemolytic anemia,[EFO_0005558],"[EFO_0000651, EFO_0005803]"
SLC4A1,ENSG00000004939,EFO_0010701,0.6628994849463845,19,mean reticulocyte volume,[EFO_0010700],[EFO_0001444]
SLC4A1,ENSG00000004939,EFO_0010700,0.6806095591856076,32,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
SLC4A1,ENSG00000004939,EFO_0004348,0.42901572349996653,9,hematocrit,[EFO_0004503],[EFO_0001444]
SLC4A1,ENSG00000004939,EFO_0004570,0.5913881092921804,30,bilirubin measurement,[EFO_0001444],[EFO_0001444]
SLC4A1,ENSG00000004939,EFO_0004568,0.23111244394265706,1,serum non-albumin protein measurement,[EFO_0004747],[EFO_0001444]
SLC4A1,ENSG00000004939,EFO_0004541,0.5947165713552595,14,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
SLC4A1,ENSG00000004939,EFO_0005772,0.4619748183558772,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC4A1,ENSG00000004939,MONDO_0019350,0.7752163601401595,265,hereditary spherocytosis,[MONDO_0003689],"[OTAR_0000018, EFO_0005803]"
SLC4A1,ENSG00000004939,Orphanet_398088,0.7017407281434218,57,Hereditary cryohydrocytosis with normal stomatin,[Orphanet_98364],"[OTAR_0000018, EFO_0005803]"
SLC4A1,ENSG00000004939,MONDO_0001909,0.41970961484359937,9,renal tubular acidosis,"[EFO_1000647, EFO_0009566, EFO_1000014]","[OTAR_0000020, EFO_0009690, EFO_0005803]"
SLC4A1,ENSG00000004939,EFO_0004526,0.6565785198550087,18,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC4A1,ENSG00000004939,EFO_0004509,0.33499634144873147,5,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
SLC4A1,ENSG00000004939,EFO_0004503,0.538904266179513,9,hematological measurement,[EFO_0001444],[EFO_0001444]
SLC4A1,ENSG00000004939,EFO_0009253,0.21886716558167765,1,Immature Reticulocyte Fraction Measurement,[EFO_0009233],[EFO_0001444]
SLC4A1,ENSG00000004939,EFO_0009188,0.6326964671785412,13,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC4A1,ENSG00000004939,EFO_0004587,0.3166398379861603,6,lymphocyte count,"[EFO_0006843, EFO_0004308, EFO_0803546]",[EFO_0001444]
SLC4A1,ENSG00000004939,EFO_0004305,0.4685052567294039,5,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
SLC4A1,ENSG00000004939,MONDO_0018440,0.2691883122299276,6,autosomal recessive distal renal tubular acidosis,"[EFO_1000017, MONDO_0015827]","[OTAR_0000018, EFO_0009690]"
SLC4A1,ENSG00000004939,EFO_0004528,0.6731812227155817,30,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC4A1,ENSG00000004939,EFO_0004527,0.4435398767354578,14,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC4A10,ENSG00000144290,EFO_0006340,0.2251993525421857,1,mean arterial pressure,[EFO_0004325],[EFO_0001444]
SLC4A10,ENSG00000144290,EFO_0006336,0.23571533578337536,1,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC4A10,ENSG00000144290,EFO_0006335,0.37988914817076774,5,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC4A10,ENSG00000144290,EFO_0000537,0.2804985876370143,2,hypertension,[MONDO_0000473],[EFO_0000319]
SLC4A10,ENSG00000144290,EFO_0009282,0.28344640998157195,1,sodium measurement,[EFO_0001444],[EFO_0001444]
SLC4A10,ENSG00000144290,EFO_0004784,0.2098891000816834,8,self reported educational attainment,[EFO_0011015],[EFO_0001444]
SLC4A10,ENSG00000144290,EFO_0004325,0.23786251488602425,1,blood pressure,[EFO_0004303],[EFO_0001444]
SLC4A10,ENSG00000144290,EFO_0009930,0.24021286446700268,1,Calcium channel blocker use measurement,[EFO_0007010],[EFO_0001444]
SLC4A10,ENSG00000144290,EFO_0004340,0.22194733621137064,2,body mass index,[EFO_0004324],[EFO_0001444]
SLC4A10,ENSG00000144290,EFO_0004875,0.32548866023532114,5,mathematical ability,[EFO_0003925],[GO_0008150]
SLC4A10,ENSG00000144290,EFO_0007828,0.22730932521114725,1,daytime rest measurement,[EFO_0004870],[EFO_0001444]
SLC4A10,ENSG00000144290,EFO_0004318,0.31778888082228435,3,smoking behavior,[GO_0007610],[GO_0008150]
SLC4A11,ENSG00000088836,Orphanet_98974,0.8135939095976522,101,Fuchs endothelial corneal dystrophy,"[EFO_0009464, Orphanet_101435]","[OTAR_0000018, MONDO_0024458]"
SLC4A11,ENSG00000088836,HP_0000539,0.2010708371095411,1,Abnormality of refraction,[HP_0000478],[EFO_0000651]
SLC4A11,ENSG00000088836,MONDO_0009019,0.8394469707834749,149,congenital hereditary endothelial dystrophy of cornea,"[MONDO_0020214, MONDO_0000766]",[MONDO_0024458]
SLC4A11,ENSG00000088836,MONDO_0009015,0.7610449237546285,115,corneal dystrophy-perceptive deafness syndrome,[MONDO_0020215],[MONDO_0024458]
SLC4A11,ENSG00000088836,EFO_0004533,0.2642154860165666,1,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC4A11,ENSG00000088836,MONDO_0018102,0.2018759690104766,119,corneal dystrophy,[EFO_0009464],[MONDO_0024458]
SLC4A11,ENSG00000088836,EFO_0003923,0.2528459576681632,1,bone density,[EFO_0004516],[EFO_0001444]
SLC4A11,ENSG00000088836,Orphanet_1490,0.6850489875229715,110,Corneal dystrophy - perceptive deafness,"[Orphanet_90642, EFO_0009464, Orphanet_101435]","[OTAR_0000018, EFO_0000618, MONDO_0024458]"
SLC4A11,ENSG00000088836,EFO_0004531,0.2528459576681632,1,urate measurement,[EFO_0001444],[EFO_0001444]
SLC4A2,ENSG00000164889,MONDO_0015827,0.2592602680613183,2,distal renal tubular acidosis,[MONDO_0017828],"[OTAR_0000018, EFO_0009690]"
SLC4A2,ENSG00000164889,EFO_0004526,0.27258069682205915,8,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC4A2,ENSG00000164889,EFO_0004509,0.23243814618311318,3,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
SLC4A2,ENSG00000164889,EFO_0009270,0.24720412089411625,5,heel bone mineral density,[EFO_0003923],[EFO_0001444]
SLC4A2,ENSG00000164889,EFO_0004305,0.24362286480161835,4,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
SLC4A2,ENSG00000164889,EFO_0004528,0.22287042278903485,3,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC4A3,ENSG00000114923,EFO_0004327,0.4075273734687184,60,electrocardiography,[EFO_0004311],[EFO_0001444]
SLC4A3,ENSG00000114923,Orphanet_51083,0.4186223941806521,8,Familial short QT syndrome,[Orphanet_98054],"[OTAR_0000018, EFO_0000319]"
SLC4A3,ENSG00000114923,EFO_0004682,0.34062485696230715,3,QT interval,"[EFO_0004327, EFO_0000719]",[EFO_0001444]
SLC4A4,ENSG00000080493,MONDO_0011422,0.779945555172825,178,autosomal recessive proximal renal tubular acidosis,"[MONDO_0008369, EFO_1000017]","[OTAR_0000018, OTAR_0000020, EFO_0009690, EFO_0005803]"
SLC4A4,ENSG00000080493,MONDO_0017828,0.3695798546847018,1,primary renal tubular acidosis,[MONDO_0015962],"[OTAR_0000018, EFO_0009690]"
SLC4A4,ENSG00000080493,EFO_0004682,0.3110885653150066,1,QT interval,"[EFO_0004327, EFO_0000719]",[EFO_0001444]
SLC4A4,ENSG00000080493,EFO_0004627,0.38328751771326675,2,IGF-1 measurement,"[EFO_0005127, EFO_0004730, EFO_0004747]",[EFO_0001444]
SLC4A4,ENSG00000080493,EFO_0009270,0.42117342987866513,6,heel bone mineral density,[EFO_0003923],[EFO_0001444]
SLC4A4,ENSG00000080493,EFO_0000729,0.30996733580199426,11,ulcerative colitis,[EFO_0003872],"[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLC4A5,ENSG00000188687,EFO_0005772,0.3605552648150209,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC4A7,ENSG00000033867,EFO_0004980,0.381878870929834,4,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0004908,0.2827941849439075,1,testosterone measurement,"[EFO_0004529, EFO_0011008]",[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0006340,0.4440571265026168,9,mean arterial pressure,[EFO_0004325],[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0006336,0.4841359118310638,17,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0006335,0.4794533408657365,25,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0000305,0.28397287712802066,23,breast carcinoma,"[EFO_0000313, MONDO_0007254]","[OTAR_0000017, MONDO_0045024, EFO_0010285]"
SLC4A7,ENSG00000033867,EFO_0000537,0.43587761701724315,20,hypertension,[MONDO_0000473],[EFO_0000319]
SLC4A7,ENSG00000033867,EFO_0004736,0.2808057444801876,1,aspartate aminotransferase measurement,"[EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0007010,0.3458621520299349,2,drug use measurement,[EFO_0001444],[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0004329,0.44161353005313037,12,alcohol drinking,[EFO_0004315],[GO_0008150]
SLC4A7,ENSG00000033867,EFO_0004325,0.2912444070687765,1,blood pressure,[EFO_0004303],[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0009931,0.36287369790685015,2,Agents acting on the renin-angiotensin system use measurement,[EFO_0007010],[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0009930,0.3626206379846524,2,Calcium channel blocker use measurement,[EFO_0007010],[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0009929,0.3302211064596141,2,Beta blocking agent use measurement,[EFO_0007010],[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0009928,0.3579976394699565,2,Diuretic use measurement,[EFO_0007010],[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0009927,0.2865718385260137,1,Antihypertensive use measurement,[EFO_0007010],[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0000319,0.36411411062117893,2,cardiovascular disease,[],[EFO_0000319]
SLC4A7,ENSG00000033867,EFO_0005763,0.44721094392704785,10,pulse pressure measurement,[EFO_0005278],[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0007878,0.34812126434227825,2,alcohol consumption measurement,[EFO_0001444],[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0007796,0.2869462379025385,1,parental longevity,[EFO_0004300],[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0004587,0.382617460462417,2,lymphocyte count,"[EFO_0006843, EFO_0004308, EFO_0803546]",[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0004309,0.4092355550544937,5,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0004308,0.24733854361048768,2,leukocyte count,[EFO_0004586],[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0004300,0.2869462379025385,1,longevity,[EFO_0000719],[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0006527,0.4393753182080854,9,smoking status measurement,[EFO_0005671],[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0007985,0.3794300979130865,4,platelet crit,[EFO_0005036],[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0007984,0.3541840791460443,2,platelet component distribution width,[EFO_0005036],[EFO_0001444]
SLC4A7,ENSG00000033867,EFO_0009762,0.2869462379025385,1,healthspan,[EFO_0000719],[EFO_0001444]
SLC4A8,ENSG00000050438,EFO_0008111,0.2671792901655293,1,diet measurement,[EFO_0001444],[EFO_0001444]
SLC4A8,ENSG00000050438,EFO_0004784,0.2513163524959021,1,self reported educational attainment,[EFO_0011015],[EFO_0001444]
SLC4A8,ENSG00000050438,EFO_0004533,0.21673723493230118,1,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC4A8,ENSG00000050438,EFO_0009458,0.32459426775967354,3,alcohol use disorder measurement,[EFO_0006848],[EFO_0001444]
SLC4A8,ENSG00000050438,EFO_0005772,0.4915894013166526,4,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC4A8,ENSG00000050438,GO_0007568,0.4045641348348562,2,aging,[GO_0032502],[GO_0008150]
SLC4A8,ENSG00000050438,EFO_0007878,0.3710190102664701,4,alcohol consumption measurement,[EFO_0001444],[EFO_0001444]
SLC4A8,ENSG00000050438,EFO_0009188,0.30747548460546525,3,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC4A8,ENSG00000050438,EFO_0004611,0.21667464350911445,3,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
SLC4A8,ENSG00000050438,EFO_0004305,0.25698136176654535,2,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
SLC4A8,ENSG00000050438,EFO_0006527,0.2419490765910422,1,smoking status measurement,[EFO_0005671],[EFO_0001444]
SLC4A8,ENSG00000050438,EFO_0004532,0.3474185881295088,2,serum gamma-glutamyl transferase measurement,[EFO_0004582],[EFO_0001444]
SLC4A9,ENSG00000113073,NA,NA,NA,NA,NA,NA
SLC40A1,ENSG00000138449,MONDO_0011631,0.8297173349851413,254,hemochromatosis type 4,[MONDO_0006507],"[OTAR_0000018, OTAR_0000020]"
SLC40A1,ENSG00000138449,MONDO_0011426,0.38241428509665865,5,aceruloplasminemia,"[MONDO_0017763, MONDO_0019118, MONDO_0004884, MONDO_0016624, MONDO_0018307]","[MONDO_0002025, OTAR_0000020, MONDO_0024458, EFO_0000618, EFO_0005803, OTAR_0000018]"
SLC40A1,ENSG00000138449,EFO_0006341,0.2536057267018381,1,transferrin measurement,"[EFO_0004747, EFO_0004461]",[EFO_0001444]
SLC40A1,ENSG00000138449,EFO_0006334,0.30682042123409475,1,total iron binding capacity,[EFO_0004461],[EFO_0001444]
SLC40A1,ENSG00000138449,EFO_1000643,0.4619748183558772,2,infantile epileptic encephalopathy,[EFO_0000474],[EFO_0000618]
SLC40A1,ENSG00000138449,EFO_0009381,0.2588255536413416,1,fibroblast growth factor 23 measurement,[EFO_0007937],[EFO_0001444]
SLC40A1,ENSG00000138449,EFO_0004747,0.27142784524634855,2,protein measurement,[EFO_0001444],[EFO_0001444]
SLC40A1,ENSG00000138449,EFO_0004348,0.3703215136991113,3,hematocrit,[EFO_0004503],[EFO_0001444]
SLC40A1,ENSG00000138449,EFO_0005772,0.3521587398939323,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC40A1,ENSG00000138449,EFO_0004526,0.42606862860529,4,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC40A1,ENSG00000138449,EFO_0004461,0.3134111422427753,2,iron biomarker measurement,[EFO_0001444],[EFO_0001444]
SLC40A1,ENSG00000138449,EFO_0004459,0.31535402740462104,2,ferritin measurement,[EFO_0004461],[EFO_0001444]
SLC40A1,ENSG00000138449,EFO_0009188,0.3861565890710558,4,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC40A1,ENSG00000138449,EFO_0004305,0.3752081412775008,6,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
SLC40A1,ENSG00000138449,EFO_0004270,0.28336975018924987,1,restless legs syndrome,[EFO_0000618],[EFO_0000618]
SLC40A1,ENSG00000138449,EFO_0004528,0.4535462413815954,6,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC40A1,ENSG00000138449,EFO_0004527,0.4381684198257485,5,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC41A1,ENSG00000133065,EFO_0007989,0.2765108294389142,3,monocyte percentage of leukocytes,[EFO_0005091],[EFO_0001444]
SLC41A1,ENSG00000133065,EFO_0010736,0.27233685305244704,2,cortical surface area measurement,[EFO_0004464],[EFO_0001444]
SLC41A1,ENSG00000133065,EFO_0006930,0.2102486664011913,1,brain volume measurement,"[EFO_0005052, EFO_0004464]",[EFO_0001444]
SLC41A1,ENSG00000133065,EFO_0004346,0.2621575285587029,2,neuroimaging measurement,[EFO_0001444],[EFO_0001444]
SLC41A1,ENSG00000133065,EFO_0004536,0.2586911787180184,1,total blood protein measurement,[EFO_0004503],[EFO_0001444]
SLC41A1,ENSG00000133065,EFO_0004840,0.270004698469411,2,cortical thickness,[EFO_0004464],[EFO_0001444]
SLC41A1,ENSG00000133065,EFO_0004464,0.26858313913393445,2,brain measurement,[EFO_0001444],[EFO_0001444]
SLC41A1,ENSG00000133065,EFO_0004627,0.2569435337111584,1,IGF-1 measurement,"[EFO_0005127, EFO_0004730, EFO_0004747]",[EFO_0001444]
SLC41A1,ENSG00000133065,MONDO_0019005,0.3374791406061497,13,nephronophthisis,"[EFO_1000017, MONDO_0015962]","[OTAR_0000018, EFO_0009690]"
SLC41A1,ENSG00000133065,EFO_0005091,0.38548035349253273,6,monocyte count,"[EFO_0004308, EFO_0803547]",[EFO_0001444]
SLC41A1,ENSG00000133065,EFO_0004309,0.2355890453841275,1,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SLC41A1,ENSG00000133065,EFO_0007985,0.2772607357448381,1,platelet crit,[EFO_0005036],[EFO_0001444]
SLC41A2,ENSG00000136052,EFO_0004747,0.30488703043158544,1,protein measurement,[EFO_0001444],[EFO_0001444]
SLC41A2,ENSG00000136052,EFO_0004339,0.3565408666075704,2,body height,[EFO_0004324],[EFO_0001444]
SLC41A3,ENSG00000114544,NA,NA,NA,NA,NA,NA
RHAG,ENSG00000112077,MONDO_0008493,0.716759063732681,13,overhydrated hereditary stomatocytosis,[MONDO_0020102],[EFO_0005803]
RHAG,ENSG00000112077,EFO_0007986,0.5960162021993319,35,reticulocyte count,[EFO_0010700],[EFO_0001444]
RHAG,ENSG00000112077,EFO_0010701,0.5818377889435631,16,mean reticulocyte volume,[EFO_0010700],[EFO_0001444]
RHAG,ENSG00000112077,EFO_0010700,0.5921635181835548,26,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
RHAG,ENSG00000112077,EFO_0004570,0.38637129685071686,10,bilirubin measurement,[EFO_0001444],[EFO_0001444]
RHAG,ENSG00000112077,EFO_0004541,0.5859890984662465,18,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
RHAG,ENSG00000112077,EFO_0004526,0.5857407604700523,17,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
RHAG,ENSG00000112077,EFO_0004503,0.5731744100117688,11,hematological measurement,[EFO_0001444],[EFO_0001444]
RHAG,ENSG00000112077,MONDO_0019107,0.7617956416224654,23,Rh deficiency syndrome,[MONDO_0020102],[EFO_0005803]
RHAG,ENSG00000112077,EFO_0004528,0.5633857656172603,13,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
RHBG,ENSG00000132677,NA,NA,NA,NA,NA,NA
RHCE,ENSG00000188672,EFO_0007986,0.28957328161425905,12,reticulocyte count,[EFO_0010700],[EFO_0001444]
RHCE,ENSG00000188672,EFO_0004329,0.20369224404097214,2,alcohol drinking,[EFO_0004315],[GO_0008150]
RHCE,ENSG00000188672,EFO_0010700,0.28167859753293345,7,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
RHCE,ENSG00000188672,EFO_0004574,0.2375368486771183,10,total cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
RHCE,ENSG00000188672,EFO_0004526,0.21452124898494956,6,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
RHCE,ENSG00000188672,EFO_0004696,0.250046240497305,6,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
RHCE,ENSG00000188672,EFO_0004615,0.3062559914844475,2,apolipoprotein B measurement,[EFO_0004732],[EFO_0001444]
RHCE,ENSG00000188672,MONDO_0019107,0.5659191524859496,5,Rh deficiency syndrome,[MONDO_0020102],[EFO_0005803]
RHCE,ENSG00000188672,EFO_0009253,0.2494213136182298,1,Immature Reticulocyte Fraction Measurement,[EFO_0009233],[EFO_0001444]
RHCE,ENSG00000188672,EFO_0009188,0.44041977972462815,10,Red cell distribution width,[EFO_0004509],[EFO_0001444]
RHCE,ENSG00000188672,EFO_0004611,0.3802726987421978,22,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
RHCE,ENSG00000188672,EFO_0004309,0.3670727943350474,8,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
RHCE,ENSG00000188672,EFO_0007984,0.3090322691864545,3,platelet component distribution width,[EFO_0005036],[EFO_0001444]
RHCE,ENSG00000188672,EFO_0007937,0.29425870866530196,5,blood protein measurement,[EFO_0004747],[EFO_0001444]
RHCG,ENSG00000140519,EFO_0003819,0.29941924871553677,1,dental caries,[MONDO_0002220],"[OTAR_0000006, EFO_0010282]"
RHCG,ENSG00000140519,EFO_0006336,0.32606808699282563,1,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
RHCG,ENSG00000140519,EFO_0006335,0.32606808699282563,1,systolic blood pressure,[EFO_0004325],[EFO_0001444]
RHCG,ENSG00000140519,EFO_0010078,0.29941924871553677,1,dentures,[EFO_0002571],[EFO_0002571]
RHCG,ENSG00000140519,EFO_0005772,0.3248635031817988,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
RHD,ENSG00000187010,EFO_0007986,0.4543142495740093,14,reticulocyte count,[EFO_0010700],[EFO_0001444]
RHD,ENSG00000187010,EFO_0010701,0.4132096257103132,4,mean reticulocyte volume,[EFO_0010700],[EFO_0001444]
RHD,ENSG00000187010,EFO_0010700,0.24976197649799933,8,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
RHD,ENSG00000187010,EFO_0004574,0.35274803762935053,9,total cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
RHD,ENSG00000187010,EFO_0004615,0.320233781151906,2,apolipoprotein B measurement,[EFO_0004732],[EFO_0001444]
RHD,ENSG00000187010,EFO_0004526,0.4258932214375387,9,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
RHD,ENSG00000187010,MONDO_0019107,0.3695798546847018,1,Rh deficiency syndrome,[MONDO_0020102],[EFO_0005803]
RHD,ENSG00000187010,EFO_0009188,0.4377427852127254,7,Red cell distribution width,[EFO_0004509],[EFO_0001444]
RHD,ENSG00000187010,EFO_0004611,0.3719815714376296,18,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
RHD,ENSG00000187010,EFO_0004309,0.35422598436294145,9,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
RHD,ENSG00000187010,EFO_0007985,0.36144380584225144,4,platelet crit,[EFO_0005036],[EFO_0001444]
RHD,ENSG00000187010,EFO_0007937,0.20318129662753898,4,blood protein measurement,[EFO_0004747],[EFO_0001444]
RHD,ENSG00000187010,EFO_0004528,0.3402606935835782,7,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
RHD,ENSG00000187010,EFO_0004527,0.2531987591517298,3,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC43A1,ENSG00000149150,NA,NA,NA,NA,NA,NA
SLC43A2,ENSG00000167703,EFO_0004995,0.27117906867780867,4,lean body mass,[EFO_0004302],[EFO_0001444]
SLC43A3,ENSG00000134802,EFO_0004584,0.2728309094431728,2,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
SLC43A3,ENSG00000134802,EFO_0004842,0.2263175937452544,7,eosinophil count,"[EFO_0803540, EFO_0007987]",[EFO_0001444]
SLC43A3,ENSG00000134802,EFO_0004309,0.3364482619169859,4,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SLC43A3,ENSG00000134802,EFO_0007984,0.2989138619365245,3,platelet component distribution width,[EFO_0005036],[EFO_0001444]
SLC44A1,ENSG00000070214,MONDO_0030028,0.5989760172660812,7,"neurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline",[EFO_0000508],[OTAR_0000018]
SLC44A1,ENSG00000070214,EFO_0010642,0.26609749537298527,1,Neurodevelopmental disorder,"[EFO_0000618, EFO_0009386]",[EFO_0000618]
SLC44A1,ENSG00000070214,EFO_0004343,0.2930307564592887,2,waist-hip ratio,[EFO_0007861],[EFO_0001444]
SLC44A1,ENSG00000070214,EFO_0007789,0.2625955853015675,1,BMI-adjusted waist circumference,[EFO_0004342],[EFO_0001444]
SLC44A1,ENSG00000070214,EFO_0007788,0.3566234845448305,3,BMI-adjusted waist-hip ratio,[EFO_0004343],[EFO_0001444]
SLC44A1,ENSG00000070214,EFO_0004530,0.27835459718520983,2,triglyceride measurement,[EFO_0004529],[EFO_0001444]
SLC44A2,ENSG00000129353,MONDO_0004596,0.206765712446006,1,cor pulmonale,[EFO_0000373],[EFO_0000319]
SLC44A2,ENSG00000129353,EFO_0003827,0.26451978089415984,3,pulmonary embolism,[MONDO_0000473],[EFO_0000319]
SLC44A2,ENSG00000129353,EFO_0000712,0.2106271631114436,1,stroke,[EFO_0003763],"[EFO_0000618, EFO_0000319]"
SLC44A2,ENSG00000129353,EFO_0007986,0.32736056640016625,11,reticulocyte count,[EFO_0010700],[EFO_0001444]
SLC44A2,ENSG00000129353,EFO_0004339,0.264618948909239,9,body height,[EFO_0004324],[EFO_0001444]
SLC44A2,ENSG00000129353,EFO_0010700,0.26667912907797964,3,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
SLC44A2,ENSG00000129353,HP_0002140,0.21583836169393408,2,Ischemic stroke,"[HP_0002637, HP_0100659]",[EFO_0000651]
SLC44A2,ENSG00000129353,HP_0001977,0.2106271631114436,1,Abnormal thrombosis,[HP_0001871],[EFO_0000651]
SLC44A2,ENSG00000129353,EFO_0004526,0.22210380314309186,2,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC44A2,ENSG00000129353,EFO_0003907,0.2669136085906239,10,deep vein thrombosis,[HP_0004936],[EFO_0000651]
SLC44A2,ENSG00000129353,EFO_0009253,0.25855716726784844,2,Immature Reticulocyte Fraction Measurement,[EFO_0009233],[EFO_0001444]
SLC44A2,ENSG00000129353,EFO_0004286,0.3166967455434891,18,venous thromboembolism,[EFO_0004264],[EFO_0000319]
SLC44A2,ENSG00000129353,EFO_0007984,0.26063758055146147,4,platelet component distribution width,[EFO_0005036],[EFO_0001444]
SLC44A2,ENSG00000129353,MONDO_0005301,0.21804073777456406,1,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
SLC44A3,ENSG00000143036,EFO_0000612,0.26949011642479814,2,myocardial infarction,[MONDO_0024643],[EFO_0000319]
SLC44A3,ENSG00000143036,EFO_0004833,0.20004584281737253,1,neutrophil count,"[EFO_0803548, EFO_0007987]",[EFO_0001444]
SLC44A3,ENSG00000143036,EFO_0010623,0.37428095176297044,7,tissue factor measurement,[EFO_0007937],[EFO_0001444]
SLC44A3,ENSG00000143036,EFO_0009552,0.2641539378959494,1,hemorrhoid,[MONDO_0004869],[EFO_0000319]
SLC44A4,ENSG00000204385,EFO_0003940,0.2142465406568159,1,physical activity,[GO_0008150],[GO_0008150]
SLC44A4,ENSG00000204385,EFO_0008377,0.25748426703050903,3,mosquito bite reaction itch intensity measurement,[EFO_0008376],[EFO_0001444]
SLC44A4,ENSG00000204385,EFO_0008328,0.25814475634012557,3,chronotype measurement,[EFO_0004870],[EFO_0001444]
SLC44A4,ENSG00000204385,EFO_0008039,0.23904197425398663,1,BMI-adjusted hip circumference,[EFO_0005093],[EFO_0001444]
SLC44A4,ENSG00000204385,MONDO_0019588,0.3695798546847018,1,"hearing loss, autosomal recessive","[EFO_1000017, MONDO_0016298, MONDO_0016297]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC44A4,ENSG00000204385,MONDO_0019587,0.46066238066233794,10,autosomal dominant nonsyndromic hearing loss,"[MONDO_0016297, MONDO_0016298, MONDO_0000426]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC44A4,ENSG00000204385,EFO_0001063,0.36433010391054466,9,deafness,[EFO_0004238],"[MONDO_0002025, EFO_0000618]"
SLC44A4,ENSG00000204385,EFO_0004329,0.3009243518045712,4,alcohol drinking,[EFO_0004315],[GO_0008150]
SLC44A4,ENSG00000204385,EFO_0009930,0.21624524648353066,1,Calcium channel blocker use measurement,[EFO_0007010],[EFO_0001444]
SLC44A4,ENSG00000204385,EFO_0004458,0.24114287110845492,1,C-reactive protein measurement,"[EFO_0004747, EFO_0004872]",[EFO_0001444]
SLC44A4,ENSG00000204385,EFO_0004574,0.24114287110845492,1,total cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
SLC44A4,ENSG00000204385,EFO_0004683,0.26323337536091657,2,wet macular degeneration,[EFO_0001365],"[MONDO_0002025, OTAR_0000018, MONDO_0024458, EFO_0000618]"
SLC44A4,ENSG00000204385,EFO_0007878,0.31758848618659047,4,alcohol consumption measurement,[EFO_0001444],[EFO_0001444]
SLC44A4,ENSG00000204385,EFO_0007789,0.2539826153187458,1,BMI-adjusted waist circumference,[EFO_0004342],[EFO_0001444]
SLC44A4,ENSG00000204385,EFO_0007788,0.33151199384018326,5,BMI-adjusted waist-hip ratio,[EFO_0004343],[EFO_0001444]
SLC44A4,ENSG00000204385,EFO_0004611,0.23955701446385208,6,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
SLC44A4,ENSG00000204385,EFO_0004314,0.2573962890880538,1,forced expiratory volume,"[EFO_0003892, EFO_0006841]",[EFO_0001444]
SLC44A4,ENSG00000204385,EFO_0006782,0.24043735870365626,1,cups of coffee per day measurement,[EFO_0006781],[EFO_0001444]
SLC44A4,ENSG00000204385,EFO_0004530,0.3499168775271034,9,triglyceride measurement,[EFO_0004529],[EFO_0001444]
SLC44A5,ENSG00000137968,EFO_0005653,0.3180400501010238,13,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC44A5,ENSG00000137968,EFO_0006930,0.4360153875325643,4,brain volume measurement,"[EFO_0005052, EFO_0004464]",[EFO_0001444]
SLC44A5,ENSG00000137968,EFO_0007937,0.2276986820586452,1,blood protein measurement,[EFO_0004747],[EFO_0001444]
SLC45A1,ENSG00000162426,EFO_0004980,0.3332383185215212,3,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
SLC45A1,ENSG00000162426,EFO_0008408,0.26207971776806216,1,susceptibility to strep throat measurement,"[EFO_0008422, EFO_0006843]",[EFO_0001444]
SLC45A1,ENSG00000162426,EFO_0008006,0.2682627705923574,1,skin aging measurement,[EFO_0001444],[EFO_0001444]
SLC45A1,ENSG00000162426,EFO_0007352,0.2575399160552779,1,lymphatic system disease,"[EFO_0005803, MONDO_0044986]","[EFO_0000540, EFO_0005803]"
SLC45A1,ENSG00000162426,MONDO_0019502,0.3695798546847018,1,autosomal recessive non-syndromic intellectual disability,"[EFO_1000017, MONDO_0000509, MONDO_0017706]","[MONDO_0002025, OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC45A1,ENSG00000162426,EFO_0004747,0.36112871898168836,3,protein measurement,[EFO_0001444],[EFO_0001444]
SLC45A1,ENSG00000162426,EFO_0007986,0.2862288410270623,2,reticulocyte count,[EFO_0010700],[EFO_0001444]
SLC45A1,ENSG00000162426,EFO_0000676,0.3335901262303247,3,psoriasis,"[MONDO_0002406, EFO_1000636, EFO_0000540, MONDO_0100118]","[OTAR_0000018, EFO_0000540, EFO_0010285]"
SLC45A1,ENSG00000162426,EFO_0010700,0.31565952658992874,2,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
SLC45A1,ENSG00000162426,MONDO_0044322,0.6126547443840276,20,intellectual developmental disorder with neuropsychiatric features,[MONDO_0000508],"[MONDO_0002025, EFO_0000618]"
SLC45A1,ENSG00000162426,MONDO_0005148,0.26601060282010874,1,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC45A1,ENSG00000162426,EFO_0003924,0.33152112037189413,7,hair color,[EFO_0005038],[EFO_0000651]
SLC45A1,ENSG00000162426,EFO_0007822,0.3386600976311923,3,hair colour measurement,[EFO_0007821],[EFO_0001444]
SLC45A2,ENSG00000164175,MONDO_0018910,0.6098376740974927,70,oculocutaneous albinism,"[MONDO_0100118, MONDO_0020275, MONDO_0018134, MONDO_0019290]","[OTAR_0000018, OTAR_0000020, MONDO_0024458, EFO_0010285]"
SLC45A2,ENSG00000164175,EFO_0003963,0.28954309312564314,2,freckles,[EFO_0003784],[EFO_0000651]
SLC45A2,ENSG00000164175,EFO_0003958,0.36887680398444106,2,sunburn,"[EFO_0000701, EFO_0009516]","[OTAR_0000009, EFO_0010285]"
SLC45A2,ENSG00000164175,EFO_0003949,0.42292827903662533,4,eye color,[EFO_0000651],[EFO_0000651]
SLC45A2,ENSG00000164175,EFO_0000701,0.3691185026170152,2,skin disease,[EFO_0010285],[EFO_0010285]
SLC45A2,ENSG00000164175,EFO_0000389,0.453721107232548,8,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLC45A2,ENSG00000164175,EFO_0000508,0.3673349061544438,11,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC45A2,ENSG00000164175,EFO_0003784,0.6986687270674653,28,skin pigmentation,[EFO_0000651],[EFO_0000651]
SLC45A2,ENSG00000164175,EFO_0008006,0.3619051135466323,2,skin aging measurement,[EFO_0001444],[EFO_0001444]
SLC45A2,ENSG00000164175,EFO_1001927,0.30981525277313954,2,cutaneous squamous cell carcinoma,[EFO_0000707],[MONDO_0045024]
SLC45A2,ENSG00000164175,EFO_0000756,0.42158349239552195,62,melanoma,[MONDO_0021143],[MONDO_0045024]
SLC45A2,ENSG00000164175,EFO_0000707,0.35362709101601214,6,squamous cell carcinoma,"[MONDO_0002532, EFO_0000313]",[MONDO_0045024]
SLC45A2,ENSG00000164175,HP_0009762,0.24119142231025892,1,Facial wrinkling,"[HP_0011121, EFO_0004743]",[EFO_0000651]
SLC45A2,ENSG00000164175,EFO_0007009,0.6949706147953099,26,skin pigmentation measurement,[EFO_0001444],[EFO_0001444]
SLC45A2,ENSG00000164175,EFO_0010176,0.22326413335957213,1,keratinocyte carcinoma,[EFO_0009260],"[MONDO_0045024, EFO_0010285]"
SLC45A2,ENSG00000164175,MONDO_0002898,0.395448863147413,3,skin cancer,"[EFO_0004198, MONDO_0000653]","[MONDO_0045024, EFO_0010285]"
SLC45A2,ENSG00000164175,EFO_0010554,0.29583828918102933,1,retinal vasculature measurement,[EFO_0004731],[EFO_0001444]
SLC45A2,ENSG00000164175,EFO_0009565,0.3691185026170152,2,radiation-induced disorder,[OTAR_0000009],[OTAR_0000009]
SLC45A2,ENSG00000164175,MONDO_0011683,0.8396194249910388,165,oculocutaneous albinism type 4,[MONDO_0018910],"[OTAR_0000018, OTAR_0000020, MONDO_0024458, EFO_0010285]"
SLC45A2,ENSG00000164175,EFO_0002496,0.3258142222495051,2,actinic keratosis,"[MONDO_0000611, EFO_0004198]","[MONDO_0045024, EFO_0010285]"
SLC45A2,ENSG00000164175,EFO_0005772,0.20902763730570986,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC45A2,ENSG00000164175,MONDO_0019296,0.3022671379716263,1,subcutaneous tissue disorder,[EFO_0010285],[EFO_0010285]
SLC45A2,ENSG00000164175,MONDO_0004992,0.37111611344433415,16,cancer,[EFO_0000616],[MONDO_0045024]
SLC45A2,ENSG00000164175,GO_0007568,0.20902763730570986,1,aging,[GO_0032502],[GO_0008150]
SLC45A2,ENSG00000164175,EFO_0005422,0.3140867782558105,1,skin aging,[GO_0007568],[GO_0008150]
SLC45A2,ENSG00000164175,MONDO_0018264,0.4873672862800946,20,oculocutaneous albinism type 6,[MONDO_0018910],"[OTAR_0000018, OTAR_0000020, MONDO_0024458, EFO_0010285]"
SLC45A2,ENSG00000164175,EFO_0003924,0.49510118519606094,13,hair color,[EFO_0005038],[EFO_0000651]
SLC45A2,ENSG00000164175,EFO_0004632,0.3045012532439301,2,nevus count,[EFO_0001444],[EFO_0001444]
SLC45A2,ENSG00000164175,EFO_0007822,0.6994738314211104,24,hair colour measurement,[EFO_0007821],[EFO_0001444]
SLC45A2,ENSG00000164175,EFO_0007821,0.4409268780728451,6,hair morphology measurement,[EFO_0001444],[EFO_0001444]
SLC45A2,ENSG00000164175,EFO_0007817,0.26137656243159063,1,sleep apnea measurement,[EFO_0001444],[EFO_0001444]
SLC45A2,ENSG00000164175,EFO_0009260,0.3952704136016986,4,non-melanoma skin carcinoma,[EFO_0009259],"[MONDO_0045024, EFO_0010285]"
SLC45A2,ENSG00000164175,EFO_0009259,0.296964703497293,1,skin carcinoma,"[EFO_0000313, MONDO_0021634, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLC45A2,ENSG00000164175,EFO_0009180,0.2960664842352433,1,rosacea severity measurement,[EFO_0001444],[EFO_0001444]
SLC45A2,ENSG00000164175,EFO_0004279,0.44145829979744083,6,suntan,[EFO_0003784],[EFO_0000651]
SLC45A2,ENSG00000164175,EFO_0004198,0.2970982522571532,3,skin neoplasm,"[EFO_0000701, EFO_0000616]","[MONDO_0045024, EFO_0010285]"
SLC45A2,ENSG00000164175,EFO_0004193,0.39662400946706233,6,basal cell carcinoma,"[EFO_1001763, EFO_0000313, EFO_0010176]","[MONDO_0045024, EFO_0010285]"
SLC45A2,ENSG00000164175,MONDO_0004892,0.31765104005394423,1,refractive error,[EFO_0003966],[MONDO_0024458]
SLC45A2,ENSG00000164175,EFO_0007906,0.29641667409689393,1,synophrys measurement,[EFO_0007821],[EFO_0001444]
SLC45A2,ENSG00000164175,EFO_0009764,0.28143325334343094,1,eye colour measurement,[EFO_0004731],[EFO_0001444]
SLC45A3,ENSG00000158715,EFO_0010972,0.24093443577657228,1,blood phosphate measurement,[EFO_0001444],[EFO_0001444]
SLC45A3,ENSG00000158715,EFO_0010750,0.24792030166735776,1,PHF-tau measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
SLC45A3,ENSG00000158715,EFO_0007995,0.21483807669222535,1,basophil percentage of granulocytes,[EFO_0005090],[EFO_0001444]
SLC45A3,ENSG00000158715,EFO_0007992,0.21616858669120856,1,basophil percentage of leukocytes,[EFO_0005090],[EFO_0001444]
SLC45A3,ENSG00000158715,EFO_0000673,0.37077585615888975,4,prostate adenocarcinoma,"[EFO_0000228, EFO_0001663]","[OTAR_0000017, MONDO_0045024]"
SLC45A3,ENSG00000158715,EFO_0004842,0.22643454446031328,1,eosinophil count,"[EFO_0803540, EFO_0007987]",[EFO_0001444]
SLC45A3,ENSG00000158715,EFO_0004696,0.3434528751193092,4,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
SLC45A3,ENSG00000158715,EFO_0004624,0.38161328265711797,4,prostate specific antigen measurement,"[EFO_0004747, EFO_0005127]",[EFO_0001444]
SLC45A3,ENSG00000158715,EFO_0005090,0.32705331549242456,6,basophil count,"[EFO_0004872, EFO_0803539, EFO_0007987]",[EFO_0001444]
SLC45A4,ENSG00000022567,HP_0000539,0.3032377214341869,1,Abnormality of refraction,[HP_0000478],[EFO_0000651]
SLC45A4,ENSG00000022567,EFO_0006335,0.36035118842240166,6,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0005653,0.2907470215943971,1,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0009390,0.2926551234769105,1,sum of neutrophil and eosinophil counts,[EFO_0007987],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0009388,0.291953884635247,1,sum of basophil and neutrophil counts,[EFO_0007987],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0004833,0.4828651055192921,15,neutrophil count,"[EFO_0803548, EFO_0007987]",[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0004747,0.32831559822422907,3,protein measurement,[EFO_0001444],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0004736,0.4306217832524161,3,aspartate aminotransferase measurement,"[EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0007991,0.3006219042792794,1,eosinophil percentage of leukocytes,[EFO_0004842],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0007990,0.36510517524520836,2,neutrophil percentage of leukocytes,[EFO_0004833],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0007988,0.44042401008935594,6,myeloid white cell count,[EFO_0004308],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0007987,0.2926551234769105,1,granulocyte count,[EFO_0007988],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0007986,0.4849464298502733,11,reticulocyte count,[EFO_0010700],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0004339,0.4172103846195242,6,body height,[EFO_0004324],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0010736,0.383666537604573,2,cortical surface area measurement,[EFO_0004464],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0010700,0.4559381752529388,6,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0004344,0.44363969722955093,4,birth weight,[EFO_0004338],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0004584,0.4587432365775242,5,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0004568,0.2893619245363983,1,serum non-albumin protein measurement,[EFO_0004747],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0004536,0.39453441242263076,2,total blood protein measurement,[EFO_0004503],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0004535,0.3954904459447234,2,serum albumin measurement,[EFO_0004747],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0004840,0.34920725053099627,2,cortical thickness,[EFO_0004464],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0005763,0.3293823109277442,2,pulse pressure measurement,[EFO_0005278],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0004627,0.3123412480018422,1,IGF-1 measurement,"[EFO_0005127, EFO_0004730, EFO_0004747]",[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0004509,0.31680170242383787,1,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0004464,0.3096440348892823,1,brain measurement,[EFO_0001444],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0005090,0.279704046338345,1,basophil count,"[EFO_0004872, EFO_0803539, EFO_0007987]",[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0009270,0.3970289402996398,3,heel bone mineral density,[EFO_0003923],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0009253,0.46342770350574475,5,Immature Reticulocyte Fraction Measurement,[EFO_0009233],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0004587,0.4498506918566919,5,lymphocyte count,"[EFO_0006843, EFO_0004308, EFO_0803546]",[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0004312,0.2820107130549054,1,vital capacity,[EFO_0003892],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0004309,0.4593712191919203,6,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0004308,0.47762466615208093,12,leukocyte count,[EFO_0004586],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0007985,0.445828059896473,5,platelet crit,[EFO_0005036],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0007937,0.3162420198538588,1,blood protein measurement,[EFO_0004747],[EFO_0001444]
SLC45A4,ENSG00000022567,EFO_0004527,0.30412997092505295,1,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC46A1,ENSG00000076351,MONDO_0009238,0.8166678178834526,165,hereditary folate malabsorption,"[MONDO_0016624, MONDO_0015179, MONDO_0017313, MONDO_0015823, MONDO_0001700]","[OTAR_0000018, OTAR_0000020, EFO_0000540, EFO_0005803, EFO_0010282]"
SLC46A1,ENSG00000076351,EFO_0000508,0.3982786941579596,7,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC46A1,ENSG00000076351,EFO_0008321,0.20661104911212858,1,WNT1-inducible-signaling pathway protein 1 measurement,[EFO_0007937],[EFO_0001444]
SLC46A1,ENSG00000076351,EFO_0008313,0.20694354994698766,1,UMP-CMP kinase measurement,[EFO_0007937],[EFO_0001444]
SLC46A1,ENSG00000076351,EFO_0008280,0.20694354994698766,1,serine protease 27 measurement,[EFO_0007937],[EFO_0001444]
SLC46A1,ENSG00000076351,EFO_0008278,0.2197309540232103,1,semaphorin-3A measurement,[EFO_0007937],[EFO_0001444]
SLC46A1,ENSG00000076351,EFO_0008185,0.2137427888950856,1,interleukin 5 measurement,[EFO_0007937],[EFO_0001444]
SLC46A1,ENSG00000076351,EFO_0008063,0.2137427888950856,1,calcium/calmodulin-dependent protein kinase type 1D measurement,[EFO_0007937],[EFO_0001444]
SLC46A1,ENSG00000076351,EFO_0004614,0.207480763267493,2,apolipoprotein A 1 measurement,"[EFO_0004872, EFO_0005278, EFO_0004732]",[EFO_0001444]
SLC46A1,ENSG00000076351,EFO_0004611,0.208946108343396,7,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
SLC46A2,ENSG00000119457,EFO_0004348,0.3835719779832686,3,hematocrit,[EFO_0004503],[EFO_0001444]
SLC46A2,ENSG00000119457,EFO_0004509,0.34366848140668377,2,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
SLC46A2,ENSG00000119457,EFO_0007978,0.26646427307545234,2,red blood cell density measurement,[EFO_0005047],[EFO_0001444]
SLC46A3,ENSG00000139508,NA,NA,NA,NA,NA,NA
SLC47A1,ENSG00000142494,EFO_0005208,0.45891317632066947,10,glomerular filtration rate,[EFO_0004742],[EFO_0001444]
SLC47A1,ENSG00000142494,EFO_0007993,0.3374262014275462,3,lymphocyte percentage of leukocytes,[EFO_0004587],[EFO_0001444]
SLC47A1,ENSG00000142494,EFO_0007990,0.31936157224898964,2,neutrophil percentage of leukocytes,[EFO_0004833],[EFO_0001444]
SLC47A1,ENSG00000142494,EFO_0005772,0.4601410989064171,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC47A1,ENSG00000142494,EFO_0004518,0.6585011743746901,11,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC47A1,ENSG00000142494,EFO_0009188,0.42442417815016553,5,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC47A1,ENSG00000142494,EFO_0004587,0.4395580811948096,6,lymphocyte count,"[EFO_0006843, EFO_0004308, EFO_0803546]",[EFO_0001444]
SLC47A1,ENSG00000142494,EFO_0003870,0.282038579329988,1,brain aneurysm,[EFO_1000859],"[EFO_0000618, EFO_0000319]"
SLC47A1,ENSG00000142494,EFO_0004531,0.4289686169420718,4,urate measurement,[EFO_0001444],[EFO_0001444]
SLC47A2,ENSG00000180638,EFO_0004527,0.23741931995449322,1,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC48A1,ENSG00000211584,EFO_0004705,0.26135708908204675,1,hypothyroidism,[EFO_1000627],[EFO_0001379]
SLC48A1,ENSG00000211584,EFO_0003779,0.3261400822130143,2,Hashimoto's thyroiditis,[EFO_0006812],"[EFO_0001379, EFO_0000540]"
SLC48A1,ENSG00000211584,EFO_0006335,0.23633277784766124,3,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC48A1,ENSG00000211584,EFO_0010700,0.23147601897853462,3,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
SLC48A1,ENSG00000211584,EFO_0004526,0.20019079169025603,5,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC48A1,ENSG00000211584,EFO_0004527,0.2000501112175368,4,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
FLVCR1,ENSG00000162769,MONDO_0012177,0.7834555160448031,190,posterior column ataxia-retinitis pigmentosa syndrome,[MONDO_0100449],"[MONDO_0002025, MONDO_0024458, EFO_0000618, OTAR_0000018]"
FLVCR1,ENSG00000162769,EFO_0000508,0.4929083375857784,30,genetic disorder,[OTAR_0000018],[OTAR_0000018]
FLVCR1,ENSG00000162769,Orphanet_71862,0.4408073812657626,9,Retinal dystrophy,[Orphanet_98657],"[OTAR_0000018, MONDO_0024458]"
FLVCR1,ENSG00000162769,Orphanet_88628,0.7572900850726446,187,Posterior column ataxia - retinitis pigmentosa,"[MONDO_0957003, Orphanet_98539, Orphanet_183518, Orphanet_98693]","[OTAR_0000018, MONDO_0024458, EFO_0000618]"
FLVCR1,ENSG00000162769,MONDO_0100449,0.3695798546847018,1,FLVCR1-related retinopathy with or without ataxia,"[MONDO_0019118, MONDO_0020046]","[MONDO_0002025, MONDO_0024458, EFO_0000618, OTAR_0000018]"
FLVCR1,ENSG00000162769,EFO_0007986,0.2794967000491299,4,reticulocyte count,[EFO_0010700],[EFO_0001444]
FLVCR1,ENSG00000162769,MONDO_0015461,0.25870589827929125,1,short rib-polydactyly syndrome,"[MONDO_0019691, MONDO_0015929]","[OTAR_0000006, OTAR_0000018, OTAR_0000010]"
FLVCR1,ENSG00000162769,MONDO_0015364,0.26852948166573093,8,hereditary sensory and autonomic neuropathy,"[MONDO_0020127, MONDO_0002321]","[OTAR_0000018, EFO_0000618]"
FLVCR1,ENSG00000162769,EFO_0004348,0.2577047908277872,4,hematocrit,[EFO_0004503],[EFO_0001444]
FLVCR1,ENSG00000162769,EFO_0005772,0.4239846509621333,4,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
FLVCR1,ENSG00000162769,MONDO_0019353,0.25870589827929125,1,Stargardt disease,"[EFO_0001365, MONDO_0016420]","[MONDO_0002025, OTAR_0000018, MONDO_0024458, EFO_0000618]"
FLVCR1,ENSG00000162769,MONDO_0019200,0.5949383429917249,25,retinitis pigmentosa,"[MONDO_0019216, MONDO_0019118]","[MONDO_0002025, OTAR_0000018, OTAR_0000020, MONDO_0024458, EFO_0000618]"
FLVCR1,ENSG00000162769,GO_0007568,0.42264492398890124,2,aging,[GO_0032502],[GO_0008150]
FLVCR1,ENSG00000162769,EFO_0004509,0.29562143634939614,5,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
FLVCR1,ENSG00000162769,MONDO_0018770,0.26069238999822153,3,Jeune syndrome,"[MONDO_0015461, MONDO_0022409, MONDO_0015962]","[OTAR_0000006, OTAR_0000018, EFO_0009690, OTAR_0000010]"
FLVCR1,ENSG00000162769,EFO_0007978,0.21529720661722507,2,red blood cell density measurement,[EFO_0005047],[EFO_0001444]
FLVCR2,ENSG00000119686,MONDO_0009168,0.7737825405340243,48,Fowler syndrome,[OTAR_0000018],[OTAR_0000018]
FLVCR2,ENSG00000119686,EFO_0000508,0.4091471089836119,17,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC49A3,ENSG00000169026,NA,NA,NA,NA,NA,NA
SLC49A4,ENSG00000138463,EFO_0004535,0.27021240203621427,2,serum albumin measurement,[EFO_0004747],[EFO_0001444]
SLC49A4,ENSG00000138463,EFO_0003924,0.43491986612131606,5,hair color,[EFO_0005038],[EFO_0000651]
SLC49A4,ENSG00000138463,EFO_0007822,0.29877231056010145,1,hair colour measurement,[EFO_0007821],[EFO_0001444]
SLC49A4,ENSG00000138463,EFO_0004532,0.2925212772418102,1,serum gamma-glutamyl transferase measurement,[EFO_0004582],[EFO_0001444]
SLC5A1,ENSG00000100170,EFO_0008465,0.21037568374674565,1,glucagon-like peptide-1 measurement,"[EFO_0006842, EFO_0004747, EFO_0004730]",[EFO_0001444]
SLC5A1,ENSG00000100170,EFO_0008464,0.21063921279719078,1,glucose-dependent insulinotropic peptide measurement,"[EFO_0006842, EFO_0004747, EFO_0004730]",[EFO_0001444]
SLC5A1,ENSG00000100170,EFO_0003144,0.39277230598208696,40,heart failure,[EFO_0003777],[EFO_0000319]
SLC5A1,ENSG00000100170,EFO_0004541,0.28086862533570006,2,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
SLC5A1,ENSG00000100170,MONDO_0011731,0.7933588381051481,353,glucose-galactose malabsorption,"[MONDO_0015178, MONDO_0019226]","[OTAR_0000018, OTAR_0000020, EFO_0010282]"
SLC5A1,ENSG00000100170,HP_0001952,0.3709163991647407,7,Glucose intolerance,[HP_0011014],[EFO_0000651]
SLC5A1,ENSG00000100170,MONDO_0005147,0.3670637797046027,28,type 1 diabetes mellitus,"[MONDO_0000569, MONDO_0000588, EFO_0000400]","[OTAR_0000020, EFO_0001379, EFO_0000540, EFO_0009605, EFO_0010282]"
SLC5A1,ENSG00000100170,MONDO_0005148,0.4671325390409865,96,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC5A1,ENSG00000100170,EFO_0004307,0.2632331337338772,2,glucose tolerance test,[EFO_0004468],[EFO_0001444]
SLC5A1,ENSG00000100170,EFO_0000400,0.4112269229326278,147,diabetes mellitus,"[EFO_0009406, MONDO_0001933]","[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC5A1,ENSG00000100170,EFO_0007629,0.2021244246230988,1,hemoglobin A1 measurement,[EFO_0004509],[EFO_0001444]
SLC5A1,ENSG00000100170,EFO_0004531,0.2641055298805391,2,urate measurement,[EFO_0001444],[EFO_0001444]
SLC5A10,ENSG00000154025,EFO_0008009,0.2450642695416011,2,"1,5 anhydroglucitol measurement",[EFO_0001444],[EFO_0001444]
SLC5A11,ENSG00000158865,EFO_0004995,0.22598525637495376,12,lean body mass,[EFO_0004302],[EFO_0001444]
SLC5A11,ENSG00000158865,EFO_0004980,0.23476417319927625,4,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
SLC5A11,ENSG00000158865,EFO_0006335,0.26855215903955393,8,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC5A11,ENSG00000158865,EFO_0005670,0.22291227207213346,2,smoking initiation,[GO_0007610],[GO_0008150]
SLC5A11,ENSG00000158865,EFO_0004340,0.22883259777932663,7,body mass index,[EFO_0004324],[EFO_0001444]
SLC5A11,ENSG00000158865,EFO_0009458,0.24223545763920576,2,alcohol use disorder measurement,[EFO_0006848],[EFO_0001444]
SLC5A11,ENSG00000158865,EFO_0007878,0.3120783927039458,7,alcohol consumption measurement,[EFO_0001444],[EFO_0001444]
SLC5A11,ENSG00000158865,EFO_0007800,0.2005107343486873,6,body fat percentage,[EFO_0005106],[EFO_0001444]
SLC5A12,ENSG00000148942,NA,NA,NA,NA,NA,NA
SLC5A2,ENSG00000140675,HP_0001919,0.4750861992015508,140,Acute kidney injury,[HP_0000083],[EFO_0000651]
SLC5A2,ENSG00000140675,HP_0001653,0.4625291881379043,3,Mitral regurgitation,[HP_0031481],[EFO_0000651]
SLC5A2,ENSG00000140675,HP_0031273,0.25870589827929125,1,Shock,[HP_0011025],[EFO_0000651]
SLC5A2,ENSG00000140675,HP_0012664,0.332583371314702,7,Reduced left ventricular ejection fraction,[HP_0011025],[EFO_0000651]
SLC5A2,ENSG00000140675,EFO_1001482,0.25870589827929125,1,cardiotoxicity,"[EFO_0011061, EFO_0003777]","[OTAR_0000009, EFO_0000319]"
SLC5A2,ENSG00000140675,MONDO_0009297,0.688041910978719,103,familial renal glucosuria,"[MONDO_0019226, MONDO_0100191, EFO_1000647]","[OTAR_0000018, OTAR_0000020, EFO_0009690]"
SLC5A2,ENSG00000140675,HP_0000093,0.3695798546847018,1,Proteinuria,[HP_0003110],[EFO_0000651]
SLC5A2,ENSG00000140675,EFO_0000266,0.3695798546847018,1,aortic stenosis,[EFO_0009531],[EFO_0000319]
SLC5A2,ENSG00000140675,EFO_0000373,0.389794242936465,60,congestive heart failure,[EFO_0003144],[EFO_0000319]
SLC5A2,ENSG00000140675,EFO_0000195,0.29143374222191337,14,metabolic syndrome,[EFO_0000589],[OTAR_0000020]
SLC5A2,ENSG00000140675,EFO_0000275,0.527628821231069,116,atrial fibrillation,"[EFO_0004269, MONDO_0007263]",[EFO_0000319]
SLC5A2,ENSG00000140675,Orphanet_79161,0.5708713237127758,12,Disorder of carbohydrate metabolism,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
SLC5A2,ENSG00000140675,Orphanet_69076,0.712853837013881,138,Renal glucosuria,"[Orphanet_98056, Orphanet_79161]","[OTAR_0000018, OTAR_0000020, EFO_0009690]"
SLC5A2,ENSG00000140675,HP_0003074,0.384015128609912,484,Hyperglycemia,[HP_0011015],[EFO_0000651]
SLC5A2,ENSG00000140675,EFO_0001073,0.4957866374164261,209,obesity,[MONDO_0003916],[OTAR_0000020]
SLC5A2,ENSG00000140675,EFO_0000660,0.5406442910978032,25,polycystic ovary syndrome,"[EFO_0001379, EFO_0005771, EFO_0000508]","[OTAR_0000017, OTAR_0000018, EFO_0001379]"
SLC5A2,ENSG00000140675,EFO_0003770,0.2657065669844475,29,diabetic retinopathy,"[EFO_0000589, MONDO_0002311, EFO_0009486]","[EFO_0000618, OTAR_0000020, MONDO_0024458, EFO_0000319]"
SLC5A2,ENSG00000140675,EFO_0001645,0.4542803264657984,41,coronary artery disease,"[MONDO_0000473, EFO_0003777]",[EFO_0000319]
SLC5A2,ENSG00000140675,EFO_0004997,0.3888159728156868,6,type 2 diabetes nephropathy,[EFO_0000401],"[OTAR_0000020, EFO_0009690]"
SLC5A2,ENSG00000140675,EFO_0000612,0.5178638271914916,173,myocardial infarction,[MONDO_0024643],[EFO_0000319]
SLC5A2,ENSG00000140675,EFO_1000728,0.3695798546847018,1,lipomatosis,"[MONDO_0044983, EFO_0000701]","[OTAR_0000006, MONDO_0045024, EFO_0010285]"
SLC5A2,ENSG00000140675,EFO_1000647,0.3695798546847018,1,renal tubular transport disease,[EFO_0003086],[EFO_0009690]
SLC5A2,ENSG00000140675,EFO_0004236,0.3722932093070938,9,focal segmental glomerulosclerosis,[MONDO_0000490],[EFO_0009690]
SLC5A2,ENSG00000140675,EFO_0000407,0.32439101786919106,6,dilated cardiomyopathy,[MONDO_0000591],"[OTAR_0000006, EFO_0000319]"
SLC5A2,ENSG00000140675,EFO_0008583,0.2784365966254422,48,acute myocardial infarction,[EFO_0000612],[EFO_0000319]
SLC5A2,ENSG00000140675,EFO_0000537,0.4741485864456861,174,hypertension,[MONDO_0000473],[EFO_0000319]
SLC5A2,ENSG00000140675,EFO_0003144,0.6207042272809681,1590,heart failure,[EFO_0003777],[EFO_0000319]
SLC5A2,ENSG00000140675,EFO_1001984,0.37176976931531475,6,cardiac amyloidosis,[EFO_1001875],[OTAR_0000020]
SLC5A2,ENSG00000140675,HP_0001397,0.266162267892399,55,Hepatic steatosis,"[HP_0001392, HP_0001939]",[EFO_0000651]
SLC5A2,ENSG00000140675,EFO_0000319,0.38917759361795656,533,cardiovascular disease,[],[EFO_0000319]
SLC5A2,ENSG00000140675,EFO_0003095,0.5622269965090796,253,non-alcoholic fatty liver disease,[MONDO_0004790],"[EFO_0001379, EFO_0010282]"
SLC5A2,ENSG00000140675,HP_0001943,0.29690263150639007,448,Hypoglycemia,[HP_0011015],[EFO_0000651]
SLC5A2,ENSG00000140675,MONDO_0005147,0.5748224732668282,262,type 1 diabetes mellitus,"[MONDO_0000569, MONDO_0000588, EFO_0000400]","[OTAR_0000020, EFO_0001379, EFO_0000540, EFO_0009605, EFO_0010282]"
SLC5A2,ENSG00000140675,EFO_0005761,0.37300873444760985,4,lupus nephritis,"[MONDO_0002462, EFO_1002003]","[EFO_0000540, EFO_0009690]"
SLC5A2,ENSG00000140675,EFO_1002048,0.43849643512746705,51,kidney failure,[EFO_0003086],[EFO_0009690]
SLC5A2,ENSG00000140675,MONDO_0005148,0.6239186207318483,3349,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC5A2,ENSG00000140675,EFO_0002614,0.3584680355796959,223,insulin resistance,[HP_0001939],[EFO_0000651]
SLC5A2,ENSG00000140675,EFO_0004593,0.2664568091205954,5,gestational diabetes,"[EFO_0000400, EFO_0009682]","[EFO_0001379, OTAR_0000014, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC5A2,ENSG00000140675,EFO_0000401,0.38211255771293756,493,diabetic nephropathy,"[EFO_0000589, EFO_0003884]","[OTAR_0000020, EFO_0009690]"
SLC5A2,ENSG00000140675,EFO_0000400,0.6248422996685433,2141,diabetes mellitus,"[EFO_0009406, MONDO_0001933]","[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC5A2,ENSG00000140675,EFO_0004194,0.5424123875576891,15,IGA glomerulonephritis,"[EFO_0004128, MONDO_0002462]","[OTAR_0000018, EFO_0009690]"
SLC5A2,ENSG00000140675,EFO_0003884,0.5976385732169802,1009,chronic kidney disease,[EFO_0003086],[EFO_0009690]
SLC5A2,ENSG00000140675,EFO_0003877,0.3711030883218918,5,sleep apnea,"[EFO_0000684, MONDO_0003406]","[MONDO_0002025, EFO_0000618, OTAR_0000010]"
SLC5A2,ENSG00000140675,EFO_1001249,0.3004948651898279,99,non-alcoholic steatohepatitis,[EFO_0003095],"[EFO_0001379, EFO_0010282]"
SLC5A2,ENSG00000140675,EFO_1001207,0.37022661943040003,3,systolic heart failure,[EFO_0000373],[EFO_0000319]
SLC5A2,ENSG00000140675,EFO_1001121,0.3931021943842976,15,prediabetes syndrome,"[EFO_0009406, EFO_0000400]","[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC5A2,ENSG00000140675,MONDO_0004790,0.37239208669908763,14,fatty liver disease,[EFO_0001421],"[EFO_0001379, EFO_0010282]"
SLC5A2,ENSG00000140675,MONDO_0100096,0.29228504335804917,85,COVID-19,[MONDO_0020753],[EFO_0005741]
SLC5A2,ENSG00000140675,EFO_0009658,0.3695798546847018,1,adverse effect,[EFO_0009518],[OTAR_0000009]
SLC5A2,ENSG00000140675,EFO_0004531,0.47867748876687505,9,urate measurement,[EFO_0001444],[EFO_0001444]
SLC5A3,ENSG00000198743,MONDO_0021661,0.2310823169747046,2,coronary atherosclerosis,"[EFO_0003914, EFO_0001645]",[EFO_0000319]
SLC5A3,ENSG00000198743,EFO_0010820,0.2148452277511571,2,spontaneous coronary artery dissection,[EFO_0001645],[EFO_0000319]
SLC5A3,ENSG00000198743,EFO_0001645,0.2976562908195961,13,coronary artery disease,"[MONDO_0000473, EFO_0003777]",[EFO_0000319]
SLC5A3,ENSG00000198743,EFO_0006336,0.24491176706805384,3,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC5A3,ENSG00000198743,EFO_0000612,0.2838564920818576,12,myocardial infarction,[MONDO_0024643],[EFO_0000319]
SLC5A3,ENSG00000198743,EFO_1001375,0.2528121427327114,3,Myocardial Ischemia,"[MONDO_0005053, EFO_0001645, MONDO_0024643]",[EFO_0000319]
SLC5A3,ENSG00000198743,EFO_0004348,0.23573995338693304,8,hematocrit,[EFO_0004503],[EFO_0001444]
SLC5A3,ENSG00000198743,EFO_0004343,0.2639655134744947,4,waist-hip ratio,[EFO_0007861],[EFO_0001444]
SLC5A3,ENSG00000198743,EFO_0000319,0.23895022206505118,2,cardiovascular disease,[],[EFO_0000319]
SLC5A3,ENSG00000198743,EFO_0005772,0.48900365374785354,3,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC5A3,ENSG00000198743,EFO_0005763,0.2670838632538359,5,pulse pressure measurement,[EFO_0005278],[EFO_0001444]
SLC5A3,ENSG00000198743,GO_0007568,0.24325951852778688,1,aging,[GO_0032502],[GO_0008150]
SLC5A3,ENSG00000198743,EFO_0004518,0.3226698874505143,5,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC5A3,ENSG00000198743,EFO_0004509,0.307678776795118,10,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
SLC5A3,ENSG00000198743,EFO_0003913,0.2809179847582608,7,angina pectoris,[HP_0001626],[EFO_0000651]
SLC5A3,ENSG00000198743,EFO_0004617,0.36288831748051553,6,cystatin C measurement,"[EFO_0004747, EFO_0004742]",[EFO_0001444]
SLC5A3,ENSG00000198743,EFO_0007789,0.24611321197248048,3,BMI-adjusted waist circumference,[EFO_0004342],[EFO_0001444]
SLC5A3,ENSG00000198743,EFO_0007788,0.30354264413111665,6,BMI-adjusted waist-hip ratio,[EFO_0004343],[EFO_0001444]
SLC5A3,ENSG00000198743,EFO_0009270,0.29396259704308586,5,heel bone mineral density,[EFO_0003923],[EFO_0001444]
SLC5A3,ENSG00000198743,EFO_0004309,0.3006638815489853,6,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SLC5A3,ENSG00000198743,EFO_0004305,0.3201123926587367,7,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
SLC5A3,ENSG00000198743,EFO_0007985,0.24064373986150608,2,platelet crit,[EFO_0005036],[EFO_0001444]
SLC5A3,ENSG00000198743,EFO_0007978,0.20808744401762128,2,red blood cell density measurement,[EFO_0005047],[EFO_0001444]
SLC5A3,ENSG00000198743,MONDO_0005277,0.2133743179859771,2,migraine disorder,"[MONDO_0017181, EFO_0005774, MONDO_0043218]","[EFO_0000618, EFO_0000319]"
SLC5A4,ENSG00000100191,NA,NA,NA,NA,NA,NA
SLC5A5,ENSG00000105641,MONDO_0010132,0.6290323850295475,109,familial thyroid dyshormonogenesis,"[MONDO_0016409, EFO_0000589]","[EFO_0001379, OTAR_0000020]"
SLC5A5,ENSG00000105641,MONDO_0018612,0.45611750695746367,40,congenital hypothyroidism,[EFO_0004705],[EFO_0001379]
SLC5A6,ENSG00000138074,MONDO_0033546,0.7261204229810214,18,"neurodegeneration, infantile-onset, biotin-responsive",[EFO_0000508],[OTAR_0000018]
SLC5A7,ENSG00000115665,Orphanet_98914,0.7478537169235311,352,Presynaptic congenital myasthenic syndromes,[Orphanet_590],"[OTAR_0000006, OTAR_0000018, MONDO_0024458]"
SLC5A7,ENSG00000115665,MONDO_0015358,0.3695798546847018,1,hereditary motor and sensory neuropathy,[MONDO_0020127],"[OTAR_0000018, EFO_0000618]"
SLC5A7,ENSG00000115665,MONDO_0015355,0.5607071704524746,342,distal hereditary motor neuropathy type 7,[MONDO_0015362],"[OTAR_0000018, EFO_0000618]"
SLC5A7,ENSG00000115665,Orphanet_590,0.6695264682173598,353,Congenital myasthenic syndromes,"[Orphanet_98495, Orphanet_98690, Orphanet_98577]","[OTAR_0000006, OTAR_0000018, MONDO_0024458]"
SLC5A7,ENSG00000115665,MONDO_0018993,0.26609749537298527,1,Charcot-Marie-Tooth disease type 2,[MONDO_0015626],"[OTAR_0000018, EFO_0000618]"
SLC5A8,ENSG00000256870,EFO_0007789,0.2930516616727697,1,BMI-adjusted waist circumference,[EFO_0004342],[EFO_0001444]
SLC5A8,ENSG00000256870,EFO_0007788,0.2930516616727697,1,BMI-adjusted waist-hip ratio,[EFO_0004343],[EFO_0001444]
SLC5A8,ENSG00000256870,EFO_0006797,0.28947451309920236,1,neurofibrillary tangles measurement,[EFO_0004464],[EFO_0001444]
SLC5A9,ENSG00000117834,EFO_0004761,0.2810513862457576,1,uric acid measurement,"[EFO_0004742, EFO_0004298]",[EFO_0001444]
SLC5A9,ENSG00000117834,EFO_0004531,0.38865777970467963,3,urate measurement,[EFO_0001444],[EFO_0001444]
SLC50A1,ENSG00000169241,EFO_0004736,0.22063077862502023,2,aspartate aminotransferase measurement,"[EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC50A1,ENSG00000169241,EFO_0004735,0.25503299964865195,4,serum alanine aminotransferase measurement,"[EFO_0004582, EFO_0004747]",[EFO_0001444]
SLC51A,ENSG00000163959,MONDO_0012160,0.5280246885398888,8,spondylometaphyseal dysplasia-cone-rod dystrophy syndrome,[MONDO_0016763],"[OTAR_0000006, OTAR_0000018]"
SLC51A,ENSG00000163959,EFO_0004908,0.41072731686449765,5,testosterone measurement,"[EFO_0004529, EFO_0011008]",[EFO_0001444]
SLC51A,ENSG00000163959,EFO_0005664,0.22264763883430608,1,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC51A,ENSG00000163959,EFO_0005653,0.4180069952807737,8,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC51A,ENSG00000163959,Orphanet_85167,0.5280246885398888,8,Spondylometaphyseal dysplasia - cone-rod dystrophy,[Orphanet_364526],"[OTAR_0000006, OTAR_0000018]"
SLC51A,ENSG00000163959,EFO_0004526,0.20292488807541872,23,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC51A,ENSG00000163959,EFO_0004528,0.23038912580170157,18,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC51A,ENSG00000163959,EFO_0004527,0.20697235064250832,13,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
TMEM184A,ENSG00000164855,EFO_0004339,0.3131228964060013,3,body height,[EFO_0004324],[EFO_0001444]
TMEM184A,ENSG00000164855,EFO_0005772,0.409834195972199,3,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
TMEM184B,ENSG00000198792,EFO_0005941,0.31805550306597813,2,mammographic density measurement,[EFO_0001444],[EFO_0001444]
TMEM184B,ENSG00000198792,EFO_0006503,0.2536892594410581,1,dense area measurement,[EFO_0005941],[EFO_0001444]
TMEM184B,ENSG00000198792,EFO_0006502,0.2546331882057136,1,mammographic density percentage,[EFO_0005941],[EFO_0001444]
TMEM184B,ENSG00000198792,EFO_0005772,0.35475246839158125,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
TMEM184B,ENSG00000198792,EFO_0007789,0.3085050477062175,2,BMI-adjusted waist circumference,[EFO_0004342],[EFO_0001444]
TMEM184C,ENSG00000164168,HP_0012759,0.5218092547905743,11,Neurodevelopmental abnormality,[HP_0012638],[EFO_0000651]
TMEM184C,ENSG00000164168,EFO_0010750,0.2465754510003281,1,PHF-tau measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
TMEM184C,ENSG00000164168,EFO_0000537,0.23865675711482212,3,hypertension,[MONDO_0000473],[EFO_0000319]
SLC52A1,ENSG00000132517,MONDO_0004573,0.42063421528080924,135,ariboflavinosis,[EFO_1001067],[OTAR_0000020]
SLC52A1,ENSG00000132517,MONDO_0014013,0.4607428855069282,5,maternal riboflavin deficiency,"[MONDO_0017760, MONDO_0004573]","[OTAR_0000018, OTAR_0000020]"
SLC52A1,ENSG00000132517,EFO_0004339,0.22790369743858588,2,body height,[EFO_0004324],[EFO_0001444]
SLC52A2,ENSG00000185803,HP_0000407,0.26609749537298527,1,Sensorineural hearing impairment,[HP_0000364],[EFO_0000651]
SLC52A2,ENSG00000185803,EFO_0000508,0.519071881683201,133,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC52A2,ENSG00000185803,MONDO_0008891,0.7833656193463531,426,riboflavin transporter deficiency,[MONDO_0024257],"[OTAR_0000018, EFO_0000618]"
SLC52A2,ENSG00000185803,EFO_1001176,0.26609749537298527,1,sensorineural hearing loss,[EFO_0004238],"[MONDO_0002025, EFO_0000618]"
SLC52A3,ENSG00000101276,MONDO_0018894,0.4619748183558772,2,distal hereditary motor neuropathy,"[MONDO_0024257, MONDO_0020127]","[OTAR_0000018, EFO_0000618]"
SLC52A3,ENSG00000101276,EFO_0008538,0.20112897078538536,1,helping behavior measurement,[EFO_0001444],[EFO_0001444]
SLC52A3,ENSG00000101276,EFO_0000508,0.5213991328401484,86,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC52A3,ENSG00000101276,EFO_0003783,0.6602149921072832,28,progressive bulbar palsy,"[EFO_1000631, EFO_0005774, MONDO_0008891, EFO_0009489]","[OTAR_0000018, EFO_0000618]"
SLC52A3,ENSG00000101276,EFO_0001663,0.24664636130822604,1,prostate carcinoma,"[MONDO_0008315, EFO_0000313]","[OTAR_0000017, MONDO_0045024]"
SLC52A3,ENSG00000101276,MONDO_0015307,0.26702144500969704,2,Madras motor neuron disease,[EFO_0003782],[EFO_0000618]
SLC52A3,ENSG00000101276,EFO_0004339,0.28114892922288465,1,body height,[EFO_0004324],[EFO_0001444]
SLC52A3,ENSG00000101276,MONDO_0008891,0.7736193887163479,395,riboflavin transporter deficiency,[MONDO_0024257],"[OTAR_0000018, EFO_0000618]"
XPR1,ENSG00000143324,MONDO_0014628,0.6827217857269272,10,"basal ganglia calcification, idiopathic, 6",[MONDO_0008947],"[MONDO_0002025, OTAR_0000018, EFO_0000618]"
XPR1,ENSG00000143324,EFO_0006335,0.22744826557756204,2,systolic blood pressure,[EFO_0004325],[EFO_0001444]
XPR1,ENSG00000143324,MONDO_0008947,0.579106364827063,42,bilateral striopallidodentate calcinosis,"[MONDO_0015547, EFO_0009533]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
XPR1,ENSG00000143324,EFO_0004747,0.265868825955711,3,protein measurement,[EFO_0001444],[EFO_0001444]
XPR1,ENSG00000143324,HP_0002135,0.4841602959327702,9,Basal ganglia calcification,"[HP_0002514, HP_0002134]",[EFO_0000651]
MPC1,ENSG00000060762,MONDO_0013877,0.698370161325835,14,mitochondrial pyruvate carrier deficiency,"[MONDO_0004069, EFO_1000017, MONDO_0016789]","[OTAR_0000018, OTAR_0000020]"
MPC2,ENSG00000143158,EFO_0004696,0.28374090247774814,3,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
MPC1L,ENSG00000238205,NA,NA,NA,NA,NA,NA
LETM1,ENSG00000168924,NA,NA,NA,NA,NA,NA
LETM2,ENSG00000165046,MONDO_0002561,0.2291355878968861,1,lysosomal storage disease,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
LETM2,ENSG00000165046,EFO_0004980,0.2646098045173695,3,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
LETM2,ENSG00000165046,EFO_0005772,0.34938538494997656,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
LETM2,ENSG00000165046,MONDO_0005180,0.2291355878968861,1,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
LETM2,ENSG00000165046,MONDO_0004975,0.2291355878968861,1,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
LETM2,ENSG00000165046,MONDO_0005301,0.2291355878968861,1,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
LETMD1,ENSG00000050426,NA,NA,NA,NA,NA,NA
SFXN1,ENSG00000164466,NA,NA,NA,NA,NA,NA
SFXN2,ENSG00000156398,EFO_0006501,0.20642085352393635,1,carotid plaque build,[EFO_0005278],[EFO_0001444]
SFXN2,ENSG00000156398,EFO_0004833,0.28505473462735686,2,neutrophil count,"[EFO_0803548, EFO_0007987]",[EFO_0001444]
SFXN2,ENSG00000156398,EFO_0007988,0.2554525448078458,1,myeloid white cell count,[EFO_0004308],[EFO_0001444]
SFXN2,ENSG00000156398,EFO_0007788,0.2480140007261978,5,BMI-adjusted waist-hip ratio,[EFO_0004343],[EFO_0001444]
SFXN2,ENSG00000156398,EFO_0004318,0.20221833286869334,1,smoking behavior,[GO_0007610],[GO_0008150]
SFXN2,ENSG00000156398,EFO_0004528,0.21463506041462754,1,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SFXN3,ENSG00000107819,NA,NA,NA,NA,NA,NA
SFXN4,ENSG00000183605,EFO_0000508,0.4061422326272234,14,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SFXN4,ENSG00000183605,MONDO_0014261,0.7380903491796217,23,growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome,[MONDO_0000732],"[OTAR_0000018, OTAR_0000020]"
SFXN4,ENSG00000183605,MONDO_0013987,0.5320239928166728,16,combined oxidative phosphorylation defect type 15,[MONDO_0000732],"[OTAR_0000018, OTAR_0000020]"
SFXN4,ENSG00000183605,EFO_0005772,0.5299915497326311,5,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SFXN4,ENSG00000183605,GO_0007568,0.3634131220696444,2,aging,[GO_0032502],[GO_0008150]
SFXN5,ENSG00000144040,EFO_0005939,0.255056799644321,1,parental genotype effect measurement,[EFO_0007958],[EFO_0001444]
SFXN5,ENSG00000144040,EFO_0004784,0.20150363450602157,1,self reported educational attainment,[EFO_0011015],[EFO_0001444]
SFXN5,ENSG00000144040,EFO_0004337,0.20150363450602157,1,intelligence,[EFO_0003925],[GO_0008150]
SFXN5,ENSG00000144040,MONDO_0005090,0.20150363450602157,1,schizophrenia,[EFO_0005407],"[MONDO_0002025, EFO_0000618]"
SFXN5,ENSG00000144040,EFO_0005110,0.255056799644321,1,fatty acid measurement,[EFO_0004529],[EFO_0001444]
SFXN5,ENSG00000144040,EFO_0009092,0.255056799644321,1,breast milk measurement,[EFO_0001444],[EFO_0001444]
NIPA1,ENSG00000170113,Orphanet_100988,0.7459512400520795,252,Autosomal dominant spastic paraplegia type 6,[Orphanet_183500],"[OTAR_0000018, EFO_0000618]"
NIPA1,ENSG00000170113,MONDO_0019064,0.4373642107651774,47,hereditary spastic paraplegia,"[EFO_0009679, MONDO_0024237]","[OTAR_0000018, EFO_0000618]"
NIPA1,ENSG00000170113,MONDO_0010878,0.7314055413758407,252,hereditary spastic paraplegia 6,[MONDO_0017914],"[OTAR_0000018, EFO_0000618]"
NIPA1,ENSG00000170113,EFO_0009700,0.23251633146124512,1,visual perception measurement,[EFO_0004464],[EFO_0001444]
NIPA1,ENSG00000170113,HP_0001258,0.3664925964538892,11,Spastic paraplegia,[HP_0002061],[EFO_0000651]
NIPA2,ENSG00000140157,NA,NA,NA,NA,NA,NA
NIPAL1,ENSG00000163293,EFO_0005653,0.2771524868311971,1,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
NIPAL1,ENSG00000163293,EFO_0004736,0.39376856469820776,3,aspartate aminotransferase measurement,"[EFO_0004747, EFO_0004582]",[EFO_0001444]
NIPAL1,ENSG00000163293,EFO_0004584,0.3342404942414276,4,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
NIPAL1,ENSG00000163293,EFO_0004274,0.2050574347782488,5,gout,"[EFO_0005856, EFO_0000589]","[OTAR_0000006, OTAR_0000020]"
NIPAL1,ENSG00000163293,EFO_0004531,0.20608998281109794,1,urate measurement,[EFO_0001444],[EFO_0001444]
NIPAL2,ENSG00000104361,EFO_0010949,0.2983145767024403,1,upper face morphology measurement,[EFO_0007841],[EFO_0001444]
NIPAL2,ENSG00000104361,EFO_0004980,0.252667415249551,1,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
NIPAL2,ENSG00000104361,EFO_0006335,0.2947220961704087,1,systolic blood pressure,[EFO_0004325],[EFO_0001444]
NIPAL3,ENSG00000001461,NA,NA,NA,NA,NA,NA
NIPAL4,ENSG00000172548,MONDO_0017851,0.2683406397687799,3,erythrokeratodermia variabilis,"[MONDO_0017667, MONDO_0017262]","[OTAR_0000018, EFO_0010285]"
NIPAL4,ENSG00000172548,EFO_0004713,0.23377471117914866,11,FEV/FEC ratio,"[EFO_0006841, EFO_0003892]",[EFO_0001444]
NIPAL4,ENSG00000172548,MONDO_0017778,0.6944798563345335,105,lamellar ichthyosis,"[MONDO_0020162, MONDO_0017262]","[OTAR_0000018, MONDO_0024458, EFO_0010285]"
NIPAL4,ENSG00000172548,MONDO_0017265,0.46555489440345704,24,autosomal recessive congenital ichthyosis,"[MONDO_0017262, EFO_1000017]","[OTAR_0000018, EFO_0010285]"
NIPAL4,ENSG00000172548,MONDO_0019306,0.6927834320422996,105,congenital non-bullous ichthyosiform erythroderma,[MONDO_0017265],"[OTAR_0000018, EFO_0010285]"
MAGT1,ENSG00000102158,HP_0005387,0.4623443982105619,3,Combined immunodeficiency,[HP_0002721],[EFO_0000651]
MAGT1,ENSG00000102158,MONDO_0015286,0.4269571271245018,4,congenital disorder of glycosylation,"[MONDO_0024322, MONDO_0019052]","[OTAR_0000018, OTAR_0000020]"
MAGT1,ENSG00000102158,MONDO_0015131,0.4623443982105619,3,combined immunodeficiency,"[MONDO_0015823, MONDO_0021094]","[OTAR_0000018, EFO_0000540]"
MAGT1,ENSG00000102158,MONDO_0010455,0.7622759485685281,173,"X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia",[MONDO_0015131],"[OTAR_0000018, EFO_0000540]"
MAGT1,ENSG00000102158,EFO_0005545,0.6532549785907745,9,congenital disorder of glycosylation type I,[MONDO_0015286],"[OTAR_0000018, OTAR_0000020]"
MAGT1,ENSG00000102158,MONDO_0100096,0.37082205364072535,4,COVID-19,[MONDO_0020753],[EFO_0005741]
TUSC3,ENSG00000104723,EFO_0010750,0.20784501147829096,3,PHF-tau measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
TUSC3,ENSG00000104723,EFO_0000508,0.33782104154500464,36,genetic disorder,[OTAR_0000018],[OTAR_0000018]
TUSC3,ENSG00000104723,EFO_0004713,0.26079421235405426,1,FEV/FEC ratio,"[EFO_0006841, EFO_0003892]",[EFO_0001444]
TUSC3,ENSG00000104723,MONDO_0019502,0.6358405267677676,54,autosomal recessive non-syndromic intellectual disability,"[EFO_1000017, MONDO_0000509, MONDO_0017706]","[MONDO_0002025, OTAR_0000018, OTAR_0000020, EFO_0000618]"
TUSC3,ENSG00000104723,EFO_0004784,0.2738254959017705,1,self reported educational attainment,[EFO_0011015],[EFO_0001444]
TUSC3,ENSG00000104723,EFO_0004339,0.2500605857944329,1,body height,[EFO_0004324],[EFO_0001444]
TUSC3,ENSG00000104723,EFO_0010699,0.2681276026366998,1,diffuse plaque measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
TUSC3,ENSG00000104723,EFO_0004340,0.40516401865653284,4,body mass index,[EFO_0004324],[EFO_0001444]
TUSC3,ENSG00000104723,EFO_0004875,0.3415498138357506,3,mathematical ability,[EFO_0003925],[GO_0008150]
TUSC3,ENSG00000104723,MONDO_0002320,0.26609749537298527,1,congenital nervous system disorder,[EFO_0000618],[EFO_0000618]
TUSC3,ENSG00000104723,GO_1901554,0.3101853896008671,1,response to paracetamol,[GO_0050896],[GO_0008150]
TUSC3,ENSG00000104723,EFO_0006797,0.25341275550047565,1,neurofibrillary tangles measurement,[EFO_0004464],[EFO_0001444]
TUSC3,ENSG00000104723,MONDO_0100096,0.3695798546847018,1,COVID-19,[MONDO_0020753],[EFO_0005741]
TUSC3,ENSG00000104723,EFO_0007927,0.28486814072768324,1,schizophrenia symptom severity measurement,[EFO_0006848],[EFO_0001444]
TUSC3,ENSG00000104723,EFO_0007925,0.28486814072768324,1,response to paliperidone,[GO_0097332],[GO_0008150]
TUSC3,ENSG00000104723,HP_0001249,0.498526390062087,11,Intellectual disability,"[HP_0012759, HP_0100543]",[EFO_0000651]
MFSD2A,ENSG00000168389,HP_0000539,0.2457310698223115,1,Abnormality of refraction,[HP_0000478],[EFO_0000651]
MFSD2A,ENSG00000168389,HP_0000252,0.3684951326410479,30,Microcephaly,"[HP_0000929, HP_0012443]",[EFO_0000651]
MFSD2A,ENSG00000168389,EFO_0000508,0.40808490712341505,14,genetic disorder,[OTAR_0000018],[OTAR_0000018]
MFSD2A,ENSG00000168389,EFO_0007988,0.23124769450584942,2,myeloid white cell count,[EFO_0004308],[EFO_0001444]
MFSD2A,ENSG00000168389,EFO_0010224,0.20297391645393686,2,lysophosphatidylcholine measurement,"[EFO_0010968, EFO_0005278, EFO_0004529]",[EFO_0001444]
MFSD2A,ENSG00000168389,EFO_0004348,0.3284885304438994,4,hematocrit,[EFO_0004503],[EFO_0001444]
MFSD2A,ENSG00000168389,MONDO_0016660,0.6667823416476555,18,autosomal recessive primary microcephaly,"[MONDO_0100500, MONDO_0957008, MONDO_0016056, EFO_1000017]","[OTAR_0000018, EFO_0000618]"
MFSD2A,ENSG00000168389,EFO_0004584,0.3156425979930311,5,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
MFSD2A,ENSG00000168389,EFO_0004562,0.3453058498290106,2,cryptorchidism,"[EFO_0009555, EFO_0000508]","[OTAR_0000017, OTAR_0000018]"
MFSD2A,ENSG00000168389,HP_0002373,0.3326218692162316,1,Febrile seizure (within the age range of 3 months to 6 years),[HP_0001250],[EFO_0000651]
MFSD2A,ENSG00000168389,HP_0002194,0.3326218692162316,1,Delayed gross motor development,[HP_0001270],[EFO_0000651]
MFSD2A,ENSG00000168389,HP_0001987,0.3326218692162316,1,Hyperammonemia,[HP_0004364],[EFO_0000651]
MFSD2A,ENSG00000168389,EFO_0004526,0.2498288881807422,1,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
MFSD2A,ENSG00000168389,EFO_0004509,0.33827315188346835,5,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
MFSD2A,ENSG00000168389,EFO_0009188,0.3486090834663845,6,Red cell distribution width,[EFO_0004509],[EFO_0001444]
MFSD2A,ENSG00000168389,EFO_0004587,0.32304624040957064,5,lymphocyte count,"[EFO_0006843, EFO_0004308, EFO_0803546]",[EFO_0001444]
MFSD2A,ENSG00000168389,EFO_0004309,0.3503573629328292,7,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
MFSD2A,ENSG00000168389,EFO_0004308,0.2769668214440394,5,leukocyte count,[EFO_0004586],[EFO_0001444]
MFSD2A,ENSG00000168389,EFO_0004305,0.29246537396940636,2,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
MFSD2A,ENSG00000168389,EFO_0000495,0.33373060878028565,2,fetal growth restriction,[EFO_0007441],"[OTAR_0000017, OTAR_0000014]"
MFSD2A,ENSG00000168389,EFO_0007985,0.24774481435074203,2,platelet crit,[EFO_0005036],[EFO_0001444]
MFSD2A,ENSG00000168389,EFO_0007978,0.25976650853474326,2,red blood cell density measurement,[EFO_0005047],[EFO_0001444]
MFSD2A,ENSG00000168389,HP_0001249,0.3333475803253333,6,Intellectual disability,"[HP_0012759, HP_0100543]",[EFO_0000651]
MFSD2A,ENSG00000168389,MONDO_0013873,0.3326218692162316,1,IMAGe syndrome,[MONDO_0800063],"[OTAR_0000006, OTAR_0000018]"
MFSD2A,ENSG00000168389,EFO_0004530,0.23634896861853408,1,triglyceride measurement,[EFO_0004529],[EFO_0001444]
MFSD2A,ENSG00000168389,EFO_0004528,0.222354965845573,1,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
MFSD2B,ENSG00000205639,EFO_0008111,0.22571955972485408,1,diet measurement,[EFO_0001444],[EFO_0001444]
MFSD2B,ENSG00000205639,EFO_0007990,0.24241168704684274,2,neutrophil percentage of leukocytes,[EFO_0004833],[EFO_0001444]
MFSD2B,ENSG00000205639,EFO_0007986,0.6296392285120505,24,reticulocyte count,[EFO_0010700],[EFO_0001444]
MFSD2B,ENSG00000205639,EFO_0010700,0.6566883669206138,17,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
MFSD2B,ENSG00000205639,EFO_0004584,0.4809671919033792,5,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
MFSD2B,ENSG00000205639,EFO_0004541,0.3680256870649429,8,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
MFSD2B,ENSG00000205639,EFO_0005772,0.32878274136476676,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
MFSD2B,ENSG00000205639,EFO_0005763,0.2953321128881518,2,pulse pressure measurement,[EFO_0005278],[EFO_0001444]
MFSD2B,ENSG00000205639,EFO_0004526,0.5108256097704412,14,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
MFSD2B,ENSG00000205639,EFO_0004503,0.292689222587281,2,hematological measurement,[EFO_0001444],[EFO_0001444]
MFSD2B,ENSG00000205639,EFO_0009253,0.4430088086379607,6,Immature Reticulocyte Fraction Measurement,[EFO_0009233],[EFO_0001444]
MFSD2B,ENSG00000205639,EFO_0009188,0.2035090309265606,6,Red cell distribution width,[EFO_0004509],[EFO_0001444]
MFSD2B,ENSG00000205639,EFO_0004587,0.318047035446651,10,lymphocyte count,"[EFO_0006843, EFO_0004308, EFO_0803546]",[EFO_0001444]
MFSD2B,ENSG00000205639,EFO_0004305,0.21646851059938885,5,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
MFSD2B,ENSG00000205639,EFO_0007985,0.5477594242464568,7,platelet crit,[EFO_0005036],[EFO_0001444]
MFSD2B,ENSG00000205639,EFO_0007984,0.23158259577799142,2,platelet component distribution width,[EFO_0005036],[EFO_0001444]
MFSD12,ENSG00000161091,EFO_0000389,0.2007653874887543,1,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
MFSD12,ENSG00000161091,EFO_0004761,0.2136110794415529,1,uric acid measurement,"[EFO_0004742, EFO_0004298]",[EFO_0001444]
MFSD12,ENSG00000161091,EFO_0004736,0.21563527244634717,2,aspartate aminotransferase measurement,"[EFO_0004747, EFO_0004582]",[EFO_0001444]
MFSD12,ENSG00000161091,EFO_0007009,0.30356089312477924,3,skin pigmentation measurement,[EFO_0001444],[EFO_0001444]
MFSD12,ENSG00000161091,EFO_0006942,0.2575499776530202,2,facial pigmentation measurement,[EFO_0001444],[EFO_0001444]
MFSD12,ENSG00000161091,EFO_0003924,0.29440377078852636,2,hair color,[EFO_0005038],[EFO_0000651]
MFSD12,ENSG00000161091,EFO_0007937,0.2917744335337517,2,blood protein measurement,[EFO_0004747],[EFO_0001444]
SLC6A1,ENSG00000157103,HP_0012758,0.47577238612561723,11,Neurodevelopmental delay,[HP_0012759],[EFO_0000651]
SLC6A1,ENSG00000157103,MONDO_0016025,0.7707497137628209,598,myoclonic-astatic epilepsy,"[MONDO_0015653, MONDO_0020072, MONDO_0019216]","[OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC6A1,ENSG00000157103,EFO_0005230,0.38957572565360205,25,anxiety,[HP_0000708],[EFO_0000651]
SLC6A1,ENSG00000157103,HP_0000539,0.30589792637114305,1,Abnormality of refraction,[HP_0000478],[EFO_0000651]
SLC6A1,ENSG00000157103,EFO_0000389,0.23638980453877492,5,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLC6A1,ENSG00000157103,MONDO_0015802,0.3695798546847018,1,autosomal dominant non-syndromic intellectual disability,"[MONDO_0000509, MONDO_0100172]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC6A1,ENSG00000157103,EFO_0000508,0.5343255682056037,103,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC6A1,ENSG00000157103,EFO_0004263,0.3709375473453143,5,partial epilepsy,[EFO_0000474],[EFO_0000618]
SLC6A1,ENSG00000157103,EFO_0010642,0.3490488310319177,20,Neurodevelopmental disorder,"[EFO_0000618, EFO_0009386]",[EFO_0000618]
SLC6A1,ENSG00000157103,EFO_0003756,0.2655312655417404,4,autism spectrum disorder,[MONDO_0000594],"[MONDO_0002025, EFO_0000618]"
SLC6A1,ENSG00000157103,EFO_1001917,0.4619748183558772,2,social anxiety disorder,[EFO_1001908],"[MONDO_0002025, EFO_0000618]"
SLC6A1,ENSG00000157103,EFO_1001892,0.3682965913003799,4,generalized anxiety disorder,[EFO_0006788],"[MONDO_0002025, EFO_0000618]"
SLC6A1,ENSG00000157103,MONDO_0007295,0.3326218692162316,1,childhood epilepsy with centrotemporal spikes,"[MONDO_0000414, MONDO_0017704]","[OTAR_0000018, EFO_0000618]"
SLC6A1,ENSG00000157103,MONDO_0005090,0.27885338679414934,46,schizophrenia,[EFO_0005407],"[MONDO_0002025, EFO_0000618]"
SLC6A1,ENSG00000157103,Orphanet_1945,0.3326218692162316,1,Rolandic epilepsy,"[Orphanet_182083, Orphanet_166475]",[OTAR_0000018]
SLC6A1,ENSG00000157103,EFO_0004314,0.3172111714524824,1,forced expiratory volume,"[EFO_0003892, EFO_0006841]",[EFO_0001444]
SLC6A1,ENSG00000157103,EFO_0004312,0.3172111714524824,1,vital capacity,[EFO_0003892],[EFO_0001444]
SLC6A1,ENSG00000157103,EFO_0000474,0.38182927098501396,6,epilepsy,[EFO_0005774],[EFO_0000618]
SLC6A1,ENSG00000157103,HP_0001263,0.33368361651902123,11,Global developmental delay,[HP_0012758],[EFO_0000651]
SLC6A1,ENSG00000157103,HP_0001250,0.5431771701957829,10,Seizure,[HP_0012638],[EFO_0000651]
SLC6A1,ENSG00000157103,HP_0001249,0.49197168510174827,33,Intellectual disability,"[HP_0012759, HP_0100543]",[EFO_0000651]
SLC6A10P,ENSG00000214617,NA,NA,NA,NA,NA,NA
SLC6A11,ENSG00000132164,EFO_0010750,0.24852697140314808,1,PHF-tau measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
SLC6A11,ENSG00000132164,EFO_0000389,0.23602022468409023,4,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLC6A11,ENSG00000132164,EFO_0006797,0.25140208810271747,1,neurofibrillary tangles measurement,[EFO_0004464],[EFO_0001444]
SLC6A12,ENSG00000111181,EFO_0000389,0.23602022468409023,4,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLC6A12,ENSG00000111181,EFO_0005664,0.36928337733215805,4,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC6A12,ENSG00000111181,EFO_0005653,0.3075154576985957,8,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC6A12,ENSG00000111181,EFO_0004339,0.3633378372139527,3,body height,[EFO_0004324],[EFO_0001444]
SLC6A12,ENSG00000111181,EFO_0004471,0.36349763261741985,2,insulin sensitivity measurement,[EFO_0004467],[EFO_0001444]
SLC6A13,ENSG00000010379,EFO_0010983,0.27393052862872214,1,3-hydroxyisobutyrate measurement,[EFO_0005116],[EFO_0001444]
SLC6A13,ENSG00000010379,EFO_0010980,0.27393052862872214,1,3-aminoisobutyrate measurement,[EFO_0005116],[EFO_0001444]
SLC6A13,ENSG00000010379,EFO_0005208,0.46479010423191924,11,glomerular filtration rate,[EFO_0004742],[EFO_0001444]
SLC6A13,ENSG00000010379,HP_0000539,0.27471598309856016,1,Abnormality of refraction,[HP_0000478],[EFO_0000651]
SLC6A13,ENSG00000010379,EFO_0000389,0.23602022468409023,4,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLC6A13,ENSG00000010379,EFO_0005664,0.377922341286461,3,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC6A13,ENSG00000010379,EFO_0005653,0.4464283794269697,7,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC6A13,ENSG00000010379,EFO_0008328,0.2688520597028195,1,chronotype measurement,[EFO_0004870],[EFO_0001444]
SLC6A13,ENSG00000010379,EFO_0010464,0.31406333699101024,2,beta-aminoisobutyric acid measurement,[EFO_0005134],[EFO_0001444]
SLC6A13,ENSG00000010379,EFO_0004518,0.4552658648572253,9,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC6A13,ENSG00000010379,EFO_0005116,0.3697755629490517,2,urinary metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC6A13,ENSG00000010379,EFO_0004314,0.253232494845139,1,forced expiratory volume,"[EFO_0003892, EFO_0006841]",[EFO_0001444]
SLC6A13,ENSG00000010379,EFO_0003884,0.28789722535988754,2,chronic kidney disease,[EFO_0003086],[EFO_0009690]
SLC6A14,ENSG00000268104,EFO_0001073,0.37748192988186147,20,obesity,[MONDO_0003916],[OTAR_0000020]
SLC6A14,ENSG00000268104,MONDO_0009061,0.39356655083504655,19,cystic fibrosis,"[EFO_1000017, EFO_0000684]","[OTAR_0000018, OTAR_0000010]"
SLC6A15,ENSG00000072041,EFO_0005772,0.22329059680392602,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC6A15,ENSG00000072041,EFO_0007822,0.29700257079125897,1,hair colour measurement,[EFO_0007821],[EFO_0001444]
SLC6A16,ENSG00000063127,NA,NA,NA,NA,NA,NA
SLC6A17,ENSG00000197106,EFO_0003958,0.2679268332840494,1,sunburn,"[EFO_0000701, EFO_0009516]","[OTAR_0000009, EFO_0010285]"
SLC6A17,ENSG00000197106,EFO_0003784,0.2957365607554709,1,skin pigmentation,[EFO_0000651],[EFO_0000651]
SLC6A17,ENSG00000197106,EFO_0004833,0.22465795377324893,1,neutrophil count,"[EFO_0803548, EFO_0007987]",[EFO_0001444]
SLC6A17,ENSG00000197106,EFO_0010176,0.2666140343405337,1,keratinocyte carcinoma,[EFO_0009260],"[MONDO_0045024, EFO_0010285]"
SLC6A18,ENSG00000164363,EFO_0005406,0.27540415893538256,1,colorectal adenoma,"[EFO_0004142, EFO_1000217]","[MONDO_0045024, EFO_0010282]"
SLC6A18,ENSG00000164363,HP_0000407,0.3695798546847018,1,Sensorineural hearing impairment,[HP_0000364],[EFO_0000651]
SLC6A18,ENSG00000164363,MONDO_0005575,0.34410711089512325,2,colorectal cancer,"[EFO_0007330, EFO_0004142]","[MONDO_0045024, EFO_0010282]"
SLC6A18,ENSG00000164363,EFO_0004518,0.32320626838537353,2,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC6A18,ENSG00000164363,EFO_0004509,0.2397827614529499,2,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
SLC6A19,ENSG00000174358,HP_0003108,0.6061872111639446,68,Hyperglycinuria,[HP_0003110],[EFO_0000651]
SLC6A19,ENSG00000174358,MONDO_0009448,0.6955506784400899,71,iminoglycinuria,[MONDO_0019216],"[OTAR_0000018, OTAR_0000020]"
SLC6A19,ENSG00000174358,MONDO_0009324,0.8372283160049953,146,Hartnup disease,[MONDO_0019216],"[OTAR_0000018, OTAR_0000020]"
SLC6A19,ENSG00000174358,EFO_0004747,0.28474889950474086,1,protein measurement,[EFO_0001444],[EFO_0001444]
SLC6A19,ENSG00000174358,EFO_0004617,0.5030338010149481,4,cystatin C measurement,"[EFO_0004747, EFO_0004742]",[EFO_0001444]
SLC6A19,ENSG00000174358,EFO_0004518,0.5815677662740648,8,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC6A19,ENSG00000174358,EFO_0005116,0.32144031410528495,7,urinary metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC6A19,ENSG00000174358,EFO_0009188,0.3265731384464373,2,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC6A2,ENSG00000103546,HP_0001822,0.3233823728491141,2,Hallux valgus,[HP_0001780],[EFO_0000651]
SLC6A2,ENSG00000103546,HP_0001742,0.6044642855099372,106,Nasal congestion,[HP_0000366],[EFO_0000651]
SLC6A2,ENSG00000103546,HP_0031217,0.37706384674206694,6,Hot flashes,[HP_0025142],[EFO_0000651]
SLC6A2,ENSG00000103546,HP_0030839,0.3682965913003799,4,Knee pain,[HP_0012514],[EFO_0000651]
SLC6A2,ENSG00000103546,HP_0030834,0.4342563292545246,2,Shoulder pain,"[HP_0025142, EFO_0003843]",[EFO_0000651]
SLC6A2,ENSG00000103546,HP_0030833,0.39627173307859687,3,Neck pain,"[EFO_0003843, HP_0025142]",[EFO_0000651]
SLC6A2,ENSG00000103546,HP_0012735,0.5564670010437158,7,Cough,[HP_0002086],[EFO_0000651]
SLC6A2,ENSG00000103546,HP_0012532,0.5817074533539485,16,Chronic pain,"[EFO_0003843, HP_0025142]",[EFO_0000651]
SLC6A2,ENSG00000103546,HP_0012378,0.3956093654796861,9,Fatigue,"[HP_0025142, EFO_0003765]",[EFO_0000651]
SLC6A2,ENSG00000103546,MONDO_0024355,0.25870589827929125,1,respiratory tract infectious disorder,"[EFO_0000684, EFO_0005741]","[EFO_0005741, OTAR_0000010]"
SLC6A2,ENSG00000103546,MONDO_0024352,0.25870589827929125,1,viral respiratory tract infection,"[MONDO_0024355, EFO_0000763]","[EFO_0005741, OTAR_0000010]"
SLC6A2,ENSG00000103546,MONDO_0024290,0.47480745219909604,4,enuresis,[MONDO_0002025],[MONDO_0002025]
SLC6A2,ENSG00000103546,EFO_1000789,0.3695798546847018,1,"osteoarthritis, hand",[MONDO_0005178],[OTAR_0000006]
SLC6A2,ENSG00000103546,EFO_1000786,0.49071991816468735,3,"osteoarthritis, hip",[MONDO_0005178],[OTAR_0000006]
SLC6A2,ENSG00000103546,EFO_1000783,0.5824820932254885,26,diabetic neuropathy,"[EFO_0003100, EFO_0009532]",[EFO_0000618]
SLC6A2,ENSG00000103546,MONDO_0007254,0.3396849508835392,6,breast cancer,"[EFO_0003869, MONDO_0003274]","[OTAR_0000017, MONDO_0045024, EFO_0010285]"
SLC6A2,ENSG00000103546,EFO_0011023,0.3695798546847018,1,concussion,"[EFO_0009505, MONDO_0043510]","[EFO_0000618, OTAR_0000009]"
SLC6A2,ENSG00000103546,MONDO_0002491,0.47822606585492955,7,substance abuse,[MONDO_0002494],[MONDO_0002025]
SLC6A2,ENSG00000103546,EFO_0007214,0.6038543349288281,91,common cold,[MONDO_0001040],[OTAR_0000010]
SLC6A2,ENSG00000103546,EFO_0007169,0.27718489101352634,2,biliary dyskinesia,"[EFO_0003832, MONDO_0002886, MONDO_0002866]",[EFO_0010282]
SLC6A2,ENSG00000103546,MONDO_0018975,0.37013422446672883,2,neurofibromatosis type 1,"[MONDO_0800089, EFO_0008514, MONDO_0019755, EFO_1001502]","[OTAR_0000006, OTAR_0000018, MONDO_0045024, EFO_0000618]"
SLC6A2,ENSG00000103546,MONDO_0016158,0.5809478239587205,14,narcolepsy-cataplexy syndrome,"[EFO_0005774, MONDO_0021107]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0005230,0.5882085260196429,44,anxiety,[HP_0000708],[EFO_0000651]
SLC6A2,ENSG00000103546,EFO_0005203,0.5470273621948832,21,eating disorder,"[EFO_0000677, MONDO_0002025, EFO_0001069]","[MONDO_0002025, OTAR_0000020, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0005252,0.48494178180060443,9,orthostatic hypotension,[EFO_0005251],[EFO_0000319]
SLC6A2,ENSG00000103546,EFO_0000685,0.4619748183558772,2,rheumatoid arthritis,"[MONDO_0000589, EFO_0005140, EFO_0005755, EFO_0005856]","[OTAR_0000006, EFO_0000540]"
SLC6A2,ENSG00000103546,EFO_0000677,0.3695798546847018,1,mental or behavioural disorder,"[MONDO_0002025, EFO_0005774]","[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0003956,0.6044571543829007,108,seasonal allergic rhinitis,[EFO_0005854],"[EFO_0000540, OTAR_0000010]"
SLC6A2,ENSG00000103546,EFO_0003948,0.47917054770579043,4,gastroesophageal reflux disease,"[EFO_0009544, EFO_0000508, EFO_0009608]","[OTAR_0000018, EFO_0010282]"
SLC6A2,ENSG00000103546,EFO_0003843,0.600238976127141,70,pain,[EFO_0003765],[EFO_0000651]
SLC6A2,ENSG00000103546,EFO_0003833,0.26794539464640876,2,brain neoplasm,"[EFO_0005774, EFO_1000158]","[EFO_0000618, MONDO_0045024]"
SLC6A2,ENSG00000103546,HP_0000407,0.3695798546847018,1,Sensorineural hearing impairment,[HP_0000364],[EFO_0000651]
SLC6A2,ENSG00000103546,HP_0000360,0.3695798546847018,1,Tinnitus,[HP_0000364],[EFO_0000651]
SLC6A2,ENSG00000103546,EFO_0000239,0.5551108821980356,20,adrenal gland pheochromocytoma,"[MONDO_0021072, MONDO_0021237, Orphanet_271847]","[EFO_0000618, OTAR_0000018, MONDO_0045024, EFO_0001379]"
SLC6A2,ENSG00000103546,EFO_0008533,0.25870589827929125,1,dyspepsia,[MONDO_0001318],[EFO_0010282]
SLC6A2,ENSG00000103546,EFO_0008521,0.3233823728491141,2,rhinitis,[MONDO_0002232],[OTAR_0000010]
SLC6A2,ENSG00000103546,MONDO_0007079,0.5096010885803978,17,alcohol dependence,"[MONDO_0021698, EFO_0003890]","[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,MONDO_0005475,0.3695798546847018,1,migraine with aura,[MONDO_0005277],"[EFO_0000618, EFO_0000319]"
SLC6A2,ENSG00000103546,EFO_0000274,0.5286429176981676,6,atopic eczema,"[MONDO_0002406, MONDO_0005271, MONDO_0100118, EFO_1000636]","[OTAR_0000018, EFO_0000540, EFO_0010285]"
SLC6A2,ENSG00000103546,HP_0003419,0.5860453287325528,27,Low back pain,[HP_0003418],[EFO_0000651]
SLC6A2,ENSG00000103546,HP_0003418,0.499368484837849,8,Back pain,"[HP_0000925, EFO_0003843, HP_0025142]",[EFO_0000651]
SLC6A2,ENSG00000103546,EFO_0001074,0.38805884741893687,2,morbid obesity,[EFO_0001073],[OTAR_0000020]
SLC6A2,ENSG00000103546,EFO_0001073,0.6034273061005251,98,obesity,[MONDO_0003916],[OTAR_0000020]
SLC6A2,ENSG00000103546,EFO_0004701,0.3016193808367223,25,methamphetamine dependence,[EFO_0003890],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0004698,0.4986658850404084,6,insomnia,[EFO_0008568],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0005924,0.4619748183558772,2,binge eating,[EFO_0005203],"[MONDO_0002025, OTAR_0000020, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0005854,0.566705074196648,10,allergic rhinitis,"[MONDO_0000771, EFO_0008521]","[EFO_0000540, OTAR_0000010]"
SLC6A2,ENSG00000103546,EFO_0003768,0.5952902673910241,62,nicotine dependence,[EFO_0003890],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,MONDO_0011382,0.25870589827929125,1,sickle cell anemia,"[EFO_1000017, MONDO_0017146]","[OTAR_0000018, EFO_0005803]"
SLC6A2,ENSG00000103546,EFO_0000544,0.3695798546847018,1,infection,[OBI_1110122],[GO_0008150]
SLC6A2,ENSG00000103546,EFO_0001642,0.25870589827929125,1,lymphoid neoplasm,[MONDO_0044881],"[MONDO_0045024, EFO_0005803]"
SLC6A2,ENSG00000103546,EFO_0000313,0.4619748183558772,2,carcinoma,"[MONDO_0004992, EFO_0006858]",[MONDO_0045024]
SLC6A2,ENSG00000103546,EFO_0000612,0.25907547813397597,2,myocardial infarction,[MONDO_0024643],[EFO_0000319]
SLC6A2,ENSG00000103546,EFO_0004265,0.25870589827929125,1,peripheral arterial disease,"[MONDO_0000473, EFO_0003914, EFO_0003875]",[EFO_0000319]
SLC6A2,ENSG00000103546,EFO_0004262,0.578732265808684,21,panic disorder,[EFO_0006788],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,MONDO_0024880,0.25870589827929125,1,metastatic malignant neoplasm,"[EFO_0009709, EFO_0009812]",[MONDO_0045024]
SLC6A2,ENSG00000103546,MONDO_0024457,0.3695798546847018,1,neurodegeneration with brain iron accumulation 2A,"[MONDO_0017998, MONDO_0020127]","[MONDO_0002025, OTAR_0000020, EFO_0000618, OTAR_0000018]"
SLC6A2,ENSG00000103546,EFO_0005800,0.4619748183558772,2,substance withdrawal syndrome,"[MONDO_0002494, EFO_0000677]","[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0003890,0.5546611884131933,12,drug dependence,"[EFO_0000677, MONDO_0004938]","[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0003888,0.6308921646252953,750,attention deficit hyperactivity disorder,[MONDO_0000592],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_1000645,0.5332828841612304,33,orthostatic intolerance,"[MONDO_0000992, MONDO_0015914]","[EFO_0000618, EFO_0000319]"
SLC6A2,ENSG00000103546,EFO_0007328,0.4619748183558772,2,influenza,"[MONDO_0024352, MONDO_0100329]","[EFO_0005741, OTAR_0000010]"
SLC6A2,ENSG00000103546,HP_0100749,0.25870589827929125,1,Chest pain,"[HP_0025142, EFO_0003843]",[EFO_0000651]
SLC6A2,ENSG00000103546,HP_0100543,0.4957092462029308,5,Cognitive impairment,[HP_0011446],[EFO_0000651]
SLC6A2,ENSG00000103546,EFO_0002970,0.5727629328795701,10,muscular disease,[EFO_0009676],[OTAR_0000006]
SLC6A2,ENSG00000103546,EFO_0008507,0.3233823728491141,2,interstitial cystitis,"[EFO_1001986, EFO_1000023]","[OTAR_0000006, EFO_0009690]"
SLC6A2,ENSG00000103546,EFO_0000712,0.4755466119084654,5,stroke,[EFO_0003763],"[EFO_0000618, EFO_0000319]"
SLC6A2,ENSG00000103546,EFO_0004247,0.46980595882396925,10,mood disorder,[EFO_0000677],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0004242,0.5434725021187894,10,obsessive-compulsive disorder,"[EFO_0000508, EFO_0006788]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0008623,0.5730683707760038,11,dysthymic disorder,[EFO_0004247],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0000537,0.5082905283030416,15,hypertension,[MONDO_0000473],[EFO_0000319]
SLC6A2,ENSG00000103546,HP_0010992,0.5337455395609125,8,Stress urinary incontinence,[HP_0000020],[EFO_0000651]
SLC6A2,ENSG00000103546,HP_0010865,0.3246759023405105,4,Oppositional defiant disorder,[HP_0000708],[EFO_0000651]
SLC6A2,ENSG00000103546,HP_0008419,0.3695798546847018,1,Intervertebral disc degeneration,[HP_0000925],[EFO_0000651]
SLC6A2,ENSG00000103546,HP_0004308,0.4619748183558772,2,Ventricular arrhythmia,[HP_0030956],[EFO_0000651]
SLC6A2,ENSG00000103546,MP_0001845,0.25870589827929125,1,inflammation,[HP_0002715],[EFO_0000651]
SLC6A2,ENSG00000103546,MONDO_0100431,0.3695798546847018,1,migraine without aura,[MONDO_0005277],"[EFO_0000618, EFO_0000319]"
SLC6A2,ENSG00000103546,MONDO_0100339,0.3695798546847018,1,Friedreich ataxia,[MONDO_0020046],"[OTAR_0000018, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0000673,0.3233823728491141,2,prostate adenocarcinoma,"[EFO_0000228, EFO_0001663]","[OTAR_0000017, MONDO_0045024]"
SLC6A2,ENSG00000103546,EFO_0003761,0.6147763427394188,832,unipolar depression,[MONDO_0002050],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0003758,0.43531887133674313,4,autism,[EFO_0003756],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0003757,0.4619748183558772,2,Asperger syndrome,[EFO_0003756],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0003144,0.49647602174033084,8,heart failure,[EFO_0003777],[EFO_0000319]
SLC6A2,ENSG00000103546,EFO_0004320,0.3695798546847018,1,suicidal ideation,[EFO_0007623],[GO_0008150]
SLC6A2,ENSG00000103546,EFO_0004319,0.5836550678913457,23,smoking cessation,[GO_0007610],[GO_0008150]
SLC6A2,ENSG00000103546,EFO_0009963,0.3292956505240693,3,bipolar I disorder,[MONDO_0004985],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0009854,0.5202144437899414,7,treatment resistant depression,[EFO_0003761],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0010282,0.4443171141876081,4,gastrointestinal disease,[],[EFO_0010282]
SLC6A2,ENSG00000103546,EFO_0004344,0.4507137512530747,3,birth weight,[EFO_0004338],[EFO_0001444]
SLC6A2,ENSG00000103546,EFO_0009562,0.5030392466541774,3,polyneuropathy,[EFO_0003100],[EFO_0000618]
SLC6A2,ENSG00000103546,EFO_1001917,0.5789366412933385,15,social anxiety disorder,[EFO_1001908],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_1001904,0.3682965913003799,4,oral mucositis,[EFO_1001898],[EFO_0000651]
SLC6A2,ENSG00000103546,EFO_1001892,0.5154561031608759,8,generalized anxiety disorder,[EFO_0006788],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_1000632,0.3695798546847018,1,cerebral palsy,"[EFO_1000631, MONDO_0044996]",[EFO_0000618]
SLC6A2,ENSG00000103546,EFO_1001050,0.26332564646285,2,multiple system atrophy,"[EFO_0004280, EFO_1000096, DOID_0050890]","[GO_0008150, EFO_0000618, OTAR_0000020]"
SLC6A2,ENSG00000103546,EFO_1000999,0.25870589827929125,1,joint disease,[EFO_0002461],[OTAR_0000006]
SLC6A2,ENSG00000103546,EFO_0003100,0.5316098226427198,6,peripheral neuropathy,"[EFO_0009387, EFO_1001902]",[EFO_0000618]
SLC6A2,ENSG00000103546,HP_0002315,0.46300142906333475,3,Headache,[HP_0012638],[EFO_0000651]
SLC6A2,ENSG00000103546,HP_0002140,0.3233823728491141,2,Ischemic stroke,"[HP_0002637, HP_0100659]",[EFO_0000651]
SLC6A2,ENSG00000103546,HP_0002045,0.3695798546847018,1,Hypothermia,[HP_0004370],[EFO_0000651]
SLC6A2,ENSG00000103546,MONDO_0005090,0.5912119598023212,48,schizophrenia,[EFO_0005407],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0005762,0.5946439230548015,34,neuropathic pain,[EFO_0003843],[EFO_0000651]
SLC6A2,ENSG00000103546,EFO_0005687,0.6056903973903128,143,fibromyalgia,"[EFO_0002970, MONDO_0700057]","[OTAR_0000006, EFO_0000618]"
SLC6A2,ENSG00000103546,MONDO_0004985,0.594320703907068,34,bipolar disorder,[EFO_0004247],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,MONDO_0004979,0.4619748183558772,2,asthma,[EFO_1002018],[OTAR_0000010]
SLC6A2,ENSG00000103546,MONDO_0002277,0.5030392466541774,3,arteriosclerosis disorder,[MONDO_0000473],[EFO_0000319]
SLC6A2,ENSG00000103546,MONDO_0019338,0.3695798546847018,1,sarcoidosis,[MONDO_0017955],[OTAR_0000006]
SLC6A2,ENSG00000103546,MONDO_0004992,0.2924686116665476,15,cancer,[EFO_0000616],[MONDO_0045024]
SLC6A2,ENSG00000103546,MONDO_0043510,0.5301212371169064,6,brain injury,"[EFO_0005774, EFO_0009490]","[EFO_0000618, OTAR_0000009]"
SLC6A2,ENSG00000103546,HP_0000020,0.5446041428717276,15,Urinary incontinence,"[HP_0025142, HP_0000014]",[EFO_0000651]
SLC6A2,ENSG00000103546,EFO_1002014,0.5035936164362045,4,melancholia,[MONDO_0002050],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0000621,0.533638129014909,70,neuroblastoma,[EFO_1000393],"[EFO_0000618, MONDO_0045024]"
SLC6A2,ENSG00000103546,MONDO_0005180,0.5607234058986551,26,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
SLC6A2,ENSG00000103546,MONDO_0005178,0.5206222072775718,8,osteoarthritis,[EFO_0005856],[OTAR_0000006]
SLC6A2,ENSG00000103546,MONDO_0002050,0.6057805411037763,209,depressive disorder,[EFO_0004247],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,MONDO_0002009,0.6192527468891927,395,major depressive disorder,[MONDO_0002050],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0005543,0.25870589827929125,1,glioma,"[EFO_0009386, MONDO_0021193]","[EFO_0000618, MONDO_0045024]"
SLC6A2,ENSG00000103546,EFO_0005531,0.25870589827929125,1,urticaria,[MONDO_0002406],[EFO_0010285]
SLC6A2,ENSG00000103546,EFO_0005411,0.4619748183558772,2,schizoaffective disorder,[EFO_0005407],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,MONDO_0001583,0.27718489101352634,2,diabetic polyneuropathy,[EFO_1000783],[EFO_0000618]
SLC6A2,ENSG00000103546,EFO_0000555,0.5326563370271586,7,irritable bowel syndrome,[EFO_0009431],[EFO_0010282]
SLC6A2,ENSG00000103546,EFO_1001417,0.25870589827929125,1,"Rhinitis, Allergic, Perennial",[EFO_0005854],"[EFO_0000540, OTAR_0000010]"
SLC6A2,ENSG00000103546,EFO_0003925,0.4008914812621557,4,cognition,[EFO_0004323],[GO_0008150]
SLC6A2,ENSG00000103546,EFO_0003922,0.501984770798946,7,menopause,[EFO_0003765],[EFO_0000651]
SLC6A2,ENSG00000103546,EFO_0003918,0.4856356168566882,16,obstructive sleep apnea,[EFO_0003877],"[MONDO_0002025, EFO_0000618, OTAR_0000010]"
SLC6A2,ENSG00000103546,EFO_0004616,0.5583419914330305,9,"osteoarthritis, knee",[MONDO_0005178],[OTAR_0000006]
SLC6A2,ENSG00000103546,EFO_0000616,0.2785964830150208,57,neoplasm,[MONDO_0023370],[MONDO_0045024]
SLC6A2,ENSG00000103546,EFO_0002610,0.3044818450569705,41,cocaine dependence,[EFO_0003890],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0009267,0.25870589827929125,1,delirium,[MONDO_0002039],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0004318,0.3233823728491141,2,smoking behavior,[GO_0007610],[GO_0008150]
SLC6A2,ENSG00000103546,MONDO_0008903,0.3233823728491141,2,lung cancer,"[MONDO_0021117, MONDO_0003274, MONDO_0000376]","[OTAR_0000010, MONDO_0045024]"
SLC6A2,ENSG00000103546,EFO_0001358,0.5619803513141194,17,post-traumatic stress disorder,"[EFO_0010098, EFO_0004257]","[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0004287,0.4910894980193721,4,ventricular fibrillation,"[MONDO_0007263, EFO_0004269]",[EFO_0000319]
SLC6A2,ENSG00000103546,EFO_0004278,0.25870589827929125,1,sudden cardiac arrest,[EFO_0009492],[EFO_0000319]
SLC6A2,ENSG00000103546,EFO_0004269,0.4619748183558772,2,cardiac arrhythmia,[EFO_0003777],[EFO_0000319]
SLC6A2,ENSG00000103546,EFO_1000453,0.47788820827110523,6,Paraganglioma,"[MONDO_0025511, MONDO_0002366]","[OTAR_0000018, MONDO_0045024, EFO_0001379, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_1000948,0.3233823728491141,2,gastroparesis,[MONDO_0001318],[EFO_0010282]
SLC6A2,ENSG00000103546,EFO_0000502,0.28129133384335636,3,ganglioneuroblastoma,[EFO_1000393],"[EFO_0000618, MONDO_0045024]"
SLC6A2,ENSG00000103546,EFO_0000474,0.3695798546847018,1,epilepsy,[EFO_0005774],[EFO_0000618]
SLC6A2,ENSG00000103546,EFO_0006788,0.5847867194674438,18,anxiety disorder,[EFO_0000677],"[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,MONDO_0004975,0.46034207998394355,17,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
SLC6A2,ENSG00000103546,EFO_0007625,0.3233823728491141,2,asthenia,[EFO_0003765],[EFO_0000651]
SLC6A2,ENSG00000103546,EFO_0007533,0.25870589827929125,1,vasomotor rhinitis,[EFO_0005854],"[EFO_0000540, OTAR_0000010]"
SLC6A2,ENSG00000103546,EFO_0007486,0.5767679898067295,13,sinusitis,[EFO_0009481],"[OTAR_0000006, OTAR_0000010]"
SLC6A2,ENSG00000103546,HP_0000989,0.38292579388164927,3,Pruritus,[HP_0000951],[EFO_0000651]
SLC6A2,ENSG00000103546,MONDO_0005041,0.5035012214725333,5,glaucoma,[EFO_0003966],[MONDO_0024458]
SLC6A2,ENSG00000103546,MONDO_0005301,0.36442050734256,8,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
SLC6A2,ENSG00000103546,MONDO_0005277,0.5608788605590145,9,migraine disorder,"[MONDO_0017181, EFO_0005774, MONDO_0043218]","[EFO_0000618, EFO_0000319]"
SLC6A2,ENSG00000103546,MONDO_0005271,0.46839113527748666,4,allergic disease,[EFO_1002003],[EFO_0000540]
SLC6A20,ENSG00000163817,HP_0000407,0.3695798546847018,1,Sensorineural hearing impairment,[HP_0000364],[EFO_0000651]
SLC6A20,ENSG00000163817,HP_0003108,0.5523513388163157,187,Hyperglycinuria,[HP_0003110],[EFO_0000651]
SLC6A20,ENSG00000163817,EFO_0004725,0.3812471281244768,2,metabolite measurement,[EFO_0001444],[EFO_0001444]
SLC6A20,ENSG00000163817,EFO_0005664,0.4031464321128482,3,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC6A20,ENSG00000163817,EFO_0005653,0.20765536255310935,1,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC6A20,ENSG00000163817,EFO_0008375,0.310695155191133,1,macula measurement,[EFO_0004731],[EFO_0001444]
SLC6A20,ENSG00000163817,MONDO_0009448,0.5755937498360861,29,iminoglycinuria,[MONDO_0019216],"[OTAR_0000018, OTAR_0000020]"
SLC6A20,ENSG00000163817,EFO_0004346,0.20513702779646997,2,neuroimaging measurement,[EFO_0001444],[EFO_0001444]
SLC6A20,ENSG00000163817,EFO_0600005,0.3073487129408385,1,ganglion cell inner plexiform layer thickness measurement,[EFO_0600002],[EFO_0001444]
SLC6A20,ENSG00000163817,EFO_0600004,0.26130349331344915,1,retinal nerve fibre layer thickness measurement,[EFO_0600002],[EFO_0001444]
SLC6A20,ENSG00000163817,EFO_0600002,0.29888150670680846,1,retinal layer thickness measurement,[EFO_0004731],[EFO_0001444]
SLC6A20,ENSG00000163817,EFO_0004840,0.20840577796621088,3,cortical thickness,[EFO_0004464],[EFO_0001444]
SLC6A20,ENSG00000163817,EFO_1002009,0.2714763083334487,2,macular telangiectasia type 2,[EFO_0003839],"[EFO_0000618, MONDO_0024458]"
SLC6A20,ENSG00000163817,EFO_0004464,0.3389987820989641,2,brain measurement,[EFO_0001444],[EFO_0001444]
SLC6A20,ENSG00000163817,EFO_0005116,0.3710424541318779,2,urinary metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC6A20,ENSG00000163817,MONDO_0100096,0.44943500467612446,93,COVID-19,[MONDO_0020753],[EFO_0005741]
SLC6A20,ENSG00000163817,EFO_0007937,0.2957262293064482,1,blood protein measurement,[EFO_0004747],[EFO_0001444]
SLC6A20,ENSG00000163817,EFO_0009773,0.29629368799903927,1,proline measurement,[EFO_0005134],[EFO_0001444]
SLC6A21P,ENSG00000269009,NA,NA,NA,NA,NA,NA
SLC6A3,ENSG00000142319,HP_0012378,0.5429680606238632,15,Fatigue,"[HP_0025142, EFO_0003765]",[EFO_0000651]
SLC6A3,ENSG00000142319,MONDO_0007254,0.3285209187536865,8,breast cancer,"[EFO_0003869, MONDO_0003274]","[OTAR_0000017, MONDO_0045024, EFO_0010285]"
SLC6A3,ENSG00000142319,MONDO_0002561,0.28853761142798084,1,lysosomal storage disease,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
SLC6A3,ENSG00000142319,MONDO_0002491,0.47781963309105935,15,substance abuse,[MONDO_0002494],[MONDO_0002025]
SLC6A3,ENSG00000142319,MONDO_0018975,0.3695798546847018,1,neurofibromatosis type 1,"[MONDO_0800089, EFO_0008514, MONDO_0019755, EFO_1001502]","[OTAR_0000006, OTAR_0000018, MONDO_0045024, EFO_0000618]"
SLC6A3,ENSG00000142319,MONDO_0016158,0.5909005482437623,22,narcolepsy-cataplexy syndrome,"[EFO_0005774, MONDO_0021107]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC6A3,ENSG00000142319,EFO_0005230,0.4502807052887177,111,anxiety,[HP_0000708],[EFO_0000651]
SLC6A3,ENSG00000142319,EFO_0005203,0.523055125384997,24,eating disorder,"[EFO_0000677, MONDO_0002025, EFO_0001069]","[MONDO_0002025, OTAR_0000020, EFO_0000618]"
SLC6A3,ENSG00000142319,EFO_0005271,0.4406230725990027,3,sleep duration,[EFO_0004870],[EFO_0001444]
SLC6A3,ENSG00000142319,EFO_0005246,0.506889036807143,4,hypersomnia,[MONDO_0003406],"[MONDO_0002025, EFO_0000618]"
SLC6A3,ENSG00000142319,EFO_0003833,0.3233823728491141,2,brain neoplasm,"[EFO_0005774, EFO_1000158]","[EFO_0000618, MONDO_0045024]"
SLC6A3,ENSG00000142319,EFO_0008568,0.5678703197715422,12,Sleep Disorder,[EFO_0000677],"[MONDO_0002025, EFO_0000618]"
SLC6A3,ENSG00000142319,MONDO_0021107,0.39957605076926794,17,narcolepsy,"[EFO_0000508, MONDO_0003406]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC6A3,ENSG00000142319,HP_0003419,0.35443734674970356,4,Low back pain,[HP_0003418],[EFO_0000651]
SLC6A3,ENSG00000142319,EFO_0001074,0.3695798546847018,1,morbid obesity,[EFO_0001073],[OTAR_0000020]
SLC6A3,ENSG00000142319,EFO_0001073,0.6083695577575792,104,obesity,[MONDO_0003916],[OTAR_0000020]
SLC6A3,ENSG00000142319,EFO_0004701,0.46201842270025834,30,methamphetamine dependence,[EFO_0003890],"[MONDO_0002025, EFO_0000618]"
SLC6A3,ENSG00000142319,EFO_0004698,0.4766903412584508,7,insomnia,[EFO_0008568],"[MONDO_0002025, EFO_0000618]"
SLC6A3,ENSG00000142319,EFO_0005924,0.466450841040392,5,binge eating,[EFO_0005203],"[MONDO_0002025, OTAR_0000020, EFO_0000618]"
SLC6A3,ENSG00000142319,EFO_0003768,0.7097887315355158,86,nicotine dependence,[EFO_0003890],"[MONDO_0002025, EFO_0000618]"
SLC6A3,ENSG00000142319,MONDO_0011382,0.25870589827929125,1,sickle cell anemia,"[EFO_1000017, MONDO_0017146]","[OTAR_0000018, EFO_0005803]"
SLC6A3,ENSG00000142319,EFO_0001642,0.25870589827929125,1,lymphoid neoplasm,[MONDO_0044881],"[MONDO_0045024, EFO_0005803]"
SLC6A3,ENSG00000142319,EFO_0000313,0.4623443982105619,3,carcinoma,"[MONDO_0004992, EFO_0006858]",[MONDO_0045024]
SLC6A3,ENSG00000142319,EFO_0000174,0.27718489101352634,2,Ewing sarcoma,"[MONDO_0021038, EFO_0000691]",[MONDO_0045024]
SLC6A3,ENSG00000142319,MONDO_0024880,0.25870589827929125,1,metastatic malignant neoplasm,"[EFO_0009709, EFO_0009812]",[MONDO_0045024]
SLC6A3,ENSG00000142319,MONDO_0024622,0.2309874091779386,2,thyroid gland adenocarcinoma,"[EFO_0000228, EFO_0002892]","[MONDO_0045024, EFO_0001379]"
SLC6A3,ENSG00000142319,EFO_0003890,0.5195417964569394,67,drug dependence,"[EFO_0000677, MONDO_0004938]","[MONDO_0002025, EFO_0000618]"
SLC6A3,ENSG00000142319,EFO_0003888,0.6461301431010131,1170,attention deficit hyperactivity disorder,[MONDO_0000592],"[MONDO_0002025, EFO_0000618]"
SLC6A3,ENSG00000142319,HP_0100543,0.4760226598340445,86,Cognitive impairment,[HP_0011446],[EFO_0000651]
SLC6A3,ENSG00000142319,EFO_0003047,0.3695798546847018,1,hepatitis C virus infection,[EFO_0004196],"[EFO_0001379, EFO_0005741, EFO_0010282]"
SLC6A3,ENSG00000142319,EFO_0000712,0.450045601935221,5,stroke,[EFO_0003763],"[EFO_0000618, EFO_0000319]"
SLC6A3,ENSG00000142319,EFO_0004247,0.4709953178097437,21,mood disorder,[EFO_0000677],"[MONDO_0002025, EFO_0000618]"
SLC6A3,ENSG00000142319,EFO_0004242,0.47876489934091904,25,obsessive-compulsive disorder,"[EFO_0000508, EFO_0006788]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC6A3,ENSG00000142319,EFO_0008623,0.5414755515413864,6,dysthymic disorder,[EFO_0004247],"[MONDO_0002025, EFO_0000618]"
SLC6A3,ENSG00000142319,MONDO_0700117,0.3816210367738259,16,SLC6A3-related dopamine transporter deficiency syndrome,[EFO_0004280],[EFO_0000618]
SLC6A3,ENSG00000142319,MONDO_0100339,0.3695798546847018,1,Friedreich ataxia,[MONDO_0020046],"[OTAR_0000018, EFO_0000618]"
SLC6A3,ENSG00000142319,EFO_0003761,0.6170937354750876,312,unipolar depression,[MONDO_0002050],"[MONDO_0002025, EFO_0000618]"
SLC6A3,ENSG00000142319,EFO_0004320,0.3695798546847018,1,suicidal ideation,[EFO_0007623],[GO_0008150]
SLC6A3,ENSG00000142319,EFO_0004319,0.5836550678913457,23,smoking cessation,[GO_0007610],[GO_0008150]
SLC6A3,ENSG00000142319,EFO_0009963,0.32384434766746995,4,bipolar I disorder,[MONDO_0004985],"[MONDO_0002025, EFO_0000618]"
SLC6A3,ENSG00000142319,EFO_0009854,0.4424692149141846,3,treatment resistant depression,[EFO_0003761],"[MONDO_0002025, EFO_0000618]"
SLC6A3,ENSG00000142319,HP_0002045,0.37050380432141355,2,Hypothermia,[HP_0004370],[EFO_0000651]
SLC6A3,ENSG00000142319,MONDO_0005090,0.6127207146709182,217,schizophrenia,[EFO_0005407],"[MONDO_0002025, EFO_0000618]"
SLC6A3,ENSG00000142319,EFO_0005772,0.4425321866211271,24,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC6A3,ENSG00000142319,EFO_0005687,0.37138155647628973,3,fibromyalgia,"[EFO_0002970, MONDO_0700057]","[OTAR_0000006, EFO_0000618]"
SLC6A3,ENSG00000142319,MONDO_0004985,0.5707858153822506,84,bipolar disorder,[EFO_0004247],"[MONDO_0002025, EFO_0000618]"
SLC6A3,ENSG00000142319,MONDO_0002277,0.5030392466541774,3,arteriosclerosis disorder,[MONDO_0000473],[EFO_0000319]
SLC6A3,ENSG00000142319,MONDO_0019338,0.3695798546847018,1,sarcoidosis,[MONDO_0017955],[OTAR_0000006]
SLC6A3,ENSG00000142319,MONDO_0043510,0.5114266561341052,7,brain injury,"[EFO_0005774, EFO_0009490]","[EFO_0000618, OTAR_0000009]"
SLC6A3,ENSG00000142319,Orphanet_238455,0.6840228389663253,75,Infantile dystonia-parkinsonism,"[Orphanet_391799, Orphanet_307055]","[OTAR_0000018, EFO_0000618]"
SLC6A3,ENSG00000142319,MONDO_0054835,0.4619748183558772,2,classic dopamine transporter deficiency syndrome,"[MONDO_0700117, MONDO_0013150]","[OTAR_0000018, EFO_0000618]"
SLC6A3,ENSG00000142319,MONDO_0005180,0.5123016024107546,751,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
SLC6A3,ENSG00000142319,MONDO_0005178,0.3701002561868943,3,osteoarthritis,[EFO_0005856],[OTAR_0000006]
SLC6A3,ENSG00000142319,EFO_0003060,0.395861088795614,6,non-small cell lung carcinoma,[EFO_0001071],"[OTAR_0000010, MONDO_0045024]"
SLC6A3,ENSG00000142319,MONDO_0002050,0.5967597933833725,62,depressive disorder,[EFO_0004247],"[MONDO_0002025, EFO_0000618]"
SLC6A3,ENSG00000142319,MONDO_0002009,0.6120027338770329,114,major depressive disorder,[MONDO_0002050],"[MONDO_0002025, EFO_0000618]"
SLC6A3,ENSG00000142319,MONDO_0013150,0.7132984058449483,356,"parkinsonism-dystonia, infantile","[MONDO_0021095, MONDO_0018329]","[OTAR_0000018, EFO_0000618]"
SLC6A3,ENSG00000142319,EFO_0005543,0.25870589827929125,1,glioma,"[EFO_0009386, MONDO_0021193]","[EFO_0000618, MONDO_0045024]"
SLC6A3,ENSG00000142319,EFO_0005411,0.5276163069907102,5,schizoaffective disorder,[EFO_0005407],"[MONDO_0002025, EFO_0000618]"
SLC6A3,ENSG00000142319,EFO_0003925,0.39627173307859687,3,cognition,[EFO_0004323],[GO_0008150]
SLC6A3,ENSG00000142319,EFO_0003922,0.4619748183558772,2,menopause,[EFO_0003765],[EFO_0000651]
SLC6A3,ENSG00000142319,EFO_0003918,0.5623045720709309,14,obstructive sleep apnea,[EFO_0003877],"[MONDO_0002025, EFO_0000618, OTAR_0000010]"
SLC6A3,ENSG00000142319,EFO_0002610,0.31158442088644,109,cocaine dependence,[EFO_0003890],"[MONDO_0002025, EFO_0000618]"
SLC6A3,ENSG00000142319,EFO_0009267,0.26530516671312887,16,delirium,[MONDO_0002039],"[MONDO_0002025, EFO_0000618]"
SLC6A3,ENSG00000142319,EFO_0004318,0.3233823728491141,2,smoking behavior,[GO_0007610],[GO_0008150]
SLC6A3,ENSG00000142319,MONDO_0008903,0.3233823728491141,2,lung cancer,"[MONDO_0021117, MONDO_0003274, MONDO_0000376]","[OTAR_0000010, MONDO_0045024]"
SLC6A3,ENSG00000142319,EFO_0001358,0.4246095429629381,53,post-traumatic stress disorder,"[EFO_0010098, EFO_0004257]","[MONDO_0002025, EFO_0000618]"
SLC6A3,ENSG00000142319,EFO_0000474,0.3695798546847018,1,epilepsy,[EFO_0005774],[EFO_0000618]
SLC6A3,ENSG00000142319,MONDO_0004975,0.5478087708765961,66,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
SLC6A3,ENSG00000142319,EFO_0007625,0.3233823728491141,2,asthenia,[EFO_0003765],[EFO_0000651]
SLC6A3,ENSG00000142319,EFO_0007454,0.25870589827929125,1,postpoliomyelitis syndrome,[EFO_0007450],"[EFO_0005741, EFO_0000618]"
SLC6A3,ENSG00000142319,HP_0001249,0.46262158310157553,4,Intellectual disability,"[HP_0012759, HP_0100543]",[EFO_0000651]
SLC6A3,ENSG00000142319,MONDO_0005041,0.4619748183558772,2,glaucoma,[EFO_0003966],[MONDO_0024458]
SLC6A3,ENSG00000142319,MONDO_0005301,0.5483322840275283,11,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
SLC6A4,ENSG00000108576,HP_0031217,0.39916775468152027,12,Hot flashes,[HP_0025142],[EFO_0000651]
SLC6A4,ENSG00000108576,HP_0030839,0.3682965913003799,4,Knee pain,[HP_0012514],[EFO_0000651]
SLC6A4,ENSG00000108576,HP_0030834,0.4342563292545246,2,Shoulder pain,"[HP_0025142, EFO_0003843]",[EFO_0000651]
SLC6A4,ENSG00000108576,HP_0030833,0.39627173307859687,3,Neck pain,"[EFO_0003843, HP_0025142]",[EFO_0000651]
SLC6A4,ENSG00000108576,HP_0012532,0.5593072033708527,8,Chronic pain,"[EFO_0003843, HP_0025142]",[EFO_0000651]
SLC6A4,ENSG00000108576,HP_0012076,0.3993618313080439,6,Borderline personality disorder,[HP_0012075],[EFO_0000651]
SLC6A4,ENSG00000108576,MONDO_0024290,0.49071991816468735,3,enuresis,[MONDO_0002025],[MONDO_0002025]
SLC6A4,ENSG00000108576,MONDO_0021698,0.3695798546847018,1,alcohol-related disorders,[MONDO_0002494],[MONDO_0002025]
SLC6A4,ENSG00000108576,EFO_1000789,0.3695798546847018,1,"osteoarthritis, hand",[MONDO_0005178],[OTAR_0000006]
SLC6A4,ENSG00000108576,EFO_1000783,0.5806180112151172,24,diabetic neuropathy,"[EFO_0003100, EFO_0009532]",[EFO_0000618]
SLC6A4,ENSG00000108576,EFO_1000781,0.3695798546847018,1,overactive bladder,[EFO_1000018],[EFO_0009690]
SLC6A4,ENSG00000108576,EFO_0020092,0.21005092542662018,1,neuroinflammatory disorder,"[EFO_0009386, MONDO_0002977]","[EFO_0000540, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0011023,0.3695798546847018,1,concussion,"[EFO_0009505, MONDO_0043510]","[EFO_0000618, OTAR_0000009]"
SLC6A4,ENSG00000108576,EFO_0007228,0.25870589827929125,1,cryptococcal meningitis,"[EFO_1000942, EFO_0007229]","[EFO_0005741, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0007191,0.40255459060823684,5,cannabis dependence,[EFO_0003890],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0007169,0.27718489101352634,2,biliary dyskinesia,"[EFO_0003832, MONDO_0002886, MONDO_0002866]",[EFO_0010282]
SLC6A4,ENSG00000108576,EFO_0005230,0.6040198097657289,442,anxiety,[HP_0000708],[EFO_0000651]
SLC6A4,ENSG00000108576,EFO_0005203,0.34451740336311837,23,eating disorder,"[EFO_0000677, MONDO_0002025, EFO_0001069]","[MONDO_0002025, OTAR_0000020, EFO_0000618]"
SLC6A4,ENSG00000108576,MONDO_0004169,0.3695798546847018,1,premenstrual tension,[EFO_0009549],[OTAR_0000017]
SLC6A4,ENSG00000108576,EFO_0005407,0.5059659882947585,17,psychosis,"[EFO_0000677, MONDO_0002039]","[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0000685,0.4933993721111514,5,rheumatoid arthritis,"[MONDO_0000589, EFO_0005140, EFO_0005755, EFO_0005856]","[OTAR_0000006, EFO_0000540]"
SLC6A4,ENSG00000108576,EFO_0000677,0.5035936164362045,4,mental or behavioural disorder,"[MONDO_0002025, EFO_0005774]","[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0003948,0.5331805370251298,8,gastroesophageal reflux disease,"[EFO_0009544, EFO_0000508, EFO_0009608]","[OTAR_0000018, EFO_0010282]"
SLC6A4,ENSG00000108576,EFO_0003843,0.5734362034166121,17,pain,[EFO_0003765],[EFO_0000651]
SLC6A4,ENSG00000108576,EFO_0000694,0.3682965913003799,4,severe acute respiratory syndrome,"[EFO_0000684, MONDO_0020753]","[EFO_0005741, OTAR_0000010]"
SLC6A4,ENSG00000108576,HP_0000713,0.25870589827929125,1,Agitation,[HP_0000708],[EFO_0000651]
SLC6A4,ENSG00000108576,HP_0000360,0.47500054903919975,15,Tinnitus,[HP_0000364],[EFO_0000651]
SLC6A4,ENSG00000108576,EFO_0008568,0.4348106990365516,3,Sleep Disorder,[EFO_0000677],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0008533,0.25972224287967416,3,dyspepsia,[MONDO_0001318],[EFO_0010282]
SLC6A4,ENSG00000108576,MONDO_0007079,0.5104037199659429,75,alcohol dependence,"[MONDO_0021698, EFO_0003890]","[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,MONDO_0005475,0.3716950320558119,7,migraine with aura,[MONDO_0005277],"[EFO_0000618, EFO_0000319]"
SLC6A4,ENSG00000108576,MONDO_0005351,0.37273626154842904,10,anorexia nervosa,[EFO_0005203],"[MONDO_0002025, OTAR_0000020, EFO_0000618]"
SLC6A4,ENSG00000108576,HP_0003419,0.561864192525149,13,Low back pain,[HP_0003418],[EFO_0000651]
SLC6A4,ENSG00000108576,HP_0003418,0.4895187836369621,5,Back pain,"[HP_0000925, EFO_0003843, HP_0025142]",[EFO_0000651]
SLC6A4,ENSG00000108576,EFO_0001073,0.5905971804860121,91,obesity,[MONDO_0003916],[OTAR_0000020]
SLC6A4,ENSG00000108576,EFO_0004714,0.32696206172494763,8,sexual dysfunction,[HP_0000708],[EFO_0000651]
SLC6A4,ENSG00000108576,EFO_0004698,0.5378843646256293,11,insomnia,[EFO_0008568],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0000660,0.466450841040392,5,polycystic ovary syndrome,"[EFO_0001379, EFO_0005771, EFO_0000508]","[OTAR_0000017, OTAR_0000018, EFO_0001379]"
SLC6A4,ENSG00000108576,EFO_0003768,0.28740412467533694,15,nicotine dependence,[EFO_0003890],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0001645,0.5042121493874476,7,coronary artery disease,"[MONDO_0000473, EFO_0003777]",[EFO_0000319]
SLC6A4,ENSG00000108576,EFO_0000313,0.25870589827929125,1,carcinoma,"[MONDO_0004992, EFO_0006858]",[MONDO_0045024]
SLC6A4,ENSG00000108576,MONDO_0017276,0.3695798546847018,1,frontotemporal dementia,"[MONDO_0024237, MONDO_0015547]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0000612,0.2938394390835897,16,myocardial infarction,[MONDO_0024643],[EFO_0000319]
SLC6A4,ENSG00000108576,EFO_0004262,0.6223821142573681,142,panic disorder,[EFO_0006788],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0005800,0.4619748183558772,2,substance withdrawal syndrome,"[MONDO_0002494, EFO_0000677]","[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0003890,0.404271157564223,12,drug dependence,"[EFO_0000677, MONDO_0004938]","[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0003888,0.5866337399470373,115,attention deficit hyperactivity disorder,[MONDO_0000592],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0005669,0.25870589827929125,1,intracerebral hemorrhage,[EFO_0000551],"[EFO_0000618, EFO_0000319]"
SLC6A4,ENSG00000108576,EFO_1001375,0.3695798546847018,1,Myocardial Ischemia,"[MONDO_0005053, EFO_0001645, MONDO_0024643]",[EFO_0000319]
SLC6A4,ENSG00000108576,EFO_0007328,0.49071991816468735,3,influenza,"[MONDO_0024352, MONDO_0100329]","[EFO_0005741, OTAR_0000010]"
SLC6A4,ENSG00000108576,HP_0100749,0.45478854340367475,3,Chest pain,"[HP_0025142, EFO_0003843]",[EFO_0000651]
SLC6A4,ENSG00000108576,HP_0100543,0.43935899785623495,30,Cognitive impairment,[HP_0011446],[EFO_0000651]
SLC6A4,ENSG00000108576,EFO_0002970,0.5727629328795701,10,muscular disease,[EFO_0009676],[OTAR_0000006]
SLC6A4,ENSG00000108576,EFO_0008507,0.3233823728491141,2,interstitial cystitis,"[EFO_1001986, EFO_1000023]","[OTAR_0000006, EFO_0009690]"
SLC6A4,ENSG00000108576,EFO_0000712,0.5497943551454751,15,stroke,[EFO_0003763],"[EFO_0000618, EFO_0000319]"
SLC6A4,ENSG00000108576,EFO_0004242,0.689757719532671,150,obsessive-compulsive disorder,"[EFO_0000508, EFO_0006788]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0004234,0.3233823728491141,2,erectile dysfunction,"[MONDO_0002036, MONDO_0002134]",[OTAR_0000017]
SLC6A4,ENSG00000108576,EFO_0008623,0.576292650825318,13,dysthymic disorder,[EFO_0004247],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0000537,0.37087679451401473,9,hypertension,[MONDO_0000473],[EFO_0000319]
SLC6A4,ENSG00000108576,HP_0010992,0.5337455395609125,8,Stress urinary incontinence,[HP_0000020],[EFO_0000651]
SLC6A4,ENSG00000108576,HP_0008419,0.3695798546847018,1,Intervertebral disc degeneration,[HP_0000925],[EFO_0000651]
SLC6A4,ENSG00000108576,MONDO_0100431,0.3695798546847018,1,migraine without aura,[MONDO_0005277],"[EFO_0000618, EFO_0000319]"
SLC6A4,ENSG00000108576,MONDO_0100339,0.3695798546847018,1,Friedreich ataxia,[MONDO_0020046],"[OTAR_0000018, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0000673,0.3233823728491141,2,prostate adenocarcinoma,"[EFO_0000228, EFO_0001663]","[OTAR_0000017, MONDO_0045024]"
SLC6A4,ENSG00000108576,EFO_0003761,0.6311916900377332,1511,unipolar depression,[MONDO_0002050],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0003758,0.3902569366153324,121,autism,[EFO_0003756],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0003757,0.37152014892179647,3,Asperger syndrome,[EFO_0003756],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0004320,0.3695798546847018,1,suicidal ideation,[EFO_0007623],[GO_0008150]
SLC6A4,ENSG00000108576,EFO_0009963,0.5676983200561131,9,bipolar I disorder,[MONDO_0004985],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0009867,0.36994943453938645,2,dysphoria,[EFO_0000677],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0009854,0.4877068157382996,9,treatment resistant depression,[EFO_0003761],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0010282,0.44946161129159795,11,gastrointestinal disease,[],[EFO_0010282]
SLC6A4,ENSG00000108576,HP_0001268,0.37022661943040003,3,Mental deterioration,[HP_0100543],[EFO_0000651]
SLC6A4,ENSG00000108576,EFO_0004340,0.3499724698262469,3,body mass index,[EFO_0004324],[EFO_0001444]
SLC6A4,ENSG00000108576,EFO_0009562,0.5030392466541774,3,polyneuropathy,[EFO_0003100],[EFO_0000618]
SLC6A4,ENSG00000108576,EFO_1001917,0.5996937325441083,48,social anxiety disorder,[EFO_1001908],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_1001916,0.4342563292545246,2,separation anxiety disorder,[EFO_0006788],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_1001908,0.3906459064017298,3,phobic disorder,[EFO_0006788],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_1001892,0.5921342458524065,39,generalized anxiety disorder,[EFO_0006788],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_1001872,0.2592602680613183,2,agoraphobia,[EFO_1001908],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_1000632,0.3695798546847018,1,cerebral palsy,"[EFO_1000631, MONDO_0044996]",[EFO_0000618]
SLC6A4,ENSG00000108576,EFO_0003100,0.5098456756446206,5,peripheral neuropathy,"[EFO_0009387, EFO_1001902]",[EFO_0000618]
SLC6A4,ENSG00000108576,HP_0002315,0.5313685691264672,8,Headache,[HP_0012638],[EFO_0000651]
SLC6A4,ENSG00000108576,HP_0002140,0.33159525850877414,3,Ischemic stroke,"[HP_0002637, HP_0100659]",[EFO_0000651]
SLC6A4,ENSG00000108576,EFO_0803321,0.39193233086242274,17,premature ejaculation,[HP_0000078],[EFO_0000651]
SLC6A4,ENSG00000108576,MONDO_0005090,0.6185024437648641,124,schizophrenia,[EFO_0005407],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0005762,0.587940307502595,28,neuropathic pain,[EFO_0003843],[EFO_0000651]
SLC6A4,ENSG00000108576,EFO_0005687,0.6115511768084533,152,fibromyalgia,"[EFO_0002970, MONDO_0700057]","[OTAR_0000006, EFO_0000618]"
SLC6A4,ENSG00000108576,MONDO_0004985,0.6029418590776354,115,bipolar disorder,[EFO_0004247],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,MONDO_0004992,0.26639161854326204,14,cancer,[EFO_0000616],[MONDO_0045024]
SLC6A4,ENSG00000108576,MONDO_0043510,0.4701877040155372,3,brain injury,"[EFO_0005774, EFO_0009490]","[EFO_0000618, OTAR_0000009]"
SLC6A4,ENSG00000108576,HP_0000020,0.5446041428717276,15,Urinary incontinence,"[HP_0025142, HP_0000014]",[EFO_0000651]
SLC6A4,ENSG00000108576,EFO_1002014,0.5294642062641336,6,melancholia,[MONDO_0002050],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,MONDO_0005180,0.37878921069985894,33,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
SLC6A4,ENSG00000108576,MONDO_0005178,0.5116265309534754,7,osteoarthritis,[EFO_0005856],[OTAR_0000006]
SLC6A4,ENSG00000108576,MONDO_0005149,0.2613539357492939,26,pulmonary hypertension,[EFO_0000537],[EFO_0000319]
SLC6A4,ENSG00000108576,MONDO_0002050,0.6063966288810113,368,depressive disorder,[EFO_0004247],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,MONDO_0002046,0.3968261028606239,4,alcohol abuse,"[MONDO_0002491, MONDO_0021698]",[MONDO_0002025]
SLC6A4,ENSG00000108576,MONDO_0002009,0.6240645293799731,769,major depressive disorder,[MONDO_0002050],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0005411,0.37031901439407117,2,schizoaffective disorder,[EFO_0005407],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,MONDO_0001162,0.46326834784727366,4,impulse control disorder,[MONDO_0002025],[MONDO_0002025]
SLC6A4,ENSG00000108576,EFO_0000555,0.5813003058699516,62,irritable bowel syndrome,[EFO_0009431],[EFO_0010282]
SLC6A4,ENSG00000108576,EFO_0003922,0.5544592312683992,13,menopause,[EFO_0003765],[EFO_0000651]
SLC6A4,ENSG00000108576,EFO_0003918,0.5170524933447898,16,obstructive sleep apnea,[EFO_0003877],"[MONDO_0002025, EFO_0000618, OTAR_0000010]"
SLC6A4,ENSG00000108576,EFO_0004616,0.5316098226427198,6,"osteoarthritis, knee",[MONDO_0005178],[OTAR_0000006]
SLC6A4,ENSG00000108576,EFO_0002610,0.30439234038586443,28,cocaine dependence,[EFO_0003890],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0009267,0.36994943453938645,2,delirium,[MONDO_0002039],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0001358,0.6081072398417693,124,post-traumatic stress disorder,"[EFO_0010098, EFO_0004257]","[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,EFO_0004287,0.25870589827929125,1,ventricular fibrillation,"[MONDO_0007263, EFO_0004269]",[EFO_0000319]
SLC6A4,ENSG00000108576,EFO_0004278,0.25870589827929125,1,sudden cardiac arrest,[EFO_0009492],[EFO_0000319]
SLC6A4,ENSG00000108576,EFO_0004220,0.2853977766731864,3,chronic hepatitis C virus infection,[EFO_0003047],"[EFO_0001379, EFO_0005741, EFO_0010282]"
SLC6A4,ENSG00000108576,EFO_1000948,0.3233823728491141,2,gastroparesis,[MONDO_0001318],[EFO_0010282]
SLC6A4,ENSG00000108576,EFO_0006788,0.600683147721102,99,anxiety disorder,[EFO_0000677],"[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,MONDO_0004975,0.4544152512790093,42,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
SLC6A4,ENSG00000108576,MONDO_0100096,0.5155714860100041,19,COVID-19,[MONDO_0020753],[EFO_0005741]
SLC6A4,ENSG00000108576,EFO_0007634,0.37054681931005595,7,major depressive episode,[HP_0000708],[EFO_0000651]
SLC6A4,ENSG00000108576,EFO_0007453,0.47349839207806343,12,postpartum depression,"[EFO_0003761, EFO_0009683, MONDO_0002050]","[MONDO_0002025, OTAR_0000014, EFO_0000618]"
SLC6A4,ENSG00000108576,MONDO_0005301,0.3328887880001706,4,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
SLC6A4,ENSG00000108576,MONDO_0005277,0.5503555680397008,36,migraine disorder,"[MONDO_0017181, EFO_0005774, MONDO_0043218]","[EFO_0000618, EFO_0000319]"
SLC6A4,ENSG00000108576,EFO_0004527,0.2882330430084278,1,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC6A5,ENSG00000165970,MONDO_0021022,0.7387512468799174,598,hereditary hyperekplexia,"[MONDO_0017658, MONDO_0019253]","[OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC6A5,ENSG00000165970,MONDO_0017658,0.48464749852770456,82,hyperekplexia,[EFO_0004280],[EFO_0000618]
SLC6A5,ENSG00000165970,EFO_0005774,0.3695798546847018,1,brain disease,[EFO_0009386],[EFO_0000618]
SLC6A5,ENSG00000165970,HP_0002267,0.4157773365202895,2,Exaggerated startle response,[HP_0011442],[EFO_0000651]
SLC6A5,ENSG00000165970,GO_0006306,0.21477269558199202,1,DNA methylation,"[GO_0044260, GO_0043412, GO_0006139]",[GO_0008150]
SLC6A6,ENSG00000131389,EFO_0010750,0.2532807376454796,1,PHF-tau measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
SLC6A6,ENSG00000131389,MONDO_0004580,0.3326218692162316,2,retinal degeneration,[EFO_0003839],"[EFO_0000618, MONDO_0024458]"
SLC6A6,ENSG00000131389,EFO_0004908,0.386303321163728,4,testosterone measurement,"[EFO_0004529, EFO_0011008]",[EFO_0001444]
SLC6A6,ENSG00000131389,EFO_0006335,0.30333903131490225,1,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC6A6,ENSG00000131389,EFO_0008328,0.25693003013279825,1,chronotype measurement,[EFO_0004870],[EFO_0001444]
SLC6A6,ENSG00000131389,EFO_0004339,0.2715075030037888,2,body height,[EFO_0004324],[EFO_0001444]
SLC6A6,ENSG00000131389,EFO_0004584,0.2568555043684592,2,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
SLC6A6,ENSG00000131389,EFO_0000318,0.4180300452148525,11,cardiomyopathy,"[EFO_0003777, MONDO_0003939]","[OTAR_0000006, EFO_0000319]"
SLC6A7,ENSG00000011083,EFO_0600008,0.25489171674671707,1,mitochondrial heteroplasmy measurement,[EFO_0006312],[EFO_0001444]
SLC6A7,ENSG00000011083,EFO_0005772,0.315715131798622,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC6A8,ENSG00000130821,HP_0000369,0.26609749537298527,1,Low-set ears,[HP_0000377],[EFO_0000651]
SLC6A8,ENSG00000130821,EFO_0000508,0.502365734552688,71,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC6A8,ENSG00000130821,MONDO_0010305,0.8424927198599726,715,creatine transporter deficiency,"[MONDO_0000456, MONDO_0015159, MONDO_0015327, MONDO_0002320]","[OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC6A8,ENSG00000130821,EFO_0010642,0.26701631195615977,4,Neurodevelopmental disorder,"[EFO_0000618, EFO_0009386]",[EFO_0000618]
SLC6A8,ENSG00000130821,MONDO_0010334,0.3326218692162316,1,severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome,"[MONDO_0000761, MONDO_0044807]","[OTAR_0000018, EFO_0000618]"
SLC6A8,ENSG00000130821,HP_0001999,0.26609749537298527,1,Abnormal facial shape,[HP_0000271],[EFO_0000651]
SLC6A8,ENSG00000130821,EFO_0005772,0.5162445275749569,5,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC6A8,ENSG00000130821,Orphanet_52503,0.8233248262215642,695,X-linked creatine transporter deficiency,"[Orphanet_182076, Orphanet_71859, Orphanet_183530, MONDO_0000456]","[MONDO_0002025, OTAR_0000020, EFO_0000618, OTAR_0000018]"
SLC6A8,ENSG00000130821,MONDO_0018247,0.3326218692162316,1,CADDS,"[MONDO_0019053, MONDO_0015327, MONDO_0019046]","[OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC6A8,ENSG00000130821,HP_0001250,0.2666518651550123,2,Seizure,[HP_0012638],[EFO_0000651]
SLC6A8,ENSG00000130821,HP_0001249,0.6120761227434971,48,Intellectual disability,"[HP_0012759, HP_0100543]",[EFO_0000651]
SLC6A9,ENSG00000196517,EFO_0003857,0.37124296403078294,2,arthrogryposis,"[EFO_0004280, EFO_0005755, MONDO_0023603, EFO_0000508]","[OTAR_0000006, OTAR_0000018, EFO_0000618]"
SLC6A9,ENSG00000196517,MONDO_0011612,0.5287880423369077,212,glycine encephalopathy,"[MONDO_0019239, EFO_0005774, MONDO_0004736]","[OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC6A9,ENSG00000196517,MONDO_0017354,0.3695798546847018,1,infantile glycine encephalopathy,[MONDO_0011612],"[OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC6A9,ENSG00000196517,MONDO_0015010,0.7348781803105662,211,atypical glycine encephalopathy,[MONDO_0011612],"[OTAR_0000018, OTAR_0000020, EFO_0000618]"
SLC6A9,ENSG00000196517,MONDO_0005090,0.40101002372478756,23,schizophrenia,[EFO_0005407],"[MONDO_0002025, EFO_0000618]"
SLC6A9,ENSG00000196517,EFO_0005772,0.418494503449339,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC6A9,ENSG00000196517,EFO_0004526,0.3819547963289334,6,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC6A9,ENSG00000196517,EFO_0004528,0.30588592319037844,3,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC6A9,ENSG00000196517,EFO_0004527,0.3622133823728914,5,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
MFSD4A,ENSG00000174514,EFO_0005208,0.23959850672330424,1,glomerular filtration rate,[EFO_0004742],[EFO_0001444]
MFSD4A,ENSG00000174514,EFO_0004308,0.2089587772806684,1,leukocyte count,[EFO_0004586],[EFO_0001444]
MFSD4B,ENSG00000173214,EFO_0004704,0.23665065133573265,1,age at menopause,[EFO_0000246],[EFO_0001444]
MFSD4B,ENSG00000173214,EFO_0005670,0.37148904759858253,3,smoking initiation,[GO_0007610],[GO_0008150]
MFSD4B,ENSG00000173214,EFO_0005653,0.3411535427375874,3,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
MFSD4B,ENSG00000173214,EFO_0000676,0.4305348732053991,8,psoriasis,"[MONDO_0002406, EFO_1000636, EFO_0000540, MONDO_0100118]","[OTAR_0000018, EFO_0000540, EFO_0010285]"
MFSD4B,ENSG00000173214,MONDO_0005148,0.20077187349645184,3,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
MFSD4B,ENSG00000173214,EFO_0004526,0.20843458511812696,9,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
MFSD4B,ENSG00000173214,EFO_0009188,0.291205453065041,4,Red cell distribution width,[EFO_0004509],[EFO_0001444]
MFSD4B,ENSG00000173214,EFO_0004305,0.32100850502841066,6,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
MFSD4B,ENSG00000173214,EFO_0006527,0.3198737619879605,4,smoking status measurement,[EFO_0005671],[EFO_0001444]
MFSD4B,ENSG00000173214,EFO_0004531,0.22140272553909818,3,urate measurement,[EFO_0001444],[EFO_0001444]
MFSD5,ENSG00000182544,EFO_0005772,0.3823105501126211,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
ANKH,ENSG00000154122,EFO_0011011,0.2941704981245049,1,sitting height measurement,[EFO_0004302],[EFO_0001444]
ANKH,ENSG00000154122,EFO_0010972,0.43990647242730685,4,blood phosphate measurement,[EFO_0001444],[EFO_0001444]
ANKH,ENSG00000154122,EFO_0004190,0.40151582261718827,4,open-angle glaucoma,[MONDO_0005041],[MONDO_0024458]
ANKH,ENSG00000154122,EFO_0005664,0.36513010069205104,2,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
ANKH,ENSG00000154122,EFO_0004747,0.29606099909493055,1,protein measurement,[EFO_0001444],[EFO_0001444]
ANKH,ENSG00000154122,MONDO_0015465,0.6840844787534038,239,craniometaphyseal dysplasia,[MONDO_0042973],"[OTAR_0000006, OTAR_0000018]"
ANKH,ENSG00000154122,EFO_0004339,0.2661194244793246,1,body height,[EFO_0004324],[EFO_0001444]
ANKH,ENSG00000154122,EFO_0004541,0.5722830052553576,7,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
ANKH,ENSG00000154122,MONDO_0007319,0.7802745917793754,230,chondrocalcinosis 2,"[EFO_0005755, MONDO_0019052, MONDO_0800096, MONDO_0001314, MONDO_0023603]","[OTAR_0000006, OTAR_0000018, OTAR_0000020]"
ANKH,ENSG00000154122,EFO_0004838,0.2230023445745274,1,calcium measurement,[EFO_0001444],[EFO_0001444]
ANKH,ENSG00000154122,MONDO_0005148,0.4926778510083443,10,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
ANKH,ENSG00000154122,EFO_0004695,0.4543442834713283,5,intraocular pressure measurement,[EFO_0004731],[EFO_0001444]
ANKH,ENSG00000154122,EFO_0004468,0.3562845212758503,3,glucose measurement,[EFO_0006842],[EFO_0001444]
ANKH,ENSG00000154122,EFO_0005134,0.29606099909493055,1,amino acid measurement,[EFO_0001444],[EFO_0001444]
ANKH,ENSG00000154122,EFO_0000400,0.44229334383355745,5,diabetes mellitus,"[EFO_0009406, MONDO_0001933]","[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
ANKH,ENSG00000154122,MONDO_0005041,0.4594130918682489,6,glaucoma,[EFO_0003966],[MONDO_0024458]
SPNS1,ENSG00000169682,NA,NA,NA,NA,NA,NA
SPNS2,ENSG00000183018,HP_0000407,0.28642438738064385,2,Sensorineural hearing impairment,[HP_0000364],[EFO_0000651]
SPNS2,ENSG00000183018,EFO_0000508,0.3383623616851256,29,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SPNS2,ENSG00000183018,MONDO_0019588,0.46411666467541407,10,"hearing loss, autosomal recessive","[EFO_1000017, MONDO_0016298, MONDO_0016297]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SPNS2,ENSG00000183018,EFO_0004308,0.24895767607541286,1,leukocyte count,[EFO_0004586],[EFO_0001444]
SPNS2,ENSG00000183018,EFO_1001176,0.28642438738064385,2,sensorineural hearing loss,[EFO_0004238],"[MONDO_0002025, EFO_0000618]"
SPNS3,ENSG00000182557,NA,NA,NA,NA,NA,NA
TMEM165,ENSG00000134851,EFO_0005409,0.23464537117306075,3,fat body mass,[EFO_0004302],[EFO_0001444]
TMEM165,ENSG00000134851,MONDO_0015286,0.4888790141510349,127,congenital disorder of glycosylation,"[MONDO_0024322, MONDO_0019052]","[OTAR_0000018, OTAR_0000020]"
TMEM165,ENSG00000134851,EFO_0007800,0.30038171547991704,6,body fat percentage,[EFO_0005106],[EFO_0001444]
TMEM165,ENSG00000134851,MONDO_0013870,0.7866387791884137,110,TMEM165-congenital disorder of glycosylation,"[MONDO_0017740, MONDO_0016761, EFO_0005546, MONDO_0018292]","[OTAR_0000006, OTAR_0000018, OTAR_0000020]"
NPC1,ENSG00000141458,MONDO_0018982,0.7890564179789942,2455,Niemann-Pick disease type C,"[EFO_1001380, EFO_1000017]","[OTAR_0000018, OTAR_0000020, EFO_0000540, EFO_0005803]"
NPC1,ENSG00000141458,MONDO_0016158,0.42501683288740705,2,narcolepsy-cataplexy syndrome,"[EFO_0005774, MONDO_0021107]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
NPC1,ENSG00000141458,EFO_0005409,0.33942548174989173,5,fat body mass,[EFO_0004302],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0000195,0.25426979629421925,2,metabolic syndrome,[EFO_0000589],[OTAR_0000020]
NPC1,ENSG00000141458,EFO_0000508,0.5348019496463353,99,genetic disorder,[OTAR_0000018],[OTAR_0000018]
NPC1,ENSG00000141458,EFO_0004995,0.37616898889000294,11,lean body mass,[EFO_0004302],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0008328,0.27161297974624016,1,chronotype measurement,[EFO_0004870],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0008111,0.36557132623547545,5,diet measurement,[EFO_0001444],[EFO_0001444]
NPC1,ENSG00000141458,EFO_1001380,0.6909008302700256,34,Niemann-Pick disease,"[Orphanet_79204, MONDO_0015531, MONDO_0019255]","[OTAR_0000018, OTAR_0000020, EFO_0000540, EFO_0005803]"
NPC1,ENSG00000141458,HP_0100543,0.42757239174067,11,Cognitive impairment,[HP_0011446],[EFO_0000651]
NPC1,ENSG00000141458,EFO_0009390,0.2313247122641558,1,sum of neutrophil and eosinophil counts,[EFO_0007987],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0009388,0.23367607516422811,1,sum of basophil and neutrophil counts,[EFO_0007987],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0004833,0.456653623056766,11,neutrophil count,"[EFO_0803548, EFO_0007987]",[EFO_0001444]
NPC1,ENSG00000141458,EFO_0004784,0.39303760110773844,6,self reported educational attainment,[EFO_0011015],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0004765,0.2658164420702447,1,visceral adipose tissue measurement,[EFO_0004764],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0004735,0.3694210291548843,3,serum alanine aminotransferase measurement,"[EFO_0004582, EFO_0004747]",[EFO_0001444]
NPC1,ENSG00000141458,EFO_0007990,0.3344424597071543,6,neutrophil percentage of leukocytes,[EFO_0004833],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0007989,0.3691496006030543,7,monocyte percentage of leukocytes,[EFO_0005091],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0007988,0.3269225309923999,3,myeloid white cell count,[EFO_0004308],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0007987,0.23168633500862684,1,granulocyte count,[EFO_0007988],[EFO_0001444]
NPC1,ENSG00000141458,HP_0011098,0.42501683288740705,2,Speech apraxia,[HP_0011442],[EFO_0000651]
NPC1,ENSG00000141458,EFO_0006941,0.256918509135274,1,grip strength measurement,[EFO_0004302],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0003144,0.25143590687850187,2,heart failure,[EFO_0003777],[EFO_0000319]
NPC1,ENSG00000141458,EFO_0004339,0.2656862987178932,2,body height,[EFO_0004324],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0004338,0.33772520720168553,4,body weight,[EFO_0004324],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0004337,0.31557231506182437,2,intelligence,[EFO_0003925],[GO_0008150]
NPC1,ENSG00000141458,EFO_0010130,0.27161297974624016,1,health study participation,[EFO_0000651],[EFO_0000651]
NPC1,ENSG00000141458,EFO_0010092,0.26090876146901826,1,bitter alcoholic beverage consumption measurement,[EFO_0010089],[EFO_0001444]
NPC1,ENSG00000141458,MONDO_0003441,0.3326218692162316,2,dystonic disorder,[EFO_0004280],[EFO_0000618]
NPC1,ENSG00000141458,EFO_0010724,0.2565968464089846,1,lifestyle measurement,[EFO_0001444],[EFO_0001444]
NPC1,ENSG00000141458,HP_0001332,0.3338762848396739,7,Dystonia,"[HP_0100022, HP_0000708]",[EFO_0000651]
NPC1,ENSG00000141458,EFO_0004458,0.24297931370808795,1,C-reactive protein measurement,"[EFO_0004747, EFO_0004872]",[EFO_0001444]
NPC1,ENSG00000141458,EFO_0004343,0.25156866895028634,1,waist-hip ratio,[EFO_0007861],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0004342,0.23586118764687092,1,waist circumference,[EFO_0004324],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0004340,0.4565560147382147,15,body mass index,[EFO_0004324],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0004533,0.3289688704974824,3,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
NPC1,ENSG00000141458,EFO_0000319,0.2754612342948908,4,cardiovascular disease,[],[EFO_0000319]
NPC1,ENSG00000141458,HP_0002315,0.42501683288740705,2,Headache,[HP_0012638],[EFO_0000651]
NPC1,ENSG00000141458,HP_0002172,0.42501683288740705,2,Postural instability,[HP_0100022],[EFO_0000651]
NPC1,ENSG00000141458,HP_0001939,0.406537840153172,2,Abnormality of metabolism/homeostasis,[HP_0000118],[EFO_0000651]
NPC1,ENSG00000141458,MONDO_0005090,0.2588004630381724,4,schizophrenia,[EFO_0005407],"[MONDO_0002025, EFO_0000618]"
NPC1,ENSG00000141458,EFO_0005772,0.3378737935450162,35,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
NPC1,ENSG00000141458,MONDO_0005148,0.32955688573984426,8,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
NPC1,ENSG00000141458,EFO_0004614,0.2399709014903171,1,apolipoprotein A 1 measurement,"[EFO_0004872, EFO_0005278, EFO_0004732]",[EFO_0001444]
NPC1,ENSG00000141458,EFO_0004526,0.438622535134368,13,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0004503,0.27090620193351583,3,hematological measurement,[EFO_0001444],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0005093,0.34317258133816214,4,hip circumference,"[EFO_0004512, EFO_0004324]",[EFO_0001444]
NPC1,ENSG00000141458,EFO_0007878,0.327516810821781,3,alcohol consumption measurement,[EFO_0001444],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0007800,0.36161904650313315,7,body fat percentage,[EFO_0005106],[EFO_0001444]
NPC1,ENSG00000141458,MONDO_0000437,0.42501683288740705,2,cerebellar ataxia,"[MONDO_0002427, MONDO_0100308, EFO_0004280]",[EFO_0000618]
NPC1,ENSG00000141458,EFO_0004612,0.36830424274680507,3,high density lipoprotein cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
NPC1,ENSG00000141458,EFO_0004611,0.21855482098531706,1,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
NPC1,ENSG00000141458,EFO_0004308,0.3643390687985755,4,leukocyte count,[EFO_0004586],[EFO_0001444]
NPC1,ENSG00000141458,MONDO_0016310,0.3695798546847018,1,"Niemann-Pick disease type C, adult neurologic onset",[MONDO_0018982],"[OTAR_0000018, OTAR_0000020, EFO_0000540, EFO_0005803]"
NPC1,ENSG00000141458,MONDO_0016309,0.3695798546847018,1,"Niemann-Pick disease type C, juvenile neurologic onset",[MONDO_0018982],"[OTAR_0000018, OTAR_0000020, EFO_0000540, EFO_0005803]"
NPC1,ENSG00000141458,MONDO_0016308,0.3695798546847018,1,"Niemann-Pick disease type C, late infantile neurologic onset",[MONDO_0018982],"[OTAR_0000018, OTAR_0000020, EFO_0000540, EFO_0005803]"
NPC1,ENSG00000141458,MONDO_0016307,0.3695798546847018,1,"Niemann-Pick disease type C, severe early infantile neurologic onset",[MONDO_0018982],"[OTAR_0000018, OTAR_0000020, EFO_0000540, EFO_0005803]"
NPC1,ENSG00000141458,MONDO_0016306,0.3695798546847018,1,"Niemann-Pick disease type C, severe perinatal form",[MONDO_0018982],"[OTAR_0000018, OTAR_0000020, EFO_0000540, EFO_0005803]"
NPC1,ENSG00000141458,EFO_0007984,0.3960769771064972,10,platelet component distribution width,[EFO_0005036],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0007777,0.2324764815864432,1,base metabolic rate measurement,[EFO_0005115],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0007680,0.2510517440403352,1,gait measurement,[EFO_0001444],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0009805,0.23404349145047526,1,whole body water mass,[EFO_0004302],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0004530,0.40958106893805213,4,triglyceride measurement,[EFO_0004529],[EFO_0001444]
NPC1,ENSG00000141458,EFO_0004528,0.21946850437788692,1,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
NPC1,ENSG00000141458,EFO_0004527,0.3296330484185636,5,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
NPC1L1,ENSG00000015520,EFO_0000266,0.25870589827929125,1,aortic stenosis,[EFO_0009531],[EFO_0000319]
NPC1L1,ENSG00000015520,EFO_0000195,0.5530546937107997,8,metabolic syndrome,[EFO_0000589],[OTAR_0000020]
NPC1L1,ENSG00000015520,MONDO_0021187,0.5974271232668498,47,hyperlipidemia,[EFO_0000589],[OTAR_0000020]
NPC1L1,ENSG00000015520,HP_0003124,0.6776591317935413,152,Hypercholesterolemia,[HP_0003119],[EFO_0000651]
NPC1L1,ENSG00000015520,EFO_0001645,0.5988967567369566,50,coronary artery disease,"[MONDO_0000473, EFO_0003777]",[EFO_0000319]
NPC1L1,ENSG00000015520,EFO_0004911,0.5316098226427198,6,familial hypercholesterolemia,"[MONDO_0001336, MONDO_0037748]","[OTAR_0000018, OTAR_0000020]"
NPC1L1,ENSG00000015520,EFO_0000612,0.4346259091092093,3,myocardial infarction,[MONDO_0024643],[EFO_0000319]
NPC1L1,ENSG00000015520,EFO_0000589,0.37312730484163537,8,metabolic disease,[OTAR_0000020],[OTAR_0000020]
NPC1L1,ENSG00000015520,EFO_0004265,0.3695798546847018,1,peripheral arterial disease,"[MONDO_0000473, EFO_0003914, EFO_0003875]",[EFO_0000319]
NPC1L1,ENSG00000015520,EFO_0003047,0.37300130833916983,10,hepatitis C virus infection,[EFO_0004196],"[EFO_0001379, EFO_0005741, EFO_0010282]"
NPC1L1,ENSG00000015520,EFO_0000712,0.3695798546847018,1,stroke,[EFO_0003763],"[EFO_0000618, EFO_0000319]"
NPC1L1,ENSG00000015520,EFO_0000537,0.25870589827929125,1,hypertension,[MONDO_0000473],[EFO_0000319]
NPC1L1,ENSG00000015520,EFO_0003762,0.3695798546847018,1,vitamin D deficiency,[EFO_0005878],[EFO_0000651]
NPC1L1,ENSG00000015520,EFO_0009932,0.32311295663502004,2,HMG CoA reductase inhibitor use measurement,[EFO_0007010],[EFO_0001444]
NPC1L1,ENSG00000015520,Orphanet_309005,0.6295907314060736,18,Disorder of lipid metabolism,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
NPC1L1,ENSG00000015520,EFO_0004584,0.25936858253229894,1,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
NPC1L1,ENSG00000015520,EFO_0004574,0.6518087154049343,18,total cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
NPC1L1,ENSG00000015520,EFO_0000319,0.5844820082829361,9,cardiovascular disease,[],[EFO_0000319]
NPC1L1,ENSG00000015520,EFO_0003095,0.40192298851637154,20,non-alcoholic fatty liver disease,[MONDO_0004790],"[EFO_0001379, EFO_0010282]"
NPC1L1,ENSG00000015520,EFO_0003086,0.3695798546847018,1,kidney disease,[EFO_0009690],[EFO_0009690]
NPC1L1,ENSG00000015520,MONDO_0005147,0.3695798546847018,1,type 1 diabetes mellitus,"[MONDO_0000569, MONDO_0000588, EFO_0000400]","[OTAR_0000020, EFO_0001379, EFO_0000540, EFO_0009605, EFO_0010282]"
NPC1L1,ENSG00000015520,EFO_0005672,0.4619748183558772,2,acute coronary syndrome,[EFO_1001375],[EFO_0000319]
NPC1L1,ENSG00000015520,MONDO_0002258,0.2816917157984065,1,pharyngitis,[MONDO_0004867],[OTAR_0000010]
NPC1L1,ENSG00000015520,MONDO_0037748,0.3695798546847018,1,hyperlipoproteinemia,[EFO_0000589],[OTAR_0000020]
NPC1L1,ENSG00000015520,GO_0036273,0.2607305054231935,1,response to statin,[GO_0050896],[GO_0008150]
NPC1L1,ENSG00000015520,MONDO_0005148,0.5494522696562415,16,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
NPC1L1,ENSG00000015520,EFO_1001461,0.3695798546847018,1,endothelial dysfunction,[EFO_0004264],[EFO_0000319]
NPC1L1,ENSG00000015520,EFO_0003914,0.5273825838284634,23,atherosclerosis,"[EFO_0009086, MONDO_0002277]",[EFO_0000319]
NPC1L1,ENSG00000015520,EFO_0004615,0.4305935962660262,7,apolipoprotein B measurement,[EFO_0004732],[EFO_0001444]
NPC1L1,ENSG00000015520,MONDO_0019052,0.25870589827929125,1,inborn errors of metabolism,"[EFO_0000589, EFO_0000508]","[OTAR_0000018, OTAR_0000020]"
NPC1L1,ENSG00000015520,EFO_0004611,0.6649520548789738,24,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
NPC1L1,ENSG00000015520,EFO_0000400,0.2607730903281132,15,diabetes mellitus,"[EFO_0009406, MONDO_0001933]","[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
NPC1L1,ENSG00000015520,EFO_0004211,0.3526305119045784,6,Hypertriglyceridemia,[EFO_0000589],[OTAR_0000020]
SLC66A1,ENSG00000040487,EFO_0004705,0.31738932374324347,3,hypothyroidism,[EFO_1000627],[EFO_0001379]
SLC66A1,ENSG00000040487,EFO_0009933,0.3187181531745381,2,Thyroid preparation use measurement,[EFO_0007010],[EFO_0001444]
SLC66A1,ENSG00000040487,EFO_1001055,0.20022026587358124,1,myxedema,[EFO_0004705],[EFO_0001379]
SLC66A1LP,ENSG00000174899,NA,NA,NA,NA,NA,NA
SLC66A2,ENSG00000122490,EFO_0004980,0.20777735047658483,2,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
SLC66A2,ENSG00000122490,MONDO_0005090,0.32994208613033504,7,schizophrenia,[EFO_0005407],"[MONDO_0002025, EFO_0000618]"
SLC66A3,ENSG00000162976,EFO_0004526,0.20232588538551805,6,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC66A3,ENSG00000162976,EFO_0004587,0.2021717040513087,4,lymphocyte count,"[EFO_0006843, EFO_0004308, EFO_0803546]",[EFO_0001444]
CTNS,ENSG00000040531,MONDO_0016239,0.671464067507248,1130,cystinosis,[MONDO_0019246],"[OTAR_0000018, OTAR_0000020]"
CTNS,ENSG00000040531,EFO_0000508,0.556008048479979,416,genetic disorder,[OTAR_0000018],[OTAR_0000018]
CTNS,ENSG00000040531,EFO_0004255,0.25870589827929125,1,nephrotic syndrome,[MONDO_0002331],[EFO_0009690]
CTNS,ENSG00000040531,MONDO_0009064,0.7703664959107104,639,ocular cystinosis,"[MONDO_0019216, EFO_0003966, MONDO_0016239]","[OTAR_0000018, OTAR_0000020, MONDO_0024458]"
CTNS,ENSG00000040531,EFO_0009049,0.7876705363231573,484,Juvenile nephropathic cystinosis,"[Orphanet_98711, Orphanet_98666, Orphanet_98713, Orphanet_79207, Orphanet_98056]","[OTAR_0000018, OTAR_0000020, EFO_0009690, MONDO_0024458]"
CTNS,ENSG00000040531,EFO_0005772,0.2692396619331213,3,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
CTNS,ENSG00000040531,GO_0007568,0.21634019683677985,1,aging,[GO_0032502],[GO_0008150]
MPDU1,ENSG00000129255,MONDO_0012211,0.779153902556736,77,MPDU1-congenital disorder of glycosylation,"[MONDO_0017749, EFO_0005545]","[OTAR_0000018, OTAR_0000020]"
MPDU1,ENSG00000129255,EFO_0000508,0.3386372329282502,34,genetic disorder,[OTAR_0000018],[OTAR_0000018]
MPDU1,ENSG00000129255,MONDO_0012885,0.5543697820270527,3,SRD5A3-congenital disorder of glycosylation,"[EFO_0005545, MONDO_0017749]","[OTAR_0000018, OTAR_0000020]"
MPDU1,ENSG00000129255,EFO_0004908,0.2097052132940955,13,testosterone measurement,"[EFO_0004529, EFO_0011008]",[EFO_0001444]
MPDU1,ENSG00000129255,MONDO_0015286,0.5089666436929263,74,congenital disorder of glycosylation,"[MONDO_0024322, MONDO_0019052]","[OTAR_0000018, OTAR_0000020]"
MPDU1,ENSG00000129255,EFO_0005545,0.5926623614152177,5,congenital disorder of glycosylation type I,[MONDO_0015286],"[OTAR_0000018, OTAR_0000020]"
MPDU1,ENSG00000129255,EFO_0004696,0.28346553191342044,30,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
MPDU1,ENSG00000129255,MONDO_0008907,0.26609749537298527,1,PMM2-congenital disorder of glycosylation,"[MONDO_0017740, EFO_0005545]","[OTAR_0000018, OTAR_0000020]"
MPDU1,ENSG00000129255,HP_0001250,0.3695798546847018,1,Seizure,[HP_0012638],[EFO_0000651]
SLC7A1,ENSG00000139514,EFO_0010750,0.37273299530349446,2,PHF-tau measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
SLC7A1,ENSG00000139514,EFO_0005409,0.3536163120519898,2,fat body mass,[EFO_0004302],[EFO_0001444]
SLC7A1,ENSG00000139514,EFO_0004995,0.43466255232014733,8,lean body mass,[EFO_0004302],[EFO_0001444]
SLC7A1,ENSG00000139514,EFO_0004980,0.390013291027056,2,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
SLC7A1,ENSG00000139514,EFO_0006336,0.4186566717113042,2,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC7A1,ENSG00000139514,EFO_0006335,0.4577347498224696,3,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC7A1,ENSG00000139514,EFO_0000537,0.5104456071154787,18,hypertension,[MONDO_0000473],[EFO_0000319]
SLC7A1,ENSG00000139514,EFO_0007010,0.32920305395395577,1,drug use measurement,[EFO_0001444],[EFO_0001444]
SLC7A1,ENSG00000139514,EFO_0004339,0.39636806655903256,3,body height,[EFO_0004324],[EFO_0001444]
SLC7A1,ENSG00000139514,EFO_0004325,0.3339599262395969,1,blood pressure,[EFO_0004303],[EFO_0001444]
SLC7A1,ENSG00000139514,EFO_0009931,0.41625583791220677,2,Agents acting on the renin-angiotensin system use measurement,[EFO_0007010],[EFO_0001444]
SLC7A1,ENSG00000139514,EFO_0009930,0.33050710751311746,1,Calcium channel blocker use measurement,[EFO_0007010],[EFO_0001444]
SLC7A1,ENSG00000139514,EFO_0009928,0.4142680307729206,2,Diuretic use measurement,[EFO_0007010],[EFO_0001444]
SLC7A1,ENSG00000139514,EFO_0000319,0.3349404321227251,2,cardiovascular disease,[],[EFO_0000319]
SLC7A1,ENSG00000139514,EFO_0004314,0.21731656708123182,2,forced expiratory volume,"[EFO_0003892, EFO_0006841]",[EFO_0001444]
SLC7A1,ENSG00000139514,EFO_0004312,0.23472485491925868,2,vital capacity,[EFO_0003892],[EFO_0001444]
SLC7A1,ENSG00000139514,EFO_0007777,0.2792172786857757,1,base metabolic rate measurement,[EFO_0005115],[EFO_0001444]
SLC7A1,ENSG00000139514,EFO_0009805,0.28381816591698217,1,whole body water mass,[EFO_0004302],[EFO_0001444]
SLC7A10,ENSG00000130876,MONDO_0005405,0.25211349317833404,4,childhood onset asthma,[MONDO_0004979],[OTAR_0000010]
SLC7A10,ENSG00000130876,EFO_0000384,0.27775884571789333,3,Crohn's disease,[EFO_0003767],"[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLC7A10,ENSG00000130876,EFO_0005854,0.3113882654513692,4,allergic rhinitis,"[MONDO_0000771, EFO_0008521]","[EFO_0000540, OTAR_0000010]"
SLC7A10,ENSG00000130876,EFO_0003767,0.29555748628314366,4,inflammatory bowel disease,"[EFO_0000508, EFO_0005140, EFO_0009431]","[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLC7A10,ENSG00000130876,EFO_0007995,0.2814209137572487,5,basophil percentage of granulocytes,[EFO_0005090],[EFO_0001444]
SLC7A10,ENSG00000130876,EFO_0007993,0.21463246653803392,2,lymphocyte percentage of leukocytes,[EFO_0004587],[EFO_0001444]
SLC7A10,ENSG00000130876,EFO_0007992,0.3173573267962473,11,basophil percentage of leukocytes,[EFO_0005090],[EFO_0001444]
SLC7A10,ENSG00000130876,EFO_0007991,0.2213885788457817,2,eosinophil percentage of leukocytes,[EFO_0004842],[EFO_0001444]
SLC7A10,ENSG00000130876,EFO_0007990,0.3045322489677905,4,neutrophil percentage of leukocytes,[EFO_0004833],[EFO_0001444]
SLC7A10,ENSG00000130876,EFO_0007989,0.25216768224929476,7,monocyte percentage of leukocytes,[EFO_0005091],[EFO_0001444]
SLC7A10,ENSG00000130876,EFO_0009942,0.22064538639076262,2,Glucocorticoid use measurement,[EFO_0007010],[EFO_0001444]
SLC7A10,ENSG00000130876,EFO_0009941,0.22064538639076262,2,Inhalant adrenergic use measurement,[EFO_0007010],[EFO_0001444]
SLC7A10,ENSG00000130876,EFO_0010701,0.2840760845390201,4,mean reticulocyte volume,[EFO_0010700],[EFO_0001444]
SLC7A10,ENSG00000130876,EFO_0004348,0.24444253133498303,4,hematocrit,[EFO_0004503],[EFO_0001444]
SLC7A10,ENSG00000130876,EFO_0004584,0.25862323126703635,2,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
SLC7A10,ENSG00000130876,EFO_0004842,0.34239599102601653,7,eosinophil count,"[EFO_0803540, EFO_0007987]",[EFO_0001444]
SLC7A10,ENSG00000130876,MONDO_0004979,0.2912962576543079,23,asthma,[EFO_1002018],[OTAR_0000010]
SLC7A10,ENSG00000130876,EFO_1002011,0.22064538639076262,2,adult onset asthma,[MONDO_0004979],[OTAR_0000010]
SLC7A10,ENSG00000130876,EFO_0004526,0.3454591288455558,25,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC7A10,ENSG00000130876,EFO_0004509,0.23371090800808134,3,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
SLC7A10,ENSG00000130876,EFO_0005091,0.3123846494360442,10,monocyte count,"[EFO_0004308, EFO_0803547]",[EFO_0001444]
SLC7A10,ENSG00000130876,EFO_0005090,0.34277977617010086,23,basophil count,"[EFO_0004872, EFO_0803539, EFO_0007987]",[EFO_0001444]
SLC7A10,ENSG00000130876,EFO_0004587,0.2887158242844864,6,lymphocyte count,"[EFO_0006843, EFO_0004308, EFO_0803546]",[EFO_0001444]
SLC7A10,ENSG00000130876,EFO_0004309,0.30881919274635006,7,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SLC7A10,ENSG00000130876,EFO_0004305,0.3447979027580047,17,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
SLC7A10,ENSG00000130876,EFO_0007985,0.20156029776774584,2,platelet crit,[EFO_0005036],[EFO_0001444]
SLC7A10,ENSG00000130876,EFO_0007978,0.29993578399328197,4,red blood cell density measurement,[EFO_0005047],[EFO_0001444]
SLC7A10,ENSG00000130876,EFO_0007937,0.28345673867701016,3,blood protein measurement,[EFO_0004747],[EFO_0001444]
SLC7A10,ENSG00000130876,HP_0000964,0.24025830962549705,3,Eczema,[HP_0011123],[EFO_0000651]
SLC7A10,ENSG00000130876,EFO_0000729,0.2599576072986496,2,ulcerative colitis,[EFO_0003872],"[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLC7A10,ENSG00000130876,MONDO_0005271,0.2524106566514697,4,allergic disease,[EFO_1002003],[EFO_0000540]
SLC7A10,ENSG00000130876,EFO_0004528,0.3064767776243614,9,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC7A10,ENSG00000130876,EFO_0004527,0.3324229499367407,12,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC7A11,ENSG00000151012,EFO_0004257,0.24353126421280696,1,neurotic disorder,[EFO_0006788],"[MONDO_0002025, EFO_0000618]"
SLC7A11,ENSG00000151012,EFO_0005671,0.23049262854247873,6,smoking behaviour measurement,[EFO_0001444],[EFO_0001444]
SLC7A11,ENSG00000151012,EFO_0005653,0.252893121063382,1,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC7A11,ENSG00000151012,EFO_0008475,0.26821179516536,4,mood instability measurement,[EFO_0006848],[EFO_0001444]
SLC7A11,ENSG00000151012,EFO_0007991,0.40787484640869415,2,eosinophil percentage of leukocytes,[EFO_0004842],[EFO_0001444]
SLC7A11,ENSG00000151012,EFO_0007006,0.2585661439532999,1,depressive symptom measurement,[EFO_0006848],[EFO_0001444]
SLC7A11,ENSG00000151012,EFO_0004339,0.3716541684344618,2,body height,[EFO_0004324],[EFO_0001444]
SLC7A11,ENSG00000151012,EFO_0004842,0.49850342105621215,6,eosinophil count,"[EFO_0803540, EFO_0007987]",[EFO_0001444]
SLC7A11,ENSG00000151012,EFO_0007869,0.35224166978650967,9,wellbeing measurement,[EFO_0006848],[EFO_0001444]
SLC7A11,ENSG00000151012,EFO_0007660,0.4100603863878771,11,neuroticism measurement,"[EFO_0007911, EFO_0006848]",[EFO_0001444]
SLC7A13,ENSG00000164893,EFO_0005208,0.26185140522757644,3,glomerular filtration rate,[EFO_0004742],[EFO_0001444]
SLC7A13,ENSG00000164893,EFO_0004784,0.28980760381305093,4,self reported educational attainment,[EFO_0011015],[EFO_0001444]
SLC7A13,ENSG00000164893,EFO_0004574,0.20118858344205687,3,total cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
SLC7A13,ENSG00000164893,EFO_0004875,0.2668393876955495,2,mathematical ability,[EFO_0003925],[GO_0008150]
SLC7A13,ENSG00000164893,EFO_0004518,0.3150175676801437,3,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC7A13,ENSG00000164893,EFO_0004617,0.28964836340983624,1,cystatin C measurement,"[EFO_0004747, EFO_0004742]",[EFO_0001444]
SLC7A13,ENSG00000164893,EFO_0004611,0.2831415413671135,2,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
SLC7A13,ENSG00000164893,EFO_0004531,0.25492322326050115,2,urate measurement,[EFO_0001444],[EFO_0001444]
SLC7A14,ENSG00000013293,MONDO_0002561,0.30836642846874623,1,lysosomal storage disease,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
SLC7A14,ENSG00000013293,HP_0002619,0.2143523636625174,2,Varicose veins,[HP_0002624],[EFO_0000651]
SLC7A14,ENSG00000013293,EFO_0004749,0.26903725478157,1,CCL2 measurement,"[EFO_0006514, EFO_0004873]",[EFO_0001444]
SLC7A14,ENSG00000013293,EFO_0006810,0.26903725478157,1,oleic acid measurement,[EFO_0005110],[EFO_0001444]
SLC7A14,ENSG00000013293,EFO_0005772,0.30836642846874623,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC7A14,ENSG00000013293,MONDO_0019200,0.5756556209992142,18,retinitis pigmentosa,"[MONDO_0019216, MONDO_0019118]","[MONDO_0002025, OTAR_0000018, OTAR_0000020, MONDO_0024458, EFO_0000618]"
SLC7A14,ENSG00000013293,MONDO_0005180,0.30836642846874623,1,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
SLC7A14,ENSG00000013293,EFO_0005110,0.26903725478157,1,fatty acid measurement,[EFO_0004529],[EFO_0001444]
SLC7A14,ENSG00000013293,MONDO_0004975,0.3106764012674057,4,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
SLC7A14,ENSG00000013293,MONDO_0005301,0.30836642846874623,1,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
SLC7A15P,ENSG00000232800,NA,NA,NA,NA,NA,NA
SLC7A2,ENSG00000003989,EFO_0006336,0.2845877670830248,4,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC7A2,ENSG00000003989,EFO_0005772,0.2623946333710997,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC7A2,ENSG00000003989,EFO_0005134,0.2765279420242086,5,amino acid measurement,[EFO_0001444],[EFO_0001444]
SLC7A2,ENSG00000003989,EFO_0006524,0.26241106087361826,3,L-arginine measurement,[EFO_0020990],[EFO_0001444]
SLC7A2,ENSG00000003989,EFO_0009776,0.20571301020986324,2,ornithine measurement,[EFO_0005134],[EFO_0001444]
SLC7A3,ENSG00000165349,EFO_0005772,0.5142245862611134,4,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC7A4,ENSG00000099960,EFO_0020092,0.28853761142798084,1,neuroinflammatory disorder,"[EFO_0009386, MONDO_0002977]","[EFO_0000540, EFO_0000618]"
SLC7A4,ENSG00000099960,EFO_0005772,0.44106144828381105,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC7A5,ENSG00000103257,MONDO_0005405,0.28216740302697063,1,childhood onset asthma,[MONDO_0004979],[OTAR_0000010]
SLC7A5,ENSG00000103257,EFO_0005664,0.3103841102866538,1,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC7A5,ENSG00000103257,EFO_0005653,0.306632450542174,1,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC7A5,ENSG00000103257,EFO_0009363,0.3109329106907113,1,chronic central serous retinopathy,[EFO_0009784],"[EFO_0000618, MONDO_0024458]"
SLC7A5,ENSG00000103257,EFO_0004747,0.3284720984284295,1,protein measurement,[EFO_0001444],[EFO_0001444]
SLC7A5,ENSG00000103257,EFO_0010701,0.4053537525603915,2,mean reticulocyte volume,[EFO_0010700],[EFO_0001444]
SLC7A5,ENSG00000103257,EFO_0004348,0.45332465968469043,3,hematocrit,[EFO_0004503],[EFO_0001444]
SLC7A5,ENSG00000103257,EFO_0004584,0.22335059591269402,1,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
SLC7A5,ENSG00000103257,MONDO_0005148,0.30601353283746474,5,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC7A5,ENSG00000103257,EFO_0004526,0.5149095967617628,13,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC7A5,ENSG00000103257,EFO_0004509,0.47395650139069223,5,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
SLC7A5,ENSG00000103257,EFO_0005090,0.2892491522483177,4,basophil count,"[EFO_0004872, EFO_0803539, EFO_0007987]",[EFO_0001444]
SLC7A5,ENSG00000103257,EFO_0009188,0.31535699576870585,1,Red cell distribution width,[EFO_0004509],[EFO_0001444]
SLC7A5,ENSG00000103257,EFO_0004309,0.48847462325956226,8,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SLC7A5,ENSG00000103257,EFO_0000519,0.20001063555227222,12,glioblastoma multiforme,"[EFO_0000272, MONDO_0016680]","[MONDO_0045024, EFO_0000618]"
SLC7A5,ENSG00000103257,EFO_0007985,0.40714808734593727,4,platelet crit,[EFO_0005036],[EFO_0001444]
SLC7A5,ENSG00000103257,EFO_0004528,0.4828412860599804,7,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC7A5,ENSG00000103257,EFO_0004527,0.4870925512865933,7,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLC7A6,ENSG00000103064,EFO_0005208,0.3128454885492965,5,glomerular filtration rate,[EFO_0004742],[EFO_0001444]
SLC7A6,ENSG00000103064,EFO_0004725,0.20822630177650125,1,metabolite measurement,[EFO_0001444],[EFO_0001444]
SLC7A6,ENSG00000103064,EFO_0005664,0.3290166595361811,3,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC7A6,ENSG00000103064,EFO_0005653,0.31465579899144847,7,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC7A7,ENSG00000155465,HP_0000407,0.3695798546847018,1,Sensorineural hearing impairment,[HP_0000364],[EFO_0000651]
SLC7A7,ENSG00000155465,MONDO_0009109,0.8427042307879076,638,lysinuric protein intolerance,[MONDO_0019216],"[OTAR_0000018, OTAR_0000020]"
SLC7A7,ENSG00000155465,MONDO_0019751,0.4069994920871341,17,autoinflammatory syndrome,[EFO_0005755],[OTAR_0000006]
SLC7A7,ENSG00000155465,EFO_0003144,0.22534944614961785,3,heart failure,[EFO_0003777],[EFO_0000319]
SLC7A7,ENSG00000155465,EFO_0004541,0.33491000651201275,2,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
SLC7A7,ENSG00000155465,MONDO_0005148,0.26661487143022,1,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC7A8,ENSG00000092068,EFO_0020092,0.33063477898610943,1,neuroinflammatory disorder,"[EFO_0009386, MONDO_0002977]","[EFO_0000540, EFO_0000618]"
SLC7A8,ENSG00000092068,MONDO_0014403,0.3233823728491141,2,short stature due to GHSR deficiency,[MONDO_0019824],[EFO_0001379]
SLC7A8,ENSG00000092068,EFO_0005772,0.3745364860763527,4,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC7A8,ENSG00000092068,EFO_0003923,0.2090150385190565,1,bone density,[EFO_0004516],[EFO_0001444]
SLC7A8,ENSG00000092068,EFO_0004531,0.2090150385190565,1,urate measurement,[EFO_0001444],[EFO_0001444]
SLC7A9,ENSG00000021488,EFO_0010826,0.49713272575377637,10,cystine urolithiasis,[MONDO_0024647],[EFO_0009690]
SLC7A9,ENSG00000021488,EFO_0005208,0.39515984368062296,9,glomerular filtration rate,[EFO_0004742],[EFO_0001444]
SLC7A9,ENSG00000021488,EFO_0004725,0.20163675379481538,1,metabolite measurement,[EFO_0001444],[EFO_0001444]
SLC7A9,ENSG00000021488,EFO_0005002,0.36424492791333546,2,lysine measurement,[EFO_0005134],[EFO_0001444]
SLC7A9,ENSG00000021488,EFO_0005664,0.20058495060401002,1,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC7A9,ENSG00000021488,EFO_0005653,0.25906159090419534,1,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC7A9,ENSG00000021488,MONDO_0009067,0.849273160175283,241,cystinuria,"[MONDO_0015962, MONDO_0019216]","[OTAR_0000018, OTAR_0000020, EFO_0009690]"
SLC7A9,ENSG00000021488,MONDO_0019746,0.3717549861211274,5,cystinuria type B,[MONDO_0009067],"[OTAR_0000018, OTAR_0000020, EFO_0009690]"
SLC7A9,ENSG00000021488,EFO_0004761,0.2532113473162225,1,uric acid measurement,"[EFO_0004742, EFO_0004298]",[EFO_0001444]
SLC7A9,ENSG00000021488,EFO_0004348,0.28012805704670407,2,hematocrit,[EFO_0004503],[EFO_0001444]
SLC7A9,ENSG00000021488,EFO_0004617,0.48953303126262204,9,cystatin C measurement,"[EFO_0004747, EFO_0004742]",[EFO_0001444]
SLC7A9,ENSG00000021488,EFO_0004518,0.664186192393626,21,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC7A9,ENSG00000021488,EFO_0004509,0.34680097073455457,4,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
SLC7A9,ENSG00000021488,EFO_0005116,0.38820721402305325,17,urinary metabolite measurement,[EFO_0004725],[EFO_0001444]
SLC7A9,ENSG00000021488,EFO_0004305,0.34314913913637834,4,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
SLC7A9,ENSG00000021488,EFO_0003884,0.21470213373337124,10,chronic kidney disease,[EFO_0003086],[EFO_0009690]
SLC7A9,ENSG00000021488,EFO_0007978,0.2274519829166294,1,red blood cell density measurement,[EFO_0005047],[EFO_0001444]
SLC7A9,ENSG00000021488,EFO_0004531,0.48539803187615954,11,urate measurement,[EFO_0001444],[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_0020092,0.24222074960239087,1,neuroinflammatory disorder,"[EFO_0009386, MONDO_0002977]","[EFO_0000540, EFO_0000618]"
SLC8A1,ENSG00000183023,EFO_0005208,0.42351646747817434,3,glomerular filtration rate,[EFO_0004742],[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_0005271,0.333581699380625,2,sleep duration,[EFO_0004870],[EFO_0001444]
SLC8A1,ENSG00000183023,HP_0000539,0.2848701453371951,1,Abnormality of refraction,[HP_0000478],[EFO_0000651]
SLC8A1,ENSG00000183023,EFO_0004725,0.25300390327475786,1,metabolite measurement,[EFO_0001444],[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_0004713,0.2860511246837984,1,FEV/FEC ratio,"[EFO_0006841, EFO_0003892]",[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_0004980,0.35415668189818716,3,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_0006336,0.4108172642317741,4,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_0006335,0.4103909833459764,4,systolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_0000304,0.24153866632354165,3,breast adenocarcinoma,"[MONDO_0000653, EFO_0000228, EFO_0000305]","[OTAR_0000017, MONDO_0045024, EFO_0010285]"
SLC8A1,ENSG00000183023,EFO_0008486,0.2205688367418203,1,male homosexuality,[EFO_0008485],[EFO_0000651]
SLC8A1,ENSG00000183023,EFO_0004747,0.45050315680499475,4,protein measurement,[EFO_0001444],[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_0007993,0.3813669696288389,2,lymphocyte percentage of leukocytes,[EFO_0004587],[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_0007990,0.3795654865379459,2,neutrophil percentage of leukocytes,[EFO_0004833],[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_0000537,0.2933629787370246,32,hypertension,[MONDO_0000473],[EFO_0000319]
SLC8A1,ENSG00000183023,EFO_0006941,0.36909000775978323,4,grip strength measurement,[EFO_0004302],[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_0004339,0.2465948086993232,2,body height,[EFO_0004324],[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_0004327,0.45196380304290285,4,electrocardiography,[EFO_0004311],[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_0004342,0.20178621836116745,1,waist circumference,[EFO_0004324],[EFO_0001444]
SLC8A1,ENSG00000183023,HP_0002251,0.26609749537298527,1,Aganglionic megacolon,"[HP_0000707, HP_0002242]",[EFO_0000651]
SLC8A1,ENSG00000183023,HP_0000079,0.3077988469052953,1,Abnormality of the urinary system,[HP_0000118],[EFO_0000651]
SLC8A1,ENSG00000183023,EFO_0003931,0.29277740553828163,2,bone fracture,"[EFO_0004260, EFO_0000546]","[OTAR_0000006, OTAR_0000009]"
SLC8A1,ENSG00000183023,EFO_0003923,0.40008204319375357,3,bone density,[EFO_0004516],[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_0004682,0.4530066951753538,4,QT interval,"[EFO_0004327, EFO_0000719]",[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_0004644,0.39751998641060565,2,TPE interval measurement,[EFO_0005278],[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_0004518,0.3100548256384841,1,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_0004514,0.36709216732348426,2,bone quantitative ultrasound measurement,[EFO_0004516],[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_0004462,0.4533553546559332,4,PR interval,[EFO_0004327],[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_0007789,0.32529025444486787,2,BMI-adjusted waist circumference,[EFO_0004342],[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_0009270,0.47498891082982236,13,heel bone mineral density,[EFO_0003923],[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_0004587,0.3051256670782018,1,lymphocyte count,"[EFO_0006843, EFO_0004308, EFO_0803546]",[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_0004312,0.36142502609004623,2,vital capacity,[EFO_0003892],[EFO_0001444]
SLC8A1,ENSG00000183023,EFO_1001145,0.24388859136546687,1,Raynaud disease,"[EFO_0003875, EFO_0000508]","[OTAR_0000018, EFO_0000319]"
SLC8A2,ENSG00000118160,EFO_0000304,0.24153866632354165,3,breast adenocarcinoma,"[MONDO_0000653, EFO_0000228, EFO_0000305]","[OTAR_0000017, MONDO_0045024, EFO_0010285]"
SLC8A3,ENSG00000100678,EFO_0011011,0.2407841781778858,1,sitting height measurement,[EFO_0004302],[EFO_0001444]
SLC8A3,ENSG00000100678,EFO_0000304,0.24153866632354165,3,breast adenocarcinoma,"[MONDO_0000653, EFO_0000228, EFO_0000305]","[OTAR_0000017, MONDO_0045024, EFO_0010285]"
SLC8A3,ENSG00000100678,EFO_0004339,0.4035910137323206,4,body height,[EFO_0004324],[EFO_0001444]
SLC8A3,ENSG00000100678,EFO_0004584,0.31547956332171745,1,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
SLC8A3,ENSG00000100678,EFO_0004615,0.20475892209521587,1,apolipoprotein B measurement,[EFO_0004732],[EFO_0001444]
SLC8B1,ENSG00000089060,NA,NA,NA,NA,NA,NA
SLC9A1,ENSG00000090020,EFO_0000508,0.33660307139018064,20,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC9A1,ENSG00000090020,MONDO_0014572,0.6280529816732163,19,Lichtenstein-Knorr syndrome,[MONDO_0015244],"[OTAR_0000018, EFO_0000618]"
SLC9A1,ENSG00000090020,EFO_0004339,0.2529987984733034,2,body height,[EFO_0004324],[EFO_0001444]
SLC9A2,ENSG00000115616,EFO_0000684,0.2181676449767386,1,respiratory system disease,[OTAR_0000010],[OTAR_0000010]
SLC9A2,ENSG00000115616,HP_0004933,0.3326218692162316,1,Ascending aortic dissection,[HP_0002647],[EFO_0000651]
SLC9A2,ENSG00000115616,EFO_0009941,0.25529517194682594,1,Inhalant adrenergic use measurement,[EFO_0007010],[EFO_0001444]
SLC9A2,ENSG00000115616,EFO_0004842,0.32560491602960356,3,eosinophil count,"[EFO_0803540, EFO_0007987]",[EFO_0001444]
SLC9A2,ENSG00000115616,EFO_0005772,0.3151539870881415,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC9A2,ENSG00000115616,EFO_0007985,0.27460641246436185,1,platelet crit,[EFO_0005036],[EFO_0001444]
SLC9A2,ENSG00000115616,EFO_0004532,0.2917544149744779,1,serum gamma-glutamyl transferase measurement,[EFO_0004582],[EFO_0001444]
SLC9A3,ENSG00000066230,EFO_0005208,0.26768898966976734,1,glomerular filtration rate,[EFO_0004742],[EFO_0001444]
SLC9A3,ENSG00000066230,HP_0002905,0.3927814804397839,17,Hyperphosphatemia,[HP_0100529],[EFO_0000651]
SLC9A3,ENSG00000066230,MONDO_0009061,0.3753757863432704,23,cystic fibrosis,"[EFO_1000017, EFO_0000684]","[OTAR_0000018, OTAR_0000010]"
SLC9A3,ENSG00000066230,EFO_0000676,0.20871130801614118,2,psoriasis,"[MONDO_0002406, EFO_1000636, EFO_0000540, MONDO_0100118]","[OTAR_0000018, EFO_0000540, EFO_0010285]"
SLC9A3,ENSG00000066230,EFO_0003756,0.3326218692162316,1,autism spectrum disorder,[MONDO_0000594],"[MONDO_0002025, EFO_0000618]"
SLC9A3,ENSG00000066230,MONDO_0015170,0.6091572775287197,26,congenital sodium diarrhea,"[MONDO_0015178, MONDO_0000824]","[OTAR_0000018, EFO_0010282]"
SLC9A3,ENSG00000066230,HP_0002019,0.37131405367958853,8,Constipation,[HP_0011458],[EFO_0000651]
SLC9A3,ENSG00000066230,EFO_0005772,0.46526764190668585,3,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC9A3,ENSG00000066230,MONDO_0002203,0.4619748183558772,2,constipation disorder,[MONDO_0004880],[EFO_0010282]
SLC9A3,ENSG00000066230,GO_0007568,0.24430841201933354,1,aging,[GO_0032502],[GO_0008150]
SLC9A3,ENSG00000066230,EFO_0000555,0.5632505413686252,28,irritable bowel syndrome,[EFO_0009431],[EFO_0010282]
SLC9A3,ENSG00000066230,EFO_0004617,0.2799224826891111,1,cystatin C measurement,"[EFO_0004747, EFO_0004742]",[EFO_0001444]
SLC9A3,ENSG00000066230,EFO_0004518,0.2805213322449374,1,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC9A3,ENSG00000066230,EFO_0001365,0.3759698778014569,8,age-related macular degeneration,"[MONDO_0019118, MONDO_0002175]","[MONDO_0002025, OTAR_0000018, MONDO_0024458, EFO_0000618]"
SLC9A3,ENSG00000066230,EFO_0009797,0.2472663804216448,1,lung disease associated with cystic fibrosis,[EFO_0003818],[OTAR_0000010]
SLC9A3,ENSG00000066230,EFO_0009718,0.24816499619986174,1,peak expiratory flow,[EFO_0003892],[EFO_0001444]
SLC9A4,ENSG00000180251,EFO_0011011,0.3035033652375237,1,sitting height measurement,[EFO_0004302],[EFO_0001444]
SLC9A4,ENSG00000180251,EFO_0005208,0.2999078227195343,1,glomerular filtration rate,[EFO_0004742],[EFO_0001444]
SLC9A4,ENSG00000180251,EFO_0005409,0.30238408821226936,1,fat body mass,[EFO_0004302],[EFO_0001444]
SLC9A4,ENSG00000180251,EFO_0000684,0.24320193550728536,1,respiratory system disease,[OTAR_0000010],[OTAR_0000010]
SLC9A4,ENSG00000180251,EFO_0000274,0.21366196956055067,13,atopic eczema,"[MONDO_0002406, MONDO_0005271, MONDO_0100118, EFO_1000636]","[OTAR_0000018, EFO_0000540, EFO_0010285]"
SLC9A4,ENSG00000180251,EFO_0004995,0.30238408821226936,1,lean body mass,[EFO_0004302],[EFO_0001444]
SLC9A4,ENSG00000180251,EFO_0004980,0.38311470275040277,2,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
SLC9A4,ENSG00000180251,EFO_0008178,0.4025530101780139,3,interleukin 18 receptor 1 measurement,[EFO_0007937],[EFO_0001444]
SLC9A4,ENSG00000180251,EFO_0008168,0.31879610852836476,2,interleukin 1 receptor-like 1 measurement,[EFO_0007937],[EFO_0001444]
SLC9A4,ENSG00000180251,EFO_0001060,0.3840704111699301,8,celiac disease,"[MONDO_0000588, EFO_0009554, EFO_0000508, MONDO_0024635]","[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLC9A4,ENSG00000180251,EFO_0007993,0.20553643002615704,3,lymphocyte percentage of leukocytes,[EFO_0004587],[EFO_0001444]
SLC9A4,ENSG00000180251,EFO_0007989,0.20443633416453635,1,monocyte percentage of leukocytes,[EFO_0005091],[EFO_0001444]
SLC9A4,ENSG00000180251,HP_0004933,0.47352418881477415,4,Ascending aortic dissection,[HP_0002647],[EFO_0000651]
SLC9A4,ENSG00000180251,EFO_0004339,0.4420401813005634,4,body height,[EFO_0004324],[EFO_0001444]
SLC9A4,ENSG00000180251,EFO_0010599,0.335851889363389,2,ST2 protein measurement,[EFO_0007937],[EFO_0001444]
SLC9A4,ENSG00000180251,MONDO_0004979,0.25483055957141637,19,asthma,[EFO_1002018],[OTAR_0000010]
SLC9A4,ENSG00000180251,EFO_0004617,0.2828369866612873,1,cystatin C measurement,"[EFO_0004747, EFO_0004742]",[EFO_0001444]
SLC9A4,ENSG00000180251,EFO_0004526,0.29478989828873087,5,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLC9A4,ENSG00000180251,EFO_0004518,0.3075370911632645,2,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
SLC9A4,ENSG00000180251,EFO_0005091,0.28081508463879234,1,monocyte count,"[EFO_0004308, EFO_0803547]",[EFO_0001444]
SLC9A4,ENSG00000180251,EFO_0005090,0.20460314355961823,2,basophil count,"[EFO_0004872, EFO_0803539, EFO_0007987]",[EFO_0001444]
SLC9A4,ENSG00000180251,EFO_0007817,0.35595479643738215,3,sleep apnea measurement,[EFO_0001444],[EFO_0001444]
SLC9A4,ENSG00000180251,EFO_0004587,0.2007622778015346,6,lymphocyte count,"[EFO_0006843, EFO_0004308, EFO_0803546]",[EFO_0001444]
SLC9A4,ENSG00000180251,EFO_0009805,0.29986129815591817,1,whole body water mass,[EFO_0004302],[EFO_0001444]
SLC9A4,ENSG00000180251,EFO_0004532,0.32865106765263835,2,serum gamma-glutamyl transferase measurement,[EFO_0004582],[EFO_0001444]
SLC9A4,ENSG00000180251,EFO_0004528,0.4063995284606926,3,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLC9A5,ENSG00000135740,EFO_0000182,0.49606855995054094,6,hepatocellular carcinoma,[MONDO_0018532],"[MONDO_0045024, EFO_0001379, EFO_0010282]"
SLC9A5,ENSG00000135740,EFO_0005772,0.4478672148269245,4,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC9A6,ENSG00000198689,HP_0011471,0.25870589827929125,1,Gastrostomy tube feeding in infancy,"[HP_0033454, HP_0008872]",[EFO_0000651]
SLC9A6,ENSG00000198689,EFO_0004152,0.26609749537298527,1,chorea,[EFO_0004280],[EFO_0000618]
SLC9A6,ENSG00000198689,HP_0000565,0.26609749537298527,1,Esotropia,[HP_0000486],[EFO_0000651]
SLC9A6,ENSG00000198689,HP_0000490,0.26609749537298527,1,Deeply set eye,[HP_0000478],[EFO_0000651]
SLC9A6,ENSG00000198689,HP_0000252,0.40016683845931345,11,Microcephaly,"[HP_0000929, HP_0012443]",[EFO_0000651]
SLC9A6,ENSG00000198689,EFO_0008568,0.25870589827929125,1,Sleep Disorder,[EFO_0000677],"[MONDO_0002025, EFO_0000618]"
SLC9A6,ENSG00000198689,EFO_0000508,0.4463353778837314,38,genetic disorder,[OTAR_0000018],[OTAR_0000018]
SLC9A6,ENSG00000198689,Orphanet_1429,0.26609749537298527,1,Benign familial chorea,"[MONDO_0015548, Orphanet_306719]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC9A6,ENSG00000198689,MONDO_0014403,0.2956638837477614,2,short stature due to GHSR deficiency,[MONDO_0019824],[EFO_0001379]
SLC9A6,ENSG00000198689,MONDO_0010278,0.8070788276830484,340,Christianson syndrome,[OTAR_0000018],[OTAR_0000018]
SLC9A6,ENSG00000198689,HP_0005484,0.26609749537298527,1,Secondary microcephaly,[HP_0000252],[EFO_0000651]
SLC9A6,ENSG00000198689,HP_0004209,0.26609749537298527,1,Clinodactyly of the 5th finger,[HP_0040019],[EFO_0000651]
SLC9A6,ENSG00000198689,EFO_0003758,0.26843805470749604,10,autism,[EFO_0003756],"[MONDO_0002025, EFO_0000618]"
SLC9A6,ENSG00000198689,HP_0001508,0.26609749537298527,1,Failure to thrive,[HP_0004325],[EFO_0000651]
SLC9A6,ENSG00000198689,HP_0001290,0.26609749537298527,1,Generalized hypotonia,[HP_0001252],[EFO_0000651]
SLC9A6,ENSG00000198689,HP_0002205,0.25870589827929125,1,Recurrent respiratory infections,"[HP_0002719, HP_0002088]",[EFO_0000651]
SLC9A6,ENSG00000198689,EFO_0005772,0.3695798546847018,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC9A6,ENSG00000198689,MONDO_0001149,0.3695798546847018,1,microcephaly,"[MONDO_0016054, EFO_0010642]","[OTAR_0000018, EFO_0000618]"
SLC9A6,ENSG00000198689,EFO_0004273,0.25870589827929125,1,scoliosis,[MONDO_0000836],[OTAR_0000006]
SLC9A6,ENSG00000198689,HP_0001263,0.33192377393516054,5,Global developmental delay,[HP_0012758],[EFO_0000651]
SLC9A6,ENSG00000198689,HP_0001250,0.34391458699826416,3,Seizure,[HP_0012638],[EFO_0000651]
SLC9A6,ENSG00000198689,HP_0001249,0.5396965795419854,15,Intellectual disability,"[HP_0012759, HP_0100543]",[EFO_0000651]
SLC9A6,ENSG00000198689,HP_0000767,0.26609749537298527,1,Pectus excavatum,[HP_0000766],[EFO_0000651]
SLC9A6,ENSG00000198689,HP_0000758,0.26609749537298527,1,Abnormal nonverbal communicative behavior,[HP_0011446],[EFO_0000651]
SLC9A7,ENSG00000065923,EFO_0000677,0.2073684831061523,1,mental or behavioural disorder,"[MONDO_0002025, EFO_0005774]","[MONDO_0002025, EFO_0000618]"
SLC9A7,ENSG00000065923,Orphanet_777,0.3695798546847018,1,X-linked non-syndromic intellectual disability,[Orphanet_101685],[OTAR_0000018]
SLC9A7,ENSG00000065923,MONDO_0020119,0.37883438780885365,16,X-linked syndromic intellectual disability,"[MONDO_0000508, MONDO_0100284]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
SLC9A8,ENSG00000197818,EFO_0000384,0.3113995991796925,3,Crohn's disease,[EFO_0003767],"[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLC9A8,ENSG00000197818,EFO_0000676,0.32271244328075344,7,psoriasis,"[MONDO_0002406, EFO_1000636, EFO_0000540, MONDO_0100118]","[OTAR_0000018, EFO_0000540, EFO_0010285]"
SLC9A8,ENSG00000197818,EFO_0010736,0.2569295014445753,1,cortical surface area measurement,[EFO_0004464],[EFO_0001444]
SLC9A8,ENSG00000197818,MONDO_0004976,0.29924731489971096,1,amyotrophic lateral sclerosis,"[EFO_0003782, MONDO_0003182]",[EFO_0000618]
SLC9A8,ENSG00000197818,EFO_0003898,0.3017094207120012,2,ankylosing spondylitis,"[MONDO_0003937, EFO_0000685, EFO_0009477, EFO_0000706]","[OTAR_0000006, EFO_0000540]"
SLC9A8,ENSG00000197818,EFO_0007874,0.2900069021396737,1,gut microbiome measurement,[EFO_0007882],[EFO_0001444]
SLC9A8,ENSG00000197818,EFO_0004268,0.3017094207120012,2,sclerosing cholangitis,"[EFO_0001421, MONDO_0004789]","[EFO_0001379, EFO_0010282]"
SLC9A8,ENSG00000197818,EFO_0000729,0.3127487481578619,7,ulcerative colitis,[EFO_0003872],"[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLC9A9,ENSG00000181804,EFO_0010750,0.3731435515008393,4,PHF-tau measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
SLC9A9,ENSG00000181804,MONDO_0005575,0.3326218692162316,1,colorectal cancer,"[EFO_0007330, EFO_0004142]","[MONDO_0045024, EFO_0010282]"
SLC9A9,ENSG00000181804,EFO_0003758,0.4926848095221977,32,autism,[EFO_0003756],"[MONDO_0002025, EFO_0000618]"
SLC9A9,ENSG00000181804,EFO_0010125,0.31430697690065285,1,viral load,[EFO_0006843],[EFO_0001444]
SLC9A9,ENSG00000181804,EFO_0010736,0.39597453711316416,2,cortical surface area measurement,[EFO_0004464],[EFO_0001444]
SLC9A9,ENSG00000181804,EFO_0004584,0.4003575871950074,5,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
SLC9A9,ENSG00000181804,EFO_0004464,0.31677962969053136,1,brain measurement,[EFO_0001444],[EFO_0001444]
SLC9A9,ENSG00000181804,EFO_0007874,0.38898046003341663,2,gut microbiome measurement,[EFO_0007882],[EFO_0001444]
SLC9A9,ENSG00000181804,EFO_0000400,0.24976837540789484,1,diabetes mellitus,"[EFO_0009406, MONDO_0001933]","[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC9B1,ENSG00000164037,EFO_0005208,0.33662057197035883,6,glomerular filtration rate,[EFO_0004742],[EFO_0001444]
SLC9B1,ENSG00000164037,EFO_0000275,0.3097923460096851,3,atrial fibrillation,"[EFO_0004269, MONDO_0007263]",[EFO_0000319]
SLC9B1,ENSG00000164037,EFO_0006336,0.24851886026108927,3,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC9B1,ENSG00000164037,EFO_0004533,0.34256249929927574,3,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
SLC9B1,ENSG00000164037,EFO_0000319,0.2302863878694502,2,cardiovascular disease,[],[EFO_0000319]
SLC9B1,ENSG00000164037,MONDO_0005090,0.31220264176454854,6,schizophrenia,[EFO_0005407],"[MONDO_0002025, EFO_0000618]"
SLC9B1,ENSG00000164037,EFO_0005772,0.22207366133355202,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLC9B1,ENSG00000164037,GO_0007568,0.22733642663706582,2,aging,[GO_0032502],[GO_0008150]
SLC9B1,ENSG00000164037,MONDO_0005148,0.29829368041669224,5,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLC9B1,ENSG00000164037,MONDO_0018105,0.36376718485907733,5,Wolfram syndrome,[OTAR_0000018],[OTAR_0000018]
SLC9B1,ENSG00000164037,EFO_0004696,0.2522157789997635,6,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
SLC9B1,ENSG00000164037,EFO_0007814,0.2142606477956638,8,refractive error measurement,[EFO_0004731],[EFO_0001444]
SLC9B1,ENSG00000164037,EFO_0009795,0.2544931298839941,1,serum urea measurement,[EFO_0004742],[EFO_0001444]
SLC9B2,ENSG00000164038,EFO_0006336,0.27207138739072934,3,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLC9C1,ENSG00000172139,EFO_0007937,0.28363776207525176,2,blood protein measurement,[EFO_0004747],[EFO_0001444]
SLC9C2,ENSG00000162753,EFO_0005423,0.27178167534670067,1,adolescent idiopathic scoliosis,[MONDO_0000726],[OTAR_0000006]
SLCO1A2,ENSG00000084453,EFO_0005409,0.23008939368114148,2,fat body mass,[EFO_0004302],[EFO_0001444]
SLCO1A2,ENSG00000084453,EFO_0000389,0.2362358466068323,3,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLCO1A2,ENSG00000084453,EFO_0004995,0.27579764722148475,8,lean body mass,[EFO_0004302],[EFO_0001444]
SLCO1A2,ENSG00000084453,EFO_0005653,0.29346030539095047,4,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLCO1A2,ENSG00000084453,EFO_0600034,0.2463803347566445,2,response to neuromuscular blocker,[GO_0009410],[GO_0008150]
SLCO1A2,ENSG00000084453,EFO_0004840,0.28270357549253716,2,cortical thickness,[EFO_0004464],[EFO_0001444]
SLCO1A2,ENSG00000084453,MONDO_0019037,0.22583683245931693,2,progressive supranuclear palsy,"[MONDO_0004884, MONDO_0020257, EFO_0004280]","[MONDO_0024458, EFO_0000618]"
SLCO1A2,ENSG00000084453,EFO_0007937,0.2545569689869106,2,blood protein measurement,[EFO_0004747],[EFO_0001444]
SLCO1A2,ENSG00000084453,EFO_0004532,0.21008649128881335,1,serum gamma-glutamyl transferase measurement,[EFO_0004582],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0011010,0.31996156178879676,1,glycodeoxycholate 3-O-glucuronide measurement,[EFO_0010493],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0011009,0.3210189602632946,1,glycochenodeoxycholate 3-O-glucuronide measurement,[EFO_0010490],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0010750,0.3176286148618225,1,PHF-tau measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0007020,0.3088277402731078,1,AR-C124910XX measurement,[EFO_0004725],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0004145,0.3324259963949751,177,myopathy,"[EFO_0002970, MONDO_0020120]",[OTAR_0000006]
SLCO1B1,ENSG00000134538,EFO_0000389,0.2362358466068323,3,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLCO1B1,ENSG00000134538,EFO_0004725,0.39185483326517256,2,metabolite measurement,[EFO_0001444],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0004908,0.4777380467302764,7,testosterone measurement,"[EFO_0004529, EFO_0011008]",[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0005664,0.5061876317878264,15,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0005653,0.518811702852111,32,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0005556,0.3443564402467539,4,Gilbert syndrome,[MONDO_0002408],"[OTAR_0000018, OTAR_0000020]"
SLCO1B1,ENSG00000134538,MONDO_0009379,0.5673412038601728,136,Rotor syndrome,[MONDO_0002408],"[OTAR_0000018, OTAR_0000020]"
SLCO1B1,ENSG00000134538,EFO_0004761,0.32096212627933163,1,uric acid measurement,"[EFO_0004742, EFO_0004298]",[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0004735,0.4172137481551092,3,serum alanine aminotransferase measurement,"[EFO_0004582, EFO_0004747]",[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0007993,0.2430370949251169,1,lymphocyte percentage of leukocytes,[EFO_0004587],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0007990,0.3733622609536453,2,neutrophil percentage of leukocytes,[EFO_0004833],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0007989,0.2799697341990337,1,monocyte percentage of leukocytes,[EFO_0005091],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0007986,0.45393760392168175,4,reticulocyte count,[EFO_0010700],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0007001,0.2764983012413727,1,dehydroepiandrosterone sulphate measurement,"[EFO_0004730, EFO_0004725, EFO_0004529]",[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0006957,0.3152502448050298,1,X12063 measurement,[EFO_0001444],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0004339,0.2712191510775234,1,body height,[EFO_0004324],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0010225,0.45503005170236943,4,lysophosphatidylethanolamine measurement,"[EFO_0010968, EFO_0005278, EFO_0004529]",[EFO_0001444]
SLCO1B1,ENSG00000134538,Orphanet_309816,0.3695798546847018,1,Disorder of bilirubin metabolism and excretion,[Orphanet_309813],"[OTAR_0000018, OTAR_0000020]"
SLCO1B1,ENSG00000134538,EFO_0010701,0.4022809009582844,2,mean reticulocyte volume,[EFO_0010700],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0010700,0.3516051930663746,2,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0010699,0.31532412898418155,1,diffuse plaque measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0010370,0.31887257419298,1,lysophosphatidylethanolamine 20:4 measurement,[EFO_0010225],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0004570,0.7159768517458531,43,bilirubin measurement,[EFO_0001444],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0004541,0.30156504001160056,1,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0004536,0.3208606842265606,1,total blood protein measurement,[EFO_0004503],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0004533,0.2708543341750389,1,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
SLCO1B1,ENSG00000134538,HP_0002140,0.3058462250686776,1,Ischemic stroke,"[HP_0002637, HP_0100659]",[EFO_0000651]
SLCO1B1,ENSG00000134538,GO_0097327,0.31304572505887096,1,response to antineoplastic agent,[GO_0050896],[GO_0008150]
SLCO1B1,ENSG00000134538,GO_0036273,0.44315448856473616,4,response to statin,[GO_0050896],[GO_0008150]
SLCO1B1,ENSG00000134538,GO_0031427,0.31421557992411714,1,response to methotrexate,[GO_0050896],[GO_0008150]
SLCO1B1,ENSG00000134538,EFO_0005524,0.3058462250686776,1,large artery stroke,"[EFO_0000712, MONDO_0000473]","[EFO_0000618, EFO_0000319]"
SLCO1B1,ENSG00000134538,EFO_0004696,0.5096103209190906,18,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0004631,0.49130404954455614,8,vitamin D measurement,"[EFO_0004529, EFO_0004729]",[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0004617,0.39978637920035204,2,cystatin C measurement,"[EFO_0004747, EFO_0004742]",[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0004526,0.49429790340993573,9,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0005130,0.31887257419298,1,thyroxine measurement,"[EFO_0005134, EFO_0004730]",[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0005116,0.49320389305382484,12,urinary metabolite measurement,[EFO_0004725],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0005091,0.4085076641828426,3,monocyte count,"[EFO_0004308, EFO_0803547]",[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0005059,0.40998357147441444,4,acylcarnitine measurement,[EFO_0004725],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0007804,0.3264289772838212,2,LDL cholesterol change measurement,[EFO_0004611],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0009270,0.4439801955446199,4,heel bone mineral density,[EFO_0003923],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0004611,0.25981558842477015,1,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0004309,0.40853339918352666,3,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0004297,0.31359340200045477,1,clinical laboratory measurement,[EFO_0001444],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0006797,0.317378831705173,1,neurofibrillary tangles measurement,[EFO_0004464],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0007985,0.39546744249985777,2,platelet crit,[EFO_0005036],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0007971,0.41815801775233447,3,estrone conjugate measurement,[EFO_0001444],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0007970,0.3012300058790067,1,estrone measurement,[EFO_0001444],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0007937,0.43611395621991556,3,blood protein measurement,[EFO_0004747],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0007922,0.30156504001160056,1,response to sulfonylurea,[GO_0009410],[GO_0008150]
SLCO1B1,ENSG00000134538,EFO_0004532,0.3527914225807471,3,serum gamma-glutamyl transferase measurement,[EFO_0004582],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0004531,0.44898921340942977,4,urate measurement,[EFO_0001444],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0004530,0.47769230517569744,6,triglyceride measurement,[EFO_0004529],[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0004528,0.4369302502241823,3,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
SLCO1B1,ENSG00000134538,EFO_0004527,0.4691395872379858,5,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
SLCO1B3,ENSG00000111700,EFO_0000389,0.2362358466068323,3,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLCO1B3,ENSG00000111700,EFO_0004908,0.20741919311819987,1,testosterone measurement,"[EFO_0004529, EFO_0011008]",[EFO_0001444]
SLCO1B3,ENSG00000111700,MONDO_0009379,0.6449889379600529,155,Rotor syndrome,[MONDO_0002408],"[OTAR_0000018, OTAR_0000020]"
SLCO1B3,ENSG00000111700,EFO_0004736,0.4056923889934116,3,aspartate aminotransferase measurement,"[EFO_0004747, EFO_0004582]",[EFO_0001444]
SLCO1B3,ENSG00000111700,EFO_0004735,0.4567962265399868,5,serum alanine aminotransferase measurement,"[EFO_0004582, EFO_0004747]",[EFO_0001444]
SLCO1B3,ENSG00000111700,EFO_0010222,0.30913422524166445,1,ceramide measurement,"[EFO_0005278, EFO_0004622]",[EFO_0001444]
SLCO1B3,ENSG00000111700,Orphanet_309816,0.3695798546847018,1,Disorder of bilirubin metabolism and excretion,[Orphanet_309813],"[OTAR_0000018, OTAR_0000020]"
SLCO1B3,ENSG00000111700,EFO_0004570,0.7229012273140113,56,bilirubin measurement,[EFO_0001444],[EFO_0001444]
SLCO1B3,ENSG00000111700,EFO_0004696,0.5187986655545757,20,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
SLCO1B3,ENSG00000111700,EFO_0004628,0.20083856675027556,1,insulin like growth factor measurement,[EFO_0001444],[EFO_0001444]
SLCO1B3,ENSG00000111700,EFO_0004627,0.20599243983397086,1,IGF-1 measurement,"[EFO_0005127, EFO_0004730, EFO_0004747]",[EFO_0001444]
SLCO1B3,ENSG00000111700,EFO_0004309,0.23911969417633905,2,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
SLCO1B3,ENSG00000111700,EFO_0004532,0.4087198547920679,3,serum gamma-glutamyl transferase measurement,[EFO_0004582],[EFO_0001444]
SLCO1B7,ENSG00000205754,NA,NA,NA,NA,NA,NA
SLCO1C1,ENSG00000139155,EFO_0011011,0.2001600976047495,3,sitting height measurement,[EFO_0004302],[EFO_0001444]
SLCO1C1,ENSG00000139155,EFO_0000389,0.21508178632773003,2,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLCO1C1,ENSG00000139155,EFO_0004980,0.2278040460571092,4,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
SLCO1C1,ENSG00000139155,EFO_0004339,0.4605194934452059,13,body height,[EFO_0004324],[EFO_0001444]
SLCO1C1,ENSG00000139155,EFO_0004570,0.44271336315388216,5,bilirubin measurement,[EFO_0001444],[EFO_0001444]
SLCO1C1,ENSG00000139155,EFO_0007789,0.2605382556609685,2,BMI-adjusted waist circumference,[EFO_0004342],[EFO_0001444]
SLCO2A1,ENSG00000174640,MONDO_0002561,0.26410544098981104,1,lysosomal storage disease,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
SLCO2A1,ENSG00000174640,EFO_0005406,0.2609792472402732,3,colorectal adenoma,"[EFO_0004142, EFO_1000217]","[MONDO_0045024, EFO_0010282]"
SLCO2A1,ENSG00000174640,MONDO_0005575,0.4517935899280038,9,colorectal cancer,"[EFO_0007330, EFO_0004142]","[MONDO_0045024, EFO_0010282]"
SLCO2A1,ENSG00000174640,EFO_0000389,0.21508178632773003,2,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLCO2A1,ENSG00000174640,MONDO_0016620,0.383466731094199,53,primary hypertrophic osteoarthropathy,[EFO_0000508],[OTAR_0000018]
SLCO2A1,ENSG00000174640,EFO_0005772,0.26410544098981104,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLCO2A1,ENSG00000174640,MONDO_0005180,0.26410544098981104,1,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
SLCO2A1,ENSG00000174640,Orphanet_2796,0.804378467428889,75,Pachydermoperiostosis,"[Orphanet_364526, MONDO_0019276]","[OTAR_0000006, OTAR_0000018, EFO_0010285]"
SLCO2A1,ENSG00000174640,MONDO_0004975,0.26595334026323453,2,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
SLCO2A1,ENSG00000174640,MONDO_0005301,0.26410544098981104,1,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
SLCO2B1,ENSG00000137491,EFO_0000389,0.21508178632773003,2,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLCO2B1,ENSG00000137491,EFO_0009700,0.2636642404294781,1,visual perception measurement,[EFO_0004464],[EFO_0001444]
SLCO3A1,ENSG00000176463,EFO_0010750,0.32578471010534543,1,PHF-tau measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
SLCO3A1,ENSG00000176463,EFO_0005409,0.44013274670335906,3,fat body mass,[EFO_0004302],[EFO_0001444]
SLCO3A1,ENSG00000176463,MONDO_0007079,0.3370673314500608,2,alcohol dependence,"[MONDO_0021698, EFO_0003890]","[MONDO_0002025, EFO_0000618]"
SLCO3A1,ENSG00000176463,EFO_0000389,0.21508178632773003,2,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLCO3A1,ENSG00000176463,EFO_0004995,0.44018780248364625,3,lean body mass,[EFO_0004302],[EFO_0001444]
SLCO3A1,ENSG00000176463,EFO_0006336,0.25923187256932456,1,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLCO3A1,ENSG00000176463,EFO_0004339,0.3220083341864445,1,body height,[EFO_0004324],[EFO_0001444]
SLCO3A1,ENSG00000176463,EFO_0004343,0.3219976062212546,1,waist-hip ratio,[EFO_0007861],[EFO_0001444]
SLCO3A1,ENSG00000176463,EFO_0004342,0.3235569721347304,1,waist circumference,[EFO_0004324],[EFO_0001444]
SLCO3A1,ENSG00000176463,EFO_0004340,0.49680218048712677,7,body mass index,[EFO_0004324],[EFO_0001444]
SLCO3A1,ENSG00000176463,EFO_0005772,0.3157151353715332,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLCO3A1,ENSG00000176463,MONDO_0002046,0.33651296166803374,1,alcohol abuse,"[MONDO_0002491, MONDO_0021698]",[MONDO_0002025]
SLCO3A1,ENSG00000176463,EFO_0000555,0.21596398434894204,1,irritable bowel syndrome,[EFO_0009431],[EFO_0010282]
SLCO3A1,ENSG00000176463,EFO_0007800,0.48355833200403797,6,body fat percentage,[EFO_0005106],[EFO_0001444]
SLCO3A1,ENSG00000176463,EFO_0004587,0.20525806986367165,1,lymphocyte count,"[EFO_0006843, EFO_0004308, EFO_0803546]",[EFO_0001444]
SLCO4A1,ENSG00000101187,EFO_0000389,0.21508178632773003,2,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLCO4A1,ENSG00000101187,EFO_0004704,0.39009876596120596,3,age at menopause,[EFO_0000246],[EFO_0001444]
SLCO4A1,ENSG00000101187,EFO_0006930,0.23226557774254986,4,brain volume measurement,"[EFO_0005052, EFO_0004464]",[EFO_0001444]
SLCO4A1,ENSG00000101187,EFO_0004346,0.22264461601043897,3,neuroimaging measurement,[EFO_0001444],[EFO_0001444]
SLCO4A1,ENSG00000101187,MONDO_0005148,0.3398972032905434,3,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
SLCO4A1,ENSG00000101187,EFO_0003922,0.2670749182988563,1,menopause,[EFO_0003765],[EFO_0000651]
SLCO4A1,ENSG00000101187,EFO_0007629,0.2526204280837398,1,hemoglobin A1 measurement,[EFO_0004509],[EFO_0001444]
SLCO4C1,ENSG00000173930,EFO_0000389,0.21508178632773003,2,cutaneous melanoma,"[MONDO_0021583, EFO_0000756, MONDO_0002898]","[MONDO_0045024, EFO_0010285]"
SLCO4C1,ENSG00000173930,EFO_0000274,0.3211364171634846,1,atopic eczema,"[MONDO_0002406, MONDO_0005271, MONDO_0100118, EFO_1000636]","[OTAR_0000018, EFO_0000540, EFO_0010285]"
SLCO4C1,ENSG00000173930,EFO_0005854,0.3211364171634846,1,allergic rhinitis,"[MONDO_0000771, EFO_0008521]","[EFO_0000540, OTAR_0000010]"
SLCO4C1,ENSG00000173930,EFO_0006340,0.2044202532310895,1,mean arterial pressure,[EFO_0004325],[EFO_0001444]
SLCO4C1,ENSG00000173930,EFO_0006336,0.38360333733325913,2,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLCO4C1,ENSG00000173930,EFO_0004339,0.2085711386698949,1,body height,[EFO_0004324],[EFO_0001444]
SLCO4C1,ENSG00000173930,EFO_0005772,0.32682058960898586,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
SLCO4C1,ENSG00000173930,EFO_0007788,0.35338053362607846,2,BMI-adjusted waist-hip ratio,[EFO_0004343],[EFO_0001444]
SLCO5A1,ENSG00000137571,EFO_0004833,0.27980912312264855,1,neutrophil count,"[EFO_0803548, EFO_0007987]",[EFO_0001444]
SLCO5A1,ENSG00000137571,EFO_0007993,0.20110791137117273,1,lymphocyte percentage of leukocytes,[EFO_0004587],[EFO_0001444]
SLCO5A1,ENSG00000137571,EFO_0007992,0.27374749236021517,1,basophil percentage of leukocytes,[EFO_0005090],[EFO_0001444]
SLCO5A1,ENSG00000137571,EFO_0007990,0.2853688745608078,1,neutrophil percentage of leukocytes,[EFO_0004833],[EFO_0001444]
SLCO5A1,ENSG00000137571,EFO_0004622,0.307699475548064,1,sphingolipid measurement,[EFO_0004529],[EFO_0001444]
SLCO5A1,ENSG00000137571,EFO_0005090,0.37894465236351677,2,basophil count,"[EFO_0004872, EFO_0803539, EFO_0007987]",[EFO_0001444]
SLCO5A1,ENSG00000137571,EFO_0004308,0.35190512450383477,2,leukocyte count,[EFO_0004586],[EFO_0001444]
SLCO5A1,ENSG00000137571,EFO_0009700,0.20689037272323318,1,visual perception measurement,[EFO_0004464],[EFO_0001444]
SLCO6A1,ENSG00000205359,EFO_0000384,0.23274428895821755,2,Crohn's disease,[EFO_0003767],"[OTAR_0000018, EFO_0000540, EFO_0010282]"
SLCO6A1,ENSG00000205359,EFO_0006340,0.21343667841402014,1,mean arterial pressure,[EFO_0004325],[EFO_0001444]
SLCO6A1,ENSG00000205359,EFO_0006336,0.2622656673289641,2,diastolic blood pressure,[EFO_0004325],[EFO_0001444]
SLCO6A1,ENSG00000205359,EFO_0004339,0.2716538934225184,3,body height,[EFO_0004324],[EFO_0001444]
SLCO6A1,ENSG00000205359,MONDO_0005090,0.27703276168230134,3,schizophrenia,[EFO_0005407],"[MONDO_0002025, EFO_0000618]"
SLCO6A1,ENSG00000205359,EFO_0007789,0.26327423442443565,2,BMI-adjusted waist circumference,[EFO_0004342],[EFO_0001444]
SLCO6A1,ENSG00000205359,EFO_0007788,0.23480383873689398,2,BMI-adjusted waist-hip ratio,[EFO_0004343],[EFO_0001444]
ABCA1,ENSG00000165029,HP_0001626,0.3412482367676145,378,Abnormality of the cardiovascular system,[HP_0000118],[EFO_0000651]
ABCA1,ENSG00000165029,EFO_1001492,0.32177358604170764,3,atrophic macular degeneration,[EFO_0001365],"[MONDO_0002025, OTAR_0000018, MONDO_0024458, EFO_0000618]"
ABCA1,ENSG00000165029,Orphanet_98977,0.24889914588340142,1,Juvenile glaucoma,[Orphanet_156005],"[OTAR_0000018, MONDO_0024458]"
ABCA1,ENSG00000165029,EFO_0010750,0.2178773510850086,1,PHF-tau measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0005271,0.41691414286443473,2,sleep duration,[EFO_0004870],[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0004190,0.45139777330765485,42,open-angle glaucoma,[MONDO_0005041],[MONDO_0024458]
ABCA1,ENSG00000165029,EFO_0003966,0.25204459849428595,1,eye disease,[MONDO_0024458],[MONDO_0024458]
ABCA1,ENSG00000165029,EFO_0003940,0.33353131429154775,1,physical activity,[GO_0008150],[GO_0008150]
ABCA1,ENSG00000165029,MONDO_0008783,0.8335885706667837,622,Tangier disease,"[MONDO_0001822, MONDO_0017773]","[OTAR_0000018, OTAR_0000020]"
ABCA1,ENSG00000165029,EFO_0000195,0.45778006174602465,23,metabolic syndrome,[EFO_0000589],[OTAR_0000020]
ABCA1,ENSG00000165029,EFO_0000508,0.33908794281391197,44,genetic disorder,[OTAR_0000018],[OTAR_0000018]
ABCA1,ENSG00000165029,MONDO_0021187,0.5143650474809064,19,hyperlipidemia,[EFO_0000589],[OTAR_0000020]
ABCA1,ENSG00000165029,HP_0003124,0.5139178136450878,27,Hypercholesterolemia,[HP_0003119],[EFO_0000651]
ABCA1,ENSG00000165029,EFO_0004723,0.30881886747489207,2,coronary artery calcification,[HP_0001626],[EFO_0000651]
ABCA1,ENSG00000165029,MONDO_0011393,0.7390416884595254,296,"hypoalphalipoproteinemia, primary, 1",[MONDO_0100189],[OTAR_0000020]
ABCA1,ENSG00000165029,EFO_0001645,0.4364536438630679,146,coronary artery disease,"[MONDO_0000473, EFO_0003777]",[EFO_0000319]
ABCA1,ENSG00000165029,EFO_0005664,0.3337844678356183,1,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0008039,0.30098110386939547,2,BMI-adjusted hip circumference,[EFO_0005093],[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0008343,0.24589029309211147,1,sex interaction measurement,[EFO_0001444],[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0008291,0.39913951263811354,2,stem Cell Factor measurement,[EFO_0007937],[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0008007,0.24589029309211147,1,age at assessment,[EFO_0000246],[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0008002,0.4765172169579048,5,physical activity measurement,[EFO_0001444],[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0000305,0.25907547813397597,2,breast carcinoma,"[EFO_0000313, MONDO_0007254]","[OTAR_0000017, MONDO_0045024, EFO_0010285]"
ABCA1,ENSG00000165029,EFO_0008593,0.34225414128135523,1,low density lipoprotein particle size measurement,"[EFO_0004732, EFO_0004529]",[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0004761,0.27724328903348205,1,uric acid measurement,"[EFO_0004742, EFO_0004298]",[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0004736,0.4418911722994681,3,aspartate aminotransferase measurement,"[EFO_0004747, EFO_0004582]",[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0004735,0.3166790467561226,1,serum alanine aminotransferase measurement,"[EFO_0004582, EFO_0004747]",[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0004732,0.6763521732313145,26,lipoprotein measurement,"[EFO_0005105, EFO_0004747]",[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0007986,0.4692127395021409,6,reticulocyte count,[EFO_0010700],[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0007010,0.2468217756548527,1,drug use measurement,[EFO_0001444],[EFO_0001444]
ABCA1,ENSG00000165029,MONDO_0015369,0.43815744994286315,3,Joubert syndrome and related disorders,[MONDO_0020043],"[OTAR_0000018, EFO_0000618]"
ABCA1,ENSG00000165029,EFO_0004329,0.5044730818214264,7,alcohol drinking,[EFO_0004315],[GO_0008150]
ABCA1,ENSG00000165029,EFO_0010118,0.3293969944170603,1,sphingomyelin measurement,"[EFO_0010968, EFO_0004622]",[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0009944,0.3290545757827603,3,Antiglaucoma preparations and miotics use measurement,[EFO_0007010],[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0009932,0.4502501626628711,3,HMG CoA reductase inhibitor use measurement,[EFO_0007010],[EFO_0001444]
ABCA1,ENSG00000165029,MONDO_0002679,0.3736888640413005,5,cerebral infarction,[EFO_0004277],"[EFO_0000618, EFO_0000319]"
ABCA1,ENSG00000165029,EFO_0010700,0.44334133013403737,4,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0004458,0.44244971978072783,3,C-reactive protein measurement,"[EFO_0004747, EFO_0004872]",[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0004348,0.36028624732762765,5,hematocrit,[EFO_0004503],[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0004343,0.48232226551620044,8,waist-hip ratio,[EFO_0007861],[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0004574,0.7243980702902583,50,total cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0004533,0.2791200194967381,4,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0000319,0.3757920963045569,63,cardiovascular disease,[],[EFO_0000319]
ABCA1,ENSG00000165029,EFO_1001022,0.25144045148246597,3,low tension glaucoma,"[EFO_0004190, MONDO_0002135]","[EFO_0000618, MONDO_0024458]"
ABCA1,ENSG00000165029,EFO_0003086,0.3739865811464631,5,kidney disease,[EFO_0009690],[EFO_0009690]
ABCA1,ENSG00000165029,GO_0036273,0.3229552808797058,1,response to statin,[GO_0050896],[GO_0008150]
ABCA1,ENSG00000165029,GO_0006306,0.33764464083785056,1,DNA methylation,"[GO_0044260, GO_0043412, GO_0006139]",[GO_0008150]
ABCA1,ENSG00000165029,EFO_0004696,0.35372385054083133,2,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0004695,0.46253784268791365,15,intraocular pressure measurement,[EFO_0004731],[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0004683,0.32352909035145994,2,wet macular degeneration,[EFO_0001365],"[MONDO_0002025, OTAR_0000018, MONDO_0024458, EFO_0000618]"
ABCA1,ENSG00000165029,EFO_0004631,0.5006719910114871,7,vitamin D measurement,"[EFO_0004529, EFO_0004729]",[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0004614,0.5313108275580588,18,apolipoprotein A 1 measurement,"[EFO_0004872, EFO_0005278, EFO_0004732]",[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0004509,0.3764795702864959,4,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0007878,0.5024253576698389,7,alcohol consumption measurement,[EFO_0001444],[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0007805,0.41535392884693473,2,HDL cholesterol change measurement,[EFO_0004612],[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0007789,0.406763105638247,3,BMI-adjusted waist circumference,[EFO_0004342],[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0007788,0.5543047319096135,23,BMI-adjusted waist-hip ratio,[EFO_0004343],[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0009253,0.20545621780388348,1,Immature Reticulocyte Fraction Measurement,[EFO_0009233],[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0009188,0.3718491442453362,2,Red cell distribution width,[EFO_0004509],[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0004612,0.7316722692472875,100,high density lipoprotein cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0004611,0.5563549905869858,21,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0001365,0.35044515596909853,72,age-related macular degeneration,"[MONDO_0019118, MONDO_0002175]","[MONDO_0002025, OTAR_0000018, MONDO_0024458, EFO_0000618]"
ABCA1,ENSG00000165029,EFO_0000401,0.40279922361394693,30,diabetic nephropathy,"[EFO_0000589, EFO_0003884]","[OTAR_0000020, EFO_0009690]"
ABCA1,ENSG00000165029,EFO_0004194,0.3695798546847018,1,IGA glomerulonephritis,"[EFO_0004128, MONDO_0002462]","[OTAR_0000018, EFO_0009690]"
ABCA1,ENSG00000165029,MONDO_0004975,0.3608764667988518,166,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
ABCA1,ENSG00000165029,MONDO_0100189,0.43712208098548266,22,apolipoprotein A-I deficiency,[MONDO_0017773],[OTAR_0000020]
ABCA1,ENSG00000165029,EFO_0007978,0.22167403744313965,1,red blood cell density measurement,[EFO_0005047],[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0007929,0.5030392466541774,3,triglyceride:HDL cholesterol ratio,"[EFO_0004732, EFO_0004529]",[EFO_0001444]
ABCA1,ENSG00000165029,MONDO_0005041,0.4529411429694069,36,glaucoma,[EFO_0003966],[MONDO_0024458]
ABCA1,ENSG00000165029,EFO_0004531,0.4577165968166907,6,urate measurement,[EFO_0001444],[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0004530,0.5184205663332174,11,triglyceride measurement,[EFO_0004529],[EFO_0001444]
ABCA1,ENSG00000165029,EFO_0004529,0.3180300434237435,1,lipid measurement,[EFO_0005105],[EFO_0001444]
ABCA10,ENSG00000154263,EFO_0010615,0.2257004911522309,2,galanin peptides measurement,[EFO_0007937],[EFO_0001444]
ABCA10,ENSG00000154263,EFO_0004574,0.3693681465646707,3,total cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
ABCA10,ENSG00000154263,EFO_0004615,0.38733625067450156,2,apolipoprotein B measurement,[EFO_0004732],[EFO_0001444]
ABCA10,ENSG00000154263,EFO_0004611,0.4064644243281473,3,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
ABCA11P,ENSG00000251595,NA,NA,NA,NA,NA,NA
ABCA12,ENSG00000144452,MONDO_0015947,0.20324646262185256,172,inherited ichthyosis,"[MONDO_0100118, MONDO_0019269]","[OTAR_0000018, EFO_0010285]"
ABCA12,ENSG00000144452,EFO_0004725,0.31723736630177696,2,metabolite measurement,[EFO_0001444],[EFO_0001444]
ABCA12,ENSG00000144452,MONDO_0017778,0.5890441560290803,18,lamellar ichthyosis,"[MONDO_0020162, MONDO_0017262]","[OTAR_0000018, MONDO_0024458, EFO_0010285]"
ABCA12,ENSG00000144452,MONDO_0017265,0.468607875237488,27,autosomal recessive congenital ichthyosis,"[MONDO_0017262, EFO_1000017]","[OTAR_0000018, EFO_0010285]"
ABCA12,ENSG00000144452,MONDO_0009443,0.7358238328649678,80,autosomal recessive congenital ichthyosis 4B,[MONDO_0011026],"[OTAR_0000018, MONDO_0024458, EFO_0010285]"
ABCA12,ENSG00000144452,EFO_0005772,0.3565673338578607,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
ABCA12,ENSG00000144452,MONDO_0019306,0.3734818205311565,13,congenital non-bullous ichthyosiform erythroderma,[MONDO_0017265],"[OTAR_0000018, EFO_0010285]"
ABCA12,ENSG00000144452,Orphanet_457,0.777446790403855,104,Harlequin ichthyosis,[Orphanet_183426],[OTAR_0000018]
ABCA12,ENSG00000144452,GO_0007568,0.3565673338578607,1,aging,[GO_0032502],[GO_0008150]
ABCA12,ENSG00000144452,MONDO_0011026,0.7888368946541279,66,autosomal recessive congenital ichthyosis 4A,"[MONDO_0017265, MONDO_0017778]","[OTAR_0000018, MONDO_0024458, EFO_0010285]"
ABCA12,ENSG00000144452,HP_0000951,0.26609749537298527,1,Abnormality of the skin,[HP_0001574],[EFO_0000651]
ABCA13,ENSG00000179869,MONDO_0005090,0.2711883150231587,15,schizophrenia,[EFO_0005407],"[MONDO_0002025, EFO_0000618]"
ABCA13,ENSG00000179869,GO_0006306,0.30216659221060815,2,DNA methylation,"[GO_0044260, GO_0043412, GO_0006139]",[GO_0008150]
ABCA13,ENSG00000179869,EFO_0007874,0.3015226568390639,1,gut microbiome measurement,[EFO_0007882],[EFO_0001444]
ABCA13,ENSG00000179869,EFO_0007883,0.3015226568390639,1,taxonomic microbiome measurement,[EFO_0007882],[EFO_0001444]
ABCA17P,ENSG00000238098,NA,NA,NA,NA,NA,NA
ABCA2,ENSG00000107331,MONDO_0032930,0.6959670941965374,46,intellectual developmental disorder with poor growth and with or without seizures or ataxia,[EFO_0000508],[OTAR_0000018]
ABCA2,ENSG00000107331,MONDO_0019502,0.3695798546847018,1,autosomal recessive non-syndromic intellectual disability,"[EFO_1000017, MONDO_0000509, MONDO_0017706]","[MONDO_0002025, OTAR_0000018, OTAR_0000020, EFO_0000618]"
ABCA3,ENSG00000167972,MONDO_0012593,0.3079293665056453,6,brain-lung-thyroid syndrome,"[EFO_0004280, MONDO_0015778, MONDO_0002320]","[EFO_0001379, EFO_0000618]"
ABCA3,ENSG00000167972,MONDO_0012580,0.562173907662705,291,hereditary pulmonary alveolar proteinosis,"[MONDO_0001437, MONDO_0015133]","[OTAR_0000018, EFO_0000540, OTAR_0000010]"
ABCA3,ENSG00000167972,EFO_0004713,0.44073397046092716,2,FEV/FEC ratio,"[EFO_0006841, EFO_0003892]",[EFO_0001444]
ABCA3,ENSG00000167972,EFO_1000644,0.4789781106686346,32,newborn respiratory distress syndrome,"[MONDO_0017015, MONDO_0100131, EFO_0010238]","[OTAR_0000014, OTAR_0000010]"
ABCA3,ENSG00000167972,EFO_0004244,0.4909366094497695,67,interstitial lung disease,[EFO_0003818],[OTAR_0000010]
ABCA3,ENSG00000167972,Orphanet_100049,0.4527353219887597,4,Primary interstitial lung disease specific to childhood due to pulmonary surfactant protein anomalies,[Orphanet_264992],"[OTAR_0000018, OTAR_0000010]"
ABCA3,ENSG00000167972,HP_0002093,0.26692905004602585,3,Respiratory insufficiency,[HP_0002086],[EFO_0000651]
ABCA3,ENSG00000167972,EFO_0005772,0.4241480294907439,3,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
ABCA3,ENSG00000167972,GO_0007568,0.35911952733928343,2,aging,[GO_0032502],[GO_0008150]
ABCA3,ENSG00000167972,Orphanet_217563,0.8171820998084133,300,Neonatal acute respiratory distress with surfactant metabolism deficiency,"[Orphanet_100049, EFO_0010238]","[OTAR_0000018, OTAR_0000014, OTAR_0000010]"
ABCA3,ENSG00000167972,Orphanet_264675,0.8022656225837593,298,Congenital pulmonary alveolar proteinosis,[Orphanet_100049],"[OTAR_0000018, OTAR_0000010]"
ABCA3,ENSG00000167972,EFO_0001361,0.3540900101270138,9,pulmonary arterial hypertension,"[MONDO_0005149, EFO_0000684]","[OTAR_0000010, EFO_0000319]"
ABCA4,ENSG00000198691,EFO_0020026,0.5212585711510038,34,autosomal recessive retinitis pigmentosa,[Orphanet_71862],"[OTAR_0000018, MONDO_0024458]"
ABCA4,ENSG00000198691,MONDO_0007934,0.3233823728491141,2,benign concentric annular macular dystrophy,[MONDO_0020242],"[MONDO_0002025, OTAR_0000018, MONDO_0024458, EFO_0000618]"
ABCA4,ENSG00000198691,MONDO_0015993,0.638706642953263,29,cone-rod dystrophy,[MONDO_0019118],"[MONDO_0002025, OTAR_0000018, EFO_0000618, MONDO_0024458]"
ABCA4,ENSG00000198691,EFO_0003966,0.4367509932736464,5,eye disease,[MONDO_0024458],[MONDO_0024458]
ABCA4,ENSG00000198691,EFO_0003959,0.4333848110864919,8,cleft lip,[HP_0000202],[EFO_0000651]
ABCA4,ENSG00000198691,EFO_0003839,0.3946405840721492,152,retinopathy,"[EFO_0000618, EFO_0003966]","[EFO_0000618, MONDO_0024458]"
ABCA4,ENSG00000198691,HP_0000618,0.3400134663099256,1,Blindness,[HP_0007663],[EFO_0000651]
ABCA4,ENSG00000198691,HP_0000603,0.39729834378605444,2,Central scotoma,[HP_0001123],[EFO_0000651]
ABCA4,ENSG00000198691,HP_0000572,0.3400134663099256,1,Visual loss,[HP_0000505],[EFO_0000651]
ABCA4,ENSG00000198691,HP_0000505,0.45967521037117237,5,Visual impairment,[HP_0000504],[EFO_0000651]
ABCA4,ENSG00000198691,HP_0000479,0.46197481835587734,4,Abnormal retinal morphology,[HP_0004329],[EFO_0000651]
ABCA4,ENSG00000198691,HP_0000202,0.3970591293713251,3,Orofacial cleft,[HP_0000153],[EFO_0000651]
ABCA4,ENSG00000198691,HP_0000175,0.4304743184003145,3,Cleft palate,[HP_0000202],[EFO_0000651]
ABCA4,ENSG00000198691,EFO_0000508,0.519357357000814,63,genetic disorder,[OTAR_0000018],[OTAR_0000018]
ABCA4,ENSG00000198691,Orphanet_71862,0.5815887722129248,491,Retinal dystrophy,[Orphanet_98657],"[OTAR_0000018, MONDO_0024458]"
ABCA4,ENSG00000198691,MONDO_0020248,0.4157773365202895,2,vitreoretinal degeneration,"[MONDO_0001377, MONDO_0024237, MONDO_0020246]","[OTAR_0000018, MONDO_0024458, EFO_0000618]"
ABCA4,ENSG00000198691,Orphanet_88628,0.417544416353998,103,Posterior column ataxia - retinitis pigmentosa,"[MONDO_0957003, Orphanet_98539, Orphanet_183518, Orphanet_98693]","[OTAR_0000018, MONDO_0024458, EFO_0000618]"
ABCA4,ENSG00000198691,MONDO_0009559,0.3400134663099256,1,mandibulofacial dysostosis with mental deficiency,[EFO_0000508],[OTAR_0000018]
ABCA4,ENSG00000198691,MONDO_0009549,0.8341343925206631,869,severe early-childhood-onset retinal dystrophy,"[MONDO_0019353, MONDO_0800406]","[MONDO_0002025, OTAR_0000018, MONDO_0024458, EFO_0000618]"
ABCA4,ENSG00000198691,HP_0007754,0.5370616987669724,60,Macular dystrophy,[HP_0001103],[EFO_0000651]
ABCA4,ENSG00000198691,MONDO_0800406,0.6503615516693939,222,ABCA4-related retinopathy,[MONDO_0019118],"[MONDO_0002025, OTAR_0000018, EFO_0000618, MONDO_0024458]"
ABCA4,ENSG00000198691,EFO_0009606,0.6163777271507714,106,macular degeneration,[MONDO_0004580],"[EFO_0000618, MONDO_0024458]"
ABCA4,ENSG00000198691,EFO_0004840,0.27603470775590766,1,cortical thickness,[EFO_0004464],[EFO_0001444]
ABCA4,ENSG00000198691,MONDO_0019353,0.7487125741598766,1165,Stargardt disease,"[EFO_0001365, MONDO_0016420]","[MONDO_0002025, OTAR_0000018, MONDO_0024458, EFO_0000618]"
ABCA4,ENSG00000198691,MONDO_0019200,0.744375002972151,354,retinitis pigmentosa,"[MONDO_0019216, MONDO_0019118]","[MONDO_0002025, OTAR_0000018, OTAR_0000020, MONDO_0024458, EFO_0000618]"
ABCA4,ENSG00000198691,EFO_0004625,0.3954065552395192,2,progranulin measurement,[EFO_0001444],[EFO_0001444]
ABCA4,ENSG00000198691,MONDO_0018998,0.5927916427793056,29,Leber congenital amaurosis,"[MONDO_0002320, MONDO_0019118, MONDO_0020210, MONDO_0020211]","[MONDO_0002025, OTAR_0000018, MONDO_0024458, EFO_0000618]"
ABCA4,ENSG00000198691,MONDO_0000455,0.5143537071081882,15,cone dystrophy,[MONDO_0020242],"[MONDO_0002025, OTAR_0000018, MONDO_0024458, EFO_0000618]"
ABCA4,ENSG00000198691,MONDO_0008865,0.36034035831758426,2,Bietti crystalline corneoretinal dystrophy,[MONDO_0016420],"[MONDO_0002025, OTAR_0000018, MONDO_0024458, EFO_0000618]"
ABCA4,ENSG00000198691,MONDO_0016293,0.39785271356808144,3,congenital stationary night blindness,[MONDO_0004587],"[MONDO_0002025, OTAR_0000018, EFO_0000618, MONDO_0024458]"
ABCA4,ENSG00000198691,EFO_0001365,0.7838683591499259,315,age-related macular degeneration,"[MONDO_0019118, MONDO_0002175]","[MONDO_0002025, OTAR_0000018, MONDO_0024458, EFO_0000618]"
ABCA4,ENSG00000198691,Orphanet_1872,0.82887986528394475,313,Cone rod dystrophy,[Orphanet_98666],"[OTAR_0000018, MONDO_0024458]"
ABCA4,ENSG00000198691,Orphanet_1871,0.424412364502856,4,Progressive cone dystrophy,[Orphanet_71862],"[OTAR_0000018, MONDO_0024458]"
ABCA4,ENSG00000198691,HP_0001105,0.39983407223347445,5,Retinal atrophy,[HP_0000479],[EFO_0000651]
ABCA5,ENSG00000154265,MONDO_0007610,0.49264937595542546,8,gingival fibromatosis-hypertrichosis syndrome,"[MONDO_0019280, MONDO_0019287]","[OTAR_0000018, EFO_0010285]"
ABCA5,ENSG00000154265,EFO_0000508,0.41517244206597154,57,genetic disorder,[OTAR_0000018],[OTAR_0000018]
ABCA5,ENSG00000154265,EFO_0004329,0.22285019250970883,1,alcohol drinking,[EFO_0004315],[GO_0008150]
ABCA5,ENSG00000154265,EFO_0005772,0.3177767824764365,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
ABCA6,ENSG00000154262,EFO_0011011,0.25993850843659694,1,sitting height measurement,[EFO_0004302],[EFO_0001444]
ABCA6,ENSG00000154262,MONDO_0021187,0.23091248965101693,1,hyperlipidemia,[EFO_0000589],[OTAR_0000020]
ABCA6,ENSG00000154262,HP_0003124,0.378098301734979,5,Hypercholesterolemia,[HP_0003119],[EFO_0000651]
ABCA6,ENSG00000154262,EFO_0004980,0.3310512378378726,2,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0004339,0.3310512378378726,2,body height,[EFO_0004324],[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0009932,0.26042791953028077,1,HMG CoA reductase inhibitor use measurement,[EFO_0007010],[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0010615,0.28823352488571424,2,galanin peptides measurement,[EFO_0007937],[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0004458,0.2442070819624188,1,C-reactive protein measurement,"[EFO_0004747, EFO_0004872]",[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0004348,0.36769124336163533,4,hematocrit,[EFO_0004503],[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0004574,0.38073346571344674,5,total cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0004541,0.26536970052188497,1,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0004536,0.2648409902702981,1,total blood protein measurement,[EFO_0004503],[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0004535,0.4476972537222552,10,serum albumin measurement,[EFO_0004747],[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0004533,0.2600258080794051,1,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0004838,0.2648409902702981,1,calcium measurement,[EFO_0001444],[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0004526,0.42585684926182904,9,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0004509,0.3780541349776506,5,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0004696,0.433868509831358,8,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0004695,0.33189251297257966,2,intraocular pressure measurement,[EFO_0004731],[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0004627,0.29650996003239277,2,IGF-1 measurement,"[EFO_0005127, EFO_0004730, EFO_0004747]",[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0004615,0.31379978369372385,4,apolipoprotein B measurement,[EFO_0004732],[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0004614,0.2617513583242826,1,apolipoprotein A 1 measurement,"[EFO_0004872, EFO_0005278, EFO_0004732]",[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0009188,0.432008281444349,5,Red cell distribution width,[EFO_0004509],[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0004611,0.38475212362796873,8,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0004309,0.33027882985136875,2,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0004286,0.25954280733042406,1,venous thromboembolism,[EFO_0004264],[EFO_0000319]
ABCA6,ENSG00000154262,EFO_0006797,0.21013770796040784,1,neurofibrillary tangles measurement,[EFO_0004464],[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0007937,0.32204707161311075,2,blood protein measurement,[EFO_0004747],[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0004531,0.2648409902702981,1,urate measurement,[EFO_0001444],[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0004528,0.3744223619183474,4,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
ABCA6,ENSG00000154262,EFO_0004527,0.3703341907431925,4,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
ABCA7,ENSG00000064687,EFO_0005653,0.23940397148594894,2,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
ABCA7,ENSG00000064687,EFO_0009390,0.2360797341410167,1,sum of neutrophil and eosinophil counts,[EFO_0007987],[EFO_0001444]
ABCA7,ENSG00000064687,EFO_0009388,0.22825470786841584,1,sum of basophil and neutrophil counts,[EFO_0007987],[EFO_0001444]
ABCA7,ENSG00000064687,EFO_0004833,0.31799561100002843,6,neutrophil count,"[EFO_0803548, EFO_0007987]",[EFO_0001444]
ABCA7,ENSG00000064687,EFO_0007988,0.24623424746167472,2,myeloid white cell count,[EFO_0004308],[EFO_0001444]
ABCA7,ENSG00000064687,EFO_0007987,0.23171569923367438,1,granulocyte count,[EFO_0007988],[EFO_0001444]
ABCA7,ENSG00000064687,EFO_0004584,0.22129185319601793,5,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
ABCA7,ENSG00000064687,EFO_0004541,0.26264556152779905,4,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
ABCA7,ENSG00000064687,EFO_1001870,0.22950906949281794,2,late-onset Alzheimers disease,[MONDO_0004975],"[MONDO_0002025, EFO_0000618]"
ABCA7,ENSG00000064687,EFO_0004526,0.4094042013303247,13,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
ABCA7,ENSG00000064687,EFO_0004509,0.2925045113162891,7,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
ABCA7,ENSG00000064687,EFO_0004503,0.2566507292301849,3,hematological measurement,[EFO_0001444],[EFO_0001444]
ABCA7,ENSG00000064687,EFO_0004622,0.25018867153077107,2,sphingolipid measurement,[EFO_0004529],[EFO_0001444]
ABCA7,ENSG00000064687,EFO_0009268,0.33858675570013724,5,family history of Alzheimer’s disease,[EFO_0006514],[EFO_0001444]
ABCA7,ENSG00000064687,EFO_0009188,0.3500794922673923,10,Red cell distribution width,[EFO_0004509],[EFO_0001444]
ABCA7,ENSG00000064687,EFO_0004305,0.2959738236415725,7,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
ABCA7,ENSG00000064687,MONDO_0004975,0.4920644606406484,210,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
ABCA7,ENSG00000064687,EFO_0004528,0.396957970128285,12,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
ABCA8,ENSG00000141338,EFO_0010917,0.2921949664648944,1,kidney injury molecule 1 measurement,[EFO_0007937],[EFO_0001444]
ABCA8,ENSG00000141338,EFO_0010911,0.30858705495962757,1,C-X-C motif chemokine 16 measurement,[EFO_0007937],[EFO_0001444]
ABCA8,ENSG00000141338,EFO_0010812,0.3077347434582673,1,T-cell immunoglobulin and mucin domain 1 measurement,[EFO_0004747],[EFO_0001444]
ABCA8,ENSG00000141338,EFO_0004908,0.41354266380010246,3,testosterone measurement,"[EFO_0004529, EFO_0011008]",[EFO_0001444]
ABCA8,ENSG00000141338,EFO_0008259,0.3077347434582673,1,"phospholipase A2, membrane associated measurement",[EFO_0007937],[EFO_0001444]
ABCA8,ENSG00000141338,EFO_0010057,0.3059687265356612,1,vascular cell adhesion molecule-1 measurement,[EFO_0004522],[EFO_0001444]
ABCA8,ENSG00000141338,EFO_0010699,0.2617395509539709,1,diffuse plaque measurement,"[EFO_0006514, EFO_0004464]",[EFO_0001444]
ABCA8,ENSG00000141338,EFO_0004536,0.29625593084845303,1,total blood protein measurement,[EFO_0004503],[EFO_0001444]
ABCA8,ENSG00000141338,EFO_0004535,0.3207113793681092,2,serum albumin measurement,[EFO_0004747],[EFO_0001444]
ABCA8,ENSG00000141338,GO_0036273,0.29574349978839665,1,response to statin,[GO_0050896],[GO_0008150]
ABCA8,ENSG00000141338,EFO_0003923,0.3117315383087701,1,bone density,[EFO_0004516],[EFO_0001444]
ABCA8,ENSG00000141338,EFO_0004696,0.27804004421408474,2,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
ABCA8,ENSG00000141338,EFO_0004615,0.3816924047658856,2,apolipoprotein B measurement,[EFO_0004732],[EFO_0001444]
ABCA8,ENSG00000141338,EFO_0004614,0.4283203330487032,4,apolipoprotein A 1 measurement,"[EFO_0004872, EFO_0005278, EFO_0004732]",[EFO_0001444]
ABCA8,ENSG00000141338,EFO_0004612,0.4710568301749609,9,high density lipoprotein cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
ABCA8,ENSG00000141338,EFO_0004611,0.3511526744977458,2,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
ABCA8,ENSG00000141338,EFO_0007937,0.4451188028860014,4,blood protein measurement,[EFO_0004747],[EFO_0001444]
ABCA8,ENSG00000141338,EFO_0004531,0.3117315383087701,1,urate measurement,[EFO_0001444],[EFO_0001444]
ABCA9,ENSG00000154258,EFO_0005423,0.2604147463820599,1,adolescent idiopathic scoliosis,[MONDO_0000726],[OTAR_0000006]
ABCA9,ENSG00000154258,EFO_0004696,0.2514078069498302,7,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
ABCA9,ENSG00000154258,EFO_0004627,0.30152197395010927,2,IGF-1 measurement,"[EFO_0005127, EFO_0004730, EFO_0004747]",[EFO_0001444]
ABCA9,ENSG00000154258,EFO_0004611,0.2382466954581929,5,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
ABCB1,ENSG00000085563,MONDO_0007254,0.3125098327909189,93,breast cancer,"[EFO_0003869, MONDO_0003274]","[OTAR_0000017, MONDO_0045024, EFO_0010285]"
ABCB1,ENSG00000085563,EFO_0000198,0.35747277591648885,20,myelodysplastic syndrome,"[MONDO_0021058, Orphanet_322126, MONDO_0015756]","[OTAR_0000018, MONDO_0045024, EFO_0005803]"
ABCB1,ENSG00000085563,EFO_0005917,0.26064619251638593,3,generalised epilepsy,[MONDO_0015653],"[OTAR_0000018, EFO_0000618]"
ABCB1,ENSG00000085563,EFO_0003767,0.24650496385297566,53,inflammatory bowel disease,"[EFO_0000508, EFO_0005140, EFO_0009431]","[OTAR_0000018, EFO_0000540, EFO_0010282]"
ABCB1,ENSG00000085563,EFO_0004251,0.25870589827929125,1,myeloproliferative disorder,"[MONDO_0004992, EFO_0002427, Orphanet_322126]","[OTAR_0000018, MONDO_0045024, EFO_0005803]"
ABCB1,ENSG00000085563,EFO_1001945,0.25870589827929125,1,childhood acute myeloid leukemia with maturation,"[EFO_0010283, EFO_0003028]","[OTAR_0000006, EFO_0005803, MONDO_0045024, EFO_0000540]"
ABCB1,ENSG00000085563,EFO_0003029,0.25870589827929125,1,acute basophilic leukemia,[MONDO_0015667],"[OTAR_0000006, EFO_0005803, MONDO_0045024, EFO_0000540]"
ABCB1,ENSG00000085563,EFO_0003028,0.25870589827929125,1,acute myeloblastic leukemia with maturation,[MONDO_0015667],"[OTAR_0000006, EFO_0005803, MONDO_0045024, EFO_0000540]"
ABCB1,ENSG00000085563,EFO_0003027,0.3233823728491141,2,acute myeloblastic leukemia without maturation,[MONDO_0015667],"[OTAR_0000006, EFO_0005803, MONDO_0045024, EFO_0000540]"
ABCB1,ENSG00000085563,EFO_0003025,0.32846409585102876,4,acute megakaryoblastic leukaemia,[MONDO_0015667],"[OTAR_0000006, EFO_0005803, MONDO_0045024, EFO_0000540]"
ABCB1,ENSG00000085563,EFO_0004339,0.32055455125788845,3,body height,[EFO_0004324],[EFO_0001444]
ABCB1,ENSG00000085563,EFO_0000330,0.25870589827929125,1,childhood acute myeloid leukemia,"[MONDO_0004355, EFO_0000222]","[OTAR_0000006, EFO_0005803, MONDO_0045024, EFO_0000540]"
ABCB1,ENSG00000085563,EFO_0022041,0.5465880568661412,601,response to tramadol,[GO_0009410],[GO_0008150]
ABCB1,ENSG00000085563,MONDO_0005090,0.210491843990557,35,schizophrenia,[EFO_0005407],"[MONDO_0002025, EFO_0000618]"
ABCB1,ENSG00000085563,EFO_0003060,0.3427281509701973,188,non-small cell lung carcinoma,[EFO_0001071],"[OTAR_0000010, MONDO_0045024]"
ABCB1,ENSG00000085563,EFO_0000565,0.33677964258143445,7,leukemia,[MONDO_0044881],"[MONDO_0045024, EFO_0005803]"
ABCB1,ENSG00000085563,EFO_0001378,0.2795097260646393,82,multiple myeloma,"[MONDO_0000621, EFO_0002427, EFO_0000200]","[OTAR_0000018, MONDO_0045024, EFO_0000540, EFO_0005803]"
ABCB1,ENSG00000085563,EFO_0000223,0.3233823728491141,2,acute myelomonocytic leukemia,[MONDO_0015667],"[OTAR_0000006, EFO_0005803, MONDO_0045024, EFO_0000540]"
ABCB1,ENSG00000085563,EFO_0000221,0.32384434766746995,4,acute monocytic leukemia,"[MONDO_0004600, EFO_0000222]","[OTAR_0000006, EFO_0005803, MONDO_0045024, EFO_0000540]"
ABCB1,ENSG00000085563,EFO_0007937,0.2674484063918904,3,blood protein measurement,[EFO_0004747],[EFO_0001444]
ABCB1,ENSG00000085563,EFO_0007710,0.2019057679855732,1,cognitive decline measurement,[EFO_0007998],[EFO_0001444]
ABCB1,ENSG00000085563,EFO_0000218,0.3233823728491141,2,acute erythroleukemia,"[MONDO_0020703, MONDO_0015667]","[OTAR_0000006, EFO_0005803, MONDO_0045024, EFO_0000540]"
ABCB10,ENSG00000135776,EFO_0007991,0.2044033572366323,1,eosinophil percentage of leukocytes,[EFO_0004842],[EFO_0001444]
ABCB10,ENSG00000135776,EFO_0004541,0.3050068994717925,2,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
ABCB10,ENSG00000135776,EFO_0004842,0.29530861815791937,6,eosinophil count,"[EFO_0803540, EFO_0007987]",[EFO_0001444]
ABCB10,ENSG00000135776,EFO_0005772,0.3695798546847018,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
ABCB10,ENSG00000135776,MONDO_0005148,0.3758599248617947,8,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
ABCB10,ENSG00000135776,EFO_0004468,0.25578895871573665,4,glucose measurement,[EFO_0006842],[EFO_0001444]
ABCB10,ENSG00000135776,EFO_0007629,0.25623064169991494,1,hemoglobin A1 measurement,[EFO_0004509],[EFO_0001444]
ABCB10,ENSG00000135776,EFO_0004527,0.37189035180324653,6,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
ABCB11,ENSG00000073734,EFO_0010934,0.2951206830331316,1,aspartate aminotransferase to alanine aminotransferase ratio,[EFO_0006845],[EFO_0001444]
ABCB11,ENSG00000073734,EFO_0003940,0.27778001772311645,1,physical activity,[GO_0008150],[GO_0008150]
ABCB11,ENSG00000073734,MONDO_0015762,0.5505571555257219,53,progressive familial intrahepatic cholestasis,"[MONDO_0017755, MONDO_0017290]","[OTAR_0000018, OTAR_0000020, EFO_0001379, EFO_0010282]"
ABCB11,ENSG00000073734,EFO_0000508,0.4128926139468312,29,genetic disorder,[OTAR_0000018],[OTAR_0000018]
ABCB11,ENSG00000073734,MONDO_0011559,0.8015615536441906,81,benign recurrent intrahepatic cholestasis type 2,[MONDO_0019008],"[OTAR_0000018, OTAR_0000020, EFO_0001379, EFO_0010282]"
ABCB11,ENSG00000073734,MONDO_0011214,0.35004817533103977,3,progressive familial intrahepatic cholestasis type 3,[MONDO_0015762],"[OTAR_0000018, OTAR_0000020, EFO_0001379, EFO_0010282]"
ABCB11,ENSG00000073734,MONDO_0011156,0.8280381823590516,294,progressive familial intrahepatic cholestasis type 2,"[MONDO_0011559, MONDO_0015762]","[OTAR_0000018, OTAR_0000020, EFO_0001379, EFO_0010282]"
ABCB11,ENSG00000073734,MONDO_0017290,0.5565276864555666,37,familial intrahepatic cholestasis,"[MONDO_0019072, MONDO_0019052, MONDO_0015509]","[OTAR_0000018, OTAR_0000020, EFO_0001379, EFO_0010282]"
ABCB11,ENSG00000073734,HP_0200148,0.3400134663099256,1,Abnormal liver function tests during pregnancy,[HP_0002910],[EFO_0000651]
ABCB11,ENSG00000073734,EFO_0009048,0.579107261240437,23,Intrahepatic cholestasis of pregnancy,"[Orphanet_101940, MONDO_0015509]","[OTAR_0000018, EFO_0001379, EFO_0010282]"
ABCB11,ENSG00000073734,EFO_0004736,0.47091523951844,7,aspartate aminotransferase measurement,"[EFO_0004747, EFO_0004582]",[EFO_0001444]
ABCB11,ENSG00000073734,EFO_0004735,0.4806550271374953,9,serum alanine aminotransferase measurement,"[EFO_0004582, EFO_0004747]",[EFO_0001444]
ABCB11,ENSG00000073734,EFO_0004329,0.35014416316236024,2,alcohol drinking,[EFO_0004315],[GO_0008150]
ABCB11,ENSG00000073734,EFO_0004458,0.4008922900874445,4,C-reactive protein measurement,"[EFO_0004747, EFO_0004872]",[EFO_0001444]
ABCB11,ENSG00000073734,EFO_0004574,0.4538882274124112,7,total cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
ABCB11,ENSG00000073734,EFO_0004541,0.2614092587790088,14,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
ABCB11,ENSG00000073734,EFO_0004533,0.7019867807204332,26,alkaline phosphatase measurement,"[EFO_0004512, EFO_0004747, EFO_0004582]",[EFO_0001444]
ABCB11,ENSG00000073734,EFO_0004615,0.3785807771869294,2,apolipoprotein B measurement,[EFO_0004732],[EFO_0001444]
ABCB11,ENSG00000073734,EFO_0004468,0.22657054604990856,5,glucose measurement,[EFO_0006842],[EFO_0001444]
ABCB11,ENSG00000073734,EFO_0004465,0.2279756935478936,11,fasting blood glucose measurement,[EFO_0004468],[EFO_0001444]
ABCB11,ENSG00000073734,MONDO_0019072,0.524564251257608,105,intrahepatic cholestasis,[MONDO_0001751],[EFO_0010282]
ABCB11,ENSG00000073734,EFO_0007878,0.34828721737258245,2,alcohol consumption measurement,[EFO_0001444],[EFO_0001444]
ABCB11,ENSG00000073734,EFO_0009188,0.4021932862748147,5,Red cell distribution width,[EFO_0004509],[EFO_0001444]
ABCB11,ENSG00000073734,EFO_0009150,0.5708100886947062,13,"cholestasis, intrahepatic, of pregnancy 3","[Orphanet_101940, MONDO_0015509]","[OTAR_0000018, EFO_0001379, EFO_0010282]"
ABCB11,ENSG00000073734,EFO_0004611,0.47002986877511105,14,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
ABCB11,ENSG00000073734,HP_0000989,0.3432785985223084,8,Pruritus,[HP_0000951],[EFO_0000651]
ABCB11,ENSG00000073734,EFO_0004532,0.5667117489863931,12,serum gamma-glutamyl transferase measurement,[EFO_0004582],[EFO_0001444]
ABCB11,ENSG00000073734,EFO_0004528,0.24994991579162526,2,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
TAP1,ENSG00000168394,EFO_0020092,0.3574585685951717,1,neuroinflammatory disorder,"[EFO_0009386, MONDO_0002977]","[EFO_0000540, EFO_0000618]"
TAP1,ENSG00000168394,MONDO_0011476,0.7686070367709501,335,MHC class I deficiency,[MONDO_0015131],"[OTAR_0000018, EFO_0000540]"
TAP1,ENSG00000168394,Orphanet_34592,0.7591365529946545,333,Immunodeficiency by defective expression of HLA class 1,[Orphanet_101972],"[OTAR_0000018, EFO_0000540]"
TAP1,ENSG00000168394,EFO_0005772,0.23892219768861414,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
TAP1,ENSG00000168394,Orphanet_572,0.5544303779276281,327,Immunodeficiency by defective expression of HLA class 2,[Orphanet_101972],"[OTAR_0000018, EFO_0000540]"
TAP2,ENSG00000204267,EFO_0000685,0.22368649101161123,5,rheumatoid arthritis,"[MONDO_0000589, EFO_0005140, EFO_0005755, EFO_0005856]","[OTAR_0000006, EFO_0000540]"
TAP2,ENSG00000204267,MONDO_0011476,0.722056328126082,361,MHC class I deficiency,[MONDO_0015131],"[OTAR_0000018, EFO_0000540]"
TAP2,ENSG00000204267,EFO_0004984,0.24738485064092877,1,complement C4 measurement,"[EFO_0006846, EFO_0004555]",[EFO_0001444]
TAP2,ENSG00000204267,EFO_0006812,0.2697130725311819,1,autoimmune thyroid disease,"[MONDO_0000569, EFO_0005140, MONDO_0004126]","[EFO_0001379, EFO_0000540]"
TAP2,ENSG00000204267,EFO_0010128,0.24616750195032447,1,immunoglobulin isotype switching measurement,[EFO_0004556],[EFO_0001444]
TAP2,ENSG00000204267,Orphanet_34592,0.6792209963574175,357,Immunodeficiency by defective expression of HLA class 1,[Orphanet_101972],"[OTAR_0000018, EFO_0000540]"
TAP2,ENSG00000204267,EFO_0009459,0.20435852056294482,5,ACPA-positive rheumatoid arthritis,[EFO_0000685],"[OTAR_0000006, EFO_0000540]"
TAP2,ENSG00000204267,MONDO_0005147,0.2697130725311819,1,type 1 diabetes mellitus,"[MONDO_0000569, MONDO_0000588, EFO_0000400]","[OTAR_0000020, EFO_0001379, EFO_0000540, EFO_0009605, EFO_0010282]"
TAP2,ENSG00000204267,Orphanet_572,0.5457616043879419,355,Immunodeficiency by defective expression of HLA class 2,[Orphanet_101972],"[OTAR_0000018, EFO_0000540]"
TAP2,ENSG00000204267,EFO_0004645,0.2647301419728944,1,response to vaccine,[GO_0009410],[GO_0008150]
TAP2,ENSG00000204267,EFO_0007924,0.24345793075055402,1,tonsillectomy risk measurement,[EFO_0001444],[EFO_0001444]
ABCB4,ENSG00000005471,EFO_0002571,0.5070815295365237,5,medical procedure,[],[EFO_0002571]
ABCB4,ENSG00000005471,EFO_0010934,0.306332926635219,1,aspartate aminotransferase to alanine aminotransferase ratio,[EFO_0006845],[EFO_0001444]
ABCB4,ENSG00000005471,EFO_0003832,0.7059606054915143,41,gallbladder disease,[EFO_0009534],[EFO_0010282]
ABCB4,ENSG00000005471,MONDO_0015762,0.6615974238899754,49,progressive familial intrahepatic cholestasis,"[MONDO_0017755, MONDO_0017290]","[OTAR_0000018, OTAR_0000020, EFO_0001379, EFO_0010282]"
ABCB4,ENSG00000005471,MONDO_0011214,0.8465936597473137,191,progressive familial intrahepatic cholestasis type 3,[MONDO_0015762],"[OTAR_0000018, OTAR_0000020, EFO_0001379, EFO_0010282]"
ABCB4,ENSG00000005471,MONDO_0017290,0.5563110154511497,32,familial intrahepatic cholestasis,"[MONDO_0019072, MONDO_0019052, MONDO_0015509]","[OTAR_0000018, OTAR_0000020, EFO_0001379, EFO_0010282]"
ABCB4,ENSG00000005471,EFO_0009048,0.7168574303079341,130,Intrahepatic cholestasis of pregnancy,"[Orphanet_101940, MONDO_0015509]","[OTAR_0000018, EFO_0001379, EFO_0010282]"
ABCB4,ENSG00000005471,EFO_0004799,0.7598194275809014,84,cholelithiasis,"[MONDO_0700225, EFO_1000018]","[OTAR_0000018, EFO_0001379, EFO_0009690, EFO_0010282]"
ABCB4,ENSG00000005471,EFO_0004736,0.46192364105919914,6,aspartate aminotransferase measurement,"[EFO_0004747, EFO_0004582]",[EFO_0001444]
ABCB4,ENSG00000005471,EFO_0004735,0.702186145073153,29,serum alanine aminotransferase measurement,"[EFO_0004582, EFO_0004747]",[EFO_0001444]
ABCB4,ENSG00000005471,EFO_0007986,0.4484960087941742,4,reticulocyte count,[EFO_0010700],[EFO_0001444]
ABCB4,ENSG00000005471,EFO_0004339,0.39009669989321794,4,body height,[EFO_0004324],[EFO_0001444]
ABCB4,ENSG00000005471,EFO_0010701,0.3951001583856663,2,mean reticulocyte volume,[EFO_0010700],[EFO_0001444]
ABCB4,ENSG00000005471,EFO_0010700,0.37326185975581305,2,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
ABCB4,ENSG00000005471,EFO_0004574,0.3885747303725154,2,total cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
ABCB4,ENSG00000005471,EFO_0004570,0.31318003389616633,1,bilirubin measurement,[EFO_0001444],[EFO_0001444]
ABCB4,ENSG00000005471,EFO_0009605,0.44159956330201894,9,pancreas disease,"[EFO_0001379, EFO_0010282]",[EFO_0009605]
ABCB4,ENSG00000005471,EFO_0009534,0.44159956330201894,9,biliary tract disease,[EFO_0010284],[EFO_0010282]
ABCB4,ENSG00000005471,EFO_0004615,0.38675811358124146,2,apolipoprotein B measurement,[EFO_0004732],[EFO_0001444]
ABCB4,ENSG00000005471,EFO_0004526,0.3916753821636772,2,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
ABCB4,ENSG00000005471,MONDO_0019072,0.6814719816169718,160,intrahepatic cholestasis,[MONDO_0001751],[EFO_0010282]
ABCB4,ENSG00000005471,EFO_0009188,0.4611524667410813,5,Red cell distribution width,[EFO_0004509],[EFO_0001444]
ABCB4,ENSG00000005471,EFO_0009150,0.7743159280001397,118,"cholestasis, intrahepatic, of pregnancy 3","[Orphanet_101940, MONDO_0015509]","[OTAR_0000018, EFO_0001379, EFO_0010282]"
ABCB4,ENSG00000005471,EFO_0004611,0.460177448593978,6,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
ABCB4,ENSG00000005471,EFO_0004606,0.3666912674497861,2,gallbladder neoplasm,"[EFO_0008550, EFO_0003832]","[MONDO_0045024, EFO_0010282]"
ABCB4,ENSG00000005471,MONDO_0008892,0.5445748457186641,22,progressive familial intrahepatic cholestasis type 1,[MONDO_0015762],"[OTAR_0000018, OTAR_0000020, EFO_0001379, EFO_0010282]"
ABCB4,ENSG00000005471,EFO_0004210,0.6038231131718775,10,gallstones,[EFO_0003832],[EFO_0010282]
ABCB4,ENSG00000005471,MONDO_0010939,0.8199517709243959,80,low phospholipid associated cholelithiasis,"[MONDO_0700225, MONDO_0004789, MONDO_0015509]","[OTAR_0000018, EFO_0001379, EFO_0010282]"
ABCB4,ENSG00000005471,HP_0001082,0.29419805599812415,1,Cholecystitis,[HP_0012438],[EFO_0000651]
ABCB4,ENSG00000005471,EFO_0004528,0.2221939802816966,1,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
ABCB5,ENSG00000004846,EFO_0000684,0.258043293329517,1,respiratory system disease,[OTAR_0000010],[OTAR_0000010]
ABCB5,ENSG00000004846,EFO_0003956,0.31190231011193936,2,seasonal allergic rhinitis,[EFO_0005854],"[EFO_0000540, OTAR_0000010]"
ABCB5,ENSG00000004846,MONDO_0005405,0.3446515826643557,2,childhood onset asthma,[MONDO_0004979],[OTAR_0000010]
ABCB5,ENSG00000004846,EFO_0000274,0.25793466992838476,1,atopic eczema,"[MONDO_0002406, MONDO_0005271, MONDO_0100118, EFO_1000636]","[OTAR_0000018, EFO_0000540, EFO_0010285]"
ABCB5,ENSG00000004846,EFO_0005854,0.3528012565488378,2,allergic rhinitis,"[MONDO_0000771, EFO_0008521]","[EFO_0000540, OTAR_0000010]"
ABCB5,ENSG00000004846,EFO_0003767,0.2120092862981885,1,inflammatory bowel disease,"[EFO_0000508, EFO_0005140, EFO_0009431]","[OTAR_0000018, EFO_0000540, EFO_0010282]"
ABCB5,ENSG00000004846,EFO_0004980,0.2926658954994523,1,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
ABCB5,ENSG00000004846,EFO_0009389,0.21605278194171512,1,sum of eosinophil and basophil counts,[EFO_0007987],[EFO_0001444]
ABCB5,ENSG00000004846,EFO_0007991,0.20183213564466992,4,eosinophil percentage of leukocytes,[EFO_0004842],[EFO_0001444]
ABCB5,ENSG00000004846,EFO_0004339,0.33322879723824744,2,body height,[EFO_0004324],[EFO_0001444]
ABCB5,ENSG00000004846,EFO_0009942,0.25375809905341623,1,Glucocorticoid use measurement,[EFO_0007010],[EFO_0001444]
ABCB5,ENSG00000004846,EFO_0010638,0.25807340652954697,1,atopic asthma,[MONDO_0004979],[OTAR_0000010]
ABCB5,ENSG00000004846,EFO_0004458,0.23472871544471974,1,C-reactive protein measurement,"[EFO_0004747, EFO_0004872]",[EFO_0001444]
ABCB5,ENSG00000004846,EFO_0004340,0.23096793582839473,1,body mass index,[EFO_0004324],[EFO_0001444]
ABCB5,ENSG00000004846,EFO_0004842,0.38548105802590205,15,eosinophil count,"[EFO_0803540, EFO_0007987]",[EFO_0001444]
ABCB5,ENSG00000004846,MONDO_0005147,0.27679601879689936,1,type 1 diabetes mellitus,"[MONDO_0000569, MONDO_0000588, EFO_0000400]","[OTAR_0000020, EFO_0001379, EFO_0000540, EFO_0009605, EFO_0010282]"
ABCB5,ENSG00000004846,MONDO_0004979,0.4376542130583648,15,asthma,[EFO_1002018],[OTAR_0000010]
ABCB5,ENSG00000004846,EFO_0003923,0.3192015284110104,1,bone density,[EFO_0004516],[EFO_0001444]
ABCB5,ENSG00000004846,HP_0000964,0.3841788695355876,3,Eczema,[HP_0011123],[EFO_0000651]
ABCB5,ENSG00000004846,MONDO_0005271,0.3366552716728946,3,allergic disease,[EFO_1002003],[EFO_0000540]
ABCB5,ENSG00000004846,EFO_0004531,0.3192015284110104,1,urate measurement,[EFO_0001444],[EFO_0001444]
ABCB6,ENSG00000115657,Orphanet_98947,0.3695798546847018,1,Coloboma of optic papilla,[MONDO_0001476],[MONDO_0024458]
ABCB6,ENSG00000115657,MONDO_0012204,0.6847661112457937,13,familial pseudohyperkalemia,[MONDO_0020102],[EFO_0005803]
ABCB6,ENSG00000115657,MONDO_0020357,0.3695798546847018,1,coloboma of eyelid,"[MONDO_0020155, MONDO_0001476]",[MONDO_0024458]
ABCB6,ENSG00000115657,MONDO_0020356,0.36994943453938645,2,coloboma of iris,[MONDO_0007350],[MONDO_0024458]
ABCB6,ENSG00000115657,MONDO_0020355,0.3695798546847018,1,coloboma of eye lens,[MONDO_0001476],[MONDO_0024458]
ABCB6,ENSG00000115657,MONDO_0020354,0.3695798546847018,1,coloboma of choroid and retina,[MONDO_0007350],[MONDO_0024458]
ABCB6,ENSG00000115657,EFO_0005569,0.37022661943040003,3,microphthalmia,[EFO_0003966],[MONDO_0024458]
ABCB6,ENSG00000115657,MONDO_0000170,0.591105494754177,13,"microphthalmia, isolated, with coloboma","[MONDO_0001476, MONDO_0016764, MONDO_0000062]","[OTAR_0000018, MONDO_0024458]"
ABCB6,ENSG00000115657,EFO_0007986,0.6112961009436473,19,reticulocyte count,[EFO_0010700],[EFO_0001444]
ABCB6,ENSG00000115657,EFO_0004339,0.2651663384629143,5,body height,[EFO_0004324],[EFO_0001444]
ABCB6,ENSG00000115657,EFO_0010701,0.23298611096196678,6,mean reticulocyte volume,[EFO_0010700],[EFO_0001444]
ABCB6,ENSG00000115657,EFO_0010700,0.6001979580213425,10,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
ABCB6,ENSG00000115657,MONDO_0007351,0.3695798546847018,1,coloboma of macula,"[MONDO_0020242, MONDO_0001476]","[MONDO_0002025, OTAR_0000018, MONDO_0024458, EFO_0000618]"
ABCB6,ENSG00000115657,Orphanet_241,0.7365103963990419,16,Dyschromatosis universalis,[Orphanet_183466],[OTAR_0000018]
ABCB6,ENSG00000115657,EFO_0004696,0.26096325395005526,4,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
ABCB6,ENSG00000115657,MONDO_0000736,0.37597658090161346,17,dyschromatosis universalis hereditaria,"[MONDO_0019289, MONDO_0100118]","[OTAR_0000018, EFO_0010285]"
ABCB6,ENSG00000115657,EFO_0009253,0.20764493300773007,3,Immature Reticulocyte Fraction Measurement,[EFO_0009233],[EFO_0001444]
ABCB6,ENSG00000115657,EFO_0009188,0.3707042711249943,9,Red cell distribution width,[EFO_0004509],[EFO_0001444]
ABCB7,ENSG00000131269,MONDO_0008119,0.3326218692162316,1,spinocerebellar ataxia type 1,"[MONDO_0019792, MONDO_0015548]","[MONDO_0002025, EFO_0000618, OTAR_0000018]"
ABCB7,ENSG00000131269,EFO_0000508,0.32662545702521123,7,genetic disorder,[OTAR_0000018],[OTAR_0000018]
ABCB7,ENSG00000131269,MONDO_0010524,0.8152058580940684,51,X-linked sideroblastic anemia with ataxia,"[MONDO_0016803, MONDO_0020099, MONDO_0016612]","[OTAR_0000020, EFO_0000618, EFO_0005803, OTAR_0000018]"
ABCB8,ENSG00000197150,EFO_0005772,0.3986168158254793,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
ABCB8,ENSG00000197150,GO_0007568,0.3548547537053265,1,aging,[GO_0032502],[GO_0008150]
ABCB9,ENSG00000150967,EFO_0007986,0.27697895627903285,6,reticulocyte count,[EFO_0010700],[EFO_0001444]
ABCC1,ENSG00000103222,EFO_0005208,0.29973703439485816,1,glomerular filtration rate,[EFO_0004742],[EFO_0001444]
ABCC1,ENSG00000103222,MONDO_0030058,0.4528995797019528,3,"hearing loss, autosomal dominant 77",[MONDO_0019587],"[MONDO_0002025, OTAR_0000018, EFO_0000618]"
ABCC1,ENSG00000103222,EFO_0005664,0.4223147908137194,4,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
ABCC1,ENSG00000103222,EFO_0005653,0.3615529796543287,2,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
ABCC1,ENSG00000103222,EFO_0008111,0.27378936887320493,1,diet measurement,[EFO_0001444],[EFO_0001444]
ABCC1,ENSG00000103222,EFO_0008039,0.23725679238330002,1,BMI-adjusted hip circumference,[EFO_0005093],[EFO_0001444]
ABCC1,ENSG00000103222,EFO_0007995,0.27619183830149197,1,basophil percentage of granulocytes,[EFO_0005090],[EFO_0001444]
ABCC1,ENSG00000103222,MONDO_0019588,0.3695798546847018,1,"hearing loss, autosomal recessive","[EFO_1000017, MONDO_0016298, MONDO_0016297]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
ABCC1,ENSG00000103222,MONDO_0019587,0.3695798546847018,1,autosomal dominant nonsyndromic hearing loss,"[MONDO_0016297, MONDO_0016298, MONDO_0000426]","[MONDO_0002025, OTAR_0000018, EFO_0000618]"
ABCC1,ENSG00000103222,EFO_0007992,0.3490740100844847,2,basophil percentage of leukocytes,[EFO_0005090],[EFO_0001444]
ABCC1,ENSG00000103222,EFO_0004339,0.4197427233741424,3,body height,[EFO_0004324],[EFO_0001444]
ABCC1,ENSG00000103222,EFO_0010701,0.4477964196555766,4,mean reticulocyte volume,[EFO_0010700],[EFO_0001444]
ABCC1,ENSG00000103222,EFO_0010700,0.20768977134495048,1,reticulocyte measurement,[EFO_0004503],[EFO_0001444]
ABCC1,ENSG00000103222,EFO_0004348,0.3299621981772803,3,hematocrit,[EFO_0004503],[EFO_0001444]
ABCC1,ENSG00000103222,EFO_0004541,0.42831808719459435,4,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
ABCC1,ENSG00000103222,EFO_0004634,0.36454854915401796,2,coagulation factor measurement,[EFO_0001444],[EFO_0001444]
ABCC1,ENSG00000103222,EFO_0004526,0.4626612706675943,7,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
ABCC1,ENSG00000103222,EFO_0004518,0.2558504487816141,1,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
ABCC1,ENSG00000103222,EFO_0005090,0.40981910101989516,4,basophil count,"[EFO_0004872, EFO_0803539, EFO_0007987]",[EFO_0001444]
ABCC1,ENSG00000103222,EFO_0009188,0.43688321028133503,4,Red cell distribution width,[EFO_0004509],[EFO_0001444]
ABCC1,ENSG00000103222,EFO_0004587,0.4354818164394604,3,lymphocyte count,"[EFO_0006843, EFO_0004308, EFO_0803546]",[EFO_0001444]
ABCC1,ENSG00000103222,MONDO_0016419,0.47533869957627156,12,hereditary breast carcinoma,"[EFO_0000305, EFO_0000508]","[OTAR_0000017, OTAR_0000018, MONDO_0045024, EFO_0010285]"
ABCC1,ENSG00000103222,EFO_0007937,0.2920663189973194,1,blood protein measurement,[EFO_0004747],[EFO_0001444]
ABCC1,ENSG00000103222,EFO_0007629,0.30776434999875035,1,hemoglobin A1 measurement,[EFO_0004509],[EFO_0001444]
ABCC1,ENSG00000103222,EFO_0004528,0.4845849361321871,9,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
ABCC1,ENSG00000103222,EFO_0004527,0.4469932614425677,5,mean corpuscular hemoglobin,[EFO_0004306],[EFO_0001444]
ABCD2,ENSG00000173208,NA,NA,NA,NA,NA,NA
ABCC10,ENSG00000124574,NA,NA,NA,NA,NA,NA
ABCC11,ENSG00000121270,NA,NA,NA,NA,NA,NA
ABCC12,ENSG00000140798,EFO_0004838,0.32533398717976064,3,calcium measurement,[EFO_0001444],[EFO_0001444]
ABCC12,ENSG00000140798,EFO_0004528,0.2944369129315001,1,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
ABCC13,ENSG00000243064,NA,NA,NA,NA,NA,NA
ABCC2,ENSG00000023839,EFO_0000508,0.41360693510587804,44,genetic disorder,[OTAR_0000018],[OTAR_0000018]
ABCC2,ENSG00000023839,Orphanet_758,0.2601640447976285,6,Pseudoxanthoma elasticum,"[EFO_0002945, Orphanet_98702, Orphanet_98056, Orphanet_139027, Orphanet_139030, Orphanet_98054, Orphanet_228215]","[OTAR_0000006, EFO_0009690, MONDO_0024458, EFO_0000319, OTAR_0000018, EFO_0010285]"
ABCC2,ENSG00000023839,EFO_0005653,0.2879464719629341,1,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
ABCC2,ENSG00000023839,EFO_0008111,0.2529233003494399,1,diet measurement,[EFO_0001444],[EFO_0001444]
ABCC2,ENSG00000023839,MONDO_0009380,0.8066228736442956,280,Dubin-Johnson syndrome,[MONDO_0002408],"[OTAR_0000018, OTAR_0000020]"
ABCC2,ENSG00000023839,EFO_0009048,0.4765154529500572,7,Intrahepatic cholestasis of pregnancy,"[Orphanet_101940, MONDO_0015509]","[OTAR_0000018, EFO_0001379, EFO_0010282]"
ABCC2,ENSG00000023839,EFO_0004736,0.26803469394227675,2,aspartate aminotransferase measurement,"[EFO_0004747, EFO_0004582]",[EFO_0001444]
ABCC2,ENSG00000023839,EFO_0004735,0.48704240541453186,7,serum alanine aminotransferase measurement,"[EFO_0004582, EFO_0004747]",[EFO_0001444]
ABCC2,ENSG00000023839,EFO_0004570,0.668364953735388,19,bilirubin measurement,[EFO_0001444],[EFO_0001444]
ABCC2,ENSG00000023839,MONDO_0009925,0.25870589827929125,1,autosomal recessive inherited pseudoxanthoma elasticum,"[MONDO_0100118, EFO_1000017, MONDO_0100091, MONDO_0019292, MONDO_0023603]","[OTAR_0000006, OTAR_0000018, EFO_0010285]"
ABCC2,ENSG00000023839,MONDO_0001751,0.4707041628133376,47,cholestasis,[MONDO_0002887],[EFO_0010282]
ABCC2,ENSG00000023839,EFO_0004518,0.21899530638970569,1,creatinine measurement,"[EFO_0004742, EFO_0004725]",[EFO_0001444]
ABCC2,ENSG00000023839,EFO_0004305,0.27319254595556636,1,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
ABCC2,ENSG00000023839,EFO_0004532,0.4441153738843505,5,serum gamma-glutamyl transferase measurement,[EFO_0004582],[EFO_0001444]
ABCC3,ENSG00000108846,EFO_0004570,0.32231249670321915,4,bilirubin measurement,[EFO_0001444],[EFO_0001444]
ABCC3,ENSG00000108846,EFO_0005772,0.2047027727142475,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
ABCC3,ENSG00000108846,GO_0007568,0.20414840293222045,1,aging,[GO_0032502],[GO_0008150]
ABCC4,ENSG00000125257,EFO_0005664,0.3966074650306924,2,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
ABCC4,ENSG00000125257,EFO_0005653,0.33133316083273984,1,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
ABCC4,ENSG00000125257,EFO_0008446,0.41134806368910753,2,platelet-to-lymphocyte ratio,[EFO_0004503],[EFO_0001444]
ABCC4,ENSG00000125257,EFO_0000304,0.24532743859980843,3,breast adenocarcinoma,"[MONDO_0000653, EFO_0000228, EFO_0000305]","[OTAR_0000017, MONDO_0045024, EFO_0010285]"
ABCC4,ENSG00000125257,EFO_0004541,0.3225946714543287,1,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
ABCC4,ENSG00000125257,EFO_0004838,0.3233825711071977,1,calcium measurement,[EFO_0001444],[EFO_0001444]
ABCC4,ENSG00000125257,EFO_0007874,0.2774376480414297,1,gut microbiome measurement,[EFO_0007882],[EFO_0001444]
ABCC4,ENSG00000125257,EFO_0004309,0.5275026633600781,17,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
ABCC4,ENSG00000125257,EFO_0007985,0.4962303921890253,6,platelet crit,[EFO_0005036],[EFO_0001444]
ABCC5,ENSG00000114770,EFO_0005668,0.23112722518422263,1,anterior chamber depth measurement,[EFO_0004731],[EFO_0001444]
ABCC5,ENSG00000114770,EFO_0008354,0.23998676213700446,1,cognitive function measurement,[EFO_0001444],[EFO_0001444]
ABCC5,ENSG00000114770,EFO_0004833,0.4047102100152112,5,neutrophil count,"[EFO_0803548, EFO_0007987]",[EFO_0001444]
ABCC5,ENSG00000114770,EFO_0007992,0.22716305480280857,1,basophil percentage of leukocytes,[EFO_0005090],[EFO_0001444]
ABCC5,ENSG00000114770,EFO_0007989,0.2283162256996036,2,monocyte percentage of leukocytes,[EFO_0005091],[EFO_0001444]
ABCC5,ENSG00000114770,EFO_0007988,0.26387409416332913,3,myeloid white cell count,[EFO_0004308],[EFO_0001444]
ABCC5,ENSG00000114770,EFO_0004584,0.34857300086231535,5,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
ABCC5,ENSG00000114770,EFO_0004842,0.33043128633575514,7,eosinophil count,"[EFO_0803540, EFO_0007987]",[EFO_0001444]
ABCC5,ENSG00000114770,EFO_0005772,0.2942537819458466,1,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
ABCC5,ENSG00000114770,MONDO_0005148,0.30350206724429807,4,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
ABCC5,ENSG00000114770,EFO_0004526,0.384102320201684,9,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
ABCC5,ENSG00000114770,EFO_0009188,0.38970394654054996,6,Red cell distribution width,[EFO_0004509],[EFO_0001444]
ABCC5,ENSG00000114770,EFO_0004587,0.22391999863593812,2,lymphocyte count,"[EFO_0006843, EFO_0004308, EFO_0803546]",[EFO_0001444]
ABCC5,ENSG00000114770,EFO_0004309,0.37347216729262694,5,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
ABCC5,ENSG00000114770,EFO_0004308,0.40201276563214916,6,leukocyte count,[EFO_0004586],[EFO_0001444]
ABCC5,ENSG00000114770,EFO_0004305,0.20151773285863253,1,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
ABCC5,ENSG00000114770,EFO_0007985,0.28846066807065135,2,platelet crit,[EFO_0005036],[EFO_0001444]
ABCC5,ENSG00000114770,EFO_0007984,0.2961684555881449,3,platelet component distribution width,[EFO_0005036],[EFO_0001444]
ABCC5,ENSG00000114770,EFO_0004528,0.3196613690093971,4,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
ABCC6,ENSG00000091262,EFO_0010972,0.3347478919784937,1,blood phosphate measurement,[EFO_0001444],[EFO_0001444]
ABCC6,ENSG00000091262,MONDO_0016175,0.3409374159466374,2,cutis laxa,"[MONDO_0020159, MONDO_0019755, MONDO_0019292]","[OTAR_0000018, MONDO_0024458, EFO_0010285]"
ABCC6,ENSG00000091262,EFO_0003966,0.39729834378605444,2,eye disease,[MONDO_0024458],[MONDO_0024458]
ABCC6,ENSG00000091262,HP_0000368,0.25870589827929125,1,"Low-set, posteriorly rotated ears","[HP_0000369, HP_0000358]",[EFO_0000651]
ABCC6,ENSG00000091262,MONDO_0015493,0.3400134663099256,1,"lipoatrophy with diabetes, leukomelanodermic papules, liver steatosis, and hypertrophic cardiomyopathy",[MONDO_0020087],"[OTAR_0000018, OTAR_0000020, EFO_0010285]"
ABCC6,ENSG00000091262,Orphanet_758,0.8641632419296958,1161,Pseudoxanthoma elasticum,"[EFO_0002945, Orphanet_98702, Orphanet_98056, Orphanet_139027, Orphanet_139030, Orphanet_98054, Orphanet_228215]","[OTAR_0000006, EFO_0009690, MONDO_0024458, EFO_0000319, OTAR_0000018, EFO_0010285]"
ABCC6,ENSG00000091262,EFO_0004339,0.20420467475683052,2,body height,[EFO_0004324],[EFO_0001444]
ABCC6,ENSG00000091262,EFO_0004348,0.4774539380070978,5,hematocrit,[EFO_0004503],[EFO_0001444]
ABCC6,ENSG00000091262,EFO_0004541,0.33689930058692596,1,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
ABCC6,ENSG00000091262,EFO_0004838,0.45588043829519126,3,calcium measurement,[EFO_0001444],[EFO_0001444]
ABCC6,ENSG00000091262,MONDO_0009925,0.8106875364065498,689,autosomal recessive inherited pseudoxanthoma elasticum,"[MONDO_0100118, EFO_1000017, MONDO_0100091, MONDO_0019292, MONDO_0023603]","[OTAR_0000006, OTAR_0000018, EFO_0010285]"
ABCC6,ENSG00000091262,Orphanet_51608,0.7978301745367737,298,Generalized arterial calcification of infancy,"[Orphanet_233655, EFO_0005775]","[OTAR_0000018, EFO_0000319]"
ABCC6,ENSG00000091262,EFO_0004509,0.4993047484476053,6,hemoglobin measurement,"[EFO_0004747, EFO_0004503]",[EFO_0001444]
ABCC6,ENSG00000091262,EFO_0004696,0.3352755889109867,1,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
ABCC6,ENSG00000091262,EFO_0004617,0.3358874353856263,1,cystatin C measurement,"[EFO_0004747, EFO_0004742]",[EFO_0001444]
ABCC6,ENSG00000091262,EFO_0004305,0.49037968461594605,5,erythrocyte count,"[EFO_0004586, EFO_0004306]",[EFO_0001444]
ABCC6,ENSG00000091262,MONDO_0100091,0.3695798546847018,1,inherited pseudoxanthoma elasticum,[MONDO_0024308],[EFO_0010285]
ABCC6,ENSG00000091262,EFO_0007978,0.41834448131567536,2,red blood cell density measurement,[EFO_0005047],[EFO_0001444]
ABCC6,ENSG00000091262,EFO_0007937,0.45150828306717516,4,blood protein measurement,[EFO_0004747],[EFO_0001444]
ABCC6,ENSG00000091262,EFO_0004528,0.3626417680776915,9,mean corpuscular hemoglobin concentration,"[EFO_0004509, EFO_0004306]",[EFO_0001444]
CFTR,ENSG00000001626,MONDO_0021637,0.2309874091779386,2,low grade glioma,[EFO_0005543],"[EFO_0000618, MONDO_0045024]"
CFTR,ENSG00000001626,MONDO_0008185,0.7087232142278703,303,hereditary chronic pancreatitis,"[EFO_0000342, EFO_0000508]","[OTAR_0000018, EFO_0001379, EFO_0009605, EFO_0010282]"
CFTR,ENSG00000001626,MONDO_0008170,0.2309874091779386,2,ovarian cancer,"[EFO_1001331, EFO_0003893]","[OTAR_0000017, MONDO_0045024, EFO_0001379]"
CFTR,ENSG00000001626,MONDO_0018801,0.6361134095017779,16,congenital bilateral absence of vas deferens,"[MONDO_0015933, EFO_0000508]","[OTAR_0000017, OTAR_0000018]"
CFTR,ENSG00000001626,EFO_0000684,0.37098204888559105,20,respiratory system disease,[OTAR_0000010],[OTAR_0000010]
CFTR,ENSG00000001626,MONDO_0015607,0.4187579980483217,3,partial chromosome Y deletion,"[MONDO_0000761, MONDO_0700028, EFO_0004248]","[OTAR_0000017, OTAR_0000018]"
CFTR,ENSG00000001626,EFO_0000279,0.5692296555387852,135,azoospermia,"[EFO_0004248, EFO_0000508]","[OTAR_0000017, OTAR_0000018]"
CFTR,ENSG00000001626,EFO_0000278,0.40555429498897394,180,pancreatitis,[EFO_0009605],"[EFO_0001379, EFO_0009605, EFO_0010282]"
CFTR,ENSG00000001626,EFO_0000508,0.5347250339246713,204,genetic disorder,[OTAR_0000018],[OTAR_0000018]
CFTR,ENSG00000001626,EFO_0006505,0.40474265605790094,52,chronic bronchitis,"[EFO_0000341, EFO_0009661]",[OTAR_0000010]
CFTR,ENSG00000001626,MONDO_0010178,0.7875739479369999,598,congenital bilateral aplasia of vas deferens from CFTR mutation,[MONDO_0018801],"[OTAR_0000017, OTAR_0000018]"
CFTR,ENSG00000001626,MONDO_0009061,0.903332646858244,10131,cystic fibrosis,"[EFO_1000017, EFO_0000684]","[OTAR_0000018, OTAR_0000010]"
CFTR,ENSG00000001626,EFO_0000304,0.22642186461729336,4,breast adenocarcinoma,"[MONDO_0000653, EFO_0000228, EFO_0000305]","[OTAR_0000017, MONDO_0045024, EFO_0010285]"
CFTR,ENSG00000001626,EFO_0000280,0.21464996361543975,13,Barrett's esophagus,[EFO_0009544],[EFO_0010282]
CFTR,ENSG00000001626,EFO_0000731,0.2516603008993656,3,uterine fibroid,"[Orphanet_271832, MONDO_0017127, MONDO_0001572, MONDO_0021525, EFO_0002424, MONDO_0023603]","[OTAR_0000006, OTAR_0000017, OTAR_0000018, MONDO_0045024]"
CFTR,ENSG00000001626,EFO_0004248,0.3384643900554394,129,male infertility,"[EFO_0000545, EFO_0009555]",[OTAR_0000017]
CFTR,ENSG00000001626,HP_0004798,0.3695798546847018,1,Recurrent infection of the gastrointestinal tract,"[HP_0002719, HP_0012719]",[EFO_0000651]
CFTR,ENSG00000001626,EFO_0004327,0.2986752363042461,3,electrocardiography,[EFO_0004311],[EFO_0001444]
CFTR,ENSG00000001626,EFO_0004343,0.20222767203294814,4,waist-hip ratio,[EFO_0007861],[EFO_0001444]
CFTR,ENSG00000001626,HP_0002110,0.4807942276467415,134,Bronchiectasis,[HP_0002086],[EFO_0000651]
CFTR,ENSG00000001626,HP_0002028,0.3695798546847018,1,Chronic diarrhea,[HP_0002014],[EFO_0000651]
CFTR,ENSG00000001626,HP_0002014,0.5318281621658459,18,Diarrhea,[HP_0011458],[EFO_0000651]
CFTR,ENSG00000001626,HP_0001939,0.3400134663099256,1,Abnormality of metabolism/homeostasis,[HP_0000118],[EFO_0000651]
CFTR,ENSG00000001626,EFO_0000765,0.3695798546847018,1,AIDS,"[EFO_0000764, MONDO_0003780]","[OTAR_0000017, OTAR_0000018, EFO_0005741, EFO_0000540]"
CFTR,ENSG00000001626,MONDO_0001751,0.46603459683903353,15,cholestasis,[MONDO_0002887],[EFO_0010282]
CFTR,ENSG00000001626,EFO_0007788,0.2055452742302898,7,BMI-adjusted waist-hip ratio,[EFO_0004343],[EFO_0001444]
CFTR,ENSG00000001626,EFO_0000342,0.6177075262915387,13,chronic pancreatitis,[EFO_0000278],"[EFO_0001379, EFO_0009605, EFO_0010282]"
CFTR,ENSG00000001626,EFO_0009166,0.5786667913597644,32,response to ivacaftor - efficacy,[GO_0009410],[GO_0008150]
CFTR,ENSG00000001626,EFO_0004308,0.2752466621630605,3,leukocyte count,[EFO_0004586],[EFO_0001444]
CFTR,ENSG00000001626,MONDO_0008887,0.6775105199168427,173,bronchiectasis with or without elevated sweat chloride 1,[MONDO_0018956],"[OTAR_0000018, OTAR_0000010]"
CFTR,ENSG00000001626,EFO_0000519,0.2662816693339032,9,glioblastoma multiforme,"[EFO_0000272, MONDO_0016680]","[MONDO_0045024, EFO_0000618]"
CFTR,ENSG00000001626,EFO_0004229,0.22444700717230748,2,Dupuytren Contracture,[EFO_0003899],[OTAR_0000006]
CFTR,ENSG00000001626,EFO_1000888,0.3400134663099256,1,cystic lymphangioma,[MONDO_0018720],"[MONDO_0045024, EFO_0000540, EFO_0005803, EFO_0000319]"
CFTR,ENSG00000001626,EFO_0000478,0.21747843374507772,9,esophageal adenocarcinoma,"[EFO_0000228, EFO_0002916]","[MONDO_0045024, EFO_0010282]"
CFTR,ENSG00000001626,MONDO_0004822,0.4690531662975644,126,bronchiectasis,"[EFO_1002018, EFO_0000508, EFO_0000341]","[OTAR_0000018, OTAR_0000010]"
CFTR,ENSG00000001626,EFO_1000044,0.27419362038269396,19,pancreatic adenocarcinoma,"[EFO_0000228, EFO_0002618]","[MONDO_0045024, EFO_0001379, EFO_0009605, EFO_0010282]"
CFTR,ENSG00000001626,EFO_0007658,0.3695798546847018,1,carrier status,[EFO_0001444],[EFO_0001444]
ABCC8,ENSG00000006071,HP_0001693,0.3326218692162316,2,Cardiac shunt,[HP_0011028],[EFO_0000651]
ABCC8,ENSG00000006071,HP_0001561,0.26609749537298527,1,Polyhydramnios,[HP_0001560],[EFO_0000651]
ABCC8,ENSG00000006071,HP_0001520,0.26609749537298527,1,Large for gestational age,[HP_0004324],[EFO_0000651]
ABCC8,ENSG00000006071,HP_0001518,0.3326218692162316,2,Small for gestational age,[HP_0004325],[EFO_0000651]
ABCC8,ENSG00000006071,HP_0001510,0.3326218692162316,2,Growth delay,[HP_0001507],[EFO_0000651]
ABCC8,ENSG00000006071,HP_0012594,0.37561156775160426,2,Moderate albuminuria,[EFO_0004285],[EFO_0000651]
ABCC8,ENSG00000006071,HP_0011968,0.3326218692162316,2,Feeding difficulties,[HP_0011458],[EFO_0000651]
ABCC8,ENSG00000006071,EFO_1001511,0.3695798546847018,1,monogenic diabetes,"[MONDO_0019052, EFO_0000400, EFO_0005140]","[OTAR_0000018, OTAR_0000020, EFO_0000540, EFO_0001379, EFO_0009605, EFO_0010282]"
ABCC8,ENSG00000006071,EFO_1000825,0.3326218692162316,2,atrial heart septal defect,"[MONDO_0020294, MONDO_0017131, MONDO_0002078]","[OTAR_0000018, EFO_0000319]"
ABCC8,ENSG00000006071,EFO_0020865,0.24685180074017884,1,aortic measurement,[EFO_0004298],[EFO_0001444]
ABCC8,ENSG00000006071,MONDO_0018911,0.5017536049221455,472,maturity-onset diabetes of the young,"[EFO_1001511, MONDO_0017688]","[OTAR_0000018, OTAR_0000020, EFO_0000540, EFO_0001379, EFO_0009605, EFO_0010282]"
ABCC8,ENSG00000006071,EFO_0003948,0.3326218692162316,2,gastroesophageal reflux disease,"[EFO_0009544, EFO_0000508, EFO_0009608]","[OTAR_0000018, EFO_0010282]"
ABCC8,ENSG00000006071,HP_0000400,0.3326218692162316,2,Macrotia,[HP_0000377],[EFO_0000651]
ABCC8,ENSG00000006071,HP_0000343,0.26609749537298527,1,Long philtrum,[HP_0000153],[EFO_0000651]
ABCC8,ENSG00000006071,HP_0000337,0.26609749537298527,1,Broad forehead,[HP_0000271],[EFO_0000651]
ABCC8,ENSG00000006071,HP_0000325,0.26609749537298527,1,Triangular face,[HP_0001999],[EFO_0000651]
ABCC8,ENSG00000006071,HP_0000307,0.26609749537298527,1,Pointed chin,[HP_0000271],[EFO_0000651]
ABCC8,ENSG00000006071,HP_0000278,0.26609749537298527,1,Retrognathia,[HP_0000277],[EFO_0000651]
ABCC8,ENSG00000006071,HP_0000256,0.33299144907091627,3,Macrocephaly,[HP_0000929],[EFO_0000651]
ABCC8,ENSG00000006071,EFO_0000373,0.33317623899825866,3,congestive heart failure,[EFO_0003144],[EFO_0000319]
ABCC8,ENSG00000006071,EFO_0000508,0.5178790335864185,102,genetic disorder,[OTAR_0000018],[OTAR_0000018]
ABCC8,ENSG00000006071,MONDO_0012593,0.3326218692162316,2,brain-lung-thyroid syndrome,"[EFO_0004280, MONDO_0015778, MONDO_0002320]","[EFO_0001379, EFO_0000618]"
ABCC8,ENSG00000006071,HP_0003124,0.3233823728491141,2,Hypercholesterolemia,[HP_0003119],[EFO_0000651]
ABCC8,ENSG00000006071,EFO_0001073,0.34086449760246335,14,obesity,[MONDO_0003916],[OTAR_0000020]
ABCC8,ENSG00000006071,MONDO_0020525,0.7449760333909087,762,transient neonatal diabetes mellitus,[MONDO_0016391],"[OTAR_0000018, OTAR_0000020, EFO_0000540, EFO_0001379, EFO_0009605, EFO_0010282]"
ABCC8,ENSG00000006071,EFO_0001645,0.3259232343500714,4,coronary artery disease,"[MONDO_0000473, EFO_0003777]",[EFO_0000319]
ABCC8,ENSG00000006071,EFO_0004980,0.2750179191455322,2,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
ABCC8,ENSG00000006071,MONDO_0014403,0.3432308642670974,5,short stature due to GHSR deficiency,[MONDO_0019824],[EFO_0001379]
ABCC8,ENSG00000006071,MONDO_0017187,0.3695798546847018,1,diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency,"[MONDO_0019265, MONDO_0009734]","[OTAR_0000020, EFO_0009605, OTAR_0000018, EFO_0001379, EFO_0010282]"
ABCC8,ENSG00000006071,MONDO_0017184,0.7539491315463862,45,autosomal dominant hyperinsulinism due to SUR1 deficiency,[MONDO_0015624],"[OTAR_0000018, OTAR_0000020, EFO_0001379, EFO_0009605, EFO_0010282]"
ABCC8,ENSG00000006071,MONDO_0017182,0.556401241894786,193,familial hyperinsulinism,"[EFO_0007318, MONDO_0002177]","[OTAR_0000018, OTAR_0000020, EFO_0001379, EFO_0009605, EFO_0010282]"
ABCC8,ENSG00000006071,EFO_0007318,0.3695798546847018,1,hyperinsulinemic hypoglycemia,"[MONDO_0019214, EFO_0001379, Orphanet_79161]","[OTAR_0000018, EFO_0001379, OTAR_0000020]"
ABCC8,ENSG00000006071,MONDO_0009061,0.25944505798866063,2,cystic fibrosis,"[EFO_1000017, EFO_0000684]","[OTAR_0000018, OTAR_0000010]"
ABCC8,ENSG00000006071,EFO_0000713,0.469827481909878,30,subarachnoid hemorrhage,"[EFO_0005774, EFO_0003763]","[EFO_0000618, EFO_0000319]"
ABCC8,ENSG00000006071,EFO_0000537,0.32432428817320635,6,hypertension,[MONDO_0000473],[EFO_0000319]
ABCC8,ENSG00000006071,EFO_0006856,0.7372904622689085,156,leucine-induced hypoglycemia,[HP_0001943],[EFO_0000651]
ABCC8,ENSG00000006071,HP_0001319,0.26609749537298527,1,Neonatal hypotonia,[HP_0001252],[EFO_0000651]
ABCC8,ENSG00000006071,HP_0001290,0.26609749537298527,1,Generalized hypotonia,[HP_0001252],[EFO_0000651]
ABCC8,ENSG00000006071,EFO_0004562,0.26609749537298527,1,cryptorchidism,"[EFO_0009555, EFO_0000508]","[OTAR_0000017, OTAR_0000018]"
ABCC8,ENSG00000006071,EFO_0004541,0.21114129450992525,2,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
ABCC8,ENSG00000006071,MONDO_0030088,0.785985587840234,170,"diabetes mellitus, permanent neonatal 3",[MONDO_0100164],"[OTAR_0000018, OTAR_0000020, EFO_0000540, EFO_0001379, EFO_0009605, EFO_0010282]"
ABCC8,ENSG00000006071,EFO_0003095,0.3695798546847018,1,non-alcoholic fatty liver disease,[MONDO_0004790],"[EFO_0001379, EFO_0010282]"
ABCC8,ENSG00000006071,HP_0001943,0.740438029679307,213,Hypoglycemia,[HP_0011015],[EFO_0000651]
ABCC8,ENSG00000006071,MONDO_0005147,0.41127054651400385,19,type 1 diabetes mellitus,"[MONDO_0000569, MONDO_0000588, EFO_0000400]","[OTAR_0000020, EFO_0001379, EFO_0000540, EFO_0009605, EFO_0010282]"
ABCC8,ENSG00000006071,MONDO_0005129,0.29104413556420267,2,cataract,"[EFO_0009674, EFO_0000508]","[OTAR_0000018, MONDO_0024458]"
ABCC8,ENSG00000006071,EFO_0005772,0.3636947203428961,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
ABCC8,ENSG00000006071,MONDO_0019333,0.3695798546847018,1,autosomal recessive hyperinsulinism due to SUR1 deficiency,"[MONDO_0009734, MONDO_0015625]","[OTAR_0000020, EFO_0009605, OTAR_0000018, EFO_0001379, EFO_0010282]"
ABCC8,ENSG00000006071,MONDO_0019207,0.37185738012177466,11,DEND syndrome,[MONDO_0100164],"[OTAR_0000018, OTAR_0000020, EFO_0000540, EFO_0001379, EFO_0009605, EFO_0010282]"
ABCC8,ENSG00000006071,MONDO_0009734,0.8301712233476772,646,"hyperinsulinemic hypoglycemia, familial, 1",[EFO_0007318],"[OTAR_0000018, EFO_0001379, OTAR_0000020]"
ABCC8,ENSG00000006071,Orphanet_552,0.5767802712185935,551,MODY,[Orphanet_183625],"[OTAR_0000018, OTAR_0000020, EFO_0000540, EFO_0001379, EFO_0009605, EFO_0010282]"
ABCC8,ENSG00000006071,MONDO_0005148,0.8486664206799466,804,type 2 diabetes mellitus,[EFO_0000400],"[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
ABCC8,ENSG00000006071,EFO_1001461,0.25870589827929125,1,endothelial dysfunction,[EFO_0004264],[EFO_0000319]
ABCC8,ENSG00000006071,EFO_0003914,0.35323621222197826,4,atherosclerosis,"[EFO_0009086, MONDO_0002277]",[EFO_0000319]
ABCC8,ENSG00000006071,EFO_0004696,0.23018103358502037,3,sex hormone-binding globulin measurement,"[EFO_0011008, EFO_0004555]",[EFO_0001444]
ABCC8,ENSG00000006071,MONDO_0019010,0.5848754193722634,759,congenital isolated hyperinsulinism,"[MONDO_0007834, MONDO_0019716, MONDO_0015327, MONDO_0017182]","[OTAR_0000018, OTAR_0000020, EFO_0001379, EFO_0009605, EFO_0010282]"
ABCC8,ENSG00000006071,EFO_0004593,0.5739300865928786,15,gestational diabetes,"[EFO_0000400, EFO_0009682]","[EFO_0001379, OTAR_0000014, EFO_0009605, OTAR_0000020, EFO_0010282]"
ABCC8,ENSG00000006071,MONDO_0016391,0.5202746337256916,108,neonatal diabetes mellitus,[EFO_1001511],"[OTAR_0000018, OTAR_0000020, EFO_0000540, EFO_0001379, EFO_0009605, EFO_0010282]"
ABCC8,ENSG00000006071,EFO_0001361,0.24707333790517133,26,pulmonary arterial hypertension,"[MONDO_0005149, EFO_0000684]","[OTAR_0000010, EFO_0000319]"
ABCC8,ENSG00000006071,EFO_0000400,0.7204821369064326,248,diabetes mellitus,"[EFO_0009406, MONDO_0001933]","[EFO_0001379, EFO_0009605, OTAR_0000020, EFO_0010282]"
ABCC8,ENSG00000006071,Orphanet_183625,0.3712632489833534,17,Rare genetic diabetes mellitus,"[Orphanet_156638, EFO_1001511]","[OTAR_0000018, OTAR_0000020, EFO_0000540, EFO_0001379, EFO_0009605, EFO_0010282]"
ABCC8,ENSG00000006071,EFO_0003884,0.25907547813397597,2,chronic kidney disease,[EFO_0003086],[EFO_0009690]
ABCC8,ENSG00000006071,MONDO_0100164,0.7084069490278262,158,permanent neonatal diabetes mellitus,"[MONDO_0017688, MONDO_0016391]","[OTAR_0000018, OTAR_0000020, EFO_0000540, EFO_0001379, EFO_0009605, EFO_0010282]"
ABCC8,ENSG00000006071,EFO_0007629,0.20288767418757453,1,hemoglobin A1 measurement,[EFO_0004509],[EFO_0001444]
ABCC9,ENSG00000069431,HP_0001626,0.34151054606390135,312,Abnormality of the cardiovascular system,[HP_0000118],[EFO_0000651]
ABCC9,ENSG00000069431,MONDO_0022113,0.3695798546847018,1,central centrifugal cicatricial alopecia,[MONDO_0021034],"[OTAR_0000018, EFO_0010285]"
ABCC9,ENSG00000069431,EFO_0020865,0.3706378259047744,2,aortic measurement,[EFO_0004298],[EFO_0001444]
ABCC9,ENSG00000069431,MONDO_0002561,0.3695798546847018,1,lysosomal storage disease,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
ABCC9,ENSG00000069431,EFO_0004192,0.3695798546847018,1,alopecia areata,"[MONDO_0004907, MONDO_0021034, Orphanet_68346]","[OTAR_0000018, EFO_0010285]"
ABCC9,ENSG00000069431,EFO_0004191,0.5550501618283327,21,androgenetic alopecia,"[MONDO_0021208, MONDO_0021034, Orphanet_68346]","[OTAR_0000018, EFO_0010285]"
ABCC9,ENSG00000069431,MONDO_0018054,0.665179528881402,69,familial atrial fibrillation,"[EFO_0000275, EFO_0000508]","[OTAR_0000018, EFO_0000319]"
ABCC9,ENSG00000069431,HP_0000414,0.3400134663099256,1,Bulbous nose,[HP_0000366],[EFO_0000651]
ABCC9,ENSG00000069431,HP_0000347,0.3400134663099256,1,Micrognathia,[HP_0000277],[EFO_0000651]
ABCC9,ENSG00000069431,HP_0000294,0.3400134663099256,1,Low anterior hairline,"[HP_0000271, HP_0010720]",[EFO_0000651]
ABCC9,ENSG00000069431,HP_0000286,0.3400134663099256,1,Epicanthus,[HP_0000271],[EFO_0000651]
ABCC9,ENSG00000069431,HP_0000280,0.3400134663099256,1,Coarse facial features,[HP_0001999],[EFO_0000651]
ABCC9,ENSG00000069431,HP_0000271,0.3400134663099256,1,Abnormality of the face,[HP_0000234],[EFO_0000651]
ABCC9,ENSG00000069431,HP_0000256,0.34075262601929507,2,Macrocephaly,[HP_0000929],[EFO_0000651]
ABCC9,ENSG00000069431,EFO_0000508,0.32504342897378025,8,genetic disorder,[OTAR_0000018],[OTAR_0000018]
ABCC9,ENSG00000069431,MONDO_0020164,0.3400134663099256,1,epicanthal fold,[MONDO_0020163],[MONDO_0024458]
ABCC9,ENSG00000069431,EFO_0005939,0.2895949879279982,1,parental genotype effect measurement,[EFO_0007958],[EFO_0001444]
ABCC9,ENSG00000069431,EFO_0004980,0.3848474343436414,2,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
ABCC9,ENSG00000069431,MONDO_0027407,0.26609749537298527,1,Kleefstra syndrome 1,[MONDO_0012455],[OTAR_0000018]
ABCC9,ENSG00000069431,EFO_0003896,0.34075262601929507,2,left ventricular hypertrophy,[EFO_0002503],[EFO_0000651]
ABCC9,ENSG00000069431,EFO_0005571,0.37082205364072535,4,osteochondrodysplasia,[EFO_0005541],[OTAR_0000006]
ABCC9,ENSG00000069431,EFO_0000304,0.24153866632354165,3,breast adenocarcinoma,"[MONDO_0000653, EFO_0000228, EFO_0000305]","[OTAR_0000017, MONDO_0045024, EFO_0010285]"
ABCC9,ENSG00000069431,MONDO_0009406,0.7979574786365862,204,hypertrichotic osteochondrodysplasia Cantu type,"[EFO_0005571, MONDO_0018454, MONDO_0015160]","[OTAR_0000006, OTAR_0000018]"
ABCC9,ENSG00000069431,EFO_0000407,0.4220715615982375,30,dilated cardiomyopathy,[MONDO_0000591],"[OTAR_0000006, EFO_0000319]"
ABCC9,ENSG00000069431,EFO_0000537,0.5382760166105244,7,hypertension,[MONDO_0000473],[EFO_0000319]
ABCC9,ENSG00000069431,HP_0005280,0.3400134663099256,1,Depressed nasal bridge,[HP_0000366],[EFO_0000651]
ABCC9,ENSG00000069431,MONDO_0015470,0.6356770061128937,1039,familial isolated dilated cardiomyopathy,[MONDO_0016333],"[OTAR_0000006, OTAR_0000018, EFO_0000319]"
ABCC9,ENSG00000069431,MONDO_0003037,0.5041941837000672,4,hypotrichosis,"[EFO_0000508, MONDO_0002917]","[OTAR_0000018, EFO_0010285]"
ABCC9,ENSG00000069431,HP_0001382,0.3400134663099256,1,Joint hypermobility,[HP_0000924],[EFO_0000651]
ABCC9,ENSG00000069431,EFO_0004344,0.3604680918398702,3,birth weight,[EFO_0004338],[EFO_0001444]
ABCC9,ENSG00000069431,EFO_0004570,0.31561367390092915,1,bilirubin measurement,[EFO_0001444],[EFO_0001444]
ABCC9,ENSG00000069431,EFO_0000318,0.39294583354859836,78,cardiomyopathy,"[EFO_0003777, MONDO_0003939]","[OTAR_0000006, EFO_0000319]"
ABCC9,ENSG00000069431,EFO_1001103,0.3400134663099256,1,persistent fetal circulation syndrome,"[MONDO_0024239, EFO_0001361, EFO_0010238]","[OTAR_0000018, OTAR_0000014, OTAR_0000010, EFO_0000319]"
ABCC9,ENSG00000069431,HP_0001999,0.3400134663099256,1,Abnormal facial shape,[HP_0000271],[EFO_0000651]
ABCC9,ENSG00000069431,EFO_0005772,0.4492856050214515,4,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
ABCC9,ENSG00000069431,EFO_0005763,0.41861307879731297,3,pulse pressure measurement,[EFO_0005278],[EFO_0001444]
ABCC9,ENSG00000069431,EFO_0005678,0.27751095947500665,1,hippocampal sclerosis of aging,[MONDO_0044996],[EFO_0000618]
ABCC9,ENSG00000069431,MONDO_0019280,0.3726590108761454,12,hypertrichosis,[MONDO_0002917],[EFO_0010285]
ABCC9,ENSG00000069431,MONDO_0005180,0.37050380432141355,2,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
ABCC9,ENSG00000069431,EFO_0005423,0.2540709943666757,1,adolescent idiopathic scoliosis,[MONDO_0000726],[OTAR_0000006]
ABCC9,ENSG00000069431,EFO_1001450,0.29745819394225564,3,Wolff-Parkinson-White Syndrome,"[EFO_0000508, MONDO_0000992]","[OTAR_0000018, EFO_0000319]"
ABCC9,ENSG00000069431,EFO_0009142,0.5053375556620687,9,autosomal dominant dilated cardiomyopathy,[EFO_0000407],"[OTAR_0000006, EFO_0000319]"
ABCC9,ENSG00000069431,Orphanet_1517,0.814837314640917,151,"Hypertrichotic osteochondrodysplasia, Cantu type","[Orphanet_404584, Orphanet_183524, Orphanet_330197]","[OTAR_0000006, OTAR_0000018]"
ABCC9,ENSG00000069431,MONDO_0004975,0.37146625185965493,5,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
ABCC9,ENSG00000069431,MONDO_0004907,0.35822554026022174,5,alopecia,[MONDO_0019278],[EFO_0010285]
ABCC9,ENSG00000069431,EFO_0007937,0.25866137391945176,1,blood protein measurement,[EFO_0004747],[EFO_0001444]
ABCC9,ENSG00000069431,HP_0001182,0.3400134663099256,1,Tapered finger,[HP_0100807],[EFO_0000651]
ABCC9,ENSG00000069431,HP_0001176,0.3400134663099256,1,Large hands,[HP_0002817],[EFO_0000651]
ABCC9,ENSG00000069431,MONDO_0005301,0.37013422446672883,2,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
ABCD1,ENSG00000101986,EFO_0000508,0.5443351460304597,93,genetic disorder,[OTAR_0000018],[OTAR_0000018]
ABCD1,ENSG00000101986,MONDO_0019956,0.26609749537298527,1,encephalitis,[MONDO_0015144],[EFO_0000618]
ABCD1,ENSG00000101986,MONDO_0010248,0.4157773365202895,2,X-linked spondyloepimetaphyseal dysplasia,[MONDO_0016761],"[OTAR_0000006, OTAR_0000018]"
ABCD1,ENSG00000101986,MONDO_0010247,0.4430338508032862,3,X-linked cerebral adrenoleukodystrophy,[MONDO_0018544],"[MONDO_0002025, OTAR_0000020, EFO_0000618, OTAR_0000018, EFO_0001379]"
ABCD1,ENSG00000101986,MONDO_0015339,0.37441045829015074,11,adrenomyeloneuropathy,"[MONDO_0020127, MONDO_0018544]","[MONDO_0002025, OTAR_0000020, EFO_0000618, OTAR_0000018, EFO_0001379]"
ABCD1,ENSG00000101986,MONDO_0015129,0.4157773365202895,2,chronic primary adrenal insufficiency,"[EFO_0009491, MONDO_0015128]",[EFO_0001379]
ABCD1,ENSG00000101986,EFO_0009609,0.26609749537298527,1,myocarditis,"[MONDO_0024643, MONDO_0024636, MONDO_0000591]","[OTAR_0000006, EFO_0000319]"
ABCD1,ENSG00000101986,HP_0002313,0.5261379875719714,4,Spastic paraparesis,"[HP_0002385, HP_0002061]",[EFO_0000651]
ABCD1,ENSG00000101986,EFO_0005772,0.4421249318701333,9,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
ABCD1,ENSG00000101986,MONDO_0002320,0.26609749537298527,1,congenital nervous system disorder,[EFO_0000618],[EFO_0000618]
ABCD1,ENSG00000101986,Orphanet_43,0.7913670694741235,148,X-linked adrenoleukodystrophy,"[Orphanet_101960, Orphanet_181441, Orphanet_79188, Orphanet_183500, Orphanet_98543]","[OTAR_0000017, OTAR_0000018, OTAR_0000020, EFO_0001379, EFO_0000618]"
ABCD1,ENSG00000101986,GO_0007568,0.2961858725166837,1,aging,[GO_0032502],[GO_0008150]
ABCD1,ENSG00000101986,MONDO_0018309,0.3695798546847018,1,Hirschsprung disease,"[MONDO_0021189, EFO_0000508]","[OTAR_0000018, EFO_0010282]"
ABCD1,ENSG00000101986,MONDO_0019064,0.5261379875719714,4,hereditary spastic paraplegia,"[EFO_0009679, MONDO_0024237]","[OTAR_0000018, EFO_0000618]"
ABCD1,ENSG00000101986,MONDO_0018544,0.8673098785295963,1197,adrenoleukodystrophy,"[MONDO_0100372, MONDO_0015547, MONDO_0019046, EFO_0005539, MONDO_0000425]","[MONDO_0002025, OTAR_0000020, EFO_0000618, OTAR_0000018, EFO_0001379]"
ABCD1,ENSG00000101986,HP_0001258,0.26609749537298527,1,Spastic paraplegia,[HP_0002061],[EFO_0000651]
ABCD1,ENSG00000101986,HP_0001249,0.26609749537298527,1,Intellectual disability,"[HP_0012759, HP_0100543]",[EFO_0000651]
ABCD3,ENSG00000117528,Orphanet_79301,0.3695798546847018,1,Congenital bile acid synthesis defect type 1,[EFO_0009039],"[OTAR_0000018, OTAR_0000020, EFO_0001379, EFO_0010282]"
ABCD3,ENSG00000117528,EFO_0004980,0.24086285497084997,2,appendicular lean mass,"[EFO_0004516, EFO_0004302]",[EFO_0001444]
ABCD3,ENSG00000117528,MONDO_0014564,0.45392875693617907,6,congenital bile acid synthesis defect 5,"[MONDO_0100372, EFO_0009039]","[OTAR_0000020, EFO_0000618, OTAR_0000018, EFO_0001379, EFO_0010282]"
ABCD3,ENSG00000117528,EFO_0004309,0.3148611338036746,6,platelet count,"[EFO_0004586, EFO_0005036]",[EFO_0001444]
ABCD3,ENSG00000117528,EFO_0007984,0.2868673984951123,3,platelet component distribution width,[EFO_0005036],[EFO_0001444]
ABCD4,ENSG00000119688,Orphanet_79311,0.3695798546847018,1,Vitamin B12-responsive methylmalonic acidemia type cblB,"[Orphanet_98056, Orphanet_79171, Orphanet_293355]","[OTAR_0000018, OTAR_0000020, EFO_0009690]"
ABCD4,ENSG00000119688,Orphanet_79282,0.4707708188973731,6,"Methylmalonic acidemia with homocystinuria, type cblC","[Orphanet_207018, Orphanet_26, Orphanet_98713]","[OTAR_0000020, MONDO_0024458, EFO_0005803, OTAR_0000018]"
ABCD4,ENSG00000119688,MONDO_0010184,0.4707708188973731,6,methylmalonic aciduria and homocystinuria type cblC,"[MONDO_0020127, MONDO_0016826]","[OTAR_0000020, EFO_0000618, EFO_0005803, OTAR_0000018]"
ABCD4,ENSG00000119688,Orphanet_26,0.7305382326481755,15,Methylmalonic acidemia with homocystinuria,"[Orphanet_289899, Orphanet_98396, Orphanet_79171]","[OTAR_0000018, OTAR_0000020, EFO_0005803]"
ABCD4,ENSG00000119688,MONDO_0004737,0.3695798546847018,1,homocystinuria,"[MONDO_0019222, MONDO_0004736, MONDO_0037871]","[OTAR_0000018, OTAR_0000020]"
ABCD4,ENSG00000119688,MONDO_0013925,0.7669077059461593,246,"methylmalonic acidemia with homocystinuria, type cblJ",[MONDO_0016826],"[OTAR_0000018, OTAR_0000020, EFO_0005803]"
ABCE1,ENSG00000164163,EFO_0020092,0.3695798546847018,1,neuroinflammatory disorder,"[EFO_0009386, MONDO_0002977]","[EFO_0000540, EFO_0000618]"
ABCE1,ENSG00000164163,EFO_0007986,0.27351867970925703,8,reticulocyte count,[EFO_0010700],[EFO_0001444]
ABCE1,ENSG00000164163,EFO_0004339,0.20397850883216742,13,body height,[EFO_0004324],[EFO_0001444]
ABCE1,ENSG00000164163,EFO_0005772,0.28348111374097545,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
ABCF1,ENSG00000204574,NA,NA,NA,NA,NA,NA
ABCF2,ENSG00000033050,NA,NA,NA,NA,NA,NA
ABCF3,ENSG00000161204,NA,NA,NA,NA,NA,NA
ABCG1,ENSG00000160179,MONDO_0002561,0.3138709996502508,1,lysosomal storage disease,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
ABCG1,ENSG00000160179,EFO_0005772,0.39050619173226553,2,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
ABCG1,ENSG00000160179,MONDO_0005180,0.3138709996502508,1,Parkinson disease,"[EFO_0000508, MONDO_0021095]","[OTAR_0000018, EFO_0000618]"
ABCG1,ENSG00000160179,EFO_0004612,0.2139112807302935,2,high density lipoprotein cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
ABCG1,ENSG00000160179,EFO_0006798,0.28397419502876875,1,neuritic plaque measurement,[EFO_0006514],[EFO_0001444]
ABCG1,ENSG00000160179,MONDO_0004975,0.31948214106823414,16,Alzheimer disease,"[MONDO_0001627, EFO_0005815]","[MONDO_0002025, EFO_0000618]"
ABCG1,ENSG00000160179,MONDO_0005301,0.3144253694322778,2,multiple sclerosis,"[MONDO_0002562, EFO_1000870, EFO_0005774, EFO_0020092]","[EFO_0000540, EFO_0000618]"
ABCG2,ENSG00000118777,EFO_0020864,0.3426523536565869,1,cerebellar volume measurement,[EFO_0006930],[EFO_0001444]
ABCG2,ENSG00000118777,EFO_0005208,0.3322502366414068,1,glomerular filtration rate,[EFO_0004742],[EFO_0001444]
ABCG2,ENSG00000118777,EFO_0005856,0.3461528764305267,4,arthritis,"[EFO_0005755, MONDO_0002614, EFO_1000999]",[OTAR_0000006]
ABCG2,ENSG00000118777,EFO_0006337,0.4214468403292236,2,response to allopurinol,[GO_0009410],[GO_0008150]
ABCG2,ENSG00000118777,EFO_0004253,0.332881832617072,3,nephrolithiasis,"[MONDO_0024647, EFO_0003086]",[EFO_0009690]
ABCG2,ENSG00000118777,MONDO_0024647,0.461616357876792,4,urolithiasis,[EFO_0009690],[EFO_0009690]
ABCG2,ENSG00000118777,EFO_0005664,0.3302957694067677,5,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
ABCG2,ENSG00000118777,EFO_0005653,0.46688141309406134,5,serum metabolite measurement,[EFO_0004725],[EFO_0001444]
ABCG2,ENSG00000118777,EFO_0004761,0.549156017224901,22,uric acid measurement,"[EFO_0004742, EFO_0004298]",[EFO_0001444]
ABCG2,ENSG00000118777,EFO_0004747,0.31158365980708674,1,protein measurement,[EFO_0001444],[EFO_0001444]
ABCG2,ENSG00000118777,EFO_0004746,0.3427482224543415,1,lipoprotein-associated phospholipase A(2) measurement,"[EFO_0005278, EFO_0004732]",[EFO_0001444]
ABCG2,ENSG00000118777,EFO_0007986,0.427230805138418,2,reticulocyte count,[EFO_0010700],[EFO_0001444]
ABCG2,ENSG00000118777,EFO_0007010,0.520527231461747,7,drug use measurement,[EFO_0001444],[EFO_0001444]
ABCG2,ENSG00000118777,EFO_0006930,0.42498485190041924,3,brain volume measurement,"[EFO_0005052, EFO_0004464]",[EFO_0001444]
ABCG2,ENSG00000118777,EFO_0004339,0.3426523536565869,1,body height,[EFO_0004324],[EFO_0001444]
ABCG2,ENSG00000118777,EFO_0010091,0.42914855007383057,2,tea consumption measurement,[EFO_0010089],[EFO_0001444]
ABCG2,ENSG00000118777,EFO_0010089,0.318172084326299,1,bitter beverage consumption measurement,[EFO_0010088],[EFO_0001444]
ABCG2,ENSG00000118777,EFO_0004458,0.4285786627197155,2,C-reactive protein measurement,"[EFO_0004747, EFO_0004872]",[EFO_0001444]
ABCG2,ENSG00000118777,EFO_0004346,0.46345517597541114,3,neuroimaging measurement,[EFO_0001444],[EFO_0001444]
ABCG2,ENSG00000118777,EFO_0004340,0.5032806029733654,5,body mass index,[EFO_0004324],[EFO_0001444]
ABCG2,ENSG00000118777,EFO_0004541,0.4368873157228391,3,HbA1c measurement,"[EFO_0004468, EFO_0004509, EFO_0004555]",[EFO_0001444]
ABCG2,ENSG00000118777,EFO_1000999,0.34542503701296734,1,joint disease,[EFO_0002461],[OTAR_0000006]
ABCG2,ENSG00000118777,EFO_0005772,0.2619901837252071,9,neurodegenerative disease,[EFO_0009386],[EFO_0000618]
ABCG2,ENSG00000118777,GO_0036273,0.34231487434096214,1,response to statin,[GO_0050896],[GO_0008150]
ABCG2,ENSG00000118777,EFO_0000546,0.3447864505453894,3,injury,[OTAR_0000009],[OTAR_0000009]
ABCG2,ENSG00000118777,EFO_0004464,0.3423228487216577,1,brain measurement,[EFO_0001444],[EFO_0001444]
ABCG2,ENSG00000118777,EFO_0005134,0.32324765120360993,4,amino acid measurement,[EFO_0001444],[EFO_0001444]
ABCG2,ENSG00000118777,EFO_0007804,0.34231487434096214,1,LDL cholesterol change measurement,[EFO_0004611],[EFO_0001444]
ABCG2,ENSG00000118777,EFO_0004274,0.6946523596416122,283,gout,"[EFO_0005856, EFO_0000589]","[OTAR_0000006, OTAR_0000020]"
ABCG2,ENSG00000118777,EFO_0006782,0.3423228487216577,1,cups of coffee per day measurement,[EFO_0006781],[EFO_0001444]
ABCG2,ENSG00000118777,EFO_0006781,0.46566037126763254,3,coffee consumption measurement,[EFO_0010089],[EFO_0001444]
ABCG2,ENSG00000118777,EFO_0007629,0.3424835258840707,1,hemoglobin A1 measurement,[EFO_0004509],[EFO_0001444]
ABCG2,ENSG00000118777,EFO_0009676,0.3441396857996911,1,musculoskeletal system disease,[OTAR_0000006],[OTAR_0000006]
ABCG2,ENSG00000118777,EFO_0004531,0.7179176709444252,49,urate measurement,[EFO_0001444],[EFO_0001444]
ABCG4,ENSG00000172350,NA,NA,NA,NA,NA,NA
ABCG5,ENSG00000138075,EFO_0002571,0.5643105403692924,7,medical procedure,[],[EFO_0002571]
ABCG5,ENSG00000138075,HP_0001626,0.5103763509859628,206,Abnormality of the cardiovascular system,[HP_0000118],[EFO_0000651]
ABCG5,ENSG00000138075,EFO_0003832,0.27169749605527593,9,gallbladder disease,[EFO_0009534],[EFO_0010282]
ABCG5,ENSG00000138075,EFO_0000508,0.4920438525879332,29,genetic disorder,[OTAR_0000018],[OTAR_0000018]
ABCG5,ENSG00000138075,HP_0003124,0.4616014709709037,36,Hypercholesterolemia,[HP_0003119],[EFO_0000651]
ABCG5,ENSG00000138075,HP_0003119,0.25870589827929125,1,Abnormal circulating lipid concentration,[HP_0001939],[EFO_0000651]
ABCG5,ENSG00000138075,EFO_0001645,0.2847170921718802,24,coronary artery disease,"[MONDO_0000473, EFO_0003777]",[EFO_0000319]
ABCG5,ENSG00000138075,EFO_0004911,0.5461901092468925,4,familial hypercholesterolemia,"[MONDO_0001336, MONDO_0037748]","[OTAR_0000018, OTAR_0000020]"
ABCG5,ENSG00000138075,EFO_0000589,0.27541218698763836,4,metabolic disease,[OTAR_0000020],[OTAR_0000020]
ABCG5,ENSG00000138075,EFO_0005664,0.23845850071397656,1,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
ABCG5,ENSG00000138075,EFO_1000652,0.23179352379223755,2,acute pancreatitis,[EFO_0000278],"[EFO_0001379, EFO_0009605, EFO_0010282]"
ABCG5,ENSG00000138075,EFO_1001289,0.2790620894172599,2,"Cholecystitis, Acute","[EFO_0003832, EFO_1000025]","[EFO_0009690, EFO_0010282]"
ABCG5,ENSG00000138075,EFO_0004799,0.6567574136688527,32,cholelithiasis,"[MONDO_0700225, EFO_1000018]","[OTAR_0000018, EFO_0001379, EFO_0009690, EFO_0010282]"
ABCG5,ENSG00000138075,EFO_0004735,0.3499755174473131,8,serum alanine aminotransferase measurement,"[EFO_0004582, EFO_0004747]",[EFO_0001444]
ABCG5,ENSG00000138075,EFO_0004732,0.23845850071397656,1,lipoprotein measurement,"[EFO_0005105, EFO_0004747]",[EFO_0001444]
ABCG5,ENSG00000138075,Orphanet_309005,0.5058356285556074,4,Disorder of lipid metabolism,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
ABCG5,ENSG00000138075,EFO_0010282,0.20770125379229185,2,gastrointestinal disease,[],[EFO_0010282]
ABCG5,ENSG00000138075,EFO_0004458,0.20721946117850765,2,C-reactive protein measurement,"[EFO_0004747, EFO_0004872]",[EFO_0001444]
ABCG5,ENSG00000138075,EFO_0004574,0.6071817687186157,30,total cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
ABCG5,ENSG00000138075,EFO_0004570,0.25230291225569884,2,bilirubin measurement,[EFO_0001444],[EFO_0001444]
ABCG5,ENSG00000138075,EFO_0009605,0.2649788194624548,4,pancreas disease,"[EFO_0001379, EFO_0010282]",[EFO_0009605]
ABCG5,ENSG00000138075,EFO_0009534,0.24764958703526005,4,biliary tract disease,[EFO_0010284],[EFO_0010282]
ABCG5,ENSG00000138075,MONDO_0002245,0.3695798546847018,1,blood platelet disease,[EFO_0005803],[EFO_0005803]
ABCG5,ENSG00000138075,EFO_0003914,0.3747931249134533,37,atherosclerosis,"[EFO_0009086, MONDO_0002277]",[EFO_0000319]
ABCG5,ENSG00000138075,EFO_0004615,0.5531918067324636,11,apolipoprotein B measurement,[EFO_0004732],[EFO_0001444]
ABCG5,ENSG00000138075,EFO_0004611,0.611443966703675,52,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
ABCG5,ENSG00000138075,MONDO_0008863,0.7529888397185515,509,sitosterolemia,[MONDO_0015905],"[OTAR_0000018, OTAR_0000020]"
ABCG5,ENSG00000138075,EFO_0004210,0.2876090493784189,11,gallstones,[EFO_0003832],[EFO_0010282]
ABCG5,ENSG00000138075,HP_0001082,0.33681794195564113,3,Cholecystitis,[HP_0012438],[EFO_0000651]
ABCG8,ENSG00000143921,EFO_0002571,0.22895515367774494,1,medical procedure,[],[EFO_0002571]
ABCG8,ENSG00000143921,HP_0001626,0.5094195757106347,305,Abnormality of the cardiovascular system,[HP_0000118],[EFO_0000651]
ABCG8,ENSG00000143921,HP_0025031,0.2405639795330434,1,Abnormality of the digestive system,[HP_0000118],[EFO_0000651]
ABCG8,ENSG00000143921,MONDO_0021661,0.311519952876226,2,coronary atherosclerosis,"[EFO_0003914, EFO_0001645]",[EFO_0000319]
ABCG8,ENSG00000143921,MONDO_0021416,0.2843204417574235,1,polyp of gallbladder,"[EFO_0003832, EFO_0000662]","[MONDO_0045024, EFO_0010282]"
ABCG8,ENSG00000143921,EFO_1000790,0.3119026019918958,2,acalculous cholecystitis,"[MONDO_0004789, EFO_1000025, EFO_0003832]","[EFO_0001379, EFO_0009690, EFO_0010282]"
ABCG8,ENSG00000143921,EFO_0010934,0.24467792288227289,1,aspartate aminotransferase to alanine aminotransferase ratio,[EFO_0006845],[EFO_0001444]
ABCG8,ENSG00000143921,EFO_0005271,0.34247894942664114,2,sleep duration,[EFO_0004870],[EFO_0001444]
ABCG8,ENSG00000143921,EFO_0003940,0.23389129532830477,1,physical activity,[GO_0008150],[GO_0008150]
ABCG8,ENSG00000143921,EFO_0003832,0.36474135693931936,5,gallbladder disease,[EFO_0009534],[EFO_0010282]
ABCG8,ENSG00000143921,EFO_0000195,0.24530830446109017,3,metabolic syndrome,[EFO_0000589],[OTAR_0000020]
ABCG8,ENSG00000143921,EFO_0000278,0.23824645267923739,1,pancreatitis,[EFO_0009605],"[EFO_0001379, EFO_0009605, EFO_0010282]"
ABCG8,ENSG00000143921,EFO_0000508,0.4123484433922007,29,genetic disorder,[OTAR_0000018],[OTAR_0000018]
ABCG8,ENSG00000143921,MONDO_0021187,0.2367921117386193,3,hyperlipidemia,[EFO_0000589],[OTAR_0000020]
ABCG8,ENSG00000143921,HP_0003124,0.4844683656865461,25,Hypercholesterolemia,[HP_0003119],[EFO_0000651]
ABCG8,ENSG00000143921,HP_0003119,0.39729834378605444,2,Abnormal circulating lipid concentration,[HP_0001939],[EFO_0000651]
ABCG8,ENSG00000143921,EFO_0001645,0.38347416443023574,19,coronary artery disease,"[MONDO_0000473, EFO_0003777]",[EFO_0000319]
ABCG8,ENSG00000143921,EFO_0004911,0.553122692665805,4,familial hypercholesterolemia,"[MONDO_0001336, MONDO_0037748]","[OTAR_0000018, OTAR_0000020]"
ABCG8,ENSG00000143921,EFO_0005664,0.20117172844541326,1,blood metabolite measurement,[EFO_0004725],[EFO_0001444]
ABCG8,ENSG00000143921,EFO_1000652,0.29751768472375995,3,acute pancreatitis,[EFO_0000278],"[EFO_0001379, EFO_0009605, EFO_0010282]"
ABCG8,ENSG00000143921,EFO_1001289,0.2958257989217631,2,"Cholecystitis, Acute","[EFO_0003832, EFO_1000025]","[EFO_0009690, EFO_0010282]"
ABCG8,ENSG00000143921,EFO_0009048,0.3258245765016543,2,Intrahepatic cholestasis of pregnancy,"[Orphanet_101940, MONDO_0015509]","[OTAR_0000018, EFO_0001379, EFO_0010282]"
ABCG8,ENSG00000143921,EFO_0008589,0.24348645788591525,1,esterified cholesterol measurement,"[EFO_0004732, EFO_0004529]",[EFO_0001444]
ABCG8,ENSG00000143921,EFO_0004799,0.631940026369871,41,cholelithiasis,"[MONDO_0700225, EFO_1000018]","[OTAR_0000018, EFO_0001379, EFO_0009690, EFO_0010282]"
ABCG8,ENSG00000143921,EFO_0004736,0.34453252654348204,4,aspartate aminotransferase measurement,"[EFO_0004747, EFO_0004582]",[EFO_0001444]
ABCG8,ENSG00000143921,EFO_0004735,0.3738404841997176,8,serum alanine aminotransferase measurement,"[EFO_0004582, EFO_0004747]",[EFO_0001444]
ABCG8,ENSG00000143921,EFO_0004732,0.20117172844541326,1,lipoprotein measurement,"[EFO_0005105, EFO_0004747]",[EFO_0001444]
ABCG8,ENSG00000143921,EFO_0007010,0.24488838485234335,1,drug use measurement,[EFO_0001444],[EFO_0001444]
ABCG8,ENSG00000143921,EFO_0004329,0.3266487549361898,3,alcohol drinking,[EFO_0004315],[GO_0008150]
ABCG8,ENSG00000143921,EFO_0009932,0.2922298268445926,2,HMG CoA reductase inhibitor use measurement,[EFO_0007010],[EFO_0001444]
ABCG8,ENSG00000143921,EFO_0009925,0.30927466906521317,2,Antithrombotic agent use measurement,[EFO_0007010],[EFO_0001444]
ABCG8,ENSG00000143921,Orphanet_309005,0.5219311465451043,5,Disorder of lipid metabolism,[MONDO_0019052],"[OTAR_0000018, OTAR_0000020]"
ABCG8,ENSG00000143921,EFO_0010282,0.2861545658389123,2,gastrointestinal disease,[],[EFO_0010282]
ABCG8,ENSG00000143921,EFO_0004458,0.21894298828431347,1,C-reactive protein measurement,"[EFO_0004747, EFO_0004872]",[EFO_0001444]
ABCG8,ENSG00000143921,EFO_0004584,0.3518155949777077,5,mean platelet volume,"[EFO_0005036, EFO_0006846]",[EFO_0001444]
ABCG8,ENSG00000143921,EFO_0004574,0.4559622324681052,21,total cholesterol measurement,"[EFO_0004529, EFO_0004732]",[EFO_0001444]
ABCG8,ENSG00000143921,EFO_0004570,0.30560443832139966,2,bilirubin measurement,[EFO_0001444],[EFO_0001444]
ABCG8,ENSG00000143921,EFO_0000319,0.3323204133337443,11,cardiovascular disease,[],[EFO_0000319]
ABCG8,ENSG00000143921,EFO_0009605,0.2927243926484498,2,pancreas disease,"[EFO_0001379, EFO_0010282]",[EFO_0009605]
ABCG8,ENSG00000143921,EFO_0009534,0.27799165822735045,2,biliary tract disease,[EFO_0010284],[EFO_0010282]
ABCG8,ENSG00000143921,HP_0002027,0.22619440986373193,1,Abdominal pain,"[HP_0011458, HP_0025142, EFO_0003843]",[EFO_0000651]
ABCG8,ENSG00000143921,EFO_0004862,0.32834450283013134,2,phytosterol measurement,[EFO_0004529],[EFO_0001444]
ABCG8,ENSG00000143921,MONDO_0002245,0.3695798546847018,1,blood platelet disease,[EFO_0005803],[EFO_0005803]
ABCG8,ENSG00000143921,GO_0036273,0.22780089511507468,1,response to statin,[GO_0050896],[GO_0008150]
ABCG8,ENSG00000143921,EFO_0004526,0.20503311302482302,1,mean corpuscular volume,[EFO_0004306],[EFO_0001444]
ABCG8,ENSG00000143921,EFO_0003914,0.3728390626360228,25,atherosclerosis,"[EFO_0009086, MONDO_0002277]",[EFO_0000319]
ABCG8,ENSG00000143921,EFO_0004615,0.37942119213243575,5,apolipoprotein B measurement,[EFO_0004732],[EFO_0001444]
ABCG8,ENSG00000143921,EFO_0007878,0.3266487549361898,3,alcohol consumption measurement,[EFO_0001444],[EFO_0001444]
ABCG8,ENSG00000143921,EFO_0009150,0.2606596612013234,1,"cholestasis, intrahepatic, of pregnancy 3","[Orphanet_101940, MONDO_0015509]","[OTAR_0000018, EFO_0001379, EFO_0010282]"
ABCG8,ENSG00000143921,EFO_0004611,0.47868356818007907,48,low density lipoprotein cholesterol measurement,"[EFO_0004732, EFO_0005278, EFO_0004529]",[EFO_0001444]
ABCG8,ENSG00000143921,MONDO_0008863,0.7445395965411429,344,sitosterolemia,[MONDO_0015905],"[OTAR_0000018, OTAR_0000020]"
ABCG8,ENSG00000143921,EFO_0004210,0.4043518414346776,12,gallstones,[EFO_0003832],[EFO_0010282]
ABCG8,ENSG00000143921,HP_0001082,0.31560114352499635,4,Cholecystitis,[HP_0012438],[EFO_0000651]
ABCG8,ENSG00000143921,EFO_0004529,0.30575730631818676,2,lipid measurement,[EFO_0005105],[EFO_0001444]
